home0007 - COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci

COVID-19 Pandemic : Emails from 2021 FOIA request of Dr. Anthony Fauci

FULL PDF : [HG00D0][GDrive]

Part 1 / Part 2 / Part 3 / Part 4 / Part 5 / Part 6 / Part 7 / Part 8

From: Fauci, Anthony (NIH/NIAID) [E
Sent: Fri, 6 Mar 2020 03:49:45 +000
To: Haskins, Melinda (NIH/NIAID) [E
Cc: Selgrade, Sara (NIH/NIAID) [E);Crawford, Chase (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [E]
Subject: RE: Please review: House Oversight Letter on Coronavirus Diagnostics
I do not understand why you are asking me to "review" this. Is this an FYI??

From: Haskins, Melinda (NIH/NIAID) [El (b)( >
Sent: Thursday, March 5, 2020 9:53 AM ------~=
To: Fauci, Anthony (NIH/NIAID) [E;] .!::::======~=
Cc: Selgrade, Sara (NIH/NIAID) [E] ; Crawford, Chase (NIH/NIAID) [E] (b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b)(6) ---------
Subject: Please review: House Oversight Letter on Coronavirus Diagnost ics

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent : Fri, 6 Mar 2020 03:00:23 +0000
To: Muniz, Maria de Los Angeles
Cc: 'Birx, Deborah L'
Subject: RE: National Blood Supply
- Maria:
- Thanks for the note . I will bring this us in our discussions
- Best regards, Tony

From: Muniz, Maria de Los Angeles <MMuniz@vitalant.org>
Sent : Thursday, March 5, 2020 9:53 AM ------ ~=
To: Fauci, Anthony (NIH/NIAID) [E]=====~~
Cc: Fauci, Anthony (NIH/NIAID) [E) --------
Subject: National Blood Supply
- Dear Dr. Fauci: I am an ex-alumni from the Department of Transfusion Medicine at the NIH. I am sorry to bother but I wanted to not ify the Coronavirus Task force about potential blood shortages if blood centers get blood drive cancellations due to the fear in the public.
- We are starting to see this locally and my concern is that other blood centers in the country are facing the same issue.
- I tried to contact the office of the vice president, and all I could do was to send an email, which might get lost among thousands .
- I am hoping you see this and perhaps br ing this to the table. Blood centers use updated federal information when educating donors, staff and hospitals but the current fear is tr iggering blood drive cancellations. This might be experienced nationally and will impact the national blood invento ry.
- Thank you
- Maria De Los Angeles Muniz (Angie) , MD
- Medical Director
- [See full PDF for address/contact info in email footer]

From: Conrad, Patricia (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAIO) [El
Sent: Thu, 5 Mar 2020 21:27:53 +0000
To: NIAIDODAM
Subject: FW: 03 04 2020 Or. Anthony Fauci RE Invite to join my head table at Global's AcceptAbility Gala on Wed S/20
Attachments: 2020 03 GLOBAL AcceptAbility Gala Save the Date.pdf
Importance: High
- [See forwarded email]
- Patricia L. Conra / Public Health Ana lyst and Special Assistant to the Direc tor National Institute of Aller gy and Infectious Diseases
- The National Institutes of Health
- 31 Center Drive, MSC 2520 - Room 7 A03 / Bethesda, Maryland 20892
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]

From: Michelle Whitten - Global <mswhitten@gl obaldownsynd rome.org>
Sent: Wednesday, March 4, 2020 10:35 PM
To: Fauci, Anthony (NIH/NIAID) [E]------ -(-b=)(-=6)
Cc: Ashley Sparhawk <asparhawk@globaldownsyndrome .org>; Marisa Cucuzzella --------~ = <mcucuzzella@ajsfoundation .com>; Rotrosen, Daniel (NIH/NIA ID) [El (b)(6l; Deckhut, Alison (NIH/NIAID) [El CbH6)>R; othermel, Annette (NIH/N IAID) [El (b) (6) >
Subject: 03 04 2020 Dr. Anthony Fauci RE Invite to jo in my head table at Global's AcceptAbi lity Gala on Wed S/20
Importance: High
- Dear Dr. Fauci,
- First let me say we are very grateful to everyone at NIH for working to contain the coronavirus, especially your team at the NIAID. Your interviews are articulate and informative - they give Americans some comfort and some concrete ways to t hink about protecting themselves and what to expect. It must be a stressful time and we want you to know that we have confidence in our NIH and CDC to contain it and to help stave it off globally as well.
- On a happier note, I wanted to reach out and THANK YOU for all you do for our Down Syndrome research through the transformative trans-NIH INCLUDE program. It is making a HUGE difference!!
- To this end, I am writing today in hopes you will be able to join us on Wednesday, May 20th for our AcceptAbili ty Gala at my head table. Attached is our save the date for the event . We are excited to have Caroline Cardenas as our 2020 Ambassador, Rep Pete Stauber as our keynote (b)(6) •--• , and Reps Lucille Roybal-Allard and Jaime Herrera Beutler are Global's Quincy Jones Exceptional Advocacy Awardees. We believe the gala will be quite lovely and meaningfu l to so many.
- We do understand that attendance cannot be considered if the coronavirus situation worsens. However, if things are look ing much better (touch wood) we wou ld be deeply honored if you and our friends from NIAID could attend. Looking forward to hearing from you soon.
- All the Best, Michelle and family

From: Fauci, Anthony (NIH/NIAID) [E)
Sent: Thu, 5 Mar 2020 11:00:39 +0000
To: (b)(6)
Cc: Conrad, Patricia (NIH/NIAID) [E);Greg Folkers -_-_-_-_-_-_-_~_ = CbC)6);Marston, Hilary (NIH/NIAID) [E)
Subject: FW: New concerns for our randomized trial
- What do you think? I see the FDA Commissioner every day in person.

From: Kalil, Andre C (b)(6)>
Sent: Wednesday, March 4, 2020 11:27 PM
To: Seigel, John (NIH) (El (b)(6)•>; Davey, Richard (NIH/N IAID) [E] ~======(b~)(6~)>; Lane, Cliff (NIH/NIAID) [E] (b)(6); Marston, Hilary {NIH/NIAID) [E] (b)(6) >; Fauci, Anthony (NIH/NIAID) [E] (b)(6)>
Subject: New concerns for our randomized trial
I want to share with you my concerns before the situation gets worse.
I have received many calls from physicians from all over the country about how to get "compassionate use" remdesivir. (b)(4).(b)(5)
(b) (4). (b) (5)

I would appreciate hearing your thoughts on this critical issue.
Best, Andre
Andre Kalil, MD, MPH, FACP, FIDSA, FCCM
Professor, Department of Internal Medicine, Division of Infectious Diseases
[...]
University of Nebraska Med ical Center
[See full PDF for address/contact info in email footer]
[See full PDF for disclaimers in email footer]

From: Fauci, Anthony (NIH/NIAID) [E)
Sent: Thu, 5 Mar 2020 03:29:00 +0000
To: Dave Doern
Subject: RE: Go Tony
- Dave:
- Many thanks for your kind note. I hope that all is well with you.
- Best regards ,
- Tony
  - -----Original Message- ----
  - From: Dave Doern.=-------- (b =)~(=6)
  - Sent: Wednesday, March 4, 2020 12:l .9. -P'-.M;;..;.;....... ~~
  - To: Fauci, Anthony (NTH/NIA ID) [E] (b)(6) ; Fauci, Anthony (NIH/NIA ID) [E] (b)(6)>
  - Subject: Go Tony
    - Tony,
    - You always do the right thing ...... comforting for all your (b)(6) friends to see you up front in this serious coronavirus attack ....
    - We'll do the praying and you go Keep doing the liard work .....
    - Thanks, Dave
    - David Doem
    - Sent from my iPhone
    - (b)(6)

From: Fauci, Anthony (NIH/NIAID) [E)
Sent : Thu, 5 Mar 2020 03:19:47 +0000
To: (b)(6)
Cc: Greg Folkers ---------Cb)<)
Subject: RE: Conference Planning with respect to coronavirus.
- There is no way of knowing for sure. I would wait unti l May and see what the dynamics of the outbreak are globally and make your decision then whether or not to cancel.
  - From: (b)(6)
  - Sent: Wednesday, March 4, 2020 5:46 PM ------- ~=
  - To : Fauci, Anthony (NIH/NIAID) [E (b)(6)
  - Subject: Conference Planning wit h respect to coronavirus.
    - Dear Dr. Fauci
    - Dr. Miriam Kelty forme rly of NIH referred me to you . I am on the board of directors and planning committee of the Applied Superconductivity Conference that is planned to be held in Tampa, Florida the last week of July. Over 50% of our expected 1500 attendees are from outside the continental US. Our planning committee appears to have three options :
      1. Hold the conference on the original dates
      2. Postpone the conference a few months
      3. Cancel the conference
    - It would be most helpful to decision process if you can give us a prediction (anonymously of course) of how the effects of the virus will pan out.
    - I look forward to your reply .
    - Bruce Strauss
    - ScD, MBA, PE, F-IEEE

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent: Thu, 5 Mar 2020 02:59:22 +0000
To: Aliantha Angel
Subject: RE: A humble request for your wisdom
- <---- (b)(6)---->
  - From: Aliantha Angel (b)(6)
  - Sent: Wednesday, March 4, 2020 9:55 PM
  - To: Fauci,A nthony (NIH/NIAID) [E) ----- -(-b:=Ha=6)>
  - Subject: Re: A humble request for your wisdom
    - Oh my God ...
    - I honestly never expected you to reply and I thank you from the bottom of my heart for being so generous!
    - <---- (b)(6)---->
    - Is there anything I can do for you besides being grateful?
    - You and yours are in my prayers!
    - much love,
    - Aliantha
      - On Wed, Mar 4, 2020 at 9:45 PM Fauci, Anthony (NIH/N IAID) [E) -------- (b) ~ > wrote :
      - Dear Ms. Angel:
      - The severe complication of coronavirus are heavily skewed towards the elderly and those with underlying conditions (Heart disease, Chronic lung disease, kidney disease, diabetes, etc.) Most of the pneumon ias are pure viral pneumonia and so this vaccination will not help that. However, on the chance that you have a pure viral pneumonia that gets secondarily complicated by a bacterial pneumonia (pneumococcal) the vaccine would be beneficial. If you are 65 years of age or older, you should get the pneumonvax23 vaccine anyway regardless of the risk of coronavirus infection.
      - Thanks,
      - Tony
        From: Aliantha Angel (b)(6)
        Sent: Wednesday, March 4, 2020 8:44 PM
        To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)>
        Subject: A humble request for your wisdom
        Good evening!
        I know you must be completely busy and inundated with people want ing your time. I apologize that I have nothing to offer in return and completely understand if you don't have time to answer. I called the CDC but they were totally unhelpful. I have a question that makes sense to me and I was hoping you could answer and the answer might help a lot of people.
        I understand that over time I, and everyone else, will very likely get COVI0-19 and that most people won't even realize it because it will be minor. I get that, so th is is not a panicked question.
        I also understand that while most cases wil l not be severe, the bad cases are complicated by pneumonia .
        So my question is: If someone has been vaccinated against pneumonia, will that offer any protection in the event that they do contract COVID-19 and perhaps provide some barrier against the worst effects?
        Thank you for your time if you have read this and I apologize if this is just another in a long line of ignorant questions, but it made sense in my brain so I thought I would at least ask.
        Be well, be happy, and may life be kind and generous to you, those you love, and those who love you!
        sincerely, Aliantha Angel

From: Fauci, Anthony (NIH/NIAID) [El
Sent : Thu, 5 Mar 2020 02:50:29 +0000
To: Gordon, Joshua (NIH/NIMH) [E]
Subject : RE:Q uestion re: ------- (b)(6) coronavirus case
- Josh:
- You should counsel the rabbi to cancel the services this (b)(6) Are the local/city/state health departments (b)(6) doing any contact tracing?
- Tony
  - From: Gordon, Joshua (NIH/NIMH) [El -------- (b)(6)>
  - Sent : Wednesday, March 4, 2020 9:44 PM ------~=
  - To: Fauci, Anthony (NIH/NIAID) [E:] ;.::::=====(b)=(6) ~~
  - Cc: Tabak, Lawrence (NIH/OD) [E] ---------(b)(6)>; Collins, Francis (NIH/OD) [E] (b )(
  - Subject : Question re: ------- (b) (6) coronavirus case
    - Dear Tony,
    - I know you are swamped but --------------- (b)(6)
    - <---- (b)(6)---->
    - Is my reasoning sound? Should I counsel them to cancel services this Friday/Saturday? I'm hoping you can spare a bit of time for this advice, (b)(
    - Best, Josh
    - PS (b)(6) -----------------------------
    - PPS great job today in the hearing
    - Joshua A Gordon, MD, PhD
    - Director, National Institute of Mental Health

From: Fauci, Anthony (NIH/NIAID) [E)
Sent: Thu, 5 Mar 2020 02:47:27 +0000
To: Conrad, Patricia (NIH/NIAID) [El
Subject: FW: Or. Fauci for ABC News 20/20, Friday 9pm Ashton/ Muir
- Do you think that we can do this? I like Jennifer Ashton.
  - From: Strauss, Eric M.< Eric.M.St rauss@abc.com>
  - Sent: Wednesday, March 4, 2020 9:45 PM
  - To: Oplinger, Anne {NIH/NIAID) [E)-------=-c (b')"("=6' )>; Conrad, Patricia {NIH/NIAID) [E) (b)(6) ; Fauci, Anthony {NIH/NIAID) [El ======~ (b~)( ~6);----------
  - Subject: Dr. Fauci for ABC News 20/20, Friday 9pm Ashton/ Muir
    - Hello:
    - I wanted to make sure you are still considering our request for Dr. Ashton and David Muir to interview Dr. Fauci for our 2 hour program ABC News 20/20 Friday from 9pm to 11pm.
    - If a remot e interv iew from a studio -on-t he go mobile unit is prefer able we can certa inly arrange that .
    - Thank you for your consideration .
    - Eric M. Strauss, ABC News
    - Managing Editor, Medical Unit
    - www.ericmstrauss.com
    - [See full PDF for address/contact info in email footer]

From: Fauci, Anthony (NIH/NIAID) [E)
Sent: Thu, 5 Mar 2020 02:36:30 +0000
To: Rich Silverman
Subject: RE: Coronavirus Question
- Richard:
- Right!! Even if there was no coronavirus threat, ---------------- (b)(6)
- Best regards,
- Tony
  - From: Rich Silverman (b)(6)
  - Sent: Wednesday, March 4, 2020 8:56 PM --------=-:-:-=
  - To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)>
  - Subject: Coronavir us Question
    - Dear Dr. Fauci,
    - I apologize in advance for this email. I am sure you are too busy these days to answer coronavirus questions from the general public. However, you are the only individual I know of who can be trusted to speak intelligently about the pandemic.
    - I know there is no preventive vaccine or cure, and there probably won't be for quite some time- despite what our ersatz President says. But there is something I don't understand. Since the coronavirus causes pneumonia, wouldn't it be a good idea to vaccinate more of the general population with Pneumovax 23 or Prevnar 13? That certainly wouldn't prevent people from catching coronavirus, but perhaps the resulting penumonia onsets might be a little weaker/short-lived? (b)(6) I figured it couldn't hurt, right?
    - Bravo for your efforts to keep our population intelligen tly informed on this situation.
    - Sincerely, Richard E. Silverman
    - <---- (b)(6)---->

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent: Thu, 5 Mar 2020 00:10:39 +0000
To: Basser, Peter (NIH/NICHD) [E]
Subject: RE: genetic screening
- Peter:
- Thanks for the note. This would not be feasib le in an outbreak setting if you are talking about GWAS or any kind of sequencing. Things would be moving too quickly .
- Best, Tony
- Anthony S. Fauci, MD
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]

From: Basser, Peter (NIH/NICHD) [E] --------- (b)(6)
Sent: Wednesday, March 4, 2020 6:59 PM ------~~
To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)
Subject ; genetic screening
- Dear Dr. Fauci,
- I watched you and Dr. Collins (via videocast) with admiration and pride yesterday during President Trump's visit to the NIH.
- This morning, (b)(6) and I were discussing the spread of COVID-19. We were opining about why some people only have mild symptoms while others go on to develop ARDS. While we understand that age is a factor, we wondered <---- (b)(6)---->

- - - <---- (b)(6)---->

- - - Regards,
    - Peter J. Basser, Ph.D.
    - Senior Investigator, Intramural Research Program (IRP), NIH
    - Head , Section on Quantitative lm aging and Tissue Sciences (SQ ITS)
    - Associate Scientific Director (ASD), Division oflmaging, Behavior and Genomic Integrity (DIBGI)
    - Eunice Kennedy Shriver National Institute of Child Health and Human Development (N1CHD)
    - National Institut es of Health (NIH)
    - [See full PDF for address/contact info in email footer]
    - [See full PDF for disclaimers in email footer]

From: (b)(6)
Sent: Wed, 4 Mar 2020 18:25:52 -0500
To: Marc Reinoso
Subject : Re: Coronavirus Covid 19 and smoking
- Smoking is terr ible under any circumstance
  - On Mar 4, 2020, at 6:04 PM, Marc Reinoso -------- (b) (6) > wrote: >
  - Hello Dr. Fauci ,

Inu my review of data it appears there is a negative associat ion with smoki ng . ShouId smoking cessation be mentioned during public announcement s to help discourage smoking ?

- - Thank you,
  - Marc Reinoso MD

From: Conrad, Patricia (NIH/NIAID) [El on behalf of Fauci, Anthony (NIH/NIAIO) [El
Sent: Wed, 4 Mar 2020 21:27:42 +0000
To: NIAIDODAM
Subject: FW: Meeting to Assess Evaluation of COVID-19 vaccine candidates for risk of enhanced disease
Attachments: March 12th-Tentative list of questions to be discussed_JPCm g-sb[16212lversion4March-1239-CLEAN.docx, Draft agenda.Ace Assess ED.4Mar20201l_w ith annexes.pdf
- Patricia L. Conrad
- Public Health Ana lyst and
- Special Assistant to the Director
- National Inst itute of Allergy and Infectious Diseases
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]
  - From: Steve Black (b)(6) ---------
  - Sent: Wednesday, March 4, 2020 4:26 PM ------~~
  - To: Fauci, Anthony (NIH/NIAID) [E]- ------- (b)(6)>
  - Cc: Robert Chen <robert.chen@cepi.net>
  - Subject: Meeting to Assess Evaluation of COVI0-19 vaccine candidates for risk of enhanced disease
    - Dear Doctor Fauci,
    - I am writing to you as a member of the SPEAC project which CEPI has funded to assist with the evaluation of the safety of vaccines in their portfolio. As part of this effort, we are assisting with developing preclinical and clinical test ing criteria to evaluate the risk of enhanced disease following vaccination with COVID-19 vaccine cand idat es. As you know, this had been an issue with some prior SARS vaccine candidates.
    - We are convening a two day virtual meeting of experts via video conference next week on March 12 and 13 between 8 am and 1 pm Eastern tim e each day. Participants in the meet ing are shown in the attached agenda but include Paul Henri Lambert from Geneva and Barney Graham from NIH. The meeting will actively invo lve the partic ipants on the agenda the first day and on the second day the meeting will be open for several peer reviewers including Stanley Plotkin and Andy Pollard to review and comment on possible small and NHP animal models as well as appropriate immunologic testing to be done in early phase one trials.
    - I am wanted to make you aware of the meeting so that you could attend all or part as an observer if you wish but also to invit e you to consider joining on day two as one of our formal peer reviewers. The goal of the meeting would be to share recommendations with CEPI COVID-19 developers as well as other interested parties.
    - Any comments you have on the agenda or draft questions for consideration would be greatly appreciated.
    - I look forward to hearing back from you.
    - ATTACHMENTS: DRAFT AGENDA; DRAFT QUESTIONS FOR CONSIDERATION
    - Steve
    - Steven Black MD / SPEAC Project work package lead for CEPI

From: Conrad, Patricia (NIH/NIAID) [E) on behalf of Fauci, Anthony (NIH/NIAID) [E)
Sent : Wed, 4 Mar 2020 21:16:44 +0000
To: NIAIDODAM
Subject: FW: TIME 100 Summit
- Patricia L. Conrad
- Public Health Analyst and
- Special Assistant to the Director
- National Institute of Allergy and Infectious Diseases
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]
  - From: Alice Park <alice.park@time.com>
  - Sent : Monday, March 2, 2020 6:19 PM
  - To: Faud, Anthony (NIH/NIAID) [E] ______ Cb _H_6)
  - Subject : TIME 100 Summit
    - Hi Dr. Fauci -- as we discussed, sending along an invitation for you to partic ipate in our TIME 100 Summit, which will be held in New York on April 21-22 . We would welcome your insights on a panel addressing COVID-19, like ly moderated by me.
    - I certa inly hope you wi ll be able to join us; please let me know eithe r way. Looking forward to hear ing from you. Best, Alice
    - Alice Park
    - TIME
    - (b)(6)
    - alice.park@time.com
    - @aliceparkny

From: (b)(6)
Sent : Wed, 4 Mar 2020 09:46:55 -0500
To: Michael Gerson
Subject: Re: Coronavirus Live Updates: Fatality Rate of Covid-19 Is Higher Than the Flu - The New York Times
- Talk later. Am in Hearing
  - > On Mar 4, 2020, at 8: LOA M, Michael Gerson- ---------(b) (6)> wrote: >
    - Can this be true?
    - https://www.nytimes.com/2020/03/04/worlcVcoronavirus -news.html

From: Fauci, Anthony (NIH/NIAIO) [E)

Sent: Wed, 4 Mar 2020 11:21:47 +0000
To: Emanuel, Ezekiel J
Subject: RE: RE:
- No evidence in this regard, but you would assume that their would be substantial immunity post infection. It is an RNA virus and so you can expect mutations, but not sure how much is going on. Will have to check.
  - From: Emanuel, Ezekiel J (b)(6)
  - Sent: Wednesday, March 4, 2020 5-:5-8 -A-M- - -:-::~
  - To: Fauci, Anthony (NIH/NIAID) (E] (b)(6)
  - Subject: Re: RE:
    - Sorry the phone. Is a person likely to be immune once they caught the corocnavirus once? Do we know anything about likely drift?
    - Ezekiel J. Emanuel, M.D. , Ph.D.
    - Vice Provost of Global Initiatives
    - Chair, Department of Medical Ethics and Health Policy (on Leave 2019-2020)
    - Levy University Professor
    - Co-Director , Healthcare Transformation Institute
    - Perelman School of Medicine and The Whalton School
    - University of Pennsylvania
      - From: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)>
      - Sent : Tuesday, March 3, 2020 10:57 PM
      - To: Emanuel, Ezekiel J --------- (b)(6)
      - Subject: RE:
        Thanks for the note. I do not understand your question , See spelling below
        -----Original Message------------~~
        From: Emanuel, Ezekiel J- --------(b)(6)
        Sent: Tuesday, March 3, 2020 9:59 AM
        To: Fauci, Anthony (NIH/NIAID) [E] -------=- (be)-( = >
        Subject:
        Tony
        Hope they are greatng you better about media appearances after my call with trump. You were great at then press conference yesterday
        Question:. Lilelynimmunitynince a person has the Coronavirus infection? Ari is pestering me
        Ezekiel J. Emanuel, M.D. Ph.D.
        (b)(6)

From: (b)(6)
Sent: Wed, 4 Mar 2020 06:19:58 -0500
To: NIAID Public Inquiries
Subject: Fwd: (b)(6) -------------
- Sent from my iPhone
- Begin forwarded message:
  - From: Patti Taylor (b) C
  - Date: March 4, 2020 at 12:30 :52 AM ES-T- -----~~
  - To: "Fauci, Anthony (NIH/NlAID ) [E]" (b)(6 J:-
  - Subject: (b) (6)
    - Dr Fauci
    - My name is Patti Taylor and I'm a nurse. Been one for 30 years . <----- (b)(6) ---> . Sounds too simple. Anyway I was thinking of the Coronavirus and maybe it has some thing like an autoinunune part to it that makes a person unable to fight back. ....
    - Just a thought. I think a lot.
    - Sent from my iPhone

From: (b)(6)
Sent : Wed, 4 Mar 2020 06:19:08 -0500
To: Cassetti, Cristina (NIH/NIA ID) [E]
Subject: Fwd: ------------------------ (b)(4)
- Attachments : PastedGraphic-1.tiff, ATT0000l.htm, (b)(4)Executive Summary.pdf, ___ _. ATT00002.htm
- Pls respond
- Sent from my iPhone
  - Begin forwarded message:
  - From: "Gupta, Sanchay" ------------- (b)(6) Date: March 4, 2020 at l :40:30 AM EST -------= = To: "Fauci , Anthony (NIH/NIAID) [E]" (bH6J
  - Cc: Shaheer Piracha --- Subject: Meeting Request -
    - Hi Dr. Fauci,
    - <---- (b)(6)---->
    - Thank you in advance for your time.
    - Very Best,
    - Sanchay Gupta
    - (b) (4)
    - Cell (b)( 6J

From: (b)(6)
Sent: Wed, 4 Mar 2020 06:17:35 -0500
To: Conrad, Patricia (NIH/NIAID) [E)
Subject: Fwd: Press inquiry_Russia
- Sent from my iPhone
- Begin forwarded message:
  - From: Banepm1 Ilonoaa --------------- (b) (6)
  - Date: March 4, 2020 at 5: 13:38 AM EST
  - To: "Fauci, Anthony (NIH/NlAID) (E]" -------- (b)(
  - Subject: Press inquiry_Russia
    - Dear Dr Anthony S Fauci ,
    - My name is Valeria Popova , I am the senior editor of Channel One (Russia). We would like to invite you to take part in the popular international Russian-American projec t on Channe l One. The big game is a television program, within the framework of which two points of view on international eve nts are presented : American and Russian.
    - One of the presenters of the program is Dmitry Simes, chairman of the Nixon Center, a US citizen. He was foreign policy adviser to former US President Richard Nixon.
    - Only high-ranking officia ls part icipate in this discussion : presidents, diplomats, heads of ministries.
    - This is an honest and reasona ble discussion. It would be a great honor for us if you joined her and discass with our experts about situation with coronavirus. We work live and can use teleconference or skype for communication.
    - Hope to cooperate!
    - Channel One is the broadcasting leader in the Russian Federation. 250 million viewers in Russia and abroad. Today, Channel One programs have the opportunity to watch 98.8% of Russians and more than 250 million people in the world.
    - Channel One is the recognized leader of the Russian telev ision, the most popular and favorite Russian-language channel in the world. It started broadcasting in April 1995 and became the successor to the state television and radio company Ostankino , which was the main broadcaster in the USSR and covered 99.8% of the population of Russia. Channel One' s daily programs: the best entertainment shows, unique documentaries , latest news and analytics , the most headline movies and TV premieres , exclusive sports broadcasts and popular Russian music. Channe l One combines innovative television broadcasting concepts, the vastest national traditions and cutting-ed ge global trends in a unique format.
    - Hope to cooperate!
    - Sincerely ,
    - Valeria Popova
    - <---- (b)(6)---->

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent : Wed, 4 Mar 2020 03:09:35 +0000
To: Conrad, Patricia (NIH/NIAID) [El
Cc: Routh, Jennifer {NIH/NIAID) [El ;Folkers, Greg (NIH/NIAID) [E]
Subject: RE: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
- Let us discuss the feasibility, desirability and potential for clearance or not.
  - From: Conrad, Patricia (NIH/NIAID) [E] --------- (b)(6)]
  - Sent: Tuesday, March 3, 2020 8:06 PM ------~~
  - To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>
  - Cc: Routh, Jennifer {NIH/NIAID) [El======= (~b~~(6=)>; Folkers, Greg {NIH/NIAID) [El (b)(6)>
  - Subject: FW: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
    - Is this what you are talking about? Seriously recommend from wdc but again - this is really late - 10 pm to midnight .
      - From: Johnson, Christie <Christ ie.Johnson@turne r.com>
      - Sent : Tuesday, March 3, 2020 6:45 PM -------~~ To: Conrad, Patricia {NIH/NIA ID) [E) (b)(6)
      - Subject: Re: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
        Just making sure you received
        Christie Johnson
        CNN Worldwide / Senior Editorial Producer
        [See full PDF for address/contact info in email footer]
        From: Johnson, Christie
        Se nt: Tuesday, March 3, 2020 11:16:51 AM -------~~
        To: Conrad, Patricia {NIH/NIA ID) [E) (b)(6)
        Subject: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
        As promised, here is the big ticket item I wanted to flag for you. I was waiting to get through yesterday's hits to loop you in as to not overwhelm you. I have been speak ing with the WH and VP's office to see if Dr. Fauci is availab le to join CNN this Thursday for our global town hall but wanted to make sure you have the info. Would you mind checking to see if he's avail?
        Info :
        We are reaching out to invite Dr. Fauci to join Anderson Coope r and Dr. Sanjay Gupta as our featured guest on the upcom ing CNN specia l town hall - Coronavirus: Facts and Fears .
        THE LATEST :
        This Global Town Hall program will broadcast in front of a live audience from 10pm - Midnight EST on Thursday March 5 from the CNN studios in New York City. We would cover all expenses for someone from the task force to join us live in NY. If Dr. Fauci is unable to come to NY, we will take him remote ly from DC.
        Coronavirus: Facts and Fears will feature interviews with a wide range of front-line experts fighting to contain coronavirus , along with patien ts and others who have been directly impacted by it 's spread. We 're really hoping to includ e a voice from the administration in order to comfort and inform our worldwide audience.
        Thoughts?
        Thank you!
        Christie Johnson
        CNN Worldwide / Senior Editorial Producer
        [See full PDF for address/contact info in email footer]

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent: Wed, 4 Mar 2020 03:08:49 +0000
To: Conrad, Patricia (NIH/NIAID) [E)
Subject: RE: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
- No. This is not what I was talking about. I received a text from Governor Cuomo of NY State and he wants me to come up to NYC for a Press Conference with his Health Commissioner, Howard Zuycker.
  - From: Conrad, Patricia (NIH/NIAID) [E] --------- (b)(6)]
  - Sent: Tuesday, March 3, 2020 8:06 PM ------~~
  - To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>
  - Cc: Routh, Jennifer {NIH/NIAID) [El======= (~b~~(6=)>; Folkers, Greg {NIH/NIAID) [El (b)(6)>
  - Subject: FW: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
    - Is this what you are talking about? Seriously recommend from wdc but again - this is really late - 10 pm to midnight .
      - From: Johnson, Christie <Christ ie.Johnson@turne r.com>
      - Sent : Tuesday, March 3, 2020 6:45 PM -------~~ To: Conrad, Patricia {NIH/NIA ID) [E) (b)(6)
      - Subject: Re: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
        Just making sure you received
        Christie Johnson
        CNN Worldwide / Senior Editorial Producer
        [See full PDF for address/contact info in email footer]
        From: Johnson, Christie
        Se nt: Tuesday, March 3, 2020 11:16:51 AM -------~~
        To: Conrad, Patricia {NIH/NIA ID) [E) (b)(6)
        Subject: CNN Global Coronavirus Town Hall/ Thursday/ Dr. Fauci
        As promised, here is the big ticket item I wanted to flag for you. I was waiting to get through yesterday's hits to loop you in as to not overwhelm you. I have been speak ing with the WH and VP's office to see if Dr. Fauci is availab le to join CNN this Thursday for our global town hall but wanted to make sure you have the info. Would you mind checking to see if he's avail?
        Info :
        We are reaching out to invite Dr. Fauci to join Anderson Coope r and Dr. Sanjay Gupta as our featured guest on the upcom ing CNN specia l town hall - Coronavirus: Facts and Fears .
        THE LATEST :
        This Global Town Hall program will broadcast in front of a live audience from 10pm - Midnight EST on Thursday March 5 from the CNN studios in New York City. We would cover all expenses for someone from the task force to join us live in NY. If Dr. Fauci is unable to come to NY, we will take him remote ly from DC.
        Coronavirus: Facts and Fears will feature interviews with a wide range of front-line experts fighting to contain coronavirus , along with patien ts and others who have been directly impacted by it 's spread. We 're really hoping to includ e a voice from the administration in order to comfort and inform our worldwide audience.
        Thoughts?
        Thank you!
        Christie Johnson
        CNN Worldwide / Senior Editorial Producer
        [See full PDF for address/contact info in email footer]

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent : Wed, 4 Mar 2020 02 :55:36 +0000
To: Cassetti, Cristina (NIH/NIAID) [E]
Subject: FW: Covid-19 Vaccine
Attachments: Press Release Preview - EIN Presswire - Press Release Distribution Service.pdf
- Please take a look at this and act accordingly
  - From: KUMAR SHAH, MD (b)(6)>
  - Sent : Tuesday, March 3, 2020 9:48 PM
  - To: Fauci, Anthony (NIH/NIAID) [E)_ _____ "("b"")"("=6")
  - Subject: Re: Covid-19 Vaccine
    - Dear <Dr. Anthony Fauci>,
    - Humbly, Endocrine Technology, LLC is pleased to forward the enclosed press release for your comments and advice.
    - Best,
    - Kuma r Shah, M.D.
    - Diplomate American Board of Internal Medicine
    - Endocrinology, Diabetes & Metabolism
    - 326 Livingston St, Suite A / Brooklyn, N. Y 11217
    - [See full PDF for address/contact info in email footer]
    - www .etdiabetes .com

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent: Wed, 4 Mar 2020 02:27:43 +0000
To: Siegel, Marc
Subject: RE: Dr. Marc Siegel: Coronavirus public health response has been handled well; we have right leaders at helm I Fox News
- Thanks, Marc
  - -----Original Message-----
  - From: Siegel, Marc <Marc.Siegel@nyulangone.org>
  - Sent: Tuesday, March 3, 2020 9:23 PM- -----. ~=
  - To: Fauci, Anthony (NTH/NlAID) [E] (b)(6) >
  - Subject: Dr. Marc Siegel: Coronavirus public health response has been handled well; we have right leaders at helm I Fox News
    - https ://www.fox.news.com/opinion/dr-marc-siegel-coronavirus-public-heaIth-response-has-been-handled-well-we-have-right-leaders-at-helm
    - Sent from my iPhone

From : Fauci, Anthony (NIH/NIAIO) [E)
Sent : Tue, 3 Mar 2020 22:52:20 +0000
To: Conrad, Patricia (NIH/NIAID) [E)
Subject : FW: COVID-19 Webinar
- Anthony S. Fauci , MD
- Director / National Institute of Allergy and Infectious Diseases
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]
  - From: Donna Prosser <donna .prosser@patientsafetymovement .org>
  - Sent : Tuesday, March 3, 2020 5:37 -P-M-- ---~~
  - To: Fauci, Anthony (NIH/NIAID) [E) Cb)( ; Mike Ramsay <michael.ramsay@bswhealth .org>; David 8. Mayer <david .mayer@patientsafetymovemen t .org>
  - Subject: COVID-19 Webinar
    - Hello, Dr. Fauci,
    - My name is Donna Prosser, and I am the Chief Clinical Officer at the Patient Safety Movement Foundation. We are planning to host a webinar on Friday, March 6 at 8:00am PST to update our network on the coronavirus outbreak . Our network consists of 4,710 healthcare organizations across 46 countries, as well as patients, families, individual clinicians, and technology companies across the globe, who partner with us to achieve our goal of eliminating deaths from medical error.
    - During Friday's webinar, we plan to focus on how to keep patients safe from harm during this outbreak, and would love to have someone with your expertise join the call for a brief comment. Would you by any chance be available and will ing to speak with our network sometime between 8-9am PST? We would be grat eful for any amount of time that you could spare during that hour.
    - Thank you for your consideration!
    - Donna
    - Donna M. Prosser, DNP, RN, NE-BC, FACHE, BCPA
    - Chief Clinical Officer
    - Patient Safety Movement Foundation
    - [See full PDF for address/contact info in email footer]
    - w: patientsafetymovement.org

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent : Tue, 3 Mar 2020 22:51:35 +0000
To: Bob lsman
Subject: RE: How to put COVID-19 statistics in perspective
- Thank you for your note.
- AS Fauci
- Anthony S. Fauci, MD
- Director / National Institute of Allergy and Infectious Diseases
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]
  - From: Bob lsman CbH6>t>
  - Sent : Tuesday, March 3, 2020 5 :12 PM _
  - T_o_: Fauc_i,; _A_ n_t hon_y, :_(N,;_IH_/_N_:I.A. ID). :,[_E,]:- _.-..:-..!-::-:=-~~--:----~-=--(-b)(c6) -R=edf ield, Robert R. (CDC/OD) (b) (6); briefing@nytimes .com ----------------
  - Subject : How to put COVID-19 stat istics in perspective
    - Today (March 3), CNN featured a discussion with NY Gov. Cuomo regard ing a new COVID-19 case in NY City. He happened to note that there are currently about 15,000 patients in NY hospitals with the flu.
    - Although multiple government agencies, scientists and health experts keep remind ing us that there are far more cases, hospitalizations and deaths each year from influenza than this coronavirus, it strikes me that a more effective, more visual and less fear-producing way of presenting this information would be to present the current number of cases, hospitalizations and deaths from EACH of these diseases side by side. If the number of flu cases, hospitalizations and/or deaths isn't available on a daily basis, we could use extrapolations based on known rates. I think this would certainly go a long way to putting the relative risks of these diseases in clearer focus.
    - Bob lsman, DDS, MPH

From: Fauci, Anthony (NIH/NIAIO) [E)
Sent : Tue, 3 Mar 2020 22:50:50 +0000
To: Jlevyusa
Subject: RE: Idea to help with Coronavirus infection
- Thank you for your note.
- AS Fauci
- Anthony S. Fauci, MD
- Director / National Institute of Allergy and Infectious Diseases
- [See full PDF for address/contact info in email footer]
- [See full PDF for disclaimers in email footer]
  - From: Jlevyusa (b)(6)>
  - Sent : Tuesday, March 3, 2020 4 :17 PM
  - To: Fauci, Anthony (NIH/NIAID) [E]-- -----------=--c-c(b=)(6) >
  - Subject: Idea to help with Coronavirus infection
    - Dr. Fauci,
    - I first want to thank you for your service and efforts in combating this international health problem.
    - I'm neither a physician or a scientist so please accept my apology if my idea is simplistic or isn't feasible. But I was thinking about some of the information presented on why it seems to be less prevalent in children. One theory is that they are exposed to so many other coronavirus's that they experience cross-protection. So I was wondering if anyone had investigated the idea to flood adults with other, less lethal, coronavirus's as a way to develop some level of immunity? Ideally coronavirus's that are a match to what children would be exposed to is what I'm suggesting here. I wou ldn't expect that this wi ll totally protect an adult but it might reduce the severity of the illness if an adult becomes ill and help while a vaccine and treatments are launched.
    - Thank you for considering this idea.
    - Best, Jeff
    - Jeffrey Levy

From:Sent :To:Subject:Attachment s:Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 22:50:07 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: my feeble attemptCOVID-19.docxNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mai (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Tai Te Wu (b)(6)Sent : Tuesday, March 3, 2020 2:11 PM -------~= To: Fauci, Anthony (NIH/NIAID) [E)- -------- (b)(6) Subject: my feeble attemp tDear Dr. Fauci,I have seen you on the television commenting about COVID-19.Therefore, I have decided to squeeze some information out of their nucleotide and amino acidsequences as enclosed. Hope that you may soon find a cure with all the available data on thisvirus.Best regards.Tai Te WuNIH-001003From:Sent :To:(b)(6)Tue, 3 Mar 2020 13:36 :59 -0500Barasch, Kimberly (NIH/NIAID) [C]Subject : Fwd: Informal coro navirus teleconference: agenda+ background documen tsAttachment s: imageOOl.png , ATT00001.htm, 01 March_Chapeau_Crit ical preparednessreadiness and response actions for COVID 19_DRAFT.pdf, ATT00002.htm , 01 March_COVID 2019response scenarios _DRAFT.pdf, ATT00003.htm , 01 March _Preparing for Widespread Commu nityTransmission _DRAFT.pdf, ATT00004.htm, 18624 Swisscom Call code.docx, ATTOOOOS.htmFor the7 am folder plsSent from my iPh oneBegin forwarded message:From: "KABIR, Sophia" (bH6>lDate: March 3, 2020 at 1 :35:53 PM ESTTo: SHOC <shoc@who.int>, Office of the Director-General <DGOffice@who.int>,"Redfield, Robert R. (CDC/OD)" (b)(6)(b)(6) "Felicity Harvey, Jeremy Farrar(b)(6)(b)(6) "Chris.Elias"(b)(6)(b)( >'"GREIN, Thomas" (bH , "COX, Paul Michael" .------- '"SCHWARTLANDER, Bernhard F." (b)(6) , "MINHAS,Raman" (b)(6)R. Frieden" -=============-::c:;------------ L y nn Banks '---:-----:-:---~-====£:....--(b~)(6) , President~ I Resolve to Save Lives <president@resolvetosavelives.org>, (b) (6), Robynn Leidig------- (bH6,) "Dr VAN KERK.HOVE, Maria"NIH-001004(b)(6)"GRAAFF, Peter Jan"Cb()6 ), "POOLE, Marcia""(SPmig) Carlos Navarro Colorado"(b)(6,) .Tarik Mohammed(b)(6)(b)(6)Ryan MorhardCbC>6 ,l "BRIAND, Sylvie" _______ CHb_6).-----CbH6")H arries, Jenny" (b)(6)nAwwad, David (NIH/NIAID) [C]""MORGAN, Oliver"________ C>b<6,> , "SIMONSON, Stewart" CbH,6 )"SINGER, Peter Alexander" (b)(6) -...., "(SPmig) Carlos NavarroColorado" ______ (b)(6)Cc: "RY AN, Michael J." ____ CbH,_ __"""""' = , Christine Youssef'------- CbH6"),B OKO, Ivana" ------- Subject: Informal coronavirus teleconference: agenda+ backgrounddocumentsDear colleagues,On behalf of Mike Ryan, allow me to share with you the following background documentsahead of the informal coronavirus te leconferenc e tomorrow at 13.00 CET:(b) (4)Please find below, the key questions for your consideration and input tomorrow. We donot expect you all to address/speak on all the questions but just as a guide to your thinkingand the ones you have views/advice/ideas.NIH-001005(b) (4)(b) (4)The dial-in number and passcode are attached.If you exper ience any technical difficulties joining this conference call, please contact theWHO HQ EOC operator at: +41 227 912 490Best,Sophia-----Ori ginal Appointment---- From:RYAN, Michael J.Sent: Tuesday, February 25, 2020 10:07 AMTo: RYAN, Michael J.; SHOC; Office of the Director -General;Farrar;GREIN,Thomas; COX, Paul Michael; SCHWARTLANDER, Bernhard F.; MINHAS, Raman;----------------- (b)(6) MAHJOUR, Jaouad; FALL, lbrahima Soce; Thom as R. Frieden; Elhadj SY; Lynn Banks; President I Resolve to Save Lives;(b)(6) AL-SHORBAJI, Farah; ========~~-:-~--:--:""'.":"'"---:--:--:~ (b)(6); Robynn Leidig; DRURY, Patrick Anthony; Dr VAN KERKHOVE,(b)(6)Cheryl Cohen; GRAAFF, Peter Jan; POOLE, Marcia; Tarik Mohammed ;__________________________ Cb _><6J RyanMorhard; BRIAND, Sylvie; MORGAN, Oliver; Harries, Jenny; Awwad, David (NIH/NIAID) [C];SIMONSON, StewartCc: SINGER, Peter AlexanderSubje ct: Informal coronavirus teleconferenceWhen: Wednesday, February 26, 2020 1:00 PM-2:00 PM (UTC+0l:00) Amsterdam , Berlin,Bern, Rome, Stockholm, Vienna.Where: Upper SHOC {For Call in: please see dial in details attached)Dear colleagues,Dr Tedros would like to invite you to the next informal discussion about the ongoing 2019novel coronavirus.NIH-001006The te leconference will be hosted tomorrow Wednesday, 26 February at 13:00 CET andthe dial-in number with a passcode is attached .If you experience any technical difficulties joining this conference call, please contact theWHO HQ EOC operator at; +41227912490It wou ld be appreciated if you could kindly confirm your participation to Ms Sophia Kabir,email: (b)(6) mobi le no. (bHBest,MikeSophia KabirExecutive OfficerOffice of the Executive DirectorWHO Health Emergencies Programme (WHE)Tel. (b) (6)Mobile ------ (b)(6)Website: WHO in emergencies I WHO Facebook I WHO Twitte rNIH-001007HEALTHEMERGENCIESprogra1i1 neFrom:Sent:To:(b)(6)Tue, 3 Mar 2020 12:42:58 -0500Oplinger, Anne (NIH/NIAID) [E]Subject: Fwd: Interview request from the JesuitsFrom Patty on Fauci email. Not for several weeksSent from my iPhoneBegin forwarded message:From: Mike Jordan Laskey <JCUcommunica tions@jesuits .org>Date: March 3, 2020 at 12:32:38 PM EST -------~= To: "Fauci , Anthony (NIH/NIAID) [E ]" CbH6>:Subject: Interview request from the JesuitsDear Dr. Fauci,I host the AMDG Jesuit Podcast , which reaches a faith-based audience connected to Jesuitinstitutions around the country. I would love to welcome you onto the show to discuss thecoronavirus and how your Jesuit education has shaped your career. It would be great tohave 15-20 minutes of your time. Thanks very much for your consideration .Best,MikeMike Jordan LaskeySenior Communications ManagerJesuit Conference of Canada and the United States1016 16th Street NW 3rd FloorWashington , DC 20036202.629.5933jcucommunications@jesuits .orgNIH-001008From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 13:57:03 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject : FW: Corona Virus and a possible path to a vaccine?Attachments : Origin of Co-Vid 19 and possible path to vaccination.pdf, PastedGrap hic-10.tiffPis res pondAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From : expand@omcasa .com <expand@omcasa .com>Sent : Tuesday, March 3, 2020 5:00 AM -------~~ To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)>Subject : Corona Virus and a possible path to a vaccine?Importance: HighDear Dr. Fauci -Thank you for helping millions of people with your research over the years.The following information was culled from http://poleshi ft.ning.oom.Perhaps this article may help you and your colleagues develop a vaccine that may combat the Corona Virus.You were the first one I thought of who may be able to deem its worth and explore its research for practicalpurposes.Some of the links have included nih.gov so maybe your colleagues have already read this.With my limited medical know ledge, I have taken the liberty to highlight key points that seem important.Wishing you and yours all the best for remaining healthy in Mind, Body & Spirit.Warm Regards & Appreciation,NIH-001009NIH-001010Liz JanLIZ JAN BAmst, CAPSVaastu Homes instill Harmony, Tranquility, Abundance & Love; featuringUniversal Design & Aging in Place for safety, comfort & accessibility.Design & Consultations540.300.0638expand@OmCasa.comwww .OmCasa .comFrom:Sent :To:Fauci, Anthony {NIH/NIAID) [E]Tue, 3 Mar 2020 13:55:34 +0000Conrad, Patricia (NIH/NIAID) [E]Subject: FW: Covid-19 - Navigating the UnchartedAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892 -2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: El Bcheraoui, Charbel -------- (b)( > Sent: Tuesday, March 3, 2020 3:26 AMTo: Fauci, Anthony (NIH/NIAID) [E]------ .(.b..-).(-=6)Subjec t: Re: Covid-19 - Navigating the UnchartedDear Dr. Fauci,Thank you for your useful editorial published in NEJM last week, it helps confirming that the situationdoes not need to be as glim as the panic that most people are experiencing.I am writing an editorial and hoping to submit it to The Lancet soon. Differently from NIH/USGovernment institutes, I have more room for reflection in my viewpoint.For that reason, I was wondering if I can have a call with you to get your opinion/advice on the directionof my editorial. I know how busy you are and I can understand if you do not have the time, but if bychance you are willing to have this call, I'll be happy to share my editorial's draft first.As a background, I am an EIS graduate {class of 2009), and trained by Robert T. Chen.Thanks,Charbel El Bcheraoui, PhD, MScHead of Evidence-Based Public Health,Center for Internat ional Health Protection,Robert Koch Institute,Nordufer 20, 13353 Berlin,Telephone: (b)((b)(6)NIH-00 1011From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Tue, 3 Mar 2020 13:54:16 +0000NIAID Public InquiriesSubject : FW: Zinc gluconate by inhalation for early coronavirus in elderly?Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda , MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail (b)(6)The informa tion in this e-mail and any of its attachments is confidential and may contain sens itive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. lf you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Disease s (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From: Arthur --=----- (~b)- (=Sent: Tuesday , March 3, 2020 I :48 AM- -----~~ To: Fauci , Anthony (NlH/NlAID) [E] (b)(6) >Subject: Zinc gluconate by inhalation for early coronavirus in elderly?Dr Fauci,Since the elderly 's response to pulmonary coronavirus infection may be impaired, especially in those with a chronicdisord er, is there any information re: deliverin g by inhalati on, low concentrations of a Zinc salt. Ts there a potentialrationale in early coronavirus infection to try to minimize serious pneumonia , were such inhalation shown to bereasonably safe?Thank you,Arthur Bobrove , MDStanford and Palo Alto VASent from my iPhoneNIH-0010 12From:Sent:To:Subject :Anthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAID) [E)Tue, 3 Mar 2020 13:53 :42 +0000NIAID Public InquiriesFW: Coronavirus: Six Eyed Sand Spider , Habanero, water , QiNational Institute of Allergy and Infectious DiseasesBui lding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-ma il and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. lf you have received this e-mail in eITorplease inform the sen der and delete it from your mai lbox or any other storage devices. The National Institute ofAllergy and Infe ctio us Diseases (NIAID) shall not accept liability for any statements made that are the send er's ownand not expressly made on behalf of the NlAID by one of its representatives.-----Original Message----- ..=---~~=From : Lily Carnie (b) (Sent: Tuesday, March 3, 2020 12:07 A-M- ----~~ To: Fauci , Anthony (NlH/NlAID) [E] (b)(6) >Subject: Coronavirus: Six Eyed Sand Spider , Habanero . water , QiDr.Fauci ,(b)(6)---------- . I am an author on a Chinese form of healing called Qigong (a field l have studied forover 30 years) , and am exp loring Corona virus from the perspective of a combination of tbe venom of theVietname se Six Eyed Sand Spider (entering the cells externally), Habanero capsaicin enteri ng cells internally , theeleva ted water levels of infants and children and their higher levels of Qi in relat ion to them not getting the diseas e,and Qi from Tradit ional Chinese Medicine, Acupuncture, and Qigong.l believe that the above combination can be beneficial in the study of Corona virus. lam sure you are extremelybusy and I am but a simpl e author but I just wanted to lry to touch bases in case the above might help.l live in (b)(6)_I would be truly honored to hear from you.Lily of the Valley CarnieNIH-0010 13From:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElTue, 3 Mar 2020 13:52:17 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Possible treatment of COVID-19 pneumoniaPis respondAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Paul Tone, MD (b)(6)>Sent: Monday, March 2, 2020 11:10 PM -------=-,-:-= To: Fauci, Anthony {NIH/NIAID) [El (b)(6)Subject : Possible treatment of COVID-19 pneumon iaDear Dr. Fauci,Nitric Oxide (NO) has been shown to contribute to the pathogenesis of influenza virusinducedpneumonia in mouse model (Zablockiene et al., 2012).Zablockiene B, Ambrozaitis A, Kacergius T, Gravenstein S. Implication of nitricoxide in the pathogenesis of influenza virus infection . Biologija 2012; 58(1): 15-25.NO overproduction in influenza virus pneumonia results from a sustained stimulation ofinducible Nitric Oxide Synthase (iNOS) (Akaike et al., 1996).Akaike T, Noguchi Y, ljiri S, Setoguchi K, Suga M, Zheng YM, Dietzschold 8,Maeda H. Pathogenesis of influenza virus-induced pneumonia: involvement ofboth nitric oxide and oxygen radicals. Proc Natl Acad Sci US A. 1996 Mar 19;93(6) :2448-53.NO overproduction in influenza virus-induced pneumonia can generate highly reactiveoxygen species, peroxynitrite, via radical coupling reaction of NO with superoxideNIH-00 1014NIH-001015[resulting from influenza virus-induced increased levels of xanthine oxidase (XO)(Maeda and Akaike, 1998).Maeda H, Akaike T. Nitric oxide and oxygen radicals in infection, inflammation,and cancer. Biochemistr y (Mose). 1998 Jul; 63(7):854-65Peroxynitrite causes oxidative tissue injury through potent oxidation and nitrationreactions of various biomolecules (Akaike and Maeda , 2000) .Akaike T, Maeda H. Nitric oxide and virus infection. Immunolo gy. 2000 Nov;101 (3):300-8 .The crucial role of NO in influenza virus-inducedpneumonia was demonstrated on iNOS gene knockoutmice: at inocula sufficient to cause consolidatingpneumonia and death in the wild-type control mice, iNOSgene deficient mice survived with little histopathologicevidence of pneumonia (Karupiah et al., 1998).Karupiah G, Chen JH, Mahalingam 5, Nathan CF, MacMicking JD. Rapid interferongamma-dependent clearance of influenza A virus and protection fromconsolidating pneumonitis in nitric oxide synthase 2-deficient mice. J Exp Med.1998 Oct 19; 188(8):1541-6 .Both influenza and coronaviruses could have the same pathogenetic mechanismof inducing pneumonia, namely harmful overproduction NO.I would like to present you my innovative idea: Suppressing NO overproduction inCOVID-19 complicated to pneumonia with Methylene Blue (MB)Arguments pro:MB is known as a guanylate/guanylyl cyclase inhibitor but it is mainly a NOS inhibitor(nNOS and iNOS).MB is an inhibitor of superoxide generation by xanthine oxidase and NADH/NADPHoxidases.MB is a small molecule capable to penetrate in tissues and cellsMB was administered intravenously in patients with refractory septic shock andHepatopulmonary Syndrome of advanced liver cirrhosis .MB administered intravenously will definitively reach the cells where NOS is induced byCOVID-19 complicated by pneumonia both in animals and humans:-Airway epithelium (includ ing alveolar epithe lial cells);-Alveolar macrophages ;-Capillary/vascular endothel ium (endothelial cells).MB is an inexpensive medication .MB is non-toxic molecule in humansThere are only a few cases of MB toxicity published in the literature. These casesoccurred in very peculiar situations:Hemolytic anemia in patients with G6-PD deficiencySevere neuropathology after intrathecal administration of MBEye injury after topical use of MBTissue necrosis due to the extravasation of injected MBJejunal atresia following intra-amniotic MBSerotonin reuptake inhibitors (SRl's) interact with MB, causing a serious adver sereaction consistent with serotonin syndrome .Very truly yours,Paul Tone , MD, PhDInternal Medicine and Gastroenterology(b)(6)NIH-001016From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 13:51:29 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Dr. Fauci. I have a possible reason children are immune to the coronavirus.Please readPis res pondAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Rob Klein (b)(6)>Se nt: Monday, March 2, 2020 10:25 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E) (b)(6)>Subject: Dr. Fauci. I have a possible reason children are immune to the coronavirus. Please readHello Dr. Fauci. I am a (b) (6) pharmacist from Ontario, Canada. I was just reading an article that statedcovid-19 cases in children under nine y.o. are almost non-existant . I wondered why, and then an answerdawned on me. They have an immunity because one of the childhood vaccines all children get is givingthem cross immunity to coronavirus as well. A study should be done immediately to see which one givescross immuni ty, if indeed that is the reason for their seeming immuni ty to this virus. The immunity mustwear off over time which is why adults and seniors seem to lack prior immunity and get sick. Thishypothesis is certa inly worth investigating . If this is what is happening, maybe millions of lives could besaved by a simple booster of an existing vaccine. Please let me know your thoughts on this matt er.Thanks for your time . RobSent from Mail for Windows 10NIH-00 1017From :Sent :To:Subj ect :Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 13:21:11 +0000Conrad, Patricia (NIH/NIAID) [ElFW: Sky NewsWe should discussAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Szweda, Jakub (Interviews producer) <jakub.szweda2@sky.uk>Sent : Tuesday, March 3, 2020 6 :16 AM -------::-:-,= To: Fauci, Anthony (NIH/NIAID) [El (b)((;)>Subject : Sky NewsImport ance: HighHello Dr Fauci,Hope you're well. I'm a producer for Sky News, looking after our flagship evening programme Sky NewsTonight 7-lOpm UK time (2-Spm ET).I was wondering if you might be available for an interview on the coronavirus outbreak? Either today oranother day this week.Happy to explain in more detail.Any questions, please let me know .Best,JakubJakub SzwedaNIH-0010 18Inten,iews Producer I Sky NewsPhone : +44 (0)2070320436 I Mobile : (b)(6)Address: 2nd Floor, 4 Millbank , Westminster, SWIP 3JAWatched by 169m people in 138 countriesInformation in this email including any attachments may be privileged, confidential and is intendedexclusively for the addressee. The views expressed may not be official policy, but the personal views ofthe originator. If you have received it in error, please notify the sender by return e-mail and delete itfrom your system. You should not reproduce, distribute, store, retransmit, use or disclose its contents toanyone. Please note we reserve the right to monitor all e-mail communicat ion through our internal andexterna l networks . SKY and the SKY marks are trademarks of Sky Limited and Sky International AG andare used under licence.Sky UK Limited (Registration No. 2906991), Sky-In-Home Service Limited (Registration No. 2067075), SkySubscribers Services Limited (Registration No. 2340150) and Sky CP Limited (Registration No. 9513259)are direct or indirect subsidiaries of Sky Limited (Registration No. 2247735). All of the compan iesmentioned in this paragraph are incorporated in England and Wales and share the same registeredoffice at Grant Way, lsleworth, Middlesex TW7 SQDNIH-001019From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 13:10:22 +0000To: George GAOCc: Mascola, John (NIH/VRC) [E);Conrad, Patricia (NIH/NIAID) [E);Graham, Barney(NIH/VRC) [E);Conrad, Patricia (NIH/NIAID) [E)Subject: FW: Vaccine - confidential PPTAttachments : 2020 0303 For Gao laoshi.p ptxGeorge:Thanks for the note. I will send this to Dr. John Mascola Director of the NIAIDVaccine Research Center and Dr. Barney Graham to fo llow-u p with you.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone Cb) (6)FAX : (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: George GAO Cb) (6)Sent To: F:a Tuucei,s dAanyth, oMnya rc(Nh IH3,/ N2I0A2ID0 ) 7 :[1E2) ,- _A -M-_- --_~~_ __(b)(6_)Subject: Vaccine - confidential PPTDearTonyHope this email finds you wel l and the US will soon get the COVID-19 down.(b) (4)NIH-001020NIH-001021All the bestGeorge~ 13ft ~ iPhoneFrom:Sent:To:Cc:Subject:Attachments:John :Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 10:57:14 +0000Mascola, John (NIH/VRC) [E)Conrad, Patricia (NIH/NIAID) [E);Graham, Barney (NIH/VRC) [E)Important - POYUS and VP visit slidesVIP visit to VRC Coronavirus Short version - for 3-3-2020.pptxYesterday when I spoke to your IT /audio visual guy I to ld him to pull out the single slide withthe comparative time lines for various vaccines over the years and show it on the screen. Ithen asked him to have the full set of slides ready for me to show . I have now abridged that"fu ll" set so that I can whip through them if it looks like the discuss slows down. I am attachingth is abridged version here. Please ask him to subst itu te this shorter version for the full setfrom yesterday. Call me if you have any questions.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-00 1023From:Sent:To:Subject :Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 03:40:19 +0000Billet, Courtney (NIH/NIAID) [E]RE: Can we get comment please?I am not going to comment. (b)(S)From: Billet, Courtney (NIH/NIAID) [E] -------- (b)(6)> Sent: Monday, March 2, 2020 3:16 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b")'"(="6); Lane, Cliff (NIH/NIAID) [E](b) (6)'>Cc: Routh, Jennifer (NIH/NIAID) [E] (b)(6) >; Folkers, Greg (NIH/NIA ID) [E]-------- (b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b)(6)> Subject : Re: Can we get comment please?From: "Burton, Tom" <tom.burton@wsj .com>Date : Monday, March 2, 2020 at 3:09:17 PM(b) (5)--------=- c-= To: "Fauci, Anthony (NIH/N IAID) [El" (b)(6), "Lane, Cliff (NIH/NIAID) [E]"-------- (b)( , "Billet, Courtney (NIH/NIAID) [El" (b)(6) Subject : Can we get comment please?Folks, we're doing a story that focuses in part on the administration's conference call from last Thursdaynoon about a decision to send out more CDC coronavirus assays despite the fact that they had becomecontaminated and compromised. We understand that Dr. Fauci was one of four federal doctors (theothers being Drs. Hahn, Shuren and Shah) who strong ly recommended the assays not be sent out.I want to give Dr. Fauci a chance, on or off the record, to comment on the story please.Thank you,Tom BurtonThomas M. Burton, Staff ReporterThe Wall Street Journal1025 Connecticut Ave. N.W., #800Washington, D.C. 20036W: 202 862-6611Follow me @TomBurtonWSJNIH-001024From:Sent:To:Subject:Bob:Fauci, Anthony (NIH/NIAIO) [ElTue, 3 Mar 2020 03:11:52 +0000Eisinger, Robert (NIH/NIAID) [ElFW: Alert: Questions from Sen. Alexander for tomorrow's hearingPlease do me a favor and provide answers to the questions below from Sen. AlexanderThanks,TonyFrom: Haskins, Melinda {NIH/NIAID) [El -------- (b)( >Sent: Monday, March 2, 2020 8:30 PM ------ ..-.-,= To: Fauci, Anthony (NIH/NIAID) [El CbH6J>Cc: Crawford, Chase (NIH/NIAID) [El (b)( ; Selgrade, Sara (NIH/NIAID) [ElCbH >; Conrad, Patricia (NIH/NIA ID) [E] (b)(6) >; Marston, Hilary(NIH/NIAID) [El (b)(6); Folkers, Greg (NIH/N IAID) [El (b)( >Subj ect: Alert: Questions from Sen. Alexander for tomorrow's hear ingDr. Fauci,We just received a number of questions from Senate HELP that Sen. Alexander plans to ask you at thehearing. Chase will pull together the epi info . Let us know if you want to discuss these.MelindaSent from my iPhoneBegin forwarded message:From: "Hallett, Adrienne (NIH/OD) [El" (b)( >Date: March 2, 2020 at 8:15:00 PM EST ---------... ~ To: "Haskins, Melinda {NIH/NIAID) [E]" (bH >, "Selgrade, Sara(NIH/NIAID) [E]" (b)(6)>, "LaMontagne, Karen (NIH/OD) [E)"----------(b)(6)>, "Berkson, Laura (NIH/OD) [E]" (b)(6) Subject: Fwd: Questions from Sen. AlexanderSee anticipated questions below.Begin forwarded message:From: "Coulter, Margaret (HELP Committee)"(b)(6)Date : March 2, 2020 at 7:29:1-5- P-M-- E-S-T- =-cc-c= To: "Pence, Laura (HHS/ASL)" -------- (b)(6), "Bradsher, KrisNIH-001030,(;H__H_S:_ /A S_L_):"_ ..=:==~::::;;----::~-:(-b:)-(-6-)>, "Berkson, Laura (NIH/OD) [E]"(b )( 6) >, "Hallett, Adrienne (NIH/OD) [E]"======== (~b)~(6~)>Cc: "Bell, Kathryn (HELP Committee)" (b)(6) ,.:.....:========~:;;-~ "Pfaff, Melissa (HELP Committee)" CbH >, "Vogt, _ _.:......========~"""'.".""'.""" Andrew (HELP Committee)" (b)(6)>, "Graham,Grace (HELP Committee)" (b)(6)>Subject: Questions from Sen. AlexanderHi Laura and team,Thanks for all your work in advance of tomorrow's HELP hearing. Below arespecific questions that Sen. Alexander plans to ask Dr. Fauci and wouldgreatly appreciate concise answers to - he is happy to allow Dr. Fauci toelaborate if there is additional time. Add itionally, he plans to ask Dr. Schuchata few ques tions abo ut CDC covering patient costs from quarantine .Thank you very much and look forward to seeing you all or your colleaguestomorrow.Best,HELP teamQuestions for Dr. Fauci:1. How many cases are there in the world? 1n the U.S.?2. How many deaths so far in the world? In the U.S.?3. How many countries have cases of the corona virus?4. How do you know if you have the coronav irus?5. What are the symptoms?6. How do you protect yourself?7. Should we all be wearing masks?8. If not, why should health care workers have to wear masks?9. What are the most effect ive ways to protect your families?10. If someone has coronavirus symptoms, what should they do?NIH-001031NIH-00103211. If a doctor has a patient with these symptoms, what should theydo?12. Who is most at risk?13. What is the mortality rate?14. Can you explain why there have been re latively few reports ofcases in children?15. This is the peak of the flu season -a. How many flu cases have we had this year so far?b. How many deaths have we had this year from the flu?c. How is the coronavirus different from the seasonal flu?d. Is it possible that we could reduce the infections ordeaths from the seasona l flu because you need to do thesame things to protect yourself for both types of viruses?16. Can a person transmit the virus even if they are not showingsymptoms?17. Are your agencies doing any research to determine when exactlyan individual may transmit the virus to others?QUESTION FOR DR. SCHUCHA T:• If a patient is under a federal government-required quarantine ,who pays the bills?• Does their insurance pay first, and then does the CDC cover theremaining bills as the payer of last resort?• If CDC is the payer of last resort, does the agency pay the doctoror the hospital directly - or is the patient obligated to send theirbills to the CDC?• How and when is this infom1ation made available to the patientsunder a federal government-required quarantine?From:Sent:To:(b)(6)Mon, 2 Mar 2020 19:06:49 -0500Johnson, Richard Allen,M .D.Subject: Re: Telecast todayThanks, Dick.On Mar 2, 2020, at 6:57 PM, Johnson, Richard Allen,M.D.(b) (6)>wrote: -------------Tony,You were the star of the broadcast today! Your in tell igence, confidence, warmth ,and humor are what we all need with COVID-19. Please keep these coming. Youappear to have a great working relationsh ip with Dr. Burks.Very best,DickNIH-001033From:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElMon, 2 Mar 2020 17:56:05 +0000Michael GersonSubject: RE: QSee my edits in red for accuracyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Michael Gerson (b)(6)> --------- Sent: Monday, March 2, 2020 11:41 AM To: Fauci, Anthony (NIH/NIAID) [El-- -----------= (b=)(6J> Subject : Re: QThis is the descript ive portion of my column. I don't want to over or under-state:America is entering a disturbing new stage in the coronavirusoutbreak. There has been community spread in at least one and likely twolocations in Washington State. And it appears the virus was beingtransmitted for at least a few weeks before current cases were recognized.So we can expect dozens or hundreds of cases in those locations unlesscontact tracing is especially efficient.That means the disease is loose and easily tran smitted.The crucial issue now is the real mortality rate, which remainsuncertain. The stated mortality is 2 percent. American experts are hopingthe rate turns out to be considerably lower. But the math remains troublingin any case. If only 5 percent of the population eventually gets infected(which is on the low side of some estimates) and the mortality rate is 1perc ent, th ere still would be a few hundred thou sand deaths.NIH-001034At this stage, the main tool that public health experts have is socialdistancing - the attempt to keep as many people as possible in affectedareas out of sneezing distance from one another. This means measures suchas closing schools, cancelling events in theaters and stadiums andencouraging employees to telework. States and localities ultimately makesuch decisions rather than the federal government. But according to somehealth experts I consulted, Washington State should be taking suchmeasures right now. The effectiveness of social distancing is limit ed whenaction comes too late or ends too early.The goal of such policies is to keep the Ro (reproduction ratio) as lowas possible. When people are in close proximity, a single infected personcan spread the disease to several others, boosting the Ro of the disease ashigh as 2 to 3 and causing an exponential increase in cases. If the Ro is lessthan one, the epidemic will gradually decline and stop on its own, with orwithout a vaccine.A vaccine, however, would be tremendously helpful. There are at leastten vaccine development projects underway. But the one furthest along atthe National Institutes of Health (NIH) is still about six weeks away fromstarting the process of a phase 1 trial in human volunteers that willtake 3 to 4 months to complete and to show that the vaccine safeand produces specific antibodies. A phase 2 trial will follow andwill take at least 6 to 8 months to determine if the vaccine isefficacious in people at risk for infection . Then production wouldneed to be scaled up by a willing pharmaceutical company to deal with aglobal crisis. All this in total will take at least a year - assuming there areno unpredicted scientific obstacles in the way.On Mar 2, 2020, at 7:54 AM, Fauci, Anthony (NIH/NIAID) [E]wrote:Mike:CbH >Social distancing is not really geared to wait for a vaccine. The major point is to preventeasy spread of infections in schools (closing them), crowded events such as theaters,stadiums (cancel events), work places (do te lewor king where possible). States andlocalities make these decisions, not the Federal government. The goal of social distancingis to prevent a single person who is infected to readily spread to several others, which isfacilitated by close contact in crowds. Close proximity of people will keep the RO higherthan 1 and even as high as 2 to 3. If we can get the RO to less than 1, the epidemic willgradually decline and stop on its own without a vaccine.(b)(6)NIH-001035Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail, (b)(~The information in this e-mail and any of its attachments is confidential and may containsensitive information. It should not be used by anyone who is not the original intendedrecipient . If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any othe r storage devices. The National Institute of Allergy andInfectious Diseases (NIAID) shall not accept liability for any statements made that are thesender's own and not expressly made on behalf of the NIAID by one of its representatives.-----Origi na I Message-----From: Michael Gerson--------~ (~b)~(6=)>Sent: Monday, March 2, 2020 7:22 AMTo: Fauci, Anthony (NIH/NIAID) [E]------ -= (b=H=6)Subject: Re: QIs the overall strategy for social distancing just to keep the percentage of Americans whoget the disease low until a vaccine is available? This seems much harder to do in a freesociety . Does this mean closing schools? Public transport? Do states and localities makesuch decisions?On Mar 2, 2020, at 6:11 AM, Fauci, Anthony (NIH/NIA ID) [E]--------- (b)(6) wrote:Mike:Thanks for the note. We are clearly getting "community spread" in at leastone and likely two non-contiguous locations. It was likely spreading inWashington State for at least a few weeks before the current cases wererecognized, which means we can expect dozens and dozens of cases (ormore) in that locat ion unless we are vey lucky and/or the contact tracing ishighly efficient. The precise mortality rate is stil l uncertain. The statedNIH-001036(b)(6)mortality is 2%; however, even if it is half that (1%) and only 5% of thepopulation get infected, you are correct in that we can have a few hundredthousand deaths. The really critical issue is what the mortality rate actuallyturns out to be. I am hoping for a considerably lower mortality rate, but thatmight be wishful thinking . Whatever it turns out to be, the major tools thatwe have are public health measures, particularly social distancing, which wehave to start doing right now in Washington State and thinking about in otherlocations. That is really the major weapon that we have. Even though we gointo phase 1 with one candidate vaccien in about 6 weeks, vaccine is out ofthe question for at least a year or more if you want to make sure that youhave an effective vaccine, i.e. some efficacy data before massive deployment.We are meeting with pharmaceutical executive today and I will bring up theissue of what the fastest possible time line would be to have a deployablevaccine.---------- Best regards,Tony-----Original Message-----. I hope that you are well.From: Michael Gerson -----------=- (b')"'=("6')Sent: Monday, March 2, 2020 5:04 -A-M-- ----:a~ aa, To: Fauci, Anthony (NIH/NIAID) (El --------- (bH > Subject: QTony,(b)(6)I was with Francis yesterday , and t he news seemed pret ty sobering. It seemslike the virus is out in the general population in the Pacific Northwest andSilicon Valley. A pandemic now appears likely. Francis gave me a guesstimatethat 5 to 20 percent of the US population may end up infected . Depending onthe mortality rate, this could result in hundreds of thousands of deaths.Not for att ribution in any way, is this a fair summary? How and when wi ll weknow if the disease is on this track? Do we have any better info on mortalityyet?And is there any news on the vaccine front? As I understand it, we are noteven to Phase 1 trials on anything. If a vaccine is promising, are well talkingabout late Fall as the earliest possibility? And are there any substantivemeasures that could be taken to make sure pharma steps up to produce avaccine on a massive scale once we have It?I'm not sure Americans have been adequately prepared for this possibility.That is partly a political problem (in my view). But what needs to happensoon to get people prepared?Hope you are hold ing up well under all of this and taking care of yourself .NIH-001037NIH-001038From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 2 Mar 2020 17:26:54 +0000Reddy, SumathiSubject: RE:?For COVID-19 the mortality rate is approximately 2%. For seasonal influenza it isapproximately 0.1%Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Reddy, Sumathi <sumathi.reddy@wsj.com>Sent : Monday, March 2, 2020 10:4-9 -AM-- ----, .....,..,= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject :?Hi thereWanted to see what's the most up-to-date info you have on mortality rate for covid-19 versusinfluenza?Sumathi ReddyThe Wall Street Journal"Your Health" columnistM:.__ _ _, ,..~,c.(..,.,,, 0 : +1212416 2945E: sumathi.reddy@wsj.comT: @rddysumA: 1211 Avenue of the Americas. New York, NY 10036NIH-001041From: (b)(6)Sent:To:Subject:Mon, 2 Mar 2020 09:24:45 -0500Conrad, Patricia (NIH/NIAID) [E)Fwd: 60 Minutes/ COVID -19Let us discussBegin forwarded message:From: Denise Cetta (b) ~Date: March 2, 2020 at 9:20:42 AM EST ------~~ To: "Fauci, Anthony (NIH/NlAID ) (E]" (b)(6J:Cc: Jon LaPook (b)( , "Stover, Kathy (NIH/NIAID) [E]"(b)(6)>, "Routh, Jenn ifer (NIH/NIAID) [E]"--------- (b)( 6), Katie Brennan <BrennanK @cbsnews.com > Subject: 60 Minutes/ COVID -19Dr. Fauci:Good morning .I know you are busy, so forgive me for reaching out directly , but time is of theessence.I know you spoke with Jon about doing a 60 Minutes story on COVID-19.We are interested in potentially cra.c;;hinga story for this weekend.Is it possible for us to have a quick brainstorming phone call on what such a storymight include if based at NIH with you?Some ideas ...Fallo wing you closely as you engage in meetings, getting up to date info, givingyou1 opinion , going to task force meeting at WH or elsewhere.Are you using the same "DNA platform" you showed us in the Zika story to build apotential vaccine for COVID-19? Or is it another approach?Will you be meeting with any patients who are currently infected? Bringing anypatients to the NIH for care/evaluation?Let us know when you can talk.DeniseDenise Schrier CettaProducer CBS News, 60 MinutesCell : (b)(6)NIH-001042From:Sent :To:(b)(6)Mon, 2 Mar 2020 09:20:56 -0500Shlomchik, Mark JaySubject: Re: Is this true?I have been very explicit in stating publicly that I am not being muzzled or censored. I sayexactly what I want to say based on scientific evidence, I have stated this on multiple TVprograms over the past few days including at a major press conference with many, manyreporters present including several TV cameras . I could not possibly be more public about this.No censor. No muzzle. Free to speak out.On Mar 2, 2020, at 9: 11 AM, Shlomchik , Mark Jay<MSHLOMCH @pitt.edu >wrote:OK, well that is good to know. It has been reported by many outlets including theNYT . So if not true I think it is cr itica lly important for you to say so publicly andshow that it is not the case. It is critical, critical that we all have faith in the scienceand medical leadership. Your personal integrity is at stake here in the communityand the world, and is a proxy for the integrity of science and medicine.According to one house member, the following :Garamendi told MSNBC's Hallie Jackson that Anthony Fauci wasscheduled to do all five major Sunday talk shows, but says Faucicanceled the appearances after Vice President Pence took over theadministration's response to the disease.Trump on Wednesday named Pence as the official overseeing thegovernment's response."I can repeat what he said, he said, 'I was not muzzled. However, Iwas to go on the Sunday talk shows five of them. The vicepresident's office then took over the control of this situation, and toldme to stand down, not to do those shows,'" Garamendi said, quotingFauci.We cannot mince words about this or have nuances. If you were told not to appearon Sunday talk shows, then a reasonable person would have to assume your speechindeed is being contro lled. Whether you call it "muzzled" or censored is a matter ofsemant ics. Is it factual that you were told/asked not to appear on these shows as hadbeen scheduled?NIH-001043I hope you understand my reason for and level of concern. I am certain it is sharedby many of your colleagues and citizens.Best,MarkMark Shlomchik, MD, PhDUPMC Endowed and Distingu ished Professor of ImmunologyChair, Department of ImmunologyUniversity of Pittsburgh School of MedicineW1052 Biomedical Science Tower200 Lothrop StPittsburgh, PA 15261Phone: Cb) (6)Fax: 412-383-8098(b)(6)https://www.immunology.pi tt.eduhttp://immunology.pitt.edu/person/mark- jay-shlomchik-md-phdCheck out our gene targeting and flow cores: http ://immunology .pitt.edu/departmentresourcesOn Mar 2, 2020, at 9:03 AM, Fauci, Anthony (NIH/NIAID) [E]Cb) (6)>wrote:The story is not true. I am not being muzzled or censor ed.On Mar 2, 2020 , at 8:51 AM, Shlomchik , Mark Jay<MSHLOMCH@pitt.edu>wrote:Dear Tony,Is the inform ation in this art icle true?https ://www.businessins ider .com/who-is-anthony-fa ucispeech-controlled-by-trump-coronavirus-2020-2If it is, I think that-in the interests of public health and theintegrity of science in the US- you must not acquiesce butinstead resign and speak out.If it is not tru e, then plea se refute it and set the recordstraight.Sincerel y,Mark Shlomchik, MD, PhDUPMC Endowed and Distinguished Professor of ImmunologyChair, Department of ImmunologyUniversity of Pittsburgh School of MedicineNIH-001044NIH-001045W1052 Biomedical Science Tower200 Lothrop StPittsburgh, PA 15261Phone: 412-648-8771Fax: 412-383-8098mshlomch@pitt.eduhttps://www .immunoloqy.pitt.eduhttp://immu noloqy.pitt.edu/pe rson/ma rk-jay-shlomch ik-md-phdCheck out our gene targeting and flowcores: http:// immunology .pitt.edu/department-resourcesFrom:Sent :To:(b)(6)Mon, 2 Mar 2020 09:10:54 -0500Cassetti, Cristina (NIH/NIAID) [E]Subject : Fwd: lay info for people who are at risk for COVID-19Attachments : Wuhan Coronavirus for Mama.20020301.pdf, ATT000Ol.htmPlease take a look at this and respond.Begin fo1warded message:From: Cynthia Bristow CbHDate: March 1, 2020 at 10:1 2:22 PM ES-T- -------=---c- T o: "Fauci , Anthony (NJH/NIAID) [E]" CbH6)Subject: lay info for people who are at risk for COVID-19Dear Tony,I would like to respectfully ask if someone in your Institute could kindly review theattached precis regard ing the current COVID-19 situation and recommend any revisionsprior to my disseminating this to my at risk family members including (b) (6) andothers in retirement communities who are concerned.I appreciate that this would not be an official endorsement by you. I am only asking if thereis anything that you or others think I could add or subtract from this precis to give solace tothose who are in need of knowledge and comfo rt.Thank you kindly for your attention to th is matter .Best wishes,Cynthia L. Bristow, PhDChief Executive OfficerAlpha-1 Biologics25 Health Sciences Drive, Suite 110Stony Brook, NY 11790-3383Office (b)(6JCell phone: (b)(6)www .alphalb iologics.com(b)(6)NIH-001046From: Fauci, Anthony (NIH/NIAID) [ElSent: Mon, 2 Mar 2020 10:43:27 +0000To: Marston, Hilary (NIH/NIAID) [ElSubject : FW: GPMB: MESSAGE ON BEHALF OF THE CO-CHAIRS: UPDATE: CONFIRMING 4MARCH TELECONFERENCEAttachment s: Agenda Board telcon 4 Mar Fnl.p df, Local_Access_en.pdfFYIFrom: Amel ie RIOUX (b)(6)>Sent: Monday, March 2, 2020 5:29 AMTo: Dzau, Victor J. (b)( ; Fauci,Anthony ( NIH/N IAI ~D:)- [:E-:"]:: '-":======~ (b,:), ,(~:6~);~F-o-re-:H"'e._"n_r":,-e-tt-a-=====~ (b")'.~=(6,:),;-:::G-::a--o-:F:u---(b)(6) Gashumba Diane (b)(6); Ilona Kiekbusch~====== (b)-:(:'6-::=)!>--; Suzuki Yasuhiro-========== (b=)=c ..--(b)(6) Vega Morales Jeanette (b)(6); VijayRaghavan------======-- _:::~=Krishnaswamy (b)( ; Skvortsova Veronika (b)(6)Cc: Gro Brund t land (b)(6)>; As Sy (b)(6)>; Elhadj SY(b)(6) Tore Godal (b)(6)> ; Godal, Tore (b)(6);(b)(6) SCHWARTLANDER, Bernhard F. (b)(6) ; RYAN,----:;=====~-- ----=--------'=-==---::-------- Mich a e I J < >; Pate Muha med (b)(6); Kanarek, Morgan(b) (6) Conrad, Patricia-~---~-:-:====================~~---(NIH/NI A ID) [E) (b)(6);===========~ (b)( ; 'Sheila Austria' --------------- ~==========:-::=-;-----(-b.)(-6) Teresa Miller de V-e-g-a- ----~~ (b)(6)>; Marston, Hilary (NIH/NIAID) [El(b)(6)Palu --------- Subject: RE: GPMB: MESSAGE ON BEHALF OF THE CO-CHAIRS: UPDATE: CONFIRMING 4 MARCHTELECONFERENCEDear Board membe rs,We are confirming the Board te leconference on Wedne sday, 4 March at 14:00 Geneva time .Please find attached the agenda (also copied below) and the call-in numbe rs. The Access code is (b)( 4)Please let us know if you have any questions .Thank you very much,NIH-001051Amel ie RiouxOn behalf of the Co-ChairsParticipant access(b) (4)Access via WebGlobal Preparedness Monitoring BoardTeleconference4 March 2020, 14:00- 15:00 CETAgenda1. Welcome and Roll call2. Updates and stock taking on the COVID-19 outbreako Update from George Fu Gao (TBC)o Update and Proposal from Jeremy FarrarOptional dial-in numbersinternational+41 58 262 07 22 (English) +41 58262 07 44 (Italiano) +41 58 26207 11 (Deutsch) +41 58 262 07 33(Fran~ais)Loca l Access3. Discussion ; Actions from the Board on the COVID-19 outbreak (30 minutes)4. AdjournFrom: Amelie RIOUXSent : Tuesday, 25 February 2020 10:18To: Dzau, Victo-r -J. ======~-:-----:-:---:----:::::===~~--:::---::------ Anthony Fauci (b)(6); Fore Henrietta -o. CbH~ >; Gao Fu(b) (6)·--"'==,::--------- ~======:,ot,(_b) ;( .6,), >. ; Gashumba Diane (b)(6); Ilona Kiekbusch(b)(6)>; Suzuki Yasuhiro (b)(6); '========~.;,..= -----~====~- (b)(6)· Ve:ga': =M'.o- rales Jeanette (b)(6)>; VijayRaghavan Krishnaswamy (b)(6)>; Skvortsova Veronika (b)(6)Cc: Gro Brundtland (b)(6); As Sy (b)(6)>; Elhadj SY(b)(6)>; Tore Godal (b)( >; Godal, Tore (b)(6)>;~-:----:--:====~(~b)(6;)-; -S-C=HW-A-RTLANDER,B ernhard F. < (b)(6)>; RYAN, Mich ae I J._ ____ C_b>_C_6)>; Pate Muha med <1 CbH6l>; Kanarek, MorganNIH-001052Subject: GPMB: MESSAGE ON BEHALF OF THE CO-CHAIRS: UPDATEMESSAGE ON BEHALF OF THE GPMB CO-CHAIRS DR BRUNDTLAND AND MR SYDear Board members,Thank you to those of you who joined the call on Thursday on short notice.In light of our discussion, we would like to update you on a few matters :(b) (4)• Coronavirus outbreak. We have asked Jeremy Farrar to act as t he Board's focal point on theCOVID-19 outbreak, to represent and advise the Board on the science of the outbreak and thefinancing of the response. We thank Jeremy for agreeing to take on this role.• Follow-up Board teleconference call. Since many of you were unable to attend Thursday's call,we wish to propose to hold a follow-up Board teleconference call on 4 March at 14 :00 Genevatime . The purpose of the call will be to discuss the coronavirus outbreak, including Jeremy'sproposal for Board action on financing. We would appreciate if you could confirm yourparticipation to Amelie Rioux (b)(6)). A more deta iled agenda and call-in detailswi ll be shared shortly.• In-person Board meeting . We wish to confirm that the next in-person Board meeting will takeplace Tuesday-Wednesday, 5-6 May 2020, in Geneva. The meeting will be an importantoppo rtunit y to further discuss strategic issues as well as a draft of the annual report. We willcommunicate further on logistical detail s.As always, thank you for your support and continued engagement.NIH-001053NIH-001054With kind regards,Gro and AsFrom:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 23:25 :39 +0000Lerner, Andrea (NIH/NIAID) [ElCc: Marston, Hilary (NIH/NIAID) [El ;Folkers, Greg (NIH/NIAID) [E];Conrad, Patricia(NIH/NIAID) [ElSubject : RE: event rundown for 3/2 webcast eventThere is no attachment with this e-mailAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origi nal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Lerner, Andrea (NIH/N IAID) [El --------- (b) ~ >Sent : Sunday, March 1, 2020 6:01 P-M- ------, .....,....,= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)Cc: Marston , Hilary (NIH/NIAID) [El ; Folkers, Greg (NIH/NIAID ) [El_______ CHb_6)>; Conrad, Patricia (NIH/NIAID) [E] _______ C)bC6)Subject : Re: event rundown for 3/2 webcast eventSending th is again as it is for tomorrow.Sent from my iPhoneOn Feb 28, 2020, at 9:10 PM, Lerner, And rea (NIH/N IAID) [El ---------(b)(6)wrote :Dear Dr. Fauci (and Hilary, if you end up doing this event as AS F's back-up),NIH-001060I've attached an "event rundown" for the Harv a rd Forum Webcast, which is scheduledfrom 11:40-lpm on Monday 3/2- a moderated panel discussion. This is a documentprepared by the event organizers outlining the run of show, noting what questions themoderator will pose, and some suggested points the organizers thought you might touchon in your answers.Although the organizers prepared this document fo llowing a planning call, they have madeit clear that the "talking points" in this document are of course not a script. I have takentheir document and highlighted where you appear . I have also added some comments.Let me know what you think. There are no slides for this event.Let me know if you would like to discuss further over the weekend or if you'd like anythingfor preparation.Sincerely,AndreaAndrea Lerner, MDMedical OfficerOffice of the DirectorNIAID/NIH31 Center Drive, Room 7A10ABethesda, MD 20892Cb()6 ) cell<2020.3.2-Coronavirus-rundown _tony _AL highlights.docx>NIH-001061From: Fauci, Anthony (NIH/NIAIO) [E)Sent : Sun, 1 Mar 2020 22:53:00 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Proposal to Mitigate Spread of COVID-19Attachments : Urgent Proposal to Mitigate Spread Fauci.pdf, HCQ, A Modest Proposal forMitigating COVID-19 2.0.pdfPlease take a look and do what you feel is appropr iate.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX : (301) 496-4409E-mail (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinfo rmation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Alexander Morden MD ---------- (b)( > Sent : Sunday, March 1, 2020 2:36 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject : Proposal to Mit igate Spread of COVID-19Enclosed is an article I have submitted which may offer an immediate stra tegy to help infection controlin the general public (and possibly in Oregon & California).NIH-001062From:Sent :To:Cc:Subject:responsesJohn:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:52:21 +0000Tsang, John (NIH/NIAID) [E]------- (b)( •;Conrad, Patricia (NIH/NIAID) [E) RE: personal Immune baseline and its impact on infection and vaccineThanks for your note. I am copying Cliff Lane here since he and his team isinvolved in a clin ical prot ocol with COVID-19 pat ient s. He may be able to pointyou in the right dir ection.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail ( (b) <6JThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Tsang, John (NIH/NIAID) [E] (b)(6)>Sent: Sunday, March 1, 2020 2:46 PM -----~ ~ To: Fauci, Anthony (NIH/NIAID) [E] (b)( >Subject: personal Immune baseline and its impact on infection and vaccine responsesDear Or. Fauci,Hope you are doing well despite the rapidly evolving situation with COVID-19.I wanted to send you a paper we just published last week that you might find relevant- please findattached and a NIAID piece below.https://www .niaid .nih.gov/news -events/immune -system-status -predicts -future -responsesNIH-001063This paper asks the question of why do ind ividuals mount variab le immune responses to vaccines ,infections , and diseases. This extends from our ear lier work on baseline predicto rs of influenzavaccination responses that you highlighted as a NIAIO Advance in 2014. A key message is that genetics isoften unlikely the answer, but the status of the immu ne system before the pert urbation may offer clues- here we ident ified such an immune cell circuit involving pOCs-Type I IFNs prior to perturbation inhumans and found that its status can predict vaccinat ion and lupus disease activ ities and is temporallystable within individuals for months.Many thanks !Best wishes,John.(b) (5)John Tsang, PhD, Senior Investigator I Chief, Multiscale Systems Biology Section, Laboratory of Immune SystemBiology I Co-Director, Center for Human Immunology (CHI) I National Institute of Allergy and Infectious Diseases(NIAID), National Institutes of Health (.lli.!:)i I emai (b)(6) I off ice: (b)(6) I cell: (b)()(6) I web: tsang lab I address: (b)(6) 4 Memorial Drive, Bethesda, MD, 20892 USAThe information 1n this e-mail and any of Its attachments 1s confidential and may contain sensitive nformat1on. It should not beused by ariyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender anddelete it from your mailbox or any othf?r storag1:>d evicPs. National Institute of AIIPrgy and Infectious Diseases shall not acceptliability for any statementsm adet hat are sender'so wn and not expresslym adeo n behaf of the N AID by one of itsrepresentatives.From: "Fauci, Anthony (NIH/NIAID) [E]" CbH6)Date : Wednesday, December 19, 2018 at 9:43 PMTo: "Tsang, John (NIH/NIAID) [E]" (b)(6)Subject : CongratulationsJohn:Congratula tions on being gra nted tenure by the NIH Central Tenure Committee. Well-deserved!Keep up your te r rific work.NIH-001064Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520Nation al Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail (b)(6)The information in this e-mail and any of its atta chments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .NIH-001065From :Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:50:11 +0000NIAIDODAMSubj ect : FW: Outreach from STATLet us di scuss.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Berke, Rick <Rick.Berke@statnews .com>Sent : Sunday, March 1, 2020 10:10- A-M-- ---~~ To: Fauci, Anthony (NIH/NIAID) [E)- -------- (b)(6) Subject : Outreach from STATTony,I know you're swamped but I'm wondering if we could arrange for you this week to take questions fromour readers about coronavirus. All of our coronavirus coverage is in front of STAT's paywall and we'd seeyour contribution as an enormous public service.We would solicit questions for a "live chat" from readers -- and you could pick and choose which onesyou want to answer -- and write most of them in advance.Among other leading figures, we 've done this format twice with Nobel winners and it's quite popular .https ://www .statnews .com/events/stat -live-chat -chat-with -a-2019-nobel-winn ing-scientist/With Helen Branswell, Sharon Begley, Matt Herper , and our whole team, we pride ourselves on coveringthe coronavirus in the most authoritative and fair-minded way. We've developed a tremendousaudience for this coverage. https://www.statnews.com/tag/coronav irus/Our readers are fairly sophist icated on health and medicine, and we're looking to focus on the healthaspects, not the White House polit ics.NIH-001066In addit ion, I'd be grateful if you'd consider writing another First Opinion for us, maybe on lessonsyou've learned regarding other outbreaks and how that might be relevant with coronavirus -- orwhatever you'd like.Your voice of course is very important and authoritative and we'd be grateful to have it again in STAT.All best,RickRick BerkeCo-founder & Executive Editor0: (617) 929-7056 M:._( __ .(;b...);(...6;.;j..@i~o ric=k=b=ke=~erSTAT Reporting from the frontiers of health andm ed ic in e@st atnew s statnews.com fac eboo k .com / statnewsSUBSCRI BE TO ST AT PWS for an all-access pass to exclusive stories.SIGN UP HERE for free newsletters withthe latest in hea lth , biopharma, and science coverage.NIH-001067From:Sent :To:Cc:Subject:Jeff:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:47:57 +0000Jeffrey SachsConrad, Patricia (NIH/NIAID) [E);Barasch, Kimberly (NIH/NIAID) [CJRE: Might we speak briefly about the coronavirus vaccine development?Thanks for the note. Happy to chat. Please give my office a call to morrow AMCbH6) to set -------- up a time when we can chat by phone.Best rega rds,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuil ding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : Cb) (6)FAX: (301 496-4409E-mail : (b)(6)The infor mation in this e-mail and any of its attachments is confidential and may conta in sensitiveinformat ion. It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Jeffrey Sachs (b)(6)Sent : Sunday, March 1, 2020 2:19 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E)- ------- (b)(6)> Subject: Might we speak briefly about the coronavirus vaccine development?Dear Tony,Thanks as always for your leadership.Deja vu of our highly productive discussions 20 years ago!JeffNIH-001068From:Sent :To:Cc:Subject:Best regards,TonyAnthony S. Fauci, MDDirectorFauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:46:11 +0000pascal goldschmidtSara Sigel;NIAID OD AMRE:- ----------(b)(6)National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail 1 (b)(6)(b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who Is not the original Intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From : pascal goldschmidt __________ (b_) (6J>Sent : Friday, February 28, 2020 9:00 PMTo: Fauci, Anthony (NIH/NIAID) [E)_ _____ (-b=)'""("6=' ) >Cc: Sara Sigel (b)(6)>Subj ect : Cb)<Greetings Tony,I know how incredibly busy you are with the coronavirus challenge.I admire so much your cool and effectiveness in the middle of a public health hurricane.With warmest regards,PascalNIH-001069(b)(6)NIH-001070Pascal J. Goldschmidt , M.D., Fellow A.C.C ., Fellow A.H .A.President and CEO, Alzady International , LLC.President and CEO, American Healthcare System Ltd.Dean Emeritus, Professor of Medicine EmeritusUniversity of Miami Miller School of Medicine USAAMERICAN HEALTHCARES YSTEMEuropean Core Global & Alzody lniornotionolFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 22:44:16 +0000Silverberg, KristenSubject: RE: question from BRTKristen:Thanks for the note. Would your companies be able to effectively advocate forimproved health care systems in low and middle income countries?Best,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Silverberg, Kristen <KSilverberg@brt.org>Sent: Thursday, February 27, 2020 11:40 AM To: Fauci, Anthony (NIH/NIAID) [El ------------=----cC=bH 6)> Subject : question from BRTDr. Fauci,I hope you are well.Last February, I moved to Business Roundtable, which represents CEOs of large U.S. companies. Josh isthe BRT CEO, and it's been great to work with him again.We wanted to check with you on something quickly . Traditionally, BRT has not weighed in on globalhealth security policy, but COVID-19 has served as a reminder that global companies need to be strongadvocates for global public health and security. If you had your choice, what would you want to seeour companies advocating for, specifical ly?No worries at all if you don't have time to respond. We fully appreciate how important your time is.NIH-00 1071NIH-001072Best,KristenFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 22:32:44 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: ARB therapy in Covid -19 infectionPlease respond.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Tom Leopold Cb()6 >i>Sent: Sunday, March 1, 2020 8:48 AM To: Fauci, Anthony {NIH/NIAID) [El ------------=---=---=(b)=((;) > Subject: ARB therapy in Covid -19 infectionThank you for responding to my email yesterday about the possibility of ARB therapyin treatment of coronavirus infection. I realize that your research is ongoing. Would youanticipate, however, that the ARB with the most potential role in preventing virusattachment would be the one that has the greatest affinity for the AT2 receptor? Am icorrect that losartan is the ARB with the lower receptor (A T1 vs AT2) selectivity andmight logically be the most promising ARB to investigate? Thanks . Dr Thomas LeopoldSent from my iPhoneNIH-001074From:Sent:To:Fauci, Anthony (NIH/ NIAIO) [E)Sun, 1 Mar 2020 22:31:42 +0000JP HankeSubject: RE: CoronavirusThanks for the note. CDC is already preparing simi lar public serviceannouncemen t s, which I am sure will find its way to YouTubeAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: JP Hanke (b)(6)>Sent: Sunday, March 1, 2020 5:30 P-M- ---- ..,.....,...= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6) Subject: CoronavirusDear Dr Fauci,I heard this idea on a radio interview with Laurie Garrett this morning - how aboutgetting your committee (or one of the government health agencie s) to produ ce aseries of short YouTube videos on how to combat the coronavirus: such things asproper handwa shing technique , when to wear a mask , how to ride the subwaysafely, etc, etc. I think this would be an excellent way to reach the public in thedigital age (provided that Mike Pence doesn't try to turn them into campaign adsfor Donald Trump), and I strongly urge you to give the strategy seriousconsiderat ion. I know I would watch them and I'm sure millions of other peoplewould too .Sincerely,NIH-001075Paul HankeCbH6)VTNIH-001076From:Sent :To:Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 22:29:32 +0000Lerner, Andrea (NIH/NIAID) [ElSubject: RE: Report from 'HHS COVI0-19 Situation Update' call todayThanks. Very helpful.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Lerner, Andrea (NIH/N IAID) [E] (b)(6)Sent : Sunday, March 1, 2020 4:06 PM -------=-:--:= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Cc: Marston, Hilary (NIH/NIAID) [E] (b)(6)>; Folkers, Greg (NIH/NIAID) [E](b)(6)>; Doepel, Laurie (NIH/NIAID) [E] (b)(6)>; Eisinger, Robert(NIH/NIAID) (El (b)((;); Conrad, Patricia (NIH/NIAID) (E) (b)(6)>Subject: Report from 'HHS COVID-19 Situation Update' call todayPassing on some main points from of an "HHS COVI0 -19 Situation Update" call that took place at 3pmtoday, FYI.• The meat of the call was a situation update by Nancy Messonnier (with epi numbers below).• She noted that the national strategy is still containment .• However, since there are some US locales wit h evidence of community spread, there isconsiderat ion if some "commun ity level act ion" may be appropr iate, with a move towards ablend of mitigat ion/containment in certain areas.Global epi update:China lab/clinically confirmed cases: 79,824 (+573 in last 24h)China deaths: 2,87061 international locations with 7,102 cases so far (Armenia, Ecuador, Ireland, Luxembourg new in last24h)NIH-001077NIH-001078107 international deathsWidespread community transmission occurring in:China, Iran, Italy, Japan, S. KoreaUS epi update:63 confirmed US cases (16 diagnosed here, 3 in Hubei repatriates, 44 in Diamond princess repatriates)11 presumptive cases (meaning they tested+ at state public health labs, but confirmatory test at CDC ispending)663 Persons Under InvestigationAndrea Lerner, MDMedical OfficerImmediate Office of the DirectorNational Institute of Allergy and Infectious Diseases (NIAID)National Institutes of Health31 Center Drive, Room 7A10ABethesda, MD 20892From:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:22:15 +0000Francis V. ChisariRE: (b)(6) -----------------Given what is going on with coronavirus, I cannot guarantee that I will be able toattend the Section meeting . I will try my best.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Francis V. Chisari <fchisari@scripps.edu>Sent: Sunday, March 1, 2020 5:19 PMTo: PAUL G AHLQUIST <ahlqu ist@wisc.edu>; Zhijian (James) Chen <zhijian .chen@utsouthwestern .edu>;Fauci, Anthony (NIH/NIAID) [E) (b)(6J; Michael Oldstone <mbaobo@scripps.edu>;Eckard Wimmer <eckard.wimmer@stonybrook.edu>Cc: Charles Rice <ricec@mail.rockefe ller.edu>; Chisari. Francis <fchisari@scripps.edu>Subject : (b) (6)Dear colleagues,(b)(6). Please let meknow if you will attend the Section meeting this year and if you're willing to say a few words ofsupport.Best regards,FrankNIH-001079From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 20:32:36 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: SARS-CoV-19Please respondAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Peter Panus (b)(6)>Sent : Sunday, March 1, 2020 10:15 AM -------::-:-, = To: Fauci, Anthony {NIH/NIAID) [El (b)((;)>Subject: SARS-CoV-19Although outside my main area of expertise I have been keeping up with CoVid-19 discussion. One itemI have noted is that the disease appears to have a lower incidence in children . The other is that the virusappears to at least in part attach through cell membrane angiotensin II type 1 recepto rs. Is the lowerincidence of the disease in children possibly due to th is cohort having a higher proportion of angiotensinII type 2 receptors compared to the adult cohort?Sincerely,Peter C. Panus PhD, PTProfessor EmeritusPharmaceutical Sciences Dept.Gatton on College of PharmacySent from Mail for Windows 10NIH-001080From:Sent :To:Fauci, Anthony (NIH/NIAID) [ElSun, 1 Mar 2020 20:23:14 +0000NIAIDODAMSubject: FW: Invita t ion to speak to the National Economists ClubLet us discuss. Unlikely I will have time depend ing on how thi ngs evolve .Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Sanchez, Emily <Emily_Sanchez@americanchemistry .com>Sent: Sunday, March 1, 2020 10:35 AM To: Fauci, Anthony (NIH/NIAID) [El ---------=c:(-b):((-;=)> sCc: Doepel, Laurie (NIH/NIAID) [El (b)(6)>; Routh, Jennifer (NIH/N IAID) [El(b)(Subject: Invitation to speak to the National Economists ClubDear Dr. Fauci,My name is Emily Sanchez and I am an economist at the American Chemistry Council. I am reaching outto you in my capacity as President of the National Economists Club (NEC}, which is an organizat ion ofover 1000 government and private sector economists based in DC. The NEC holds weekly luncheonevents which feature notable experts and economists in Washington.Increasingly, econom ists are being asked to assess the economic impacts around the incidence andspread of the corona virus as well as the impact of reduced economic activity due to behavioral changes{e.g. people not leaving their homes to work or shop, supply chain disruptions, etc.). As economists aretasked in assessments, scenario planning and communicating their estimates, accuracy around thei rassumpt ions and understanding of the corona virus and Covid-19 is imperative . We are incredib lyappreciate of the important work and research that the National Institute of Allergy and Infect iousDiseases provides and we are wondering if you would be willing to speak at one of our luncheons aboutCovid-19 and the latest developments .NIH-001081NIH-001082Do you think you might have time in your schedule t o spea k to the National Economist Club t hismonth? We would love to have you speak during the week of March 16-20.Our luncheons typically take place at the Chinatown Garden Restaurant, 618 H St. NW, with lunch atnoon and your presentation from 12:30 p.m. til 1:30 p.m. Talks are normally on the record and open tothe press, unless you request otherwise.Thank you for your consideration.Best regards,EmilyEmily Sanchez I American Chemistry CouncilDirector, Economics & Data AnalyticsEconomics & Statistics Departmentemily sanchez@americanchemist ry .com700 2nd Street, NE I Washington, DC I 200020: (202) 249-6183www. americanchem i stry. com+++++++++++++++++++++++++++++ This message may contain confidential informat ion and is intendedonly for the individual named. If you are not the named addressee do not disseminate, distribute orcopy this email. Please notify the sender immediately by email if you have received this email by mistakeand delete this email from your system. E-mail transmission cannot be guaranteed to be secure or errorfreeas information could be intercepted, corrupted, lost, destroyed, arrive late or incomplete, orcontain viruses. The sender therefore does not accept liability for any errors or omissions in the contentsof this message which arise as a result of email transmission . American Chemistry Council, 700 - 2ndStreet NE, Washington, DC 20002, www .americanchem istry .comFrom:Sent:To:Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 20:17:45 +0000Thomas MurraySubject: RE: Have you been muzzled?Mr. Murray:Thanks for the note. Please stay silent since I have not been muzzled. I will beon multiple TV shows tomorrow and was on FOX this AM. No one is censoringme.Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From:T homas Murray ---------- (b)(6) Sent: Sunday, March 1, 2020 11:04- A-M- ----=cc-c= To: Fauci, Anthony (NIH/NIAID) [El- ------- CbH6)> Subject : Have you been muzzled?Reference: I'm the nuclear/aerospace engineer who subsequent ly obtained an MPH at the University ofWashington since I was working disease transmission within commercial airlines when I was a Boeingemployee. And, my undergraduate degree is in chemistry with a minor in microbiology. I've engaged youpreviously.Hi Dr. Fauci,You've kindly allowed me to engage you, and I'll take advantage of that kindness.The news media is reporting that the White House has muzzled you. Is that true? Before entering thescience/engineeri ng world, I was a newspape r city editor in Southern CA (in the 1970s). Therefore, I getand understand the idea of coordinated messaging. (Plus, due to my media background, Boeing used meto help executives prepare for media engagements on challenging topics.) However, if it's true that youare muzzled, then I will initiate a "campaign" with my congressional representatives and the media toNIH-001083stop that action. (b)( - -------------------However, before I initiate such a campaign, will my actions possibly cause you harm? I recognize tha tyou may have backchannels that I may disrupt by engaging.As I related previously, I trust you since you focus on facts and data, you prov ide context for theinformation that you share, and you avoid emotion in your engagements. I think that residents of the US(and, fran kly the worl d) need your insights regarding COVID-19. Plus, you're one of the wor ld leaderswith regard to infectious diseases. And, if you don't know, you know whom to ask.Please let me know if I should stay silent or become noisy.Thank you. And, thanks for your service to the US and the world during this very interesting time.Thomas MurraySent from my iPadNIH-001084From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 20:13:01 +0000D.A. SonnebornSubject: RE: News about SARS-CoV-2 ad Covid-19You can tru st CDC.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb()6 )The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: D.A. Sonneborn CbH6J>Sent : Sunday, March 1, 2020 3:11 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E)- ------- Cb)( > Subject : News about SARS-CoV-2 ad Covid-19Dear Dr. Fauci,It would be good to know if you still believe Americans can trust CDC's public -facing authority orwhether we'd best look to WHO for reliable information about the virus, the disease and anynew mutations which might arise. Mike Pence does not have appropriate credentials .Sincerely,D.A. Sonneborn, Ph.D.(b)(6)NIH-001085From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 20:09:38 +0000Corey MD, LarrySubject : RE: Mike Pence?I am not going to CROI. I am sending in a taped short discu ssion of NIH research response to COYID-19Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institu tes of HealthBethe sda, MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail (b)(6)The informa tion in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. lf you have received this e-mail in e1TOrplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not expressly made on behalf of the NlAID by one of its representatives.-----Original Message----- From: Corey MD, Larry _-_-_-__-_-_- ~~ C_b)_(_.>Sent: Sunday , March 1, 2020 3:00 PM ------~~ To: Fauci, Anthony (NlH/NlAID) [E] (b)( ·Subject: Mike Pence ?Ah the great communicator of infectious di,ease epidemiology and pathogenesi s.On way back from (b) ( . News travels fast among the aficionados.We need a POW wow with John and Carl on the path to (b)( 4) J will _________________ _,schedule. You coming to CROI '? lfnot 1 could pop down to you.Excuse the I phone typing. On the runway leaving (b) (~Sent from my iPhoneNIH-001086From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 19:49:51 +0000Jon LaPookSubject: RE: My 11CBS Sunday Morning" 5-mi nutes shpiel on coronavirus and COVID-19Outstanding! !Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBui I ding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892 -2520Phone: (b) (6)FAX: (301 496-4409E-mail (b)(6) -------- The inform ation in this e-mail and any of its attachments is confiden tial and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any stateme nts made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representatives.-----Original Message-----From: Jon LaPook_ ____ "("b"' ')"("="Sent: Sunday, March 1, 2020 11: 27 AM-- -----c,-,-c c=,, To: Fauci, Anthony (N1H/N1AID) [E] (b)(6)Subject: My "CBS Sunday Morning" 5-minutes shpiel on coronavirns and COVID-19Tony,Here you go. You can enjoy it in al your spare time. Hope you managed to clear your desk last night.https://vimeo.com/user 10844306 /review/394 766243/cbaS l 43d0dBest,JonJonathan LaPook, M.D.Chief Medical Correspondent, CBS NewsProfessor of MedicineNYU Langone HealthTwitter @DrLaPookNIH-00 1089From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 19:31:54 +0000Jeffrey V. RavetchCc: Stelios BournazosSubject : RE: Fe modifications for protective anti-COVID-19 ant ibodiesJeff:Thanks for the note and the slide. Very interesting. Please send me thepreprint when it becomes available.Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail , (b)(6)The information in this e-mail and any of its attachments is confidential and may conta in sensitiveinformat ion. It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Jeffrey V. Ravetch ----------- (b)(6)Sent : Sunday , March 1, 2020 12:43 PM ------~~ To: Fauci, Anthony (N,IH../N..I;A.I .D ). :[.E.]. .:....:.::::===(b=)(6)= ~~ Cc: Stelios Bournazos ------------ (b) (6) Subject : Fe modifications for protective anti -COVID-19 antibodiesDear Tony,I wanted to share a very recent and surprising result we've obtained on themechanism of antibody protection for anti-viral antibodies. We've previously shownthat bNAbs to flu and HIV require FcR engagement for their in vivo potency.Enhancing activating FcR engagement increases the potency of these antibodies byan order of magnitude, on average, and thus are significant contributors to anti-viralprotection.NIH-001090We'll be writing up this story shortly and would be happy to share a pre-print withyou .Sincerely,JeffNIH-001091(b) (4)From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 19:30:12 +0000To: Grandi, PaolaSubject: RE:- ------ (b)(Dr. Grandi:Best regards ,A.S. FauciAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb()6 )(b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Grandi, Paola (b) (Sent: Sunday, March 1, 2020 12:59 PM To: Fauci, Anthony (NIH/NIAID) [E)- _-_-_-_- -~~ C_Hb_6)Subject: (b) (Dear Dr. Fauci,(b)(6)NIH-00 1092(b)(6)Please let me know if you would like to discuss this further . I was a former professor at the University ofPittsburgh and now (b) (6)would also be available to discuss. My cell phone is -----Best Wishes,Paola Grandi PhD M BA(b)(6)NIH-001093From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Sun, 1 Mar 2020 19:22:37 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Novel Treatment for Reducing Symptoms Associated with Coronavirus(COVID-19) - "Non-Confidential"Attachments : (O) The Science of Exulta for the Common Cold.pdf, 1) METHODS ANDCOMPOSITIONST O INHIBIT SYMPTOMS ASSOCIATEDW ITH VIRAL UPPERR ESPIRATORYT RACTINFECTIONS.pdfPlease handl e .Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Jim Iversen (b)(6)Sent: Sunday, March 1, 2020 1:53 PM ------~~ To: Fauci, Anthony ( NI_H./:N._. I_A_ID ..): ..[: .E..):..::::::=-~;---- (b-) _(6) >Cc: Jacqueline Iversen (b)(6)>Subject: Novel Treatment for Reducing Symptoms Associated with Coronavirus (COVID-19) - "No nConfidential"Dear Dr. Fauci,Sen-Jam Pharmaceutica l has a product under development to reduce the symptoms associated withUpper Respiratory Infection (URI). We believe it could provide relief to a large number of people dur ingthe COVI0-19 pandemic. Our produc t SJP-002 is a combination of an NSAID and a non-sedatingantih istamine and does not include a decongestant. Removing the decongestant makes our productideal for treating the symptoms associated with COVID-19 in pat ients with cardiac conditions whocannot tolerate taking a decongestant.What makes our product novel is that it can be administered early in the treatment phase, therebyreducing the excessive accumulation of inflammat ion, which typically results in head congestion,pulmonary congestion, coughing, & sneezing. Our experience has shown that at the 1st signs ofexperiencing symptoms of URI an indivi dual's symptoms can be drasti cally reduced after ta king ourNIH-001094product twice a day for 3 days. The dramatic reduction in inflammation has the potential to reduce thespreading of the virus by means of cough, sneezing, and spreading of germs through cont act. Current ly,when individuals experience the start of a URI, there is little effective intervention available to changethe course of the infection . Individuals delay administer ing pharmaceutical agents, until theircongestion becomes intolerable and excessive.Attached is a copy of our early research and a copy of our non-provisional patent. I share thisinformation with the hope of providing some background for an immediately accessible, safe treatment,alternative to slow the pace and impact of the pandemic.le t me now if we can be of any additional help?Thanks and all the best,JimseN-JaM,,_.._ I U C JIIJim IversenCEOSen-Jam Pharmaceutical223 Wall St., #130Huntin ton , NY 11743(b)(6)--- ~--c=sen- jam.comLinkedin : llnkedin .com/in/jimiversenNIH-001095From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 19:21:51 +0000Lawrence 0. Brown, Ph.D.Subject : RE: Info re Covid-19I can assure you that I am not being censored.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Lawrence 0. Brown, Ph.D. --------- (b)(6)Sent : Sunday, March 1, 2020 1:57 PM To: Fauci, Anthony (NIH/NIAID) [E)-- -----------~-~ Cb)( > Subject : Info re Covid-19Dear Dr. Fauci,Those of us who seek factual, scientifically -based information to the highest degree that it is possible toobtain it will remain hungry and on the alert for whatever complete, up-to -the-moment informationthat you may have as humanity proceeds deeper into the Covid-19 potential pandemic. We have trustedyou through several previous epidemics to provide such information. Therefore, I know I'm not alone inbeing appalled and frightened by President Trump wanting you to issue info rmation about the currentcrises only after it has been cleared by his administration. In his off ice as President, Donald Trump maybe de facto, Commander-in Chief. There is nothing about his office that confers Expert-in-Chief on him,and what he chooses to say or not say about Covid-19 and its spread should not be treated by the mediaor anyone as information that is trustworthy for being factual and scientifica lly-based information tothe highest degree tha t it is possible to obtain.I hope that you will find it in yourself and in the mission of your office to publicly assure the Americanpublic in no uncertain terms that you will not be censored, and that you will honor the public's trust tocontinue to provide real, research-based information about the frightening health nightmare that allhumans are facing in a way that distinguishes us from China's government in its disgraceful anddestructive efforts to muzzle those experts who might be able to save lives by merely speaking truth to apopulation whose health depends on having fact-based, totally un-massaged know ledge as soon as it isavailable.NIH-001096It is with our lives, the lives of our families, and the lives that make up our nation that we are count ingon you.Sincerely yours,Lawrence 0 . Brown, Ph.D.Clinical Psychologist/Psychoanalyst(b)(6)(b)(6JNIH-001097From: Fauci, Anthony (NIH/NIAID) [ElSent : Sun, 1 Mar 2020 16:25:41 +0000To: Marston, Hilary (NIH/NIAID) [ElCc: Conrad, Patricia (NIH/NIAID) [E);Folkers, Greg (NIH/N IAID) [E];Mascola, John(NIH/VRC) [E];Lerner, Andrea (NIH/NIAID) [E)Subject: RE: Background brieferAttachments : 20200229_VRCModerna mRNA candidate briefer - with Fauci edits.docxHere it is.From: Marston , Hilary (NIH/NIAID) [E] (b)(6)>Sent: Sunday, March 1, 2020 10:09 -A-M- --- ..,.....,..-= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Cc: Conrad, Patricia (NIH/NIAID) [E] (b) ( ; Folkers, Greg (NIH/NIAID) [E](bH6J>; Mascola, John (NIH/VRC) [E] (bH6J>; Lerner, Andrea(NIH/NIAID ) [E) (b)(6)Subject: Background brieferASF:Attached please find a proposed background briefer for the visit to the YRC (big thanks to John, Barney,Kizzmekia, the rest of their team and Andrea and Greg). We focused on the VRC itself and the mRNAcandidate, figuring that the VPOTUS office would have a tick tock etc. VRC also prepared ta lking pointsfor the round table should those be requested (I have those if you'd like to see them now, but so far theWhite House has not asked for this).Available by cell. -----(b)(6)NIH-001098From:Sent :To:Subject:Sharon:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 15:48:15 +0000Sharon EblenRE: Thank YouMany thanks for your kind words.Best regards,TonyFrom:S haron Eblen -------- (b)(6)> sent: Sunday, March l, 2020 10:45 AMTo: Fauci, Anthony (NIH/NIAID) [E)------= (b")"('=6J>Subject: Thank YouGood Morning Dr. Fauci,I just wanted to say a quick thank you for your recent words to the public. I am a high school physicsteacher, and I recognize the importance and the challenges of conveying scientifically accurateinformati on to the public. I watched you speak in the two recent press conferences held by t hePresident, and I appreciated the way in which you communicated difficult information regarding thenovel coronavirus. Please keep up the good work during what I'm sure is a very stressful time for youand everyone at the NIH.Sincerely,Sharon M. EblenNIH-00 1099From:Sent:To:(b)(6)Sun, 1 Mar 2020 10:34:15 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: NPR interview request: Or. FauciSent from my iPhoneBegin forwarded message:From: HJ Mai <HMai@npr.org>Date: March 1, 2020 at 10:29:41 AM ESTTo: "Fauci, Anthony (NIH/NIAID) [E]" -------~~Cc: "Billet , Courtney (NIH/NIAID) [E]" ---------- Subject: NPR interview request: Dr. FauciDear Dr. Fauci,I'm sorry to bother you on a Sunday, but with the fi rst coronavirus death of a U.S. patientin Washington state, we are wondering if you would be available for a live interviewtomorrow morning our show.We would like to talk to you about the significance of the death in Washington and whatstates can/must do to prevent a widespread outbreak.Kind regards,HJFrom: HJ Mai <HMai@npr .org>Sent: Friday, February 28, 2020 6:54 AMTo: Fauci, Ant hony (NIH/NIAID) [El ':::=====~~Cc: Billet, Courtney (NIH/NIAID) [El -------- Subject: Re: Confirmat ion of reportThank you for your reply Dr. Fauci.Sent from my iPhoneOn Feb 27, 2020, at 10:57 PM, Fauci, Anthony (NIH/N IAID) [E)--------- (b) (6), wrote:NIH-001100This is really not true . It was taken vey much out of context .From: HJ Mai <HMai@npr .org>Sent: Thursday, February 27, 2020 2:09 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)> _______ _,Subject: Confirmation of reportDear Dr. Fauci,This is HJ from NPR again. I was wondering if you could confirm a NYT reportthat says the White House has instructed you not to say anything about thecoronavirus outbreak without prior approval.Kind regards,HJ<image00 l .jpg>I HJ Mai I Editor, Morning Edition I hmai@npr .org I ___ Cb>C6)NIH-001101From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 12:39:59 +0000Conrad, Patricia (NIH/NIAID) [ElRE: VIP visitI hope that someone in Building 1 is letting the Secretary's office know that the VP and POTUSare coming to NIH.From: Conrad, Patricia (NIH/NIAID) [E] ---------- (b)(6)Sent: Sunday, March 1, 2020 6:58 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6) Cc: Folkers, Greg (NIH/NIAID) [El ,-.-.;-.!-:-=-=-=-=-==(b~)(6~) Subject : Fwd: VIP visitSent from my iPhoneBegin forwarded message:From : "Blackburn, Amy (NIH/OD) [El" (b)(6)>Date: February 29, 2020 at 8:16 :21 PM EST ------- ~= To: "Conrad, Patricia (NIH/NIAID) [E]" CbH >, "Burklow, John {NIH/OD)[E)" (b)( >, "Folkers, Gr_e:g::(.. N:_.I.H. ;/_N_IA_ID:)..[:.E.:.:.l."..=. ~:;----- (b)-(-6)Cc: "Daucher, Marybeth (NIH/NIAID) [E)" --------- (b)(6)> Subject: RE: VIP visitHi Patty,This is just my really rough draft of an agenda. ------------- (b)( 5)Just let me know the timing of things .-----Origi na I Message-----From: Conrad, Patricia (NIH/NIAID) [E] (b)( >Sent: Saturday, February 29, 2020 7:53 PM ------~~ To: Burklow, John (NIH/OD) [E] (b)(6); Blackburn, Amy (NIH/OD) [E]-------- (b)(6); Folkers, Greg (NIH/NIAID) [E] (b)(6) Cc: Daucher, Marybeth (NIH/NIAID) [E] (b)(6)Subject: VIP visitNIH-001102Per Dr Fauci- for the round table - he is thinking thattomorrow.Sent from my iPhoneNIH-001103From:Sent :To:Subject:Bob:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 12:12:35 +0000Bob FrankenRE: I'd like to ta lkThanks for the note. I look forward to seeing you again soon.Best regards ,Tony----- Origina l Message -----From: Bob Franken ------~ (b~)~(6=)>Sent: Sunday , March 1, 2020 7: 11 AM ------ --....-,..-- To: Fauci, Anthony (NTH/NIAID) [E] (b)(6)Subject: Re: I'd like to talkTony,First of all, thank you for getting back to me, in spite of the fact that you are so busy.Secondly, it's nice to know they're not muzzled, since you are so incredibly good at making science speak so easy tounderstand for dummies like me .Once the dust settles , I'd live to see you , to pay attention to our long friendship . Meanwhile, best ofluck.BobBob Franken,V\VW .bobfranken.tv> On Mar 1, 2020, at 6:53 AM, Fauci, Anthony (NlH/NIAlD) [E]- -------- Cb()6 )> wrote: >> Bob:> Thanks for tbe note . I hope that all is well with you. I have never been given orders to get approval from theVP's people to speak publicly about coronavirus. Ever since I have been doing this since the Reaganadministration, whenever a member of the Executive Branch such as me gets invited and goes on National TV suchas the Sunday Talk shows, there is always a routine proces s of clearing it with your department (in this case HHS)who then clears it with the White House. This is routine and has been true for the Reagan , Bush '41, Clinto n,Bush'43, Obama, and oow the Trump administrat ion. Tt is merely a formality so that they know what is comi ng outfrom the executive branch. I have always gotten clearance with very few exceptions over the past 35 years (usuallybecause they do not want you on TV al the same time that the Pre sident is making an importan t announcement). 1have never been muzzled or told that I could not spea k out publicly about anything during this administration.> I hope that this is he lpful.> Best regard s,> Tony>> -----Original Message-----> From:B ob Franken-------~ (b-)~(6=)>> Sent: Saturday, February 29, 2020 6:12 AM> To: Fauci, Anthony (NTH/NIAID) [E]-----~ (b~)(~6)> Subject: I'd like to talk>>Tony,>> 1 know you're busy, but I'd like to have a brief conversation with you.NIH-001104NIH-001105> I'm now a syndicated political columnist , writing for King Features. You don 't be surprised to hear that mycolumn is described as "an extended middle finger pointed in all directions".>> Notwithstanding tgat, what I'd like to discuss with you is any orders you've received to get approva l from theVice President's people to speak pub licly about the coronavirus.>> It can be on any basis you choose , on the record, or off. On background (knowledgeable sources) , deepbackground (sources) , whatever.>> May I call you?>> Best,>> Bob>> Bob Franken> www .bobfranken .tvFrom:Sent :To:Subject :Let us discuss.Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 12:03:24 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Connecting you twoFrom:C ollins, Francis (NIH/OD) [El_ _____...._ (b)( '>Sent: Wednesday, Febru ary 26, 20 20 7:59 AMTo: Michael Milken (mmilken@knowledgeu .com) <mmilken@knowledgeu .com>Cc: Fauci, Antho ny (NIH/ NIAID) [El (bH >Subject: Connecting you twoHi Mike,Thanks for your call on Monday evening. I've reached out to Tony Fauci and he is interested in speakingwith you about how your connections with philanthropy and industry might help as we face a majorchallenge from coronavirus. I'm ccing Tony on this e-mail and his cell phone is (b)(6). I've alsogiven him your coordinates.Best, FrancisNIH-001106From:Sent :To:Subject:We can discuss.Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 12:02:07 +0000Conrad, Patricia (NIH/NIAID) [ElRE: VIP visitFrom: Conrad, Patricia (NIH/NIAID) [E)Se nt: Sunday, March 1, 2020 6:58 AMTo: Fauci, Anthony (NIH/NIAID) [E]--------=- (b'")("=6')>Cc: Folkers, Greg (NIH/NIAID) [El (b)(6)Subject: Fwd: VIP visitSent from my iPhoneBegin forwarded message:(b)(6)>From: "Blackburn, Amy (NIH/OD) [El" CbH >Date : February 29, 2020 at 8:16:21 PM EST ------- -== To: "Conrad, Patricia (NIH/NIAID) [El" CbH6J",B urklow , John (NIH/OD)[El" (b)(6), "Folkers, Greg (NIH/NIAID) [El" (b)(6)Cc: "Daucher, Marybeth (NIH/NIAID) [El" (b)(6)Subject: RE: VIP visitHi Patty,This is just my really rough draft of an agenda. -------------- (b) (5)Just let me know the timing of things.-----Origi na I Message-----From: Conrad, Patricia (NIH/NIAID) [E] CbH >Sent: Saturday , February 29, 2020 7:53 PMTo: Burklow, John (NIH/OD) [El ----- -(=b")-("=6"J' >;B lackburn, Amy (NIH/OD) [El------- (b)( >; Folkers, Greg (NIH/NIAID) [El (b)(6) Cc: Daucher, Marybeth (NIH/NIAID) [El (b)(6)>Subject: VIP visitPer Dr Fauci- for the round table ------------------ (b)(S' ,NIH-001107(b) (5)-------------------- · This will get more fleshed outtomorrow.Sent from my iPhoneNIH-001108From:Sent:To:Subject:Bob:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 12:01:19 +0000Geller, Robert D.RE: COVID-19 QuestionsThanks for the note. I hope that all is well with you. Use an N95 if you have them available.Transmission is similar to influenza: respiratory droplets and likely a bit more as aerosol thanwith influenza . People can transmit even when they are asymptomatic . No approvedt herapies; however, we are doing clinical trials on 're-purposed" drugs such as remdesivi r(Gilead), Vaccine going into phase 1 trial in about 6 weeks, but will not be ready for at least 1.5years.Hope that this is helpful.Best regards,tonyFrom: Geller, Robert D. <RGeller@fhn.org>Sent: Wednesday, February 26, 2020 1:10 PM -------~~ To: Fauci, Anthony (NIH/NIAID) [E]- -------- (b)(6J> Subject: COVID-19 QuestionsTonyThanks for everything you are saying and doing. I'm writing to ask for the latest. Thanks Bob.What about general care of a patient suspected or confirmed COVID-19. N95 or surgical mask? Anynews on how this disease is being transmitted? Anything new on vaccine or treatmen t?This e-m.ail message and any attached file(s) is intended for the use of the individual or entity 10 which it is addressed and may contain information that is pri,~legcdand confidential. If the reader of this message is not the intended recipient or an agent or employee of the intended entity, you are hereby notified that anydissem i.nation, distribution , or copying of this com municati on is strictly prohib ited. If you have received the message in error . please notify the sen der immediatelyfor instruct ions . Thank yo u.NIH-001109From:Sent :To:Fauci, Anthony (NIH/NIAID) [ElSun, 1 Mar 2020 11:55:59 +0000Anderson, Jennifer (NIH/NIAID) [ElSubject :Attachment s:FW: Opportunity for a Research Position(b)(6)Please take a look and hand le.From: M. Burhan Majeed Rana <1- ------------- (b)(Sent : Thursday, February 27, 2020 -9-:0-7 -A-M- ..,.....,..-= To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)Subj ec t : ------------ (b)(6)Dear Dr. Fauci,Kindest regards,Rana, M uhammad Burhan MajeedNIH-001110(b)(6)From:Sent :To:Subject:W innie:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 04:14:20 +0000Winnie StachelbergRE: POSTED: Thinking CAP: Dr. Anthony Fauci: The Global Fight Against HIV/AIDSThanks for your note .Best regards,TonyFrom: Winnie Stachelberg <wstachelberg@americanprogress.org>Sent: Thursday, February 27, 2020 8:02 AM --------, .----..-.= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: RE: POSTED: Thinking CAP: Dr. Anthony Fauci: The Global Fight Against HIV/AIDSTony - sending you an email to say thanks for your steady hand at the helm in this current challengewith Coronavirus . You are such an essential part of our government's response to this public healthchallenge .Please let us know if there's anyth ing we can do at CAP to assist. We plan on hosting an event next weekand I'll send you details as they come togethe r.Again, thank you .WinnieFrom: Winnie StachelbergSent : Monday, August 19, 2019 10:42 AMToi (b)(6)Subject: FW: POSTED: Thinking CAP: Dr. Anthony Fauci: The Global Fight Against HIV/AIDSTony -Thank you so much for participating in CAP's podcast, Thinking CAP earlier t his month . We think theinterview turned out very well and hope you think so, too .Have a good rest of the month and Labor Day and I hope our paths cross again soon - either in theneighborhood or at work.WinnieFrom: Steve Bonitatibus <sbonitat ibus@americanprogress.org >Sent : Thursday, August 15, 2019 11:21 AMTo: Posted Products <postedproducts@ame ricanprogress.org>Cc: Kyle Epstein <kepstein@am ericanprogress.org>; Chris Ford <cford@ame ricanprogress.org>; DaniellaNIH-001111NIH-001112Leger <dleger@americanprogress.org >Subject: POSTED: Thinking CAP: Dr. Anthony Fauci: The Global Fight Against HIV/AIDSDaniella sits down with renowned immunologist Dr. Anthony Fauci to discuss how the UnitedStates has and can continue to combat the HIV/ AIDS epidemic, both domesticall y and abroad.https://www.americanprog ress .org/issues/hea lthcare/news/20 19/08 /15/473666/ dr-anthonyfauci-global-fight-hiva ids/For decades , the HIV/AIDS epidemic has been among the most challenging globalhealth issues to contain. Enter Dr. Anthony Fauci, immunologist and director of theNational Institute of Allergy and Infectious Diseases at the National Institutes of Health.As one of the foremost experts and advocates against the HIV/AIDS epidemic , Dr.Fauci exuded optimism when talking about the progress being made in both global anddomestic containment of the disease. He sat down with Daniella for an interview todiscuss his work fighting HIV/AIDS and to share his thoughts on the growing , dangerousanti-vaccination movement.Learn more about the podcast here.Daniella Gibbs Leger is the executive vice president for Communications andStrategy at the Center for American Progress. Ed Chung is the vice president forCriminal Justice Reform at the Center. Kyle Epstein is the media relationsmanager at the Center. Chris Ford is the broadcast coordinator at the Center.From:Sent :To:Subject :Howard:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 04:13 :25 +0000Howard SchatzRE: CommiseratingMany thanks for your note. Much appreciated.Best regards,TonyFrom:H oward Schatz- ------------(b)(6J> Sent : Thursday, February 27, 2020 8:51 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E]- ------- CbH6J> Subject: CommiseratingTony,Watching the spread of the Coronavirus worldwide(?), I can't help but feel for you, as well as the world'spopulation .It must be both challenging as well frustrating to be unable to control every important "leak" and thenwatching the consequences.I wou ld think it's also sort of exciting, while also being horrib le, given this is what you've trained formost of your professiona l life.And, I would think that most of your other important works need to be put on hold?Wishing you (and all of us) the best of luck,HowardNIH-001113From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 04:02:52 +0000David FolkenflikSubject : RE: Following upI have never been inhibited from interacting with the press.-----Original Message -----From: David Folkenflik <DFolkenflik@npr.org >Sent: Friday, February 28, 2020 7:36 A-M- ----~~ To: Fauci , Anthony (NIH/NIAID) [E]...__ ____ C)bC6.lSubject: Following upDr Fauci -T cover media and flow ofinfomiation to public for NPR and am also a host. (You and I once spoke yearsago when T covered Johns Hopkins over a science research issue.)You told a colleague the report you couldn't comment on Corona virus was taken out of context. In what way?Tbankyou -DDavid FolkenflikHost and Editor, NPR's On PointMedia Correspondent, NPR News11 W 42nd St19th FloorNew York NY 10036o) 212.880 .3438m) (b)(e) dfolkenflik@npr.orgSent from my iPhoneNIH-001114From:Sent:To:Subject :Andy:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 04:01 :29 +0000Andrew C von EschenbachRE: QuestionThanks for the note. l am sure that the Chinese are looking at this, but I have not seen any data in th.is regard,will try to find out if anyone is looking at th.is in the USA patients.Best regards,Tony-----Original Message-----From: Andrew C von Eschenbach _________ (b~_(6),Sent: Friday, February 28, 2020 9:52 A-M-- ---~~ To: Fauci, Anthony NTH/NIAID ) [E]_ _____ (bH_6J>; Fauci, Anthony (NfH/NIAID) [E](b)(6) >Subject: QuestionTonyDoes anyone know what the NK cell profile was like in patients who succumbed to Coronavirus? Is there adifference in imm une profile betwe en mild and severe cases?Anyone looking at that?Miss being there at your side in this batt le Andy PS Thank you and your team for guiding the Celularity team to getit right. Also you have as always, my utmo st respect for being the "good and faithful servant''Andrew C. von Eschenbach MDSamaritan Health Init iati vesNIH-001115From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 03:57 :44 +0000Strauss, Eric M.Subject : RE: 500k dead? (Background)That number seems exceptionally high.From: Strauss, Eric M. <Eric.M .Strauss@abc .com>Se nt: Friday, February 28, 2020 10:34 AM ------~~ To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)Subject: SO0k dead? {Background)Hello Dr Fauci: Hope you're holding up well. Remember to rest and hydrate!We had a DHS person tell us epidemiology models for US show worst case scenario 98m get COVID-19and S0Ok dead .I've seen models all over the board. And Dr Jen and I are keeping our coverage on point on what weknow and what we don't know .If that a possible number for our plann ing? Or is that outlandish?Thx.- EMSEric M. Strauss, ABC NewsManaging Editor, Medical Unit(b)(6)@ericMstraussNIH-001116From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 03:49:57 +0000Cassetti, Cristina (NIH/NIAID) [E]FW: coronavirusPlease take a look and handle. Thanks.From: William H. Sherman, MD ------------ (b)(6) Se nt: Friday, February 28, 2020 11:11 AMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b-)c(c-6-)=Subject: coronavirusAnthony Fauci, M.D.(b)(6)Dear Dr. Fauci:William H. Sherman M.D.(b)(6)I reviewed the publications about the last 2 coronavirus infections. Both MERS and SARS were severe,short lived problems that have not recurred. One would expect Covir-19 to follow a simi lar path : infecta wide group of susceptible people and then disappear, If that is so, anything that is more than sixmonths away may not be of value-remdisivir or a vaccine. Even if remdisivir works, it will take monthsto produce sufficient amounts to treat this illness.Has ribavirin been assessed for an ability to slow down the replication of this virus? We do not need toeradicate the virus. Just slowing down the rate of symptoms progression would allow time for theimmune system to mount a curative response.Ribivirin is the only approved anti-viral that may have shown some clinical benefit against similarcoronavirus infections, but the reports are anecdotal and the benefit short term . It was onlyadministered to a few patients who were already on respirator support, and most still died. If their lungswere already destroyed, eliminating the virus would not change the outcome. There were no studies oftreating mild illnesses before they progressed to needing respirator support. If the 50 year oldcoronavirus patient described in the Lancet had been treated in first week of symptoms, before needingrespiratory support, he may have survived . On autopsy, most of his lung had been destroyed .If ribavirin has even marginal benefit, decreasing hospitalization by 10% yields an enormous savings. I donot have access to the data on this virus and the possible effects of the antivirals that have beenevaluated. However, ribavirin has any effect on viral pro liferation, we can write and a randomized trialof ribav irin (b) (4)(b) (4)NIH-001120NIH-001121I look forward to hearing from you about the data on ribavirin against this virus and your thought on thisclinical study.Sincerely,William H. Sherman , M.D.From:Sent :To:Subject:Let us discuss.Fauci, Anthony (NIH/NIAIO) [ElSun, 1 Mar 2020 03:49:28 +0000Conrad, Patricia (NIH/NIAID) [E)FW: The Aspen Institute event todayFrom: Sabrina Ma lhi <smalhi@thehill .com>Sent: Friday, February 28, 2020 11:14 AM To: Fauci, Anthony (NIH/NIAID) [E]-- ------------ -(b=)( 6J~> Subject : Re: The Aspen Institute event todayHi Or. Fauci,The whole country is in a panic, could you write on beha lf of the NIH regarding the coronavirus, please?Your vo ice is very impor tant on this topic .Thanks,SabrinaOn Tue, Feb 11, 2020 at 7:12 PM Fauci, Anthony (NIH/NIAID) [El- ------- (b) C > wrote:Sabrina:Many thanks. It was nice to meet you today. I certainly will keep your offerin mind .Best rega rds,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892 -2520Phone (b) (6)FAX: (301) 496-4409E-mail : -------- (b)( 6) The information in this e-mail and any of its attachments is confidential and may containsensitive information . It should not be used by anyone who is not the original intendedrecipient. If you have received this e-mail in error please inform the sender and delete it fromyour mailbox or any other storage devices . The National Institute of Allergy and Infec tiousDiseases (NIAID) shall not accept liability for any statements made that are the sender 's ownand not expressly made on behalf of the NIAID by one of its representatives .From: Sabrina Malhi <smalhi@t hehi ll.com>Sent: Tuesday, February 11, 2020 2:58 PMNIH-001122To: Fauci, Anthony (NIH/NIAID) [E] ~. .._ ____ C_Hb.~ ...>.Subject: RE: The Aspen Institute event todayHi Or. Fauci,It was nice meeting you at the event regarding the coronavirus today at The Aspen Institute. Yourexpert voice on the virus would be great to have in our publication.As I mentioned, I am an opinion editor at The Hill and one of the areas that I focus on is health care.Please let me know if you 'd like to discuss some ideas. I look forward to hearing from you!Best,SabrinaBest,Sabrina Malhi Associate Editor I The Hill*Please note that my email address is now smalhi@thehi ll.com.Best,Sabrina Malhi Associate Editor I The Hill*Please note that my email address is now srnalhi@thehill.com.NIH-001123From:Sent:To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 03:24:03 +0000Gallin, John (OD) [El(b)(6)Subject: RE: Coronavirus vaccine centerFrom: Gall in, John (OD) [El Cb)( >Sent: Friday, February 28, 2020 1:52 PM -------- ...= To: Lane, Cliff (NIH/NIAID) [El (b)( >; Davey, Richard (NIH/NIAID) [El(b) (6) >Cc: Fauci, Anthony (NIH/NIAID) [El (b)(6J>Subject : Fwd: Coronavirus vaccine centerCliff and Rick (and Tony if you have time)My friend Barry Coller isbelow). Do you know if there is any need for this?Thanks.JohnSent from my iPhoneBegin forwarded message:From: Barry Coller (b)(6)>Date : February 27, 2020 at 10:34:24 PM ESTTo: "Gallin, John (OD) [El" (b)(6)Cc: Barry Coller ----------- (b)(6) Subject: Coronavirus vaccine centerJohn,I suspect that this is an incredibly busy time for you and the Clinical Center.Tony was fantastic last night. Please let him know that he is my hero!NIH-001127(b) (5'(b) (4) (see(b) (4)(b) (4)If you know of any organizations or companies that are looking for sites to conduct vaccinestudies, or if you would like us to collaborate with you to get studies completed morerapidly, please keep us in mind.I am going crazy writing ourBest regards to (b) (6)Barry------------ ~= (bH4J n d .1 t J.u st ge t s h ar d er.NIH-001128From:Sent:To:Subject:Let us disc uss.Fauci, Anthony (NIH/ NIAIO) [E)Sun, 1 Mar 2020 03:17:42 +0000Conrad, Patricia (NIH/NIAID) [ElRE: Brookings InvitationFrom:C onrad, Patricia (NIH/NIAID) [E)- -------- (b)(6)> Sent: Friday, February 28, 2020 2:26 PMTo: NIAID OD AM <NIAIDODAM@niaid .nih.gov>Subject: FW: Brookings InvitationPatric ia L. ConradPublic Health Analyst andSpecial Assista nt to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Inst itutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda , Maryland 20892(b)(6)301-496-4409 faxDisc laimer:The information in this e-mail and any of its attachme nts is confidential and may contain sens itive information. It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. National Institute of Allergy and Infectious Diseases (NIAID) shall not acceptliability for any statement made that are sender"s own and not expressly made on behalf of the NIAID by one of its representatives.From: John Allen <JAllen@brook ings.edu>Sent: Friday, February 28, 2020 2:23 PMTo: Fauci, Anthony (NIH/NIAID) [El ------= (bsH-=6.-)>; Conrad, Patricia {NIH/NIAID) [El(b)(6)Cc: Lucy Kim <LKim@brookings.edu>Subject : Brookings InvitationDr. Fauci,Greetings from the Brookings Institution. I'm writing to share the attached invitationfor you to speak to our Board of Trustees at th eir annual dinner on Thur sday, March 5here in Washington, DC. The Brookings Board is a distinguished group of business andcommunity leaders ... I know they would be very eager to hear your thou ghts, especiallyon the coronavirus crisis given its spread into the U.S. If this date does not work withNIH-001129NIH-001130your schedul e, we'd be glad to welcome you to Brookin gs at a mor e convenient tim e.I very much appreciate you considering our request, Dr. Fauci!My very best,John R. AllenPre sidentThe Brookings InstitutionFrom:Sent :To:Cc:Subject:Richard:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 02:58 :01 +0000Hodes, Richard (NIH/N IA) [E]Cassetti, Cristina (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [ElRE: SASP and Coronovirus 19Let me refer the e-mail to Cristina Cassetti who is in charge of the COVID-19 issues in our program. By this emailI will ask her to look into this and get back to Jim Kirkland.Best regards ,TonyCr istin a:See my note above to Dr. Hodes.Thanks,Tony-----Original Message-----From: Hodes, Richard (NIH/NlA) [E] ,___ ___(b)(_ _Sent: Saturday, February 29, 2020 9:3-2 -PM- ----=-::-=, To: Fauci, Anthony (NIH/NIAlD) [El ______ C>b<_·Subject: FW: SASP and Coronovirus 19m Tony,Please f~e me for intrudjwu>~our oven¥he lming_OJi orities. If ou have a moment to read the emai l below(b) (4)"B"-e-st_ _____________________ (b) (_4 ) Thanks for any suggestions.Richard-----Original Message-----From: Kirkland, James L., M.D., Ph.D.- --------- (b)( Sent: Saturday, February 29, 2020 8_:58_PM_ ___ ~~To: Hodes , Richard (NIH/NIA) [E]Cc: Sierra, Felipe (NlH/NIA) [E] ------- Subject: SASP and Coronovirus 19Dear Richard ,1 am sorry to bother you late on a Saturday, but I wanted to let you know that we are finding in as yet unpublished(b) (4)NIH-001133(b) (4)JimSent from my iPadNIH-001 134From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sun, 1 Mar 2020 01:27:44 +0000Barton Haynes, M.D.Subject :Than.ks, Bart.Anthony S. Fauci, MDDirectorRE:National Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda , MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. lf you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectio us Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message----From: Barton Haynes , M.D.Sent: Saturday , February 29 , 2020 8:25 PM(b)(6)To: Fauci , Anthony (NlH/NlAID) [E] -------------=- ---(b)( Subject: RE:Great job in the press conference today.Tough and high pressure situations it seems.Thanks for being there and representing truth and scie nce ... best b-----Original Message -----From: Fauci , Anthony (NTH/NIAID) [E] (b)(6) >Sent : Saturday, February 29, 2020 7: 14 PMTo: Barton Hay nes, M.D. (b)( ; Marovich, Mary (NlH/NIAID) [E]_______ C_b~_(6) > ; Dieffenbach, Carl (NlH/NWD) [E) < (b) (6)>Subject: RE:Impressive!Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Infectious Diseases Building 31, Room 7A-0331 Center Drive, MSC 2520National Institu tes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX: (301) 496-4409E-mail: (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitive information. ItNIH-001135should not be used by anyone who is not the original intended recip ient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NI AID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIA TD by one of its representatives.-----Original Message- ----From: Barton Haynes , M.D. (b)(Sent: Saturday, February 29, 2020 2:29_ P_M _____ ~~To: Fauci , Anthon (NIH/NIAJD) [E] (b)( ; M-a-ro-v-ic-h-, -M-a-i -----=-:=i ---------- (b) (6) ; Dieffenbach , Carl (NII-1/NIAID) [E] __________ __,,Subject: FW:Hi Tony, Mary and Carl:Every Saturday am, the DHVI team meets in my office to work on moving the HIV vaccine work forward, and nowa new contingent is also working on coronavirus vaccine and new therapeutics.This picture was from 9 am this Saturday morning. Great and dedicated crew listening to the presentation of data!Best bart-----Original Message----From: Barton Haynes , M.D.Sent: Saturday , Febrnary 29, 2020 2:25 PMTo: (b)(6)Subject:NIH-001136From:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 01:09:29 +0000Routh, Jennifer (NIH/NIAID) [E]RE: ClipsThanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBui I ding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892 -2520Phone: (b) (6)FAX: (30 I) 496-4409E-mail: -------- (b)(6) The inform ation in this e-ma il and any of its attachments is confiden tial and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipient. If you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any stateme nts made that are the sender's ownand not expressly made on behalf of the NIAID by one of its representatives.-----Original Message-----From: Routh, Jennifer (NIH/NIAID) (E] (b) (Sent: Saturday , February 29, 2020 10:32 AMTo: Fauci, Anthony (NIH/NIAID) [E] ------~-~Cc: Billet, Courtney (NlH/NlAID) [E] (b)(6) ; Stover , Kathy (NTH/NIAID) [E]______ .C.,b.H6) >; Folkers, Greg (NIB/NI AID) [E] (b)(6) ; Conrad , Patricia(NTH/NlAID) [E] Cb) (6)1>Subject: RE: ClipsDr. Fauci - the clips l've been able to pu ll so far are listed below:Hardball (MSNBC last night) : http s://www .msnbc.co m/hard bal l/watch/dr-anthony -fauci-i-m-not-being-muzzled-7965037375 6?c id=sm npd ms tw hbLou Dobbs (Fox Business last night) : https ://tw itte r.com/Lo uDobbs /stat us/ 1233555383 J 90507520Today (NBC this morning ): https:/ /www .today .com/v ideo/dr- fauci -on-coronavi rus - fcars-no-nccd-to-changc lifestyle-yet-7968 4677 6 16Thanks,Jen.Jennifer Routh [E]News and Science Writ ing BranchOffice of Communications and Government Re lations National Institute of Allergy and Infectio us Diseases (NIAJD)NIH/HHS31 Center Drive Room 7 Al 7CBethesda, Jv(D 20892Direct: (b) (6)(b)(6)Disclaimer: The information in this e-mai l and any of its attachments is confidential and may contain sensitiveNIH-001141information. It should not be used by anyone who is not the original intended recipient. If you have received this emailin error please inform the sender and delete it from your mailbox or any other storage devices. The Nationall nstitute of Allergy and Infectio us Diseases shall not accept liability for any statem ents made that are sender's ownand not express ly made on behalf of the NIA TD by one of its representatives.-----Original Message -----From: Fa uci , Anthony (NIH/NJATD) [E] ______ C_)b_(6J,>Sent: Saturday, February 29, 2020 8:42 AMTo: Routh, Jennifer (NIH/NlAI D) [E] ...--------, (.b-),""(='Subject: ClipsJen:This AM I did NBC Today and MSNBC. Please make sure that I get the clips.ThanksTonyNIH-001142From :Sent :To:Subject :Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 01:05:03 +0000Holland, Steven (NIH/NIAID) [E]RE: Human lung miceLease the decision up to HHS.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Holland, Steven (NIH/NIAID) [El- --------(b)(6) Sent: Saturday, February 29, 2020 11:03 AMTo: (b)(6) Fauci, Anthony (NIH/N IAID) [E]-..!:=====::;: (b-)=('6=):"-=-------------Subject : Re: Human lung miceSteveDirector, Division of Intramural ResearchNational Institute of Allergy and Infectious DiseasesNational Institutes of HealthBldg. 10/11N248 MSC 1960Bethesda, MD 20892-1960----(-b)-( 6)-vo-ice 301 -480 -4507 fax-----Cb()6 ) emailAssistant lab:NIH-001143(b) (5)Assistan t to SD: ~~ (b) (C> fFrom: ' (b)(6) ------------------------ Date: Saturday, February 29, 2020 at 10:55 AMTo: Anthony Fauci Cb)( >, Steven Holland ---------- (b)(6)Subject: Human lung miceHi Ton and Steve I thoug ht I'd bette r fil l ou in on some recent communications. Dr.(b) (5)(b)(GINIH-001144From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 00:55:28 +0000(b)(6)Subject: RE: in case you need to hear itMi chael:Thanks fo r t he note. I hope that all is we ll with yo u.Best rega rds,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail Cb()6 )The information in this e-mail and any of its attachments is confidential and may conta in sensitiveinformat ion. It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) sha ll notaccept liability for any statements made t hat are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Michael Specter (b)(6)Sent : Saturday, February 29, 2020 -12-:-3-9 -P-M --.~ To: Fauci, Anthony (NIH/NIAID) [E] -------- CbH > Subject: in case you need to hear itYou are one of my very few heroes.And in case you have not seen it, here is my personal love letter to the president (in which you featuresemi prominent ly)https://www .newyo rker.com/news/da ily-comment/donald -trumps -ant i-globa list-response-to -a-globalcoronavirusMichael SpecterStaff WriterThe New YorkerAdjunct Professor of BioengineeringStanford University(b)(6)Phone: (Work, Cell, SMS)- ----- (b)(6)NIH-001145From:Sent:To:Subject :Fauci, Anthony (NIH/NIAID) [ElSun, 1 Mar 2020 00:53:55 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: COVID-19Please take a look and respond. Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institu tes of HealthBethesda , MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recip ient. lf you have received this e-mail in e1TOrplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----From : Fred Schaich <fred.schaich @ifaratv.org>TSeon: tF: aSuactiu,r dAanyt,h oFneyb ru(NarlyH /2N9lA, 2I0D2)0 [1E2]: 5--5-- -P-M--- ----=- ---(b)( · Subject: COVID-19Dear Dr. Fauci,1'11n ot be at the CROl this year (b)(6)So 1 hope I may be able to askyou a few questions as a concerned citizen.Will we learn:Why there are new cases in the US of unknown origin?Could this virus infect carriers who do not present with :.,ymptoms or present in various levels of very mildinfect ion and never get identified as infected?Could individuals host the virus di fferently due to genet ics or ethnici ty?ls this virus consistently similar after multip le generation or is it capable of mutating?Ts the re an ability to develop an antibody immunity through in fect ion? Can one be reinfected?Could the level of infection be detenn ined by the amount of inoculant?Could we leam the level of infect ability of this virus by testing everyone in a given geographic area wherethere is a deep outbreak? We might also learn about the pathogenesis in a way that we cannot learn otherwise.If this virus is so transmissible could we end up with almost everyone eventually being infected and presentwith various levels of serious acute infection and death to indistinguishable cases or just carriers?With the clamp/filter on infonnation from this administration, please tell us where we may find regular reports atva1ious levels of current science on what we learn about this virus and vaccine progress, and where we may askquestion s? I hope there is place for formal and infonna l community input into treatment , care and vaccinedevelopment.Thank you for all your help over the years with your wise perspective through our interviews and leadership at theNIH-001146NlH in such a reasonable and responsible way.Warm regards ,FredFred Schaich(b)(6) ORNIH-001147From: Fauci, Anthony (NIH/ NIAIO) [E)Sent: Sun, 1 Mar 2020 00:27:04 +0000To: Cassetti , Cristina (NIH/NIAID) [E]Subject: FW: Coronavirus - New Idea for treatment & clin ical studyAttachments : The Nine Lives of Hydroxychloroquine .docx, Chloroquine & COVID-19pneumonia.pdf, Remdesivir & Chloroquine Effective lnVitro Against COVID-19.pdf, 6-27-19 (5).jp gPlease take a look and respond to them. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinfo rmation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: (b)(6)> ---------------- Sent: Saturday, February 29, 2020 7:23 PMTo: vice.president@whitehouse.gov ------ ::;..,...,= Cc: Fauci, Anthony {NIH/NIAID) (E] (b)(6J>; Redfield, Robert R. (CDC/OD)____ Cb>_C_6 JSecretary@HHS.govSubject: Coron avirus - New Idea for treatment & clinical studyImportance: HighDear Vice President Pence,We are thankful for your leadership of the White House Coronavirus Task Force ingathering the latest information about the outbreak, working with doctors andscientists to find solution s, and communicat ing with the general publi c regardingthe situation . We were blessed to meet with you back in August, 2019, when ~had expressed a desire to meetyou . I have attached a picture from our meeting to help you remember . We prayfor you often.NIH-001152NIH-001153Since we are both physicians, we have been following the details of the COVID-19 outbreak closely. My husband was researching the anti-viral drug remdesivirthis morning, and he came across some articles from Chinese studies thatindicated a very well-known drug called hydroxychloroquine {already widelyused for 70 years to treat malaria and rheumatological diseases) had verypotent activity against COVID-19 infection and pneumonia. This was rathersurprising to us, but as we read about the study and the characteristics ofhydroxychloroquine, we realized that this could be a very good drug to use for thetreatment of high-risk patients infected with COVID-19, who might deterioraterapidly and progress to hospitalization and need for ICU care. Remdesivir alsoseems like an excellent anti-viral drug, but it is given intravenously, and isprobably reserved for COVID-19 patients who are already entering into severerespiratory distress in the hospital.Hydroxychloroguine, on the other hand, is given orally, and is cheap and readilyavailable.Low doses (6.5 mg/ kg) have been effective in the management of SystemicLupus Erythematosus and Rheumatoid Arthritis. 200 mg tablets are usuallyprescribed twice a day with meals; dosage can be increased up to therecommended 6.5 mg/kg if the patient tolerates the lower dose. We wondered ifthe low dose hydroxychloroquine would be able to be studied quickly in variousCOVID-19 patients, especially those who are older and / or with medicalconditions that put them at higher risk for pneumonia and complications{cardiovascular disease, chronic pulmonary disease, hypertension, diabetes,etc.). In addition, hydroxychloroquine may even be a useful drug to prevent thedevelopment of pneumonia in patients diagnosed with COVID-19.Because hydroxychloroquine in an older drug that is generic, currentpharmaceutical companies have no incentive to do studies or research on itseffectiveness for any new medical conditions. Therefore, the federalgovernment would most likely have to construct and fund the studies. PerhapsDr. Fauci has already considered this kind of study with hydroxychloroquine.We understand that vaccines are already being studied, and Israel is working onan oral (pill) vaccine. Vaccines take time to go through testing and trials, which iswhy we are suggesting to you that studies be done on hydroxychloroquine, areadily-available oral drug that could "bridge the gap" to provide some potentialtreatment and mitigation of the COVID-19 infections while vaccines are beingdeveloped and mass produced.We have attached several articles, which are electronic publications madeavailable in advance (Feb. 4th & Feb 19th , 2020) of the printed journalpublications . We wi ll send a copy of this emai l to Dr. Fauci, Dr. Redfield, and Dr.Azar.Sincerely yours,Drs. Paul & Karyl StantonNIH-001154(b)( 6)From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 00:14:14 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: One solution in the armoury to protect Health Care Sector Workers againstCovid-19Please handle . Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: (b)(6) ------------------------- Sent : Saturday, February 29, 2020 2:10 PM ------~~ = To: Fauci, Anthony (NIH/NIAID) [E)- -------- (b)(6)> Subject: One solut ion in the armoury to protect Health Care Sector Workers against Covid-19Dear Dr FauciA PPE device, tested and proven at Public Health England Porton Down (PHE), based on innovativetechnology could be ready to go into production within 20 weeks. It sterilises all airborne pathogens asair is inhaled by the wearer. See www .medi-immun e.com and in part icular the published report on thetests, by clicking on the report under "The Science" The device is due to undergo further tests, at PHEwithin the next week, specifically against Covid-19. For verification please contact Professor NigelSilman at PHE Porton Down.Health Services around the world are doing what they can to prepare for a significant increase ininfections from this highly transmissible virus and if those people in the Health Care Sectors are infectedthe situation could become untenable.The production of vaccines is under way but no one expects them to be available within the next 12 to18 months. The Medi-Immune "Protect ivAir®", which has been under development for some years andcould be available within a few months, will give a far greater level of protection than the current masksand respirators and more importantly can remain in use in the future for other emerg ing airbornepathogens - known, unknown or mutating .NIH-001155Please take a little time to investigate this option, via the website, or pass it on to those who you believeneed to be made aware of it. I will be happy to answer any questions, technical or otherwise, at myemai l address below or on my mobile num ber, also below.Kind regardsJames LoveJames LoveDirectorm: (b)(6)t:www.medi-immune.comwww.revaxb iotech .comMEDI-IMMUNEGroundbreaking Protection & ImmunityMedi-Imm une Limited, registered in England and Wales I Company registrat ion No: 04554706 1 Registered Office: 4 Lady Bank ITamworth Staffo rdshire I B79 7NB I UKDISCLA IMER: Privileged/COnfidential informat ion and/or Copyright Material may be contained in this email. The informat ion andmateria l is intended for the use of the addressee(s ) only . If you are not the addressee or the person responsible for del ivering it tothe intended addressee(s) , you may not copy or deliver it to anyone else or use it in any unaut horised manner. To do so isprohibited and may be unlawful. If you rece ive this email by mistake, advise the sender immediately by using the reply facility in youremail softwa re. Any views or opin ions presented are solely those of the author and do not necessarily represent those of MediImmuneLid . Although this email and attachments are believed to be free of any virus or other defects which might affect anycomputer or IT systems into which they are received, no responsibility is accepted by Medi- Immune Ltd for any loss of damagearising in any way from the receipt or use thereof .NIH-001156From: Fauci, Anthony (NIH/NIAIO) [ElSent: Sun, 1 Mar 2020 00:12:45 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: A sharing on COVID ARDS researchAttachments : Dexa_ARDS_COVID-19 for Dr. Tugwell.doc, Tsai 2020_Ann of IntensiveCare ARDS_ corticosteroid .pdfPlease take a look at this and handle. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinfo rmation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Paul Elias Alexander --------- (b) (6)> Sent: Saturday, February 29, 2020 2:34 PM ------ ::;.,...,= To: Fauci, Anthony {NIH/NIAID) [El- ------- (b)(6J> Subject: A sharing on COVID ARDS researchHi Dr. Fauci, I am a trained epidemiologist and expert in evidence based medicine. Particularlyin developing clinical practice guidelines and I teach EBM and GRADE methods.You have no idea how much 1 have ad.mired you across the year s, yoW' intelligence and poise.May I ask how I may help you in this matter, this response, I am not talking about money, 1 wishto help, volunteer.I draw your attention to 2 attachments ...1) one is a one page 1 wrote to summarize a meta analysis my team just completed and seeking topublish. It pertains to corticosteroids and ARDS. We are raising that this suggests indirectevidence that we may be able to extrapolate to the COVID patient with severe illness. Thiswithin the life threatening issue and emergency and no effective treatment. I share if this canNIH-001157NIH-001158help you as I know you are leading this and listened to you today with the president. I supportth is president fully.2) I share a paper published today , it on the other hand raises serious questions on the use ofcorticosteroids in influenza associated ARDS , and one may argue this patient set, is the closes t tothe COV ID 19 pat ient.My sense is that the accumulated evidence thus far is weak and argues against corticosteroids.For example, this recently published multicenter retrospective cohort study in medical centerICUs across Ta iwan sought to assess the effect iveness of cort icostero ids in patients presentingwith influenza-associated ARDS (viro logy -proven ARDS and are on mechanical vent ilation).Researchers examined the impact of early corticosteroid treatment (2: 200 mg hydrocortisoneequivalent dose within 3 days after ICU admission , determined by a sensitivity analysis) onsubseque nt hosp ital mortality. The study revea led that of the 241 pat ients with in fluenzaassociatedARDS , those rece iving early cort icostero id had a sign ificantly highe r hosp italmortality rate than those who did not get early corticos teroid [43.5% (37/85) vs. 19.2% (30/ 156),p < 0.001 ). Early corticosteroid treatment was independently associated with increased hospitalmorta lity in overall patients [an adjus ted OR of 5.02 (95% CI 2.39- 10.54), p < 0.001) and in allexamined subgroups . Researchers found that a higher dose and earlier treatment was linked tohigher hospital mortality. Moreover, they found that earlier trea tment was related to asignificantly increased odds of subsequent bacteremia [an adjusted OR of 2.37 (95% CI 1.01-5.56)]. These resu lts underscore the urgency for robust comparat ive randomized researc h giventh is study is based on weake r observat iona l evidence that is confounded by select ion bias andconfounded. However this was a stronger study that used statistical adjustment and propensityscore matching. Thus this study suggests caution with corticosteroid and thus the importance forcaut ion by clin icians as to the potential harms of cort icosteroids in th is po pulat ion. These results ,while based on weake r methodology , have revea led large estimates of effect, is the stro ngestevidence to date on treatment for ARDS , and brings us closest to the COVID- 19 ARDS patient.Best,Paul E. Alexander, MSc, MHSc, PhDAssistant Professorhttp://hei .mcmas ter .ca/McMaster University, 1280 Main Street W,Hamilton, ON L8S 4KIGUIDE Research Methods Grouphttp://guidecanad a.org/From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 29 Feb 2020 23:56:39 +0000Les GardonyiSubject: RE: SuggestionLeslie:Thank you for your note . We are actually looking into the effect of ACEinhibitors on the coronavirus.Best regards ,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Les Gardonyi (b)(6)>Sent: Saturday, February 29, 2020 3:06 PM To: Fauci, Anthony (NIH/NIAID) [E)- _-_-_-_- -~~ C_)bC_6>)Subject : SuggestionDear Mr. Fauci,This may be way too presumptive of a note ...As an engineer I've always liked to understand the mechanics of how things work so I looked intoeducating myself about the coronavirus and it's mechanics. (b)(6)I've correlated a possible research route for your organization regarding theprevent ion aspect.A quick overlook on this strategy is the follow ing:Coronaviruses are RNA virnses that typically enter human cells when their glycoproteins bindproteins on the cell surface. In the case of the virus that cau ses SARS , that human pro tein isangiotensin-converting enzyme 2 (ACE2). At this time , scientists think the novel coronavirns issimilar enough to SARS that its entry point is likely ACE2 as well.NIH-001159NIH-001160source: h ttps: // cen. acs. org/b io I ogical -chemis try/infectio us-disease /novel -corona virus -hi tsChina/98/web/2020 /0 lIrbesartan is used to treat high blood pressure (hypertens ion) and to help protect the kidneys fromdamage due to diabetes . Lowering high blood pressure helps prevent strokes, heart attacks ,and kidney problems . Irbesartan belongs to a class of drugs called angiotensin receptor blockers(ARBs). It works by relaxing blood vesse ls so that blood can flow more easily.source: https ://www .webmd.com / drugs /2/drug-4720 /irbesartan -oral/ detailsIdea:Can Irbesartan, being an angiotensin receptor blocker , possib ly help prevent Coronavirus infections ...since the Coronavirus entry to humans is via ACE-2?I share this suggestion with you in the hopes that it may help your department in the research toprevent the spread of the coronavirus ... or to a presumptuous email slated for deletion .Sincerely,-Leslie GardonyiFrom:Sent:To:Subject:Ellen:Fauci, Anthony (NIH/NIAIO) [E)Sat, 29 Feb 2020 23:54:27 +0000Ellen ButlerRE: (b) (6)Thank you for your kind note. Very nice family pictures! ----- but in any event, thanks for the note.Best regards ,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b) (6)(b)(6)The information in this e-ma il and any of its attachments is confidential and may c ontain sensit iveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made t hat are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Ellen Butler (b) (6)Sent: Saturday, February 29, 2020 3:13 PM To: Fauci, Anthony (NIH/NIAID) [E] -----------~-~-- (b)(6) Subject: (b) (6)I just watched you this afternoon at the press conference. Over the years I have seenyou and wondered along with family members if (b)(6lAlso I just wanted to say how professional you are and that I don't believe what #45 orhis administration have to say regarding the coronavirus but have 100% confidence inwhat you say and do. Thank you for being the adult in the room.(b)(6) I am very proud of you. ----------Sincerely,Ellen ButlerNIH-001161From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sat, 29 Feb 2020 23:44:17 +0000Margaret LiuSubject: RE: kudos and comment about JAMA Coronavirus articleMargaret:Thanks for the note. You make a valid point and I appreciate what you aresaying. . On that issue, I have been vocal about making sure that we do notstigmatize Chinese people here in the USA or anywhere in relationship to theCOVI0-19 outbreak.Best regards ,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Margaret Liu <liu@protherimmune.com>Sent: Saturday, February 29, 2020 3:55 PMTo: Fauci, Anthony (NIH/NIAID) [E)r------ --..(b.)._c=. . >; Marston, Hilary (NIH/N IAID) [E](b)(6)>Cc: Alice Huang <stephen.lin@80-20ef.org>; president@80-20.usSubject: kudos and comment about JAMA Coronavirus articleDear Tony,Wonderful articles in JAMA and NEJM. So glad you are still heading NIAID - it is comforting that thereare experts of your caliber still in the room. And thrilled that the NIAID has done so much to developrapid timelines for DNA vaccines and that you highlighted that progress in the article, since people call methe "Mother of DNA vaccines,".As a former NIAID Council member, I felt I should write to raise an issue that I am sensitized to as ascientist who is ethnically Chinese while American:Why in the JAMA article was it necessary to state that the first travel-related case to the US was aChinese man (italics mine) who had visited Wuhan. Did his being Chinese either ethnically or bycitizenship affect anything biologically?NIH-001162NIH-001163I ask because not only have many Asian people now encountered increased racism in public places(due to fear that any Asian person is a source of COVID-19), but now that the President is turning thisepidemic into additional fear-mongering about "borders" it seems all the more important that scientists donot inadvertently add to "xenophobia" (even though non-white skin does not mean a person is foreign)and do not seem to advance any political perspective.Sincerely and with best personal regards,MargaretMargaret A. Liu, MD, DSchc, MDhc, FISVProTherlmmune &Foreign Adjunct Professor, Karolinska InstituteStockholm, SwedenAdjunct Full Professor , UCSFSan Francisco, CA USAPresident Emeritus, International Society for VaccinesLiu@ProTherimmune.comFrom:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sat, 29 Feb 2020 23:40:04 +0000Tom LeopoldCc: Cassetti, Cristina (NIH/NIAID) [E]Subject: RE:? Al TERNATIVE/SUPPLEMENTAL rx for COVID-19: Angiotensin ReceptorBlockersl have received this message and we are in fact looking into this.Anthony S. Fauci , MDDirectorNational Institu te of Allergy and Infectious DiseasesBuildiog 31, Room 7 A-0331 Center Driv e, MSC 2520National Institu tes of HealthBethesda, MD 20892 -2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The informa tion in this e-ma il and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipie nt. If you have received this e-mail in eITorplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NIALD by one of its representatives.-----Original Message---------~~= From : Tom Leopold (b) (6)Sent : Saturday, February 29, 2020 4:24- -P-M- ---~~ To: Fauci , Anthony (NlH/NlAlD) [E] (b) (Subject: ? ALTERNATIVE /SUPPL EMENTAL rx for COVID - 19: Angiotensin Receptor BlockersMuch appreciation for all of your work past and present. I am a cardio logist in New Jersey and whe n I read that thevirus attaches to the AT2 receptors in the lungs 1 couldn 't help but think that maybe the class of ARB 's that we useso frequently for HTN and heart failure management could possibly block entry of virus into cells and prevent ormitigate the severity of infection. Has this approach ever been stud ied and is it wo11h looking into? lma gine if ARBscould lessen the severity of infection how 1eadily available and relatively inexpensive this class of medication is!Would appreciate if someone could get back to infonn me whether you recei ved th is message. Thanks . Dr ThomasLeopold Email: (b)(6)Sent from my iPhoneNIH-001164From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Sat, 29 Feb 2020 23:34:59 +0000Tom LeopoldSubject : RE: Angiotensin Receptor Blockers: a possible therapy for Covid-19Than.ks for the note. We are looking into this possibility.Anthony S. Fauci, MDDirectorNational Institu te of Allergy and Infectious DiseasesBuilding 31, Room 7 A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitive infom1ation. Itshould not be used by anyone who is not the original intended recipient. lf you have received this e-mail in e1TOrplease inform the sender and delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statements made that are the sender's ownand not express ly made on behalf of the NlAID by one of its representatives.-----Original Message-----.,...---- -:.,._.-,. --,From : Tom Leopold (b) (Sent: Saturday, February 29 , 2020 5:01 PM --------= To: Fauci, Anthony (NlH/NlAID) [E] (b)( ·Subject: Angiotensin Receptor Blockers: a possible therapy for Covid-l 9Much appreciation for all of your work past and present. I am a cardiologist in New Jersey and when I read that thevirus attaches to the AT2 receptors in the lungs I couldn't help but think that maybe the class of ARB's that we useso frequently for HTN and heart failure management could possibly block entry of virus into cells and prevent ormitigate the severity of infection. Has this approach ever been studied and is it wo11h looking into? Imagine if ARBscould lessen the severity of infoction how 1eadily available and relatively inexpensive this class of medication is!Would appreciate if someone could get back to infonn me whether you received this message. Thanks. Dr ThomasLeopold Email: (b)(6)Sent from my iPhoneNIH-001165From:Sent :To:Subject:Richard:Fauci, Anthony (NIH/NIAIO) [ElSat, 29 Feb 2020 23:29:47 +0000Richard GoodmanRE: Coronavirus questionThere are no CDC-issued trave l restrict ions wit hin the USA. The CDC made thi sclear at t he White House press conference t his aft ernoon .Best regards,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Richard Goodman <goodmanr@ohsu .edu>Sent : Saturday, February 29, 2020 5-:-31- -PM- --=-,-=, To: Fauci, Anthony (NIH/NIAID) [El- -------(b)(6) Subject: Coronavirus questionWe met many years ago, Tony,... at an event marking Shelly Wolff's 10 year anniversary at New England Medica l Center. (I had thedistinction of being the first medical intern in that program who he reamed out.)My question relates to travel restrictions . The current restr ict ions appear to be quite lim ited, but severalorganizations, including Google, Amazon, and the HHMI have restricted, or cancelled, even domesticmeet ings. As a result of the HHMI cancelation, my own program director indicated his intention tocancel our upcoming Scientific Advisory meeting and, in the non-academic world, (b)(6)(which is ironic since there aremore coronavirus infections in my town of (b)(6)Oregon than there are in all of New York).In addition to announcing the new travel restrictions, could you also say something publicly about whatdoesn't need to be restricted? In part icular, is domestic travel OK, or not? Does the HHMI knowsomething the rest of us don't?Sincerely,Richard Goodman MD PhDNIH-001166NIH-001167Vollum InstituteOregon Health & Science UniversitySent from my iPadFrom: Fauci, Anthony (NIH/NIAID) [E)Sent : Sat, 29 Feb 2020 23:06:38 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Rapid Collaborat ion for Hand & Nasal Decontamination FormulationAttachment s: NORS-viral review_ V3.pdf, 1998 Reiss NO plays a role in viral infections .pdf,2005 Akerstrom NO inhibits Corona Viral replication.pdf, 2010 Jung Nitric & SARS corona virus.pdf , 2013Regev Nitric reduces viral infectivity.pdf, 2015Regev Nitric cattle vs antibiotics BRD.pdfPlease handle . Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Gilly Regev (b)(Se nt: Saturday, February 29, 2020 5-:-50- -PM- ---, .....,....,= To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)Cc: Chris Miller (b)(Subject: Fwd: Rapid Collaboration for Hand & Nasal Decontamination FormulationDear Dr Fauci,Dr Murad sits on our BOD and has suggested that we contact you to help expedite a rapid testing of ourproduct on the COVID-19 virus. I know you are probably overwhelmed but hope you might pass thisalong or suggest a strategy that would be a win-win for us all.We have developed a non-alcohol based formulation that utilizes the nanomolecule nitric oxide (NO). asyou know, NO is produced in our body and is our first line of defense against microbes . We haveharnessed this in a patented formulation called nitric oxide releasing solution/gel (NORGS). We arefocused on the development of products for chronic sinusitis, diabetic foot wounds, warts and toenailfungus.However, internally & personally, we have been using NORGS as an extremely effective natural handsanitizer and nasal spray to protect ourselves from the common cold and flu for years.There are strong independen t published research that NO is antiviral against Corona viral species. Wehae data showing definite virucidal characteristics and moderate antiviral effects in host cells.NIH-001168With the recent concern with COVID-19, we felt we should try to rapidly test the hand rub and nasalspray against the COVID-19 but need to collaborate with a laboratory that could test this fo r us. Fundingcollaborators are welcome too, as this was not in our budget but we feel a social responsibility to movethis forward .I have included a short white paper of our data and a few articles to support our claims.Feel free to contact me any time (b)(6) ) or have one of your senior staff contact me.Sincerely,Chris Miller and Gilly RegevGilly Regev, Ph.D.CEO / Co-founderSaNOtize Research and Development Corp.Phone-: !::====~~ emai l (b)(6)(b)(6)htt ps://www .linkedin.com/ in/gi lly-regev-694b4a16/http s://www .sanot ize.comNIH-001169From:Sent:To:Subject :Joseph and Heathe r:(b)(6)Sat, 29 Feb 2020 06:58:29 -0500Heather DaViaRe: Thank YouMany thanks for your kind words. Much appreciated.Best rega rds,Tony> On Feb 28, 2020, at 8:45 PM, Heather OaV ia ---------- (b) (6) > wrote: >> Dear Or. Fauci:>> Please accept my personal and heartfelt thanks for your continued efforts to keep the American public informedconcerning the coronavims. While listening to you on the radio or at press conferences , your calm, thoughtful, andmeasured words are very comforting and reassuring. Both your caring response and scientific /medica l expertise arean examp le of the very best in the Federal Government.>> Again, thank you for your pub lic service and your efforts to keep us as safe as possible.>> Sincerely,>> Joseph P. DaVia> (b)(6)NIH-001170(b)(6)From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Sat, 29 Feb 2020 03:15:14 +0000Tabak , Lawrence (NIH/OD) [E)Cc:Subject:Collins, Francis (NIH/OD) [El;Schwetz, Tara (NIH/OD) [ElRE: OSTP callLarry:Thanks you very much.TonyFrom:T abak, Lawrence (NIH/OD) [El ---------- (b)(6) Sent: Friday, Februa ry 28, 2020 8:22 PM -----~~ To: Fauci, Ant hony (NIH/ NIAID) [E] (b)( >Cc: Collins, Francis (NIH/OD) [El .;...;.======~ (b")=("6'=)-S'-"chwetz, Tara (NIH/ OD) [El(b)( >Subject: OSTP callTony,Tara and I took the call with Kelvin Droegeme ier, France Cordova (NSF), and Paul Dabbar (DOE).Please let me know if you need anyt hing else. (Tara -if I left anything out please add).LarryNIH-001171(b) (5)NIH-001172Sent from my iPhoneFrom: (b)(6)Sent: Fri, 28 Feb 2020 19:48:05 -0500To:Subject:Harris, Kara (NIH/NIAID) [E];Haskins, Melinda (NIH/NIAID) [E]Fwd: Coronavirus on surfacesPublic inq plsSent from my iPhoneBeg in forwarded message:From: Deborah Greene (b) (6)Date: February 28, 2020 at 7:38:44 PM ESTTo: "Fauci, Anthony (NIH/NlAID ) (E]" <{------ (b-H~6J;>Subject: Coronavirus on surfacesHello Dr Fauci,I am trying to find out how long the coronavirus can remain infect ious on thesurface of an object handled by someone with the virus.My concern is with purcha sing items for my jewelry shop that come from China ,South Korea, and Turkey.I have not been able to find anything that addresses this question and hope you canclar ify this for me. Thank you.Since rely yours,Deborah GreeneSent from my iPhoneNIH-001173From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Fri, 28 Feb 2020 23:18:10 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject : FW: Corona VirusAttachment s: US Biotest Letter re COVID-19 Fauci, A.pdf, Coronavirus (b)( 4)Rationale.pptx, US Biotest Regulatory History o (b)( 4) pdf, US Biotest COVID-19___ Cb>_C4) References.pdfPlease handle . Thanks.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(The information in this e-mail and any of its attachments is confidential and may contain sens itiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not express ly made onbehalf of the NIAID by one of its representatives .From: Samantha Mauro ------------- (b)( 6)> Sent: Friday, February 28, 2020 6:11 PM -------~= To: Fauci, Anth ony {NIH/NIAID) (E] (b)(6) ;...,;.._.;.__....:..,.:....:..====-~;;----Cc: Gere diZerega- ---------- CHb 6J> Subject: Corona VirusDear Dr. Fauci:NIH-001174(b)( 4)Please contact us if we can be of any help in moving t his potential life-support initiative forwa rd.Sincerely,NIH-001175(b) (4)Gere diZerega MDProfessorKeck School of MedicineUniversity of Southern CaliforniaAndPresident and CEOUS Biotest, LLCSan Luis Obispo, CA(b)(Kathleen Rodgers PhDProfessor, Department of PharmacologyCollege of MedicineCenter for Innovation in Brain SciencesAssociate Director of Translational NeurosciencesUniversity of ArizonaTucson, AZ(b)(NIH-001176From: (b)(6)Sent: Fri, 28 Feb 2020 16:54:13 -0500To: Cassetti, Cristina (NIH/NIAID) [E]Subject: Fwd: Urgent Email/Strategy to attack 2019-nCoV coronavirusAttachments : Nucleotide_Analogues_as_lnhibitors of SARS-CoV Polymerase_2_28_2020.pdf,ATT000Ol.htm, Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus(2019-nCoV) in vitro.pdf, ATT00002.htmPls handleSent from my iPhoneBegin forwarded message:From: Jingyue Ju CbC) >Date: February 28, 2020 at 4:46:04 PM EST To: "Fauci, Anthony (NIH/NIAID) [E]" --------::-:--C:b-H=6)~~~ Cc: "Barasch, Kimberly (NIH/NIAID) [C]" CbH6J,"direc torsincoming @cdc.gov" <directorsincomi ng@cdc.gov>, "Redfie ld, Robert R.(CDC/OD)" Cb)(6.,) "Davis , Mindy (NIH/NIAID). .[.E-.]-". -. ----=-cc-c= --------- CbH6) , "Eakin, Ann (NIH/NIAID) [E]" CbH6) "Stemmy, Erik (NIH/NIAI D) [E]" CbH6J>", Sciotti, Rick(NIH/N IAID) [E]" Cb)C6"JS chiltz, Helen (NIH/N IAID) [E]"CbH6>J, "Krafft , Amy (NIH/NIAID) [E]"(b)(6)Subject: Re: Urgent Email/Strategy to attack 2019-nCoV coronavirusDear Dr. Fauci ,Following my previous ema il regarding our work on developing strategies to attackthe 2019-nCo V coronavirus, I am attaching in this email our experimental resultsdemonstrating that 2 nucleotide analogues are inhibitors of the SARS-Co Vpolymerase. Since the SARS-Co V polymerase has over 96% similarity to thepolymerase from SARS-Co V-2, we expect that the nucleotide analogues, 2 '-F ,MeUTPand 3' -F-dTTP, will also inhibit the SARS -CoV -2 polymerase.At this point, it is imperative that the prodrug forms ( one is Sofosbuvir that is FDAapproved for HepC) of these molecules begin immediate in vitro testing withinfected cells (similar to the studies carried out for Remdesivir and chloroquine inthe Cell Research article at the link, https ://www.natu r e.com/articles/s41422-02 0-0282-0 ; PDF file of the article also attached) followed by animal testing trialsASAP. Since we do not have access to the SARS-CoV-2 viral strains, we need yourassistance to identify resources at the NIH laboratories to embark on this next stepNIH-001177invest igation ASAP. We can provide the prodrugs to the labs at NIH that youidentify for carrying out these studies. In view of the worldwide SARS-Co V-2emergency , we'd like yom assistance in getting this off the ground ASAP.I can be reached any time at -----(b)(6)All the best,Jingyue Ju, Ph .D.Samuel Ruben-Peter G. Viele Professor of EngineeringProfessor of Chemical Engineering and PharmacologyDirector , Center for Genome Technology &Biomolecular EngineeringColumbia UniversityNorthwest Corner Building , Room lO0OMl550 West I 20th StreetNew York, NY 10027Phone:-------- (b)(6)>wrote: De a r Drs. Fauci and Redfield,Scientist s in my laboratory at Columbia University are actively engaged in designstrategies to cope with the new strain of corona virus, 20 l 9-nCo V, which hascaused a global public health emergency. We have embarked on a project ent itled"Nuc leotide Analogues as Inhibitors of Viral Polymerases". We providea summary of this work below.Coronaviruses such as the newly discovered virus from Wuhan, China, 2019-nCo V, and the viruses that cause SARS and MERS, have resulted in regional andglobal public health emergencies. Based on our molecular insight that thehepatitis C virus and the coronavirus use a similar viral genome replicationmechanism, we reasoned that the FDA-approved drug EPCLUSA(Sofosbuvir /Velpa tasvir) for the treatment of hepatitis C will also inhibit theabove coronaviruses, including 2019-nCoV . To develop broad spectrum ant i-viralagents, we fmther describe a novel strategy to design and synthesize viralpolymerase inhibitor s, by comb ining the ProTide Prodrug approach used in thedevelopment of Sofosbuvir with the use of 3 ' -blockin g groups that we havepreviously built into nucleotide analogues that function as polymeraseterminator s.Please let me know if you would like to receive the full manusc ript.Thank you very much for your consideration .NIH-001178NIH-001179Sincerely,JingyueJingyue Ju, Ph.D.Samuel Ruben-Peter G. Viele Professo r of EngineeringProfessor of Chemical Engineering and PharmacologyDirector , Center for Genome Technology &Biomolecular EngineeringColumbia Univers ityNorthwest Corne r Building, Room l000MlPhone:From: Fauci, Anthony (NIH/NIAIO) [ElSent : Fri, 28 Feb 2020 21:27:35 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subj ect : FW: Corona VirusAttachment s: US Biotest Regulatory History of (b)(4).pdf, US Biotest COVID-19----(b)(4) References .pdf , US Biotest Letter re COVID-19 Fauci, A.pdfPlease take a look and handle if necessa ry.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6lThe information in this e-m ail and any of its attachments is confidential and may contain sensitiveinfo rmation. It should not be used by anyone who is not the origi nal intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Gere diZerega (b)(6)Sent : Friday, February 28, 2020 3:56 PM -------= =-- To: Fauci, Anthony ;{N_IH_/N_;I_A_ID ). :[.E.l. .;.-=.:===(b~)(6~J>- -- Cc: Gere diZerega CbH6J>Subj ect : Corona VirusDear Dr. Fauci:(b) (4)NIH-001180Please contact us if we can be of any help in moving this potential life-support initiative forwa rd.Sincerely,GereG ERE DI Z ER EG AP RE S IDENT AND CEOUS B lOT ES T, ] NC .231 BON ETT I DRLVE, SUIT E 240SAN LULS OBISPO, CA 93401-73 10TEL : (b)(6) "} FAX : 805.595 . 1350(b) (4)The information transmitted is intended only for the person or entity to which it is addressed and may contain confidentialand/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon,this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contactthe sender and delete the material f rom any computer.NIH-001181From: (b)(6)Sent:To:Subject:Fri, 28 Feb 2020 13:41:02 -0500Cassetti, Cristina (NIH/NIAID) [E]Fwd: As bad as measles?Please handleBegin forwarded message:From: Ed Charlton (b)(6)>Date: Februa ry 28, 2020 at l :07:32 PM E--S-T- ---~~ To: "Fauci , Anthon y (NIH/NIAID) [E]" --------- (b)(6) Subject: As bad as measles?Dr Fauci, you are the pre-eminent infectious disease physician in the world. I'mconcerned the public has lost perspective on COVID-19. At this point, it wouldseem the r0 and CFR are more simila r to rubeo la than they are to Ebola. Can weremind the public of that? Commu nicat ing that influenza will kill more Amer icansthan SARS-2 hasn't gained traction. Might someone like yourself or Dr Carsoncommunicate more strongly to the public the risks compared to other viruses theyare familiar with, like rubeola , rubella, varicella, etc?NIH-001182From:Sent:To:(b)(6)Fri, 28 Feb 2020 13:39:34 -0500Cassetti, Cristina (NIH/NIAID) [E]Subject: Fwd: Experimental vaccine for Covid-19Please respond. Mention risk of enhancementBegin forwarded message:From: "William J. Buikema" (b)(6)>Date: February 28, 2020 at l :08:50 PM E-S-T- ----~~ To: "Fauci , Anthon y (NIH/NIAID ) [E]" (b)(6J: --------- Subject: Experimental vaccine for Covid-19Dear Dr. Fauci,I understand the need for the variom stages of testing a new experimental vaccine, but in listening toyou give a timeline for any new vaccine for the corona virus, it struck me that perhaps a modifiedapproach might be considered. Why not allow early use of a vaccine that has passed a phase 1 safetytesting, similar to what was done for the Ebola vaccines. If a vaccine is shown to be reasonably safe,why not allow its use it in more at-risk people (elderly , smokers) before phase 2 trials are finished . Itcould also be helpful as with the Ebola vaccines to prevent transmission in hot spots of communityacquired infections. There doesn't seem to be much downside compared to the potential forpreventing many more deaths than was seen in the Ebola situation.Sincerely yours,Bill BuikemaWilliam J. Buikema, PhD, Research AssociateTechnical Director, DNA Sequencing & Genotyping CoreUniversity of Chicago, KCBD 1230H&I900 E 57th Street, Chicago, IL 60637773-702-1088, cancer-seqbase.uchicago.eduNIH-001183From: (b)(6)Sent:To:Subject:Fri, 28 Feb 2020 11:21 :22 -0500Conr ad , Patr icia (NIH/ NIAID) [E)Fwd : coron av irus vacc ine story ?Sent from my iPhoneBegin forwarded message:From: Olga Khazan <olga@theatlantic.com>Date: February 28, 2020 at 11: 09:49 AM -E-S--T-- ~~To: "Fauci , Anthony (NIH/NIAID) [E]" CbH6>:Subject: coronavirus vaccine story?Hi Tony -- It's Olga at the Atlantic ... I'm hearing that there's a coronavirusvaccine trial in the works at the VTEU sites. We'd love to tell the story, buteveryone is directing me to you and NIAID. Would you be able to talk withme about this today for a story? My cell is CbH6J, and my desk is202-266-7387.Thanks,OlgaOlgaKhazanStaff Wr iterThe Atlanticolga@theatlantic .comcell: (b)(6JNIH-001184From: (b)(6)Sent:To:Subject:Fri, 28 Feb 2020 08:59 :04 -0500Conrad, Patricia (NIH/NIAID) [E]Fwd: MEDIA INQUIRYSent from my iPhoneBegin forwarded message:From: Lemonov Alexander <anlemonov @rttv.ru>Date: February 28, 2020 at 8:13:34 AM EST To: "Fauci, Anthony (NIH/NIAID) [E]" --------=-=C-b)-C6:) -= --------- Subject: MEDIA INQUIRYDear Dr. Fauci,My name is Alexander Lemonov, I am a producer for RT International TV channel.I would like to invite you to appear on "Worlds Apart", RT's 26-minute uncensored one-on-oneinterview show .We would like to talk about t he spread of the COVID-19 coronavirus, the response measurescountries should take, the world's general preparedness for pandemics, COVID-19's possibleconsequences for other areas: healthcare, economy, security, etc.Would you be available?FYI: "Worlds Apart" is an uncensored interview show that is aired on RT International, RTAmerica, RT UK, and RT Russia (in Russian).All episodes get featured on RT social media accounts, watched by the ir multimillioninternational crowd .Our guests endorse widely diffe rent views, and we are happy to broadcast different opinions.Here's the link to our show: https://www .rt.com/shows/worlds-apart-oksana-boyko/"Worlds Apart" has featured:businessman Richard Branson, lawyer Alan Dershowitz, former Israeli FM Tzipi Livni, UNSecretary General Antonio Guterres, UN Women Executive Director Phumzile Mlambo-Ngcuka,former Prime Min ister of Italy Giuliano Amato, former U.S. State Department coordinator forJCPOA Jarrett Blanc, foreign minister of Iran Javad Zarif, adviser on international affairs toSupreme Leader of Iran Ali Akbar Velayati, former chief economist of the World Bank AnneKrueger, Secretary General of OSCE Thomas Greminger, special adviser to PM of JapanTomohiko Taniguchi, senior fellow at the Brookings Institution Mike O'Hanlon, etc.I would appreciate a reply.NIH-001185Kind regards,Alexander LemonovProducer'Worlds A art ", RTMobile: .._ _____ CHb_6.)Office: +7 (499) 75-000-75, ext. 2492AlleKcaHAP neMoHoBnpoAiocep"Worlds A art", RTMo6. : (b)(6)Pa6.: +7 (499} 75-000-75, A06. 2492rt.comtwitt er.com /rt comfacpbook.com/RTnPw~youtube .com/user / Russia Todayplus.google .com/102728491 539958 529040/post sCONFIDENTIALITY.The Information contained in this transm,ssion Is Intended exclusively for tho proper use by the Intended addressees and may containconfidenbal and/or privileged material. Any views expressed in this transmission are those of the individual sender, except where thetransmission states otherwise and the sender being authorised appropriately. My review, dissemination and other use of thisinformation, as well as any act ion in reliance upon this info rmation by persons and/or entitles othe r lh an the intended add ressees ,sprohibited. If you received this information In error, please note lhat no confidentiality or pnv1lege ,s waived or lost by any misstransrn,ssion Note that we monitor e-mails sent or recerved Further co'!lmunication will signify your consent to the above.NIH-001186From:Sent :To:Subject:Ed:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 11:50:04 +0000Kaplan, Edward HRE: CoronavirusThanks for the note. Great to hear from you. I hope that all is well.Best regards,Tony----- Origina l Message ----- -------~~ = From: Kaplan , Edward H (b) (6)Sent: Thursday, February 27, 2020 I 0:42 AM ------ -,.-.,-,,= To: Fauci, Anthony (NTH/NIAID) [E] (b)(6) >Subje ct: RE: Coronaviru:sHi again Tony. Here's a link to a non-technical exp lanation of the paper I shared with you earlier:https:// insights.som.yale.edu/insights/new-outbreaks-of-coronavirus-can-bc-halted-,vith-isolation-measures according-to-studyI have seen predictions stating that upwards of 30% of the world's popu lation will be infected , but I don't see thishappening. What I do see are lots of local outbreaks from imported cases, some larger than others , but all headingtowards containment. I find Israel to be an interesting test case. A group of infected Korean tourists who visited thecountry only tested positive for coronavirus after their re turn to Korea, joining the large outbreak that has beenreported there. The itinerary of their travel group has been made public so that retrospectively, [sraeli public healthofficials could ascertain who was exposed where and when (seehttps://www.hea ltb.gov.il/E nglish/News and Events/Spokespersons Messages/Page s/23022020 J .aspx). Already1,600 Israelis have been quarantined on account of possible exposure. It has been twelve days since this group oftourists returned to Korea , and no new infect ions have been reported in Israel associated with this group (there aretwo Israelis who were infected on the Diamond Princess cruise ship, and one infected while in ltaly). Seehttps://www.ynetn ews.com/artic1e/H lnXPa7E8 . lt will be interesting (and important) to see how many newinfections are detected in the days ahead, and if such new infections are found among those already under preventivewatch.Nonetheless I totally concur with preparing as if major tran smission will occur. Much better to err by over- ratherthan under- preparing (a familiar perspect ive from those bygone smallpox debates).Finally, a reporter asked me yesterday afternoon what I wanted the Pres ident to say last n.ight. Here was myresponse :In a sober way summaiize the facts of lhe outbreak, state that the US has an excellent preparedness team betweenCDC and NIH, that at the advice of this team travel restriction s and quarantine measures have already been enact.ed,but as of now the public is at very low risk of infection. Still, citizens should go to cdc.gov now to learn from ourexperts how to prepare in the event that more extreme measures are needed, stay abreast of the situation here andabroad and follow the advice of our experts , get a flu shot(!), and know that the US has a very strong public healthsystem that can withstand this cha llenge .Anyway,just wanted to share all this with you. Keep up the good work and good luck with the vaccine research, Ed-----Original Message----From:Kaplan , Edward H(b)(Sent: Saturday , February 8, 2020 I 0: 13 PMTo: Fauci, Anthony (NIH/NIAID) [E] ----------NIH-001187Subject: Coronavirus containment modelingDear Dr. Fauci,It has been many years since we corresponded regarding smallpox bioten-orism and vaccinat ion control.The attached paper on containing a commun ity coronavirus outbreak from a few initial cases via isolation andquarantine might interest you. The news is mostly good - isolation and quarantine can get the transmission ratebelow epidemic threshold - bur the key is rapid detection of infected persons. Also discussed are some ideas foralleviating congestion in the hospital. ! hope that you find it helpful.Best, Ed KaplanEdward H. Kaplan, Ph.D.William N. and Marie A. Beach Professor of Operations Research Professor of Public Health Professor ofEngineering Yale School of Management Box 208200 New Haven, Connecticut 06520 -8200Phone:e-mai l(b)(6)(b)(6)https://nam05.safelinks.pro tection.outlook.comnu rl=http%3A%2F%2 Ffaculty.som.ya le.edu%2FEdKap lan%2F&data=02% 7C0 I% 7Cedward.kaplan%40yale.edu% 7Cb00 l l 9dcdbe24bc635d2 08d7bb9b24c7% 7Cdd8c bebb2 l 394df8b4 114e3e87abeb5c%7C0%7C0% 7C6371841473 15834392&amp:sdata =l lLC4xAuAc%2BjdNuG%2BA2o GxcS9LS95PoORi7yO0dLR d0%3D&reserved=0NIH-001188NIH-001189From:Sent:To:Subject:FYIFauci, Anthony (NIH/NIAID) [ElFri, 28 Feb 2020 11:25:43 +0000Conrad, Patricia (NIH/NIAID) [ElFW: Coronavirus update for your upcom ing Keystone Symposia meetingFrom: Allison Ogdon <Allison0@keystonesymposia.org>Sent: Friday, February 28, 2020 12:10 AMTo: Allison Ogdon <AllisonO@keystonesymposia.org>Cc: Heidi Daetwyler <HeidiD@keystonesymposia .org>Subject: Coronavirus update for your upcoming Keystone Symposia meetingImportance: HighKEYSTON,Ef fS YMPOSIAon Molecular and Cellular BiologyAccelerating Life Science DiscoveryGreetings,In light of th e current coronavirus situ at ion, we would like to provide an update on your upcomingKeyston e Symposia conference.The health and safety of our meeting attendees and speakers is our top priority , and we are carefullymonitoring the coronavirus situation around the world to ensure we take the necessary precautions asrecommended by healthcare providers and public health organizations .Currently, your meet ing will proceed as scheduled, and we will contact you immediately if anyth ingchanges. Decisions will be made on a moment to moment basis, as new information becomes available .We assure you that the leadersh ip team at Keystone Symposia is closely monitoring globaldevelopments and will take swift action to ensure the health and safety of all meeting participants .As a speaker, you hold a very special role at the meeting as a field leader. We very much appreciateyour contribution to both the scientific program, and the community of luminary scientists who willconvene to direct the future of the field. Your presentation will be a highlight for many attendees, andyour insights will inspire others to take on new and innovative directions in their own work . This is theessence of Keystone Symposia -- convening communities of leading scientists to inspire each other toadvance biomed icine, and this would not be possible without your engagement .We realize the current situation may add some inconveniences to travel at this time, but we also remindyou that each and every one of our speakers is hand-selected by a committee of the world's leadingexperts to represent their field at the meeting . You are among a very select few to receive this honor.The meeting organizers, and our team at Keystone Symposia, have put a great deal oftime and effortover the last two years into designing the program, and your presentation is a key part of that. We hopeyou will take these though ts into consideration as the meeting approaches.While th is is a t ime we must all be vigilant about publ ic health measures, we are remind ing conferenceattendees that this is also a t ime to remain calm, rat ional and scient ific in addressing the situatio n. Weencourage you to engage with your fellow colleagues at the meeting as you normally would, to forgenew collaborations and novel ideas that w ill dri ve your research and the field in innovative and fruitfu ldi rections . At the meet ing, we are prov iding the follo wing suggestions based on recommendations fromt he Nat ional Foundation of Infect ious Disease:• The best way to protect yourself aga inst COVID-19 is similar to how you would takeprecautions against the cold or flu. Wash your hands of ten using soap and wate r for at least 20seconds. Cover your cough or sneeze with a t issue or the crook of your elbow rather than yourhands.• There is no need to wear a face mask if you are well and do not have symptoms- masksprotect the sick from spread ing germs but wi ll not prevent you from gett ing sick.• Do not assume that anyone of Asian descent is more likely to have coronavirus- do not forgetabout the importance of inclusivity and evidence-based information.Again, we thank you for your contributions and commitment to Keystone Symposia and wish for a verysuccessful and inspiring meet ing.Sincerely,(b)( 6)Debora h L. Johnson, Ph.D.President and Chief Executive OfficerKeystone Symposia on Molecular and Cellula r BiologyKEYSTONE~ SYMPOSIA~on Molecular and Ce l lular BiologyAccelerating Life Science DiscoveryD I VERS I T Y IN T H E SC IE NTIF IC W O Rl< F OR CEPO Box 1630 I Silverthorne I co 80498 I USA (regular mail only)160 us Highway 6, Ste. 200 I Silverthorne I CO 80498 I USA (courier only)970.262 .1230 I 800.253.0685 I www.keystonesympoias.orgVisit virtual.keystonesympos.oiargt o view our digital content.NIH-001190NIH-001191OC, 0 0From:Sent :To:Subject :Lydia:Fauci, Anthony (NIH/NIAID) [ElFri, 28 Feb 2020 04:25:27 +0000Kline, Lydia (NIH/OD) [ElRE: thank youThanks for your kind note.Best regards,TonyFrom: Kline, Lydia (NIH/OD) [El CbH6J>Sent : Thursday, February 27, 2020 9:45 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6J>Subject: thank youTony,I'm sure many people are telling you this, but I wanted to add my thanks to you for everyth ing you do tokeep the world safer and healthier! You are doing an incredible job (as always) out there withcoronavirus.Best,LydiaNIH-001192From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 04:23:12 +0000Conrad, Patricia (NIH/NIAID) [E)Subject:Attachments:FW: inv itation to speak on COVIO 19 at the International ATS Conference in MayimageOOl.png, image003.pngSorry noFrom: Fennelly, Kevin (NIH/NHLBI) [E] ______ C>b<_ >Sent: Thursday, February 27, 2020 9:02 AMTo: Fauci, Anthony (NIH/NIAID) [E]_ _____ "("b"")"("=6")Subject: invita t ion to speak on COVID 19 at the Inte rnational ATS Conference in MayDear Dr. Fauci,I don't believe that we've formally met, but I have seen you frequent ly on SSE as I admit patients thereand often participate in the ward rounds. I am an Al on several of Steve Hollands protocols, and I oftenhelp with the drug-res istant TB cases. I have been at the NIH now for over 4 years, although I still feellike the new guy on the block! Most of my career has been focused on quantifying the infectiousaerosols generated by TB patients . I am very involved in the leadership of the American ThoracicSociety (ATS) as the Past Chair of the Assembly on Pulmonary Infections and TB. I am writing to inviteyou to be a keynote speaker at a special Scientific Session being added to our Internat ional ConferenceMay 16-20 due to the emerging pandemic of COVID-19. The exact time and data are not yet known,but the conference is relatively close in Philadelphia. This would be an opportunity to address andeducate global academic leaders in pulmonary and critical medicine, infectious diseases, and publichealth . We usually have over 15,000 attendees at the ATS meeting. I am attaching the email stringbelow to give you an idea of other speakers being considered.I can only imagine how busy you must be now, so I apologize if this invitation is a distraction or anuisance. And I would certainly understand if you are unable to jo in us given the demands on your time,but we would be absolutely delighted if you could speak.Please feel to call or contact me at any time with questions or comments.Sincerely,Kevin FennellyMobile (b)(6)Kevin P Fennelly, MD, MPH, ATSFSenior Research ClinicianLaboratory of Chronic Airway Infect ionPulmonary BranchDivision of Intramural ResearchNationa l Heart, Lung, and Blood Institute (NHLBI)Nationa l Institutes of Health {NIH)NIH-001193Build ing 10, Room 5-142110 Center DriveBethesda, MD 20892From: Saukkonen, Jussi J (b)( >Sent : Wednesday, February 26, 2020 7:15 PMTo: Dela Cruz, Charles (b) ( >Cc : Kristina Crothe-rs! ========::::::=:-(:b:)(;6b~; -N-a-h-id-, Payam (b)(6) ; Sauk k one n, Jussi (b)( >; Maria Novozhilova (b)(6); MiriamRodriguez (b)(6); Fennelly, Kevin (NIH/NHLBI) [E)(b)(6)Hicks, Lauri (CDC/0D10/NCEZID/DHQP)-----:--:~============~-__:__--2~======-(b-)(=6)>~; Y-eligar, (b )( 6) McGinniss, John E----!:==========; (.b:);,:;(;6:,:):>a;---------------Subject; Re: Pl-TB Executive Committee CallThis looks like a great program . Hope you can get these speakers who will be in demand.On Feb 26, 2020, at 2:44 PM, Dela Cruz, Charles -----------(b)(6) wrote:Thank you all for your great suggestions ...Here is a possible Agenda for the Special Session on Coronavirus.Ideally, we should have some ATS attendees to be speakers. If anyone knows possiblecandidate, please let us know. I also know that ATS would like to encourage some highprofile speakers if possible. Someone from CDC, NIAID, etc.Please let us know additional suggestions.I highlighted bold are possible speakers.We wi ll need to wait until the ATS BOD this week to get t he go ahead to invite thespeakers.NIH-001194(b) (4)(b) (4)NIH-001195Charles S. Dela Cruz, MD, PhDAssociate ProfessorSection of Pulmonary, Critical Care and Sleep Medic ineDepartment of Internal MedicineDepartment of Microbial PathogenesisDirector , Center of Pulmonary Infection Research and Treatment (CPIRT)Yale University300 Cedar Street TAC S441-DNew Haven, CT 06513Phone: Cb()6 )FAX: 203 785-5952Email: Cb) (6)Faculty(b) (4)profile: http://medicine.ya le.edu/ intmed/pulrnonary/people/charles delacruz.profileLab website: http ://rnedicine.yaJe.edu /la b/delacruz/index.aspxCPIRT website: cpirt.yale.edu<irnage00 1. png><image003.png>From: "Crothers, Kristina"Date: Tuesday , February 25, 2020 at 8:52 PMCb)( >, "Nahid, Payam"(b)(6)(b)(6) To: "Saukkonen , Jussi J" -------Cc: "Dela Cruz, Charles' (b)(6) "Saukkonen, Jussi"(b)(6)>, Maria Novozh ilova>, "Kevin P. Fennelly, MD"NIH-001196(b)(6),(b)(6)(b) (6)>,(b) (6)>Subject : Re: Pl-TB Executive Committee CallHi - these are great suggestions.KristinaFrom: Saukkonen, Jussi J (b)(6)Sent: Tuesday, February 25, 2020 9:02 :43 AMTo: Nahid, Payam(b) (4)Cc: Dela Cruz, Charles; Saukkonen, Jussi; Crothers, Kristina; Maria Novozhilova; MiriamRodriguez; (b)(6) · Kevin P. Fennelly, MD; (b)(6J.; Evans,Scott; Yeligar, Samantha M.;----------------- (b)(6); McGinniss, John E Subject : Re: Pl-TB Executive Committee CallThese would be excellent speakers to also try to get!NIH-001197(b) (4)> On Feb 25, 2020, at 11:50 AM, Nahid, Payam (b) (6) wrote: ______ _,>> Agree, these are excellent suggestions. An FYI below on what CROI has assembled for ad hocsession on COVID-19:>> ------------------------------------------------------------------------> Payam Nahid, MD, MPH> Professor of Medicine> University of California, San Francisco> Associate Director, Clinical Trials Operations, UCSF Office of Research> Medical Director, UCSF CTSI Trials Innovation Network (TIN)> Director, UCSF Center for Tuberculosis (http :// tb.ucsf.edu )UCSF Center for Tuberculosis I UCSF Center for TBtb.ucsf .edu>> Zuckerberg San Francisco General Hospital> Division of Pulmonary & Critical Care Medicine> 1001 Potrero Avenue, Room SKl> San Francisco, CA 94110> Email: (b) (> UCSF Profile: htt p:// pro fil es.ucsf .edu/ payam .nahidPayam Nahid I UCSF Profilesprofiles. ucsf .eduPayam N_ahid'~ profile, public~tions, research topi~s, an~ co-autho~s> Tel : ------ (b)(6) . > Pronouns: he, him, hisNIH-001198(b) (4)>>>> On 2/25/20, 6:47 AM, "Dela Cruz, Charles" ----------(b)(6) wrote: >> Thanks Jussi for your great suggestions . We will try to incorporat e these into the final session.> Much appreciated> Charles>>>> ------------------------------------------> Charles S. Dela Cruz, MD, PhD> Associate Professor> Section of Pulmonary , Critical Care and Sleep Medicine> Departme nt of Internal Medicine> Department of Microbial Pathogenesis> Director, Center of Pulmonary Infection Research and Treatment (CPIRT)> Yale University> 300 Cedar Street TAC S441-D> New Haven, CT 06513> Phone: (b)(6)> FAX: 203 785-5952>> Email: (b)(6)> Faculty profile: https ://urldefense .proofpo int.com/v2/ur l?u=http -3A med icine.yale.edu intm ed pulmonary people charles -SFde I a cru z. p rofile&d =Dw IGaQ& c=iO RugZ I s2 LIYyCAZR B3Xlg & r=Xo HvlY Ap U j67iV1KyA lzSg&m=OCAEXv-43B0vEiVln TNd--DXvFYATI j FpvUftbD e3o4&s =XbJr53zM ilg0yYn -iXh9t9 vBPfjcNC8h-jRJ2lihVk&e=XCharles Dela Cruz, MD,PhD < Pulmonary,Critical Care and SleepMedicineurldefense.proofpoint.comDr. Dela Cruz completed his researchtraining through an MD/PhD programin the area of immunology andvirology from University of Torontoand Yale. Clinically, he is trained ininternal medicine, and specializes inpulmonary and critical care medicineNIH-001199and is currently an AssociateProfessor at Yale University in the> Lab website: https ://u rldefe nse.proofpoi nt. com/v2/ur l?u=http -3A med icine .yale .edu lab delacr uz index .aspx&d=DwlGaQ&c= iORugZIs2LIYyCAZRB3XLg&r=Xo HvlYApUi67iV1KyA l zSg&m=OCAEXv-43BOvEiVlnTNd-DXvFYATliFpvUf tbDe3o4&s=F7cVz fOPwStmglz95Y984or0dPHCoEYBNsv iP7GA2g& e=Dela Cruz Laburldefense.p roofp oint.comDr. Dela Cruz completed his research train ing through an MD/PhD program in thearea of immunology and virology from University of Toronto and Yale. Clinically, heis trained in internal medicine, and specializes in pulmonary and critical caremedicine and is currently an Assistant Professor at Yale University in the> CPIRT website: cp irt .yale.edu>>>>> On 2/25/20, 9 :34 AM, "Saukkone n, Jussi" _______ _.C.,b.)_(6..), wrote :>> Gr,~e•'a---------------------------- ~= (b)(4)NIH-001200XFirst US MERS-CoVCases Underscore Needfor PreparednessIGlobal Health I JAMA IJAMA Networkurldefense.proofpoint.comConfirmation of the first 3 us casesof Middle East respiratory syndromecoronavirus (MERS-CoV) infectionhighlighted the importance ofpreparedness plans and infectioncontrol policies for hospitals andother facilities in dealing with apotentially dangerous infectiousdisease .(b)(4l..._. ._________________________ (_b_~ , .(4,)NIH-001201X2019 NovelCoronavriu s-Im portan tInformation forCliniciansl GlobalHealth l JAMA l JAMANetworkurldefense .proofpoint.comThis Viewpoint summarizes theepidemiology and clinical features of2019-nCoV infection and reviewsCDC criteria to guide evaluation andmanagement of patients withpossible infection.NIH-001202(b) (4)----- Origi na I Message----- From: Dela Cruz, Charles -_-_-__-_-_-_-_- -~~ (b_) _(6_),Sent: Monday, February 24, 2020 9:49 PM>>>_>_ ____T o: Crothers,; ._K_rist i(-nb=a)~- ("=1>" "_'_________ (b)(6_)_>_; Maria Novozhi lova> c: Miriam Rodrigu; Saukkonen, JussiMcGinniss, John E (b) (6)> Subject: [EXTERNAL) Re: Pl-TB Executive Committee Call>> Dear colleagues>> Hope all is well .>(b)(6)(b) (4)(b)(6)> As part of ATS 2020 in May, PITB Programming has been requesting to see if there wou ld be avenue for a coronavirus session.>> The ICC chair and ATS was able to seek out a possib le forum for a Special Session onCoronavirus on the Monday Afternoon during ATS.>> Payam and I have been d iscussing a possible session title, content and speakers.>> The session ti tle could be --(b) (4)NIH-001203> Many t hanks> Charles>>Charles S. Dela Cruz, MD, PhDAssociate Professor(b) (4)>>>> Sect ion of Pulmonary, Critical Care and Sleep Medic ine Department of Internal MedicineDepartment of Microbial Pathogenesis Director , Cente r of Pulmonary Infection Research andTreatment (CPIRT) Yale University> 300 Cedar Stre et TAC S441-D> New Haven, CT 06513> Phone: (b) (6)> FAX: 203 785-5952>> Email: (b)(6)> Faculty profile: https ://urld efe nse.proofp oint. com/v2/ url?u=ht tps-3A namOS.safe links.protect ion .ou t look .com -3Furl -3Dhttp -253A -252F-252Fmed icine.ya le .edu-252 Fi ntmed -25 2 F pu I mo nary-252 Fpeo pie-25 2Fcha rle s-5Fdelacruz. profi le-2 6a m p-3 Bd ata -3D02 -2 S 7C01-25 7Cchar les.delacruz -2540ya le.edu -25 7C07f45 f4dbd77 4 f4a3d cc08d7b9 ffcld2 -257Cdd8cbebb21394df8 b4114e3 e87a beb5c-257C0-257C0-257C6371823804254 42155 -26a mp-3Bsdata -3DQWWL8cDOcYtHaxgi lDZfU7dywm TyCbpPS4bl002Rp Hs-253D-26amp -3Breserv ed-3DO&d= Dw I Ga Q&c= iO R ugZ1s2 LI YyCAZRB3X Lg& r=XoHv lY Ap Ui6 7iV1 KyA l zSg& m =OCAEXv-43 BOv EiVl n TNd--DXvFY ATI j F pvUftb De 3o4&s= TVWeA9SztU xTE K8J SyH Fc0kt3 Cy ArZWDsYQDZPge u EQ&e=NIH-001204XCharles Dela Cruz, MD,PhD < Pulmonary,Critical Care and SleepMedicineurldefense.proofpoint.comDr. Dela Cruz completed his researchtraining through an MD/PhD programin the area of immunology andvirology from University of Torontoand Yale. Clinically, he is trained ininternal medicine, and specializes inpulmonary and critical care medicineand is currently an AssociateProfessor at Yale University in the> Lab website : https:// url defe nse.proofpo int .com/v2/u rl?u=https -3A namOS.safelinks.protect ion .out look.com -3Furl-3Dht tp -253A-252F-252Fmedicine.yale.edu-252Flab-252Fdelacruz-252Findex.aspx-26amp -38data -3D02-257C01-257Ccharles .delacruz-2540yale.edu-257C07f45f4d bd774f4 a3dcc08d7 b9ff cld2 -257Cdd8c bebb21394df8 b4114 e3e87abeb5c-257C0-257C0-257C637182380425442155 -26am p-3Bsdata-3DaUEJSTgiaCXmTQiuABOKOYrM iqFxdd2HiPhGuq8Psig-253D-26am p-3Breserved-3DO&d=DwlGaQ&c=iORugZls2LIYyCAZRB3Xl g&r =XoHvlYApUj67iV1 KyAl zSg&m=OCAEXv-43BOvEiVl nTNd--DXvFYATlj FpvUft bDe3o4&s =s6rn Kn Ylg iuU r8011 HRKyYFhvJwdc4 t9rmpZzq ixY&e=Dela Cruz Laburldefense . proof point.comDr. Dela Cruz completed his research train ing through an MD/PhD program in thearea of immunology and virology from University of Toron to and Yale. Clinically, heis trained in internal medicine, and specializes in pulmonary and critical caremedicine and is currently an Assistant Professor at Yale University in the> CPIRT website: cpirt.yale.edu>>>NIH-001205>>>On 2/22/20, 7:47 PM, "Crothers, Krist ina" --------------(b)- (6)wrote:> Hi all - we need to reschedule the call as both Rachel and I will be t raveling to the ATS boardmeeting next Wednesday. Please let me and Mar ia know if you could join a call Wednesday March 4at 4pm eastern instead.> Kristina>> Sent from my iPhone>» On Feb 21, 2020, at 12:20 PM, Mar ia Novozhilova (b) (6)> wrote: __________ _.>>>>» <Pl-TB Executive Committee Call>>>>> Privileged, confidential or patient identifiable information may be contained in thismessage. This information is meant only for the use of the intended recipients. If you are not theintended recipient, or if the message has been addressed to you in error, do not read, disclose,rep roduce, distr ibute, disseminate or otherwise use this t ransmission. Instead, please notify thesender by reply e-mail, and then destroy all copies of the message and any attachments.>>>>>>NIH-001206NIH-0012078From:Sent :To:Subject:RSVP sorry no.Fauci, Anthony (NIH/NIAID) [E]Fri, 28 Feb 2020 04:21:24 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Invitation to Spanih meetingFrom: Jose Alcami Pertejo <ppalcami@isciii .es>Sent: Thursday, February 27, 2020 10:16 AM To: Fauci, Anthony (NIH/NIAID) [E] ---------- ---- (~b)=(6) > Cc: Jose Alcami Pertejo <ppalcami@isciii.es>Subject: Invitation to Spanih meetingDear Dr Fauci ,Hope this mail finds you well. We had the opporttmity to meet in Madrid dur ing the R4Pmeeting. I was the local chair of the Confe rence and had the privi lege of introducing your talk tothe plenary.I would like lo invite you as plenary speaker to the meeting of the Spanish AIDS Society(GESIDA) that will take place in Malaga , Spain next 30th November 2020. GESIDA Congress isthe most important HIV national meetings in Spain that brings together the full "HIVCommunity" including clinicians , basic researchers , experts in epidemiology and public healthand member from NGOs and patien ts' associa tions. Overall 700 attendees are expected to cometo the meeting.We would love to have you as a speaker in the Opening Plenary Session in evening the 30thNovember. Your challenging articles regarding the strategies to end the HIV epidemic in theUnited States , will be a great topic to be addressed in such session and an inspiration to Spanishresearchers. If you prefer to talk about a different top ic as the co-morbid ities scenar io in HIVinfection it will be welcome too.We would be more than happy if you could participate in this meeting .If know your agenda is always full, even more these days with the current Coronavirus outbreak ,NIH-001209NIH-001210but if you could accept this invitation I think this can represent a real boost in the fight againstHIV epidem ics in Spain, a field in which the Spanish AIDS Society is strongly committed .It would we wonderful if we can have you as a speaker.Best wishesJose Alcarni************************* AVISO LEGAL************************* Este mensajeelectr6nico esta dirigido exclusivamente a sus destinatarios, pudiendo contener documentosanexos de caracter privado y confidencial. Si por error ha recibido este mensaje y noseencuentra entre los destinatarios, por favor no use, informe, distribuya, imprima o copie sucontenido por ningun medio. Le rogamos lo comunique al remitente y borre completamente elmensaje y sus anexos. El lnstituto de Salud Carlos Ill no asume ningun tipo de responsabilidadlegal por el contenido de este mensaje cuando no responda a las funciones atribuidas alremitente del mismo por la normativa vigente.From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 04:13:52 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: RE: David Rubenstein's invitation to Dr. FauciI always like to do things with David RubensteinFrom: Conrad, Patricia (NIH/NIAID) [ElSent: Thursday, February 27, 2020 12:19 PMTo: NIAID OD AM <NIAIDODAM@niaid.nih.gov>Subject: FW: David Rubenstein's invitation to Dr. FauciPatricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520- Room 7A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaime r:(b)(6)>The information in this e-mail and any of its attachments is confidential and may contain sensitive information . It should not be usedby anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices . National Institute of Aller gy and Infectious Diseases (NIAID) shall not acceptliabi lity for any statement made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.From: Mary Brady <MBrady@economicclub.org>Sent: Wednesday, February 26, 2020 6:07 PM -------- :7'C= To: Conrad, Patricia (NIH/NIAID) [El (b)(6)>Cc: (b)(6); Judi lrastorza <Judi.l rastorza@economicclub.org>Subject : David Rubenstein's invitation to Dr. FauciPatricia,David Rubenstein asked that we reach out to you in an effort to schedule an Economic Club ofWashington event that would feature Dr. Fauci in a conversation with David on COVID-19. It ismy understanding that David had a similar interview with Dr. Fauci in the last week or so.Below are several dates from David's calendar for your consideration.Wednesday, April 22 - BreakfastNIH-001211Tuesday, April 28- Breakfast or lunchTuesday, May 5 - Breakfast or LunchFriday, May 15 - LunchAdditionally, I have attached an invitation letter from Mr. Rubenstein to Dr. Fauci for yourconvenience. The Economic Club has the ability to turn around an event in a relatively shortperiod of time. As you may recall, our events typically take place at breakfast, lunch or dinner,at downtown Washington, D.C. hotels. Events that feature a prominen t world leader, such asDr. Fauci, generally attract a select audience of over 500 members and guests from amongWashington 's business and government leaders, as well as the diplomatic corps.We understand the complexities and constraints of Dr. Fauci's schedule and can be responsiveto his needs. If none of the dates above work with Dr. Fauci's schedule, please suggest somethat will and we wil l work with David to confirm a date and begin the process. I have copiedJudi lrastorza, who I believe you have worked with in the past, and she will coord inate anythingyou need.Sincerely,MaryMary C. BradyExecutive DirectorThe Economic Club of Washington, D.C.1601 K Street NW, Suite 210, Washington, DC 20006Office: (202) 481-3260 I Mobile: (b)(6)mbradv@economicclub.orgOur SponsorsI www.EconomjcC1ub.org@TheEconomicCluI bL inkedlnI YouTubeNIH-001212From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 04:10:35 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: Invita tion to join Scientific Advisory BoardPlease handle.From: Ajay Gupta (b)( >Se nt: Thursday, February 27, 2020 1:04 PMTo: Fauci, Anthony (NIH/NIAID) [E] -------= (b-)c(-c6-)=Subject: Re: Invitation to join Scientific Advisory BoardHi Dr. Fauci,thanks,AjayFrom: "Fauci, Anthony (NIH/ NIAID) [E]" ---------(b)(6) 0 ate: Monday, February 17, 2020 at 3:59 AMTo: Ajay Gupta (b)(6)Subject: RE: Invitation to join Scientific Advisory BoardThanks for the note . My position in the US Government does not allow me to join suchBoards .From: Ajay Gupta (b)(6)>Se nt: Sunday, February 16, 2020 10:21 PM ------ ::;..,..-,= To: Fauci, Anthony {NIH/NIAID) [E]- ------- (b)(6)> Subject; Invitation to join Scientific Advisory BoardDear Dr. Fauci,By way of this email, I wou ld like to introduce our new biotech company based in California , CelestialTherapeut ics Inc.(b)(4lNIH-0012 13We wou ld like to extend an invitation to you to join our company's Scientific Advisory Board.Please see attached herewith the executive summary and a slide deck of our company.Thanks and looking forward to hearing from you shortly.Best regards,Ajay Gupta, Ph.D.President, Chairman & CEOCelestial Therapeutics Inc.Tel: (b)(6)NIH-0012 14(b) (4)From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 04:07:36 +0000Billet, Courtney (NIH/NIAID) [E]Subject: FW: lack of preparedness for the coronavirus pandemicFYI. Does this deserve a response.From: Nejat Duzgunes (b) (6)Sent: Thursday, February 27, 2020 1:55 PMTo: Collins, Francis (NIH/OD) [E] (b)( >; Fauci, Anthony (NIH/NIAID) [E](b)(6)>Cc: Nejat Duzgunes -------- (b)(Subject: lack of preparedness for the coronavirus pandemicImportance: HighDear Dr. Collins and Dr. Fauci,I am sorry to say that our lack of preparedness for the coronavirus pandemic hasits roots in the way biomedical research is funded in the United States, as well asin the lack of leadership and vision on the part of NIH and its institutes since theSARS coronavirus outbreak in 2003. I try to expand on these problems in thearticle below. I would welcome your response to my thesis.Sincerely,Nejat Duzgune~, Ph.D.Professor of MicrobiologyDepartment of Biomedical SciencesArthur A. Dugoni School of DentistryUniversity of the Pacific155 Fifth Street, Room 412San Francisco, CA 94103(b)(6)lJ',;fVl~'-fTYI>J 1111 PACIFIC\ r I h 11 , \ I)" ~ ,, n 1"t..ht,,)I nl lltn11,lr\The Wuhan Coronavirus (COVID-19): Why there is no cure or vaccineNIH-001215NIH-001216In their Medical Virology text published in 1994, 0 .0 . White and F.J. Fenner stated"No convincing evidence has yet been obtained to link human coronaviruses withserious disease ... , but they are an important cause of that trivial but annoyingdisease, the common cold." This generalization changed drastically with theemergence of the severe acute respiratory syndrome coronavirus in 2002-2003(SARS-CoV), and the National Institutes of Health (NIH) immediately sought theexpertise of these two scientists at the time. Now, 17 years later, we still do nothave an antiviral medicine or a vaccine against the novel coronavirus thatoriginated in China, now designated as COVID-19 by the World HealthOrganization (WHO). On February 21, there were 75,567 cases and 2,239 deathsin China; and 1,152 cases outside China, with 8 deaths, according to the DirectorGeneralof the WHO. The two viruses appear to use the same gate (or "receptor")on host cells to infect them. Despite such expected similarities between new andold strains of the viru s, research on coronaviruses has not been a priority for theNational Institute of Allergy and Infectious Diseases (NIAID). In the end, all thatthe Director of NIAID was able offer is "good healthcare" as a remedy for COVID-19 infections.The major reason we do not have a cure for coronaviruses is that there has beenno coordinated effort by the NIAID to establish long-term research programsfocused on coronaviruses . Realizing the insufficient progress in this area,the NIAID announced on February 6 a "Notice of Special Interest to highlight theurgent need for research on the 2019 novel Coronavirus." Grants have indeedbeen awarded to some scientists since 2003, but such grants are highlycompetitive, with success rates of applications to NIAID between 14 and 18%,indicating that 82-86% of applicants are unable to obtain funding to carry outresearch. The time and effort spent on preparing grant applications to NIH areenormous, diverting these precious resources from actual research to what somescientists call "grantsmanship" (essentially, the ability to sell your idea to a reviewcommittee!). These "games scientist play" to procure funding are a hindrance tothe progress of science. The fact that we do not have a cure or a vaccine againstcoronaviruses over the past 17 years since the SARS epidemic, attests to thisdetrimental effect .Development of a vaccine against COVJD-19t is also not straightforward. SARSwas probably not considered by NIH to be an important pathogen on which toNIH-001217spend resources. Even if the biomedical research community had developed avaccine against coronaviruses, pharmaceutical companies would probably nothave considered it a profitable endeavor. Therefore, it is essential for public fundsto be used by NIH and the CDC to both discover an effective vaccine and tomanufacture it.We need to ensure that long-term projects to develop antivirals and vaccinesagainst coronaviruses and other infectious agents, including tuberculosis andinfluenza virus, are implemented and fully funded. We need to have a fundingsystem that does not depend on the often unfounded criticism or whims of grantreviewers . Although the current peer review system is touted generally as thebest way to allocate funding , it has never been tested scientifically against analternative. While half of the NIH budget (currently $39 billion) may still beallocated for high-cost projects, including clinical trials , the other half should beawarded for periods of 10 years or longer to established scientists who have atrack-record of scientific work, as well as to young scientists who are starting theirfirst independent position . The budgets of these grants would be somewhatlimited, but would provide uninterrupted funding and alleviate the stress ofcompeting for renewals every 3-5 years. Scientists opting for these grants will nothave to submit extensive grant applications. More importantly , this system willmore than double the number of independent investigators . After a 10-12 yearperiod, the scientific productivity (per grant dollar) of scientists on the classicalgrant system would be compared with that of scientists on long-term funding.After all, the way we choose the mode of science funding should conform to theway science progresses , by experimentation and analysis .From:Sent :To:Subject :Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 04:05:11 +0000Robert DurrRE: Covid-19We will be looking at this.From: Robert Durr (b)(6) Sent : Thursday, Fe-bru-ar-y -27,- 2-02-0 -2-:-0-3- -P-M--- - ::;..,..-,= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6 )1> Subject : Covid-19Dr. Fauci,This may be terribly simp listic, but if Covid-19 binds to ACE2 recep tors in host cells, has anyone lookedat ACE2 recep tor blockers as potent ially ameliorating disease severity or infectivity?Sincerely,Robert Alan Durr, M.D.NIH-0012 18From:Sent:Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 04:04:26 +0000To: HMS-Faculty Affairs Senior AppointmentsSubject: RE: Confidential Evaluation Request on behalf of Harvard Medical School DeanGeorge Q. Daley, MD, PhD (b)(6)Dear Dr. Cotti:I am very sor ry, but I just do not have time to do this right now. I am inundated 24/7 withcoronav irus issues. I hope thatyou understand.Best regards,TonyFrom: HMS-Faculty Affairs Senior Appointments<FacultyAffairs _SeniorAppointments@hms.harvard.edu>Sent: Thursday , February 27, 2020 1:59 PMTo: Fauci>A nthony (NIH/NIAID) [E] ------- (=b)- (~6)>Cc: Cott i, Dagmara <Dagmara_Cotti@hms .harvard.edu>; Tekleab, Sarah<Sarah_Tekleab@hms.harvard .edu>Subject: Confidential Evaluation Request on behalf of Harvard Medical School Dean George Q. Daley,MD, PhD - (b)(6]Dear Dr. Fauci,-Attached is a letter from George Q. Daley, MD, PhD, Dean of the Faculty of Medicine at HarvardUniversity and Caroline Shields Walker Professor of Medicine, requesting your evaluation of H- academic accomplishments. The fol lowing materials are also attached: (b)(6)curriculum vitae, an annotated bibliography of(b)(6)' self-selected 10 most significant scholarly works, andthe criteria by which 'Cb6H>q:ualifications are to be evaluated .Please confirm receipt of this communication and let me know if you will be able to complete anevaluation. When composing your evaluation, please address the questions in Dean Daley's letter . Wewould greatly appreciate receiving letters of evaluation by Thursday, March 26, 2020. We are gratefulfor your time and expertise and we apprec iate your consideration of this request.Warm regards,DagmaraDAG MARA COTTI, PhDNIH-0012 19NIH-001220Program Director for Academic AffairsHarvard Medical School I Office for Faculty AffairsGordon Hall, 25 Shattuck Street, Suite 206 I Boston, MA 02115office : 617.432.6889 I fax: 617.734.4382 I Hours: M-F 8:30am-4:00pmfa.hms.harvard.eduExecutive Assistant: Sarah TekleabSarah Tekleab@hms.harva rd.edu I office: 617.432.7438From:Sent :To:Cc:Subject:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 03:57:45 +0000HJ MaiBillet, Courtney (NIH/NIAID) [ElRE: Confirma tion of reportThis is really not true. It was taken vey much out of context.From: HJ Mai <HMai@npr .org>Se nt: Thursday, February 27, 2020 2:09 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El (b)(6)> _______ _.Subject: Confirmation of reportDear Dr. Fauci,This is HJ from NPR again. I was wondering if you could confirm a NYT report that says the White Househas instructed you not to say anything about the coronavirus outbreak without prior approval.Kind regards,HJI HJ Mai I Editor, Morning Edition I hmai@npr.org I- ---(b)-(6)NIH-001221From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 03:54:23 +0000Billet, Courtney (NIH/NIAID) [E]Subject: FW: Idea for coronavirus contentionNIAID inquiries, PleaseFrom: Blanco, Luz {NIH/NIAMS) [E] (b) ( '> _______ _.Sent: Thursday, Febru ary 27, 2020 2:51 PMTo: Collins, Francis (NIH/OD) (E]Cc: Gottesman, Michael {NIH/0D~)-:[~E]:-=====~- ("b"~'""('= >; Fauci, Anthony {NIH/NIAID) [E](b) (6) >Subject: Idea for coronavirus contentionImportance: HighDears Dr Collins, Dr Gottesman, and Dr. Fauci:I am reaching to you with t his idea that might sound weird but I th ink it might be helpful. I have this ideato reduce the coronavirus infection and spreading. It is very simple but can get more complex as well.(b)(5)--------------- (b)( 5 . I do not have the capacity to work or promote these ideas but hope f u II y you have the power for doing so. Thanks, regardsLuz P. Blanco PhD.Staff ScientistSAB, NIAMS, NIHNIH-001222From:Sent :To:Subject :Fauci, Anthony (NIH/NIAID) [ElFri, 28 Feb 2020 03:54:22 +0000Cassetti, Cristina (NIH/NIAID) [ElFW: Coronavirus: CONFIDENTIAL: (b)( 4) infoAttachment s: image00l.png , 2018_Book_ UnderstandingTheHostl mmuneResp.pdf, Advancesin Clinical Chemistry 2018.pdf, BBASR-2016.pdf, Ch-22-francisandtaylor-2017.pdf, chapter-2012.pdf,GSH2005.pdf, HIVclinical trial2015.pdf, HIVclinical trial2017.pdf, macrophages2012.pdf,macrop hages2013 .pdf, NKCELLS2008.pdf, NKCELLS2012.pdf, RBC-HIV paper_2014 .pdfPlease take a look at this.-----Original Message-----From: ParikJ1, Purvi _________ .(,b..).,(..=.6)>Sent: Thursday, Febrnary 27, 2020 10:-3-9 -P-M- -~~ To: Fauci, Anthony (NTH/NIA ID) [E] (b)(6);Subject: Coronavin.1s: CONFIDENTIAL: (b)( 4) infoHi Dr FauciYou must be swamped with corona virus related correspondence but wanted to pass on some resea rch that may provehelpfu l with coronavirus_This pham1acist also plans to meet with Trump administration in upcoming weeks .Jt may prove useful. l havent had a chance to dive deeply into the science of it so dont know efficacy but they arepreparing a proof concept.Main researcher is Nayan Patel and his email is ________ C_b)_(_6,)Sincererely,Purvi Parikh , M.D., FACPAllcrgy /lmrmmology Attending PhysicianClini cal Assistant Profe ssor , Department of Medicine and Department of Pediatrics Division oflnfectious Diseasesand Immunolo&'Y Division of Rheumato logy Allergy and Asthma Associa tes of Murray Hill212-685-4225 (office numb er)212-696-5682 (fax)From: Purvi Parikh (b)(Sent: Thursday, February 27, 2020 9:43:18 PMTo: Parikh, PurviSubject: Fwd: CONFIDENTIAL: (b) (4) info(EXTERNA L]Sent from my iPhoneBegin forwarded message:NIH-001223From: Heather Pixton (b) (6)Date: Februa 3, 2020 at 12:43:59 PM ESTTo: ___________ _Subject: FW: Fwd: CONFTDENTTAL:(b)(6)(b) (4) infoHi Purvi,Here is the email from Dr Patel with his research and other relevant PubMed links. The body of the emai l providesan idea of what he has been working on and how he hopes to conu·ibute to the CWTent outbreak.I would be happy to connect Dr Patel with you (or someone you suggesl) should you find the informa tion providedwarrants further inquiry.Warm Regards,HeatherHeather PixtonCSO Pharmacology & Compliance r CABODf[bttps://res.cloudi nary.com/drasifo 1s/image/upload/vl5449 l 0436/1130-cedrecfc.el I. jpg) <tel: (b) ((b) (6) I Q1ttps://res.cloudinary.com/drasifolsiimage/----- upload/v1 544910437/ 1130-cedrec/mail.jpg] <mailto:Cedrec@SpectrumHP.com> Heather@CabodiCo.com<mailto:Heather@CabodiCo.com> L[https://res.cloudinary.com/drasifo 1 s/image/upload/vl5449 l 0436/ l l 30-cedrec/web.ipg)http://www.bestefekt.com<https :/ furl defense. proofpoint. com/v2/url?u=http-3 A www.bestefekt.com &d=DwMFaO&c=j5oPpO0eBHl iio48DtsedeEIZfc04rx3ExJHeIIZuCs&r=TxeKofMBvUAkTP9Z8swJDuMT3NwOKJuoZJ8jdtz5TG0&m=yoSwihtDg3ar56w9cgDSwhynOlHOCP4NL4AZXwE63E&s=eCWhMi iUaJaCzK I mNZOpB2 I poltX9tSrTR2KsTm Rof&e=>(b)(6)From: Heather (b)(6) >Sent: Monday , Februar 03, 2020 12:21 PMTo: Heather Pixton --------. (b)( ..._--~~Subject: FW: Fwd: CONFIDENTIAL : (b)( 4) infoSent from Mai l<https:// go.micro soft.com/fwlink/?Linkld =550986> for Windows 10From: Cedrec Sumimoto<mailto -_,..,---------(b)( Sent: Saturday , Febrnary I, 2020 12:30 PMTo : Heather Pixton<mailtoSubject: Fwd: CONFfDENTlAL:(b)(6)-------- Forwarded Message -------Subject:CONFIDENTIAL: (b)(4 infoDate:F1i, 3 I Jan 2020 15:25:40 -0800(b)(6)(b)(4) infoNIH-001224From:Nay an Pate I_ _____________________ (_b~<_,To:Cedrec Sum imoto (b)(Hello Cedric,(b) (4)NIH-001225(b) (4)Best Wishes,(b) (4)CONFIDENTIALITY NOTICE: This e-ma il message from Cent11tl Drugs (including all attachments) is for the soleuse of the intended recipient(s) and may contain confidential and privileged information. Any w1authorized review ;use, disclosure, copying or distribut ion is st.rictly prohibi ted. If you are not the intended recipient, please contact thesender by reply e-mail and destroy all copies of the original message."·-fe-ltNIH-001226From: Fauci, Anthony (NIH/NIAID) [E)Sent : Fri, 28 Feb 2020 03:53:06 +0000To: Leonard SchleiferCc: Erbelding, Emily (NIH/NIAID) [E);Mascola, John (NIH/VRC) [E];Cassetti, Cristina(NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [ElSubject : RE: Regeneron COVID-19 updateLen:Thanks for the note . Of course, we would be interested in working with you as you developt hese antibodies.Best regards,TonyFrom: Leonard Schleifer (b)(6) -------------- Sen t: Thursday, February 27, 2020 3:25 PM ------~~ To: Fauci, Anthony {NIH/NIAID) [E] (b)(6)>Cc: Conrad, Patricia (NIH/NIAID) [E!] .=======~ (b')"(6"")Subject: Regeneron COVID-19 updateTony,Obviously you are swamped and the country is likely safer for it ! I wanted to be sure you were up todate on our efforts re COVID-19. (b)(4 )(b)(4)We have had discussions with our part ners at BARDA and have had contact with the White House.(b) (4)In the near future we will have a cocktail of antibodies ready for testing and we would be delighted towork with you and the NIH if that makes sense.If you would like to discuss further, please call my cell -----(b)(6) at anytime.Len* *** ** *** **** ******** ***** **** *** ** *** ********* **** **** **** *** ** **** This e-mail and anyattachment hereto, is intended only for use by the addressee(s) named above and may contain legallyprivileged and/or confidential information . If you are not the intended recipient of this e-mail, anydissemination , distribution or copying of this email, or any attachment hereto, is strictly prohibited . Ifyou receive this email in error please immediately notify me by return electronic mail and permanentlydelete this email and any attachment hereto, any copy of this e-mail and of any such attachment, andany printout thereof . Finally, please note that only authorized representatives of RegeneronNIH-001227NIH-001228Pharmaceuticals, Inc. have the power and authority to enter into business dealings with any third party.********************************************************************From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 03:42:11 +0000Phillips, KyraSubject : RE: ConfidentialThan.ks, Kyra.-----Original Message -----From: Phillips, Kyra <Kyra.Ph illips@abc.com>Sent : Thursday, February 27, 2020 4:3-3- P-M-- -~~ = To: Fauci , Anthony (NIH/NIAID) [E] ...__ ____ C)bC6.lSubject: ConfidentialDear Tony,This note is between long time colleagues.This entire Coronavirus sto1y, and the handling of it, has really escalated into an unexpected journey. [ want you toknow how much I have respected you professionally and medically for nearly 20 years. I also want you to know thatJ have appreciated how we have communicated through the years about threats to om world's health and howhonest and transparent you have aJways been. l know you are in a unique situation and I want you to know that 1respect that and would never put you in a situation with my co1Tespondence that would j eopard ize you in anyway.With that said, I hope you can keep me informed, off the record if need be, so I can continue to cover this storyhonestly and fairly.With utmost respect,Kyra@KyraPbillipsABC Newslnvestigative Correspon dentKyraPhillips.Com(b)(6)NIH-001229From:Sent:To:Cc:Subject :Alice:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 03:16:38 +0000Alice ParkConrad, Patricia (NIH/NIAID) [E]RE: Time follow upI am so sorry that I have not gotten back to you. I have been inundated 18 to 19 hours perday. By the t ime I get to e-mail it is late at night. I will try to connect with you tomorrow.Best,TonyFrom: Alice Park <alice.park@time.com>Sent : Thursday, February 27, 2020 5:17 PM To: Fauci,A nthony (NIH/NIAID) [E]-- ---------~-~-- (b)(6) Subject : Re: Time follow upHi -- do you have a few minutes to talk about the following? Happy to chat whenever you'refree. Best, AliceOn Wed, Feb 26, 2020 at 11:50 AM Alice Park <alice.park@t ime.com> wrote:Hi Dr. Fauci -- have a couple of requests for you, one of which is to speak at ourupcoming Time 100 Summit in April -- about COVID-19. I'l l be sending a formal invite butwanted to explore your interest and availability.Also wanted to speak to you about a story I'm work ing on concern ing the risk of communityspread of COVID-19 in the US. Wanted to get your perspective on the CDC warning andwhere those cases might come from. Happy to chat whenever you 're free; I'm relatively freetoday and this evening. Best, AlicePLEASE NOTE NEW PHONE NUMBERAlice ParkTIME212 522 9830alice.park@time.com@aliceparknyNIH-001230From:Sent:To:Subject :Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 02:49:34 +0000Suzanne BradleyRE: URGENTThere is much misinformation. I actually bave not been muzzled at all by the Vice President. And BTW, it is safeto fly domestically (b) ( ·.-----Original Message----- From: Suzanne Bradley -----------------~-~-- (b) ( > Sent: Thursday , February 27, 2020 5:3-2- P-M-- ~~= To: Fauci, Anthony (NTH/NTAID[)E ]- ------- (b)(6) > Subject: URGENTDear Dr. Fauci ,J understand Vice President Pence has ordered you to not inform the public about Coronavirus without approval.This is quite terrifying, espec ially since Trump has already shown his desire to spread false or incompleteinformation about this public healtJ1 crisis.J'm planning to fly domestica lly TOMORROW -------- (b) ( ·. Is it safe??Thank you,Suzanne BradleyNIH-001233From:Sent :To:Subject :Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 02:46:07 +0000NIAIDODAMFW: questionLet us discuss, but almost certain ly no.From: Fleisher, Thomas {NIH/CC/DLM) [VJ -------- (b) (6) >Sent : Thursday, February 27, 2020 5:36 PM To: Fauci, Anthony {NIH/NIAID) [E]-- -------------- (~b)(=6) Cc: Lang, David <LANGD@ccf.org>; Kay Whalen <KWhalen@aaaai.org>; Rebecca Brandt (AAAAI)<rbrandt@aaaai.org>Subject: questionTony,As you are acute ly aware , the COVID-19 situation is on everyone's mind and accordingly there havebeen questions raised by members of the AAAAI about what the organization can do to provide moreguidance in this evolving situation. In light of this linked to the fact that our annual meet ing beginsMarch 13 in Philadelphia, we have made the decision to have a 45-60 minute session in the main hall onSaturday (March 14) morning from 7:00-8:00 prior to the scheduled plenary session slated to start at8:15. My question is whether you would consider taking the Acela up Friday evening returning Saturdaymorning to host this session with a presenta tion followed by a Q&A session. If that is not possible,would you be willing to provide a 10-15 minute (shorter if you deem that appropriate) video generatedas close to the 14th as possible that we would have projected in the main hall as noted above. If thelatter, would you have a suggestion of an ID person in Philadelphia who would be knowledgeable andcould field quest ions following your video. I recognize that even if you are willing to come toPhiladelphia, that circumstances could arise that would preclude your traveling in which case we wouldask for a video if at all possible . Finally, if neither option is possible, is there somebody in DC (includ ingNIH), Baltimore or Philadelphia who could provide the short review and then sit for 30-45 minutes ofQ&A. I am well aware that this is last minute and you have been incredibly busy with issues related tothe pandemic, any help you could provide would be much appreciated by my colleagues and me.Regards,TomThomas A. Fleisher, M.D.Scientist EmeritusDepartment of Laboratory MedicineNIH Clinical CenterBethesda, MD 20892(b) (6) (tel)301 -402 -1612 (fax)The contents of this message, together with any attachments, are intended only for the use of the person(s)to which they are addressed and may contain confidentia l and/or privileged information . Further, anymedical information herein is confidential and protected by law. It is unlawful for unauthorized persons toNIH-001234NIH-001235use, review, copy, disclose, or disseminate confidentia l medical information. If you are not the intendedrecipient, immediately advise the sender and delete this message and any attachments. Any distribution, orcopying of this message, or any attachment, is prohibited.From:Sent :To:Subject :Attachments :Let us discuss.Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 02:43:32 +0000NIAIDODAMFW: Invita tion to speak at National Academies workshopFMT Vaccines SOT 12.20.pdfFrom: Pavlin, Julie <JPavlin@nas.edu>Sent: Thursday, February 27, 2020 6:04 PM -------~= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)>Cc: Conrad, Patricia (NIH/NIA ID) [E!l.= ======~ (b.H.-=6)>Subject : Invitation to speak at Nationa l Academies workshopDear Dr. Fauci,It is my pleasure to invite you to present at the National Academies of Sciences, Engineering, andMedicine workshop on "The Critical Public Health Value of Vaccines -Tackling Issues of Access andHesitancy." This workshop will be held on May 28-29, 2020 at the Pan American Health Organization(PAHO) headquarters in Washington, DC. The statement of task for the workshop is attached.The 1.5-day workshop will provide a venue to examine the current state of vaccine preventable diseasesand the impact of vaccine access and hesitancy on vaccine preventable diseases globally, as well as themultidimensional drivers and impacts of declining vaccine confidence . This workshop wi ll explore healthsystems, research opportunities , communication strategies, and policies that could be considered toaddress access, perceptions, att itudes, and behaviors towa rd vaccination. The workshop will bebroadcast live over the web to an international audience, and is being hosted by the NationalAcademies' Forum on Microbial Threats .Due to your in-depth expertise in this field, we would like to invite you to give a plenary presentation onthe developmento f new vaccinesi n the midst of an outbreak, specificallyo n the prospects of acoronavirus vaccine. The primary audience for the event will be researchers, health practitioners,industry leaders, and policy makers in infectious diseases and global health, so we are looking to in itia tethis workshop with relevant discussions of barri ers to accessing vaccines. Your responsib ilit ies would beto prepare and deliver a 15-minute presentat ion. We would cover your travel expenses in accordancewith U.S. federal government rules. We would be thankful to have your involvement in this workshop.Please let me know if you might be interested. I would be happy to answer any questions you may have.Thank you in advance for your time and considerat ion. We understand that th is is a very busy time andyour calendar may be in flux.Best wishes,JulieJulie A. Pavlin, MD, PhD, MPHDirector, Board on Globa l HealthHealth and Medicine Division - Find us at nationa lacademies .org/HMDThe National Academies of Sciences, Engineering, and MedicineNIH-001236NIH-001237500 Fifth Street, NWWashington, DC 20001Phone: 202-334-2171Follow UsThe National Academi ofCIE G · M DIC!----------------------------ORGANIZING COMM ITTEE -THE CRITICAL PUBLIC HEALTH VALUE OF VACCINES -TACKLING ISSUES OFACCESSA ND HESITANCYHEIDI LARSON (Co-Chair), Professor of Anthropology, Risk and Decision Science, London School ofHygiene & Trop ical MedicineMATTHEW ZAHN (Co-Chair), Medical Director , Division of Epidem iology and Assessment, Orange CountyHealth Care AgencyKEVIN ANDERSON, Senior Program Manager, Chemical & Biological Defense Division, Science &Technology Directorate, Department of Homeland SecurityALISON BUTTENHEIM, Associate Professor, Family and Commun ity Health, School of Nursing, Universityof PennsylvaniaANDREW CLEMENTS, Deputy Directo r, Pandemic Influenza and Othe r Emerging Threats Unit, USAIDAMANDA COHN, Executive Secretariat, Advisory Committee on Immun ization Practices, US Centers forDisease Control and Prevent ionPETER DASZAK, President, EcoHealth AllianceEVA HARRIS, Professor and Director, Division of Infectious Diseases and Vaccino logy, Center for GlobalPublic Health, University of Californ ia, BerkeleyELIZABETH D. HERMSEN, Head, Global Antim icrob ial Stewardship , Merck & Co., Inc.NONI MACDONALD, Professor, Department of Pediatrics, Dalhous ie University, Nova Scotia, CanadaWALT ORENSTEIN, Professor and Associate Director , Emory Vaccine CenterFrom:Sent :To:Cc:Subject:Jon:Fauci, Anthony (NIH/NIAID) [E)Fri, 28 Feb 2020 02:42:42 +0000Jon CohenConrad, Patricia (NIH/NIAID) [ElRE: Interview request--typo fixedI am drowning right now. However , I am always happy to speak with you. Cannot do it until I dig out fromunder. Hopefully, soon.Best,Tony----- Original Message- ----From: Jon Cohen <jcohen@aaas.org>Sent: Thursday, February 27. 2020 5:48- P-M-- --::-::-:-= To: Fauci, Anthony (NTH/NIAJD) [E] (b)( >Su~ject: Interview request- -typo fixedDr.Fauci,J was most pleased to bear Sec. Azar 's commitment to "radical transparen cy." 1n that vein, l would like to interviewyou about COVID-19 for a Science magazine article! am preparing .Thanks in advance,Jon CohenScienceNIH-001238From:Sent:To:Cc:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 02:32:50 +0000Billet, Courtney (NIH/NIAID) [E]Folkers, Greg (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [E]Subject : RE: Question on report Dr. Fauci told he cannot speak with media unless clearedby White HouseThat is not what I said. I said for SARS the virus went from bat to civet cat to human; for MERSit went from bat to camel to human. I said we did not know what the animal reservoir was forthe jump from animal to human with the nove l coronavirus. Please tell her that. Thanks.From: Billet, Courtney (NIH/NIAID) [E] -------- (b)(6) Sent: Thursday, February 27, 2020 7:12 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Cc: Folkers, Greg (NIH/NIAID) [E ] ..:.::====== (~b~~(6")" Conrad, Patricia (NIH/NIAID) [E](b) (6) >Subject: Fwd: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseQ from Donna Young re comments In VP pool report:Do they now know the novel coronavirus jumped from a bat to a civet cat [skunk]served at feasts in China and then jumped to humans?Is that the source for certain? Or was he just giving an example? Is theresomething you can provide to show that information?From: "Young, Donna" <Donna.Young@spglobal.com>Date: Thursday, February 27, 2020 at 7:01:00 PM ------~~ To: "Billet, Courtney (NIH/NIAID) [E]" < (b)(6)Cc: "Stover , Kathy (NIH/NIAID) [E]" (b)(6) _>, "NIAID NEWS (NIH/NIAID)"<NIAIDNEWS@niaid.nih.gov>, "My les, Renate (NIH/OD) [E]" (b)(6)Subject : Re: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseThank you. Also, can you please clar ify what was in the VP pool report today.Do they now know the novel coronavi rus jumped from a bat to a civet cat [skunk] served atfeasts in China and then jumped to humans?Is that the source for certain? Or was he just giving an example? Is there something you canprov ide to show that information?Than k you again.NIH-001239Donna YoungSenior Reporter , Healthcare (Washington , DC)S&P Global Newsdonna .young@sp global.com301.216 .2433 deskCb) (6) cell@DonnaYoungDC - 'the pharma diviner'http://market intelligence .spglobal.com/our-thinking/news.htmlFrom: Billet, Courtney (NIH/NIAID) [El -------- (b)(6)> Sent : Thursday, February 27, 2020 6:55 PMTo: Young, Donna <Donna.Young@spglobal.com>Cc: Stover, Kathy (NIH/NIAID) [E] (b)(6)>; NIAID NEWS (NIH/NIAID)<NIAIDNEWS@niaid .nih .gov>; Myles, Renate (NIH/OD) [El CbH ; Billet , Courtney(NIH/NIAID) [El Cb)( >Subject : Re: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseCan you just attribute to NIAID spox? I ask because he's on meetings and calls .. ,,From: "Young, Donna" <Donna .Young@spglobal.com>Date : Thursday, February 27, 2020 at 6:52:48 PMTo: "Billet, Courtney (NIH/N IAID) [E;l-" l.======~~Cc: "Stover, Kathy (NIH/NIAID) [El" (b)(6), "NIAID NEWS (NIH/NIAID)"<NIAIDNEWS@niaid .nih .gov>, "My les, Renate (NIH/OD) [E]" (b)(6)>Subject: Re: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseThank you. Is Dr. Fauci stating it is not tru e? Do I attribute to him or you stating the New YorkTimes report is not true?Thank you for your help.Donna YoungSenior Reporter , Healthcare (Washington , DC)S&P Global Newsdonna.young@sp global.comNIH-001240301.216.2433 desk(b) (6) cell@DonnaYoungDC - 'the pharma diviner'http://mark etintelligence.spglobal.com/our-thinking/news .htmlFrom: Billet, Courtney (NIH/NIAID) [El -------- (b)(6) Sent: Thursday, February 27, 2020 6:39 PMTo: Young, Donna <Donna .Young@spglobal.com>Cc: Stover, Kathy (NIH/NIAID) [E] (b)(6)>; NIAID NEWS (NIH/NIAID)<NIAIDNEWS@niaid .nih .gov>; Myles, Renate (NIH/OD) [El (b)( >Subject: Re: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseDonna, so sorry, it's been a crazy day. We are not sure exactly where this came from. It's not true.From: "Young, Donna" <Donna .Young@spgloba l.com>Date: Thursday, February 27, 2020 at 5:32:22 PMTo: "NIAID NEWS (NIH/NIAID)" (b)(6)>, "Stover, Kathy (NIH/NIAID) [E]"(bH6J>, "Myles, Renate (NIH/OD) [El" (b)(6)>, "Billet, Courtney(NIH/NIAID) [El" (b)(6)Subject: Re: Question on report Dr. Fauci told he cannot speak with media unless cleared by WhiteHouseHi. I'm still waiting for a response on th is. Could you at lest tell me me you are going torespond?Thank you.Donna YoungSenior Reporter , Healthcare (Washington, DC)S&P Global Newsdonna.young@spglobal .com301.216.2433 desk(b) (6) cell@DonnaYoungDC - 'the pharma diviner'NIH-001241http ://marketi ntell iqence .s pg lobal. com/our-th i nkinq/news . htm IFrom: Young, DonnaSent: Thursday, February 27, 2020 1:35 PMTo: NIAID NEWS (NIH/N IAID) <NIAIDNEWS@niaid.nih .gov>; Stover, Kathy (NIH/NIAID) [ElCbH6J>M; yles, Renate (NIH/OD) [El (b)(6) ; Billet, Courtney(NIH/NIAID) [E] (b)( >Subject: Question on report Dr. Fauci told he cannot speak with media unless cleared by White HouseGood Day: Could you please comment on this report from the New York Times that Dr. Faucihas been told that he must clear anything he plans to say about the coronavirus outbreak withthe White House before he speaks to any media?https://www .nyt imes.com/2020/02/27 /us/ po lit ics/us -coron avi rus -pen ce.htm I"Dr. Anthony S. Fauci, one of the country's leading experts on viruses and the director of theNational Institute of Allergy and Infections Diseases, told associates that the White House hadinstructed him not to say anything else without clearance."Has Dr. Fauci or any other NIH official been told by the White House t hey cannot speak to themedia unless cleared by the White House?Please do let me know.Thank you for your help.Donna YoungSenior Reporter , Healthcare (Washington, DC)S&P Global Newsdonna.young@spgloba l.com301.216.2433 desk(b) (6) cell@DonnaYoungDC - 'the pharma diviner'http://ma rketintelligence .spglobal.com/our-thinking/news .htmlNIH-001242NIH-001243The information contained in this message is intended only for the recipient, and may be a confidential attorney-client communication or mayotheiwise be privileged and confidential and protected from disclosure. If the reader of this message is not the intended recipient. or anemployee or agent responsible for delivering this message to the intended recipient. please be aware that any dissemination or copying ofthis communication is strictly prohibited. If you have received this communication in error, please immediately notify us by replying to themessage and deleting it from your computer. S&P Global Inc. reserves the right, subject to applicable local law, to monitor, review andprocess the content of any electronic message or information sent lo or from S&P Global Inc. e-mail addresses without informing the senderor recipient of the message. By sending electronic message or Information to S&P Global Inc. e-mail addresses you, as the sender, areconsenting to S&P Global Inc. processing any of your personal data therein .From:Sent:To:Fauci, Anthony (NIH/ NIAIO) [E)Fri, 28 Feb 2020 00:47:19 +0000Mark ZuckerbergSubject: RE:Mark:Thanks for the note . If we start in April ( ~6-7 weeks from now ) with a phase 1trial of 45 subjects, it will take another 3-4 months to determ ine safety and someimmunogenicity . The next step is phase 2 for efficacy . We may need help withresources for the phase 2 tria l if we do not get our requested budgetsupplement. I believe that we will be OK. If thi s goes off track, I will contactyou. Many thanks for the offer . Much appreciated .Best regard s,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuild ing 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Mark Zuckerberg Cb) (6)Sent : Thursday, February 27, 2020 7: 16 PM ------~= To: Fauci, Anth ony (NIH/ NIAID) [E] (b)(6)> _______ _.Subject :Tony:I was glad to hear your statement that the covid -19 vaccine will be ready for human trials in six weeks.Are there any resources our found ation can help provide to pot ent ially accelerate this or at least makesure it stays on track?MarkNIH-001245From:Sent :To:(b)(6)Thu, 27 Feb 2020 17:43:18 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Or. Fauci--Coronavirus comment 3/2 Healthline MEDIASent from my iPhoneBegin forwarded message:From: Kristen Fischer Cb)(Date: February 27, 2020 at 5:20:21 PM E--S-T- ----~= To: "Fauci , Anthony (NIH/NIAID) [E]" CbH6)Subject: Dr. Fauci--Coronavirus comment 3/2 Healthline MEDIAHi there,I'm writing for Healthline about coronavirus and how the virus spread may be differen t in theSouthern Hemisphere (they mention that in the story below). Care to weigh in?I'd love to know :I. Will coro navirus be any less severe in the Sout hern Hemisp here due to the summe r weather thereat the moment?2. Will the virus spread in North America slow down due to geog raphy or wam1er weather at all?What can we expect in 3 months --and in one year as far as coronav irus in the U.S .?3. Will it differ in how it spreads /tapers off in Asia, due to proximity of the outbreak?4. Will this event ually be gone or will it be som ething that is a new health threat that could return in ayear or so?5. Any insight inl'o the outlook of corona virus, how it will spread or how long it will be active?Lookin g for a brief email response by Monda y morn ing at 10 a.m. Let me know if you can assist !Warmly,Kris ten FischerKristen Fischerv,rww . kristenfischer .com(b) (6jFind your family fun at the Jersey Sbore --get yourfree weekly e-newsletter today!See your product or serv ice Re-viewed by Kristen FischerNIH-001246From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 16:29:44 +0000Conrad, Patricia (NIH/NIAID) [ElSubject: FW: Covid-19--Conference Call InvitationLet us di scuss. Likely do not have tim e fo r t his.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone (b) (6)FAX: (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Buono, Lucia <LBUONO@imf.org> On Behalf Of Gopinath, GitaSent : Wednesday, February 26, 2020 2:22 PM -------::-::-=, To: Fauci, Anthony (NIH/NIAID) [El (b)((;)>Cc: Gopinath, Gita <GGopinath@imf.org>; Milesi -Ferretti, Gian Maria <GMILESIFERRETlT@imf.org>;Celasun, Oya <0Celasun@imf .org>; Na bar, Malhar Shyam <MNabar@imf .org>; Christiansen, Lone Engbo<LChristiansen@imf .org>; Buono, Lucia <LBUONO@imf.org>Subject: Covid-19--Conference Call InvitationOn behalf of Ms. Gopinath:Dear Professor Fauci:We are contacting you in the context of the evolving spread of Covid-19, which is already impactinglivelihoods and economic activity in several countries. As you may know, the IMF publ ishes forecasts ofeconomic growth for member countries four times a year, as well as macroeconomic policyrecommendations. In that context, it would be invaluable for us to hear public health experts' views onthe likely trajectory of the virus-the number of people that are likely to get infected in differentcountries and the likely time path. We would also benefit from hearing experts' views on the optimalpublic health policy response in different types of countries (countries with stronger or weaker healthsystems, different development levels, etc.), and the implied resource needs.We are planning to set up a conference call with several experts to discuss these issues and werewondering if you would be available to join us. If you would be interested in joining, would you be ableNIH-001247NIH-001248to let my assistant Lucia Buono (lbuono@imf.org ) know of some dates and times that would work foryou this week or early next week?We would be extremely grateful for any guidance you might be able to offer as we strive to do our partin helping member countries respond to the epidemic.Best regards,Gita GopinathEconomic Counsellor and DirectorResearch DepartmentInternational Monetary FundFrom:Sent :Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 13:31:19 +0000To:Subject:Conrad, Patricia (NIH/NIAID) [E);Barasch, Kimberly (NIH/NIAID) [C]FW: The global health leaders call, Wednesday 4 March at 13:00 CETAttachment s:FYIAnthony S. Fauci, MDDirector(b)(4) Swisscom Call code.pdfNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e -mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: RYAN, Michael J. ------ (b)(6bSent : Thursday, February 27, 2020 7:55 AMTo: Redfield, Robert R. (CDC/OD)--------------------~~(b)(6); Jeremy Farrar(b) (6); Fauci, Anthony(b)(6)Conrad, Patricia (NIH/NIAID) [E]Tarik Mohammed ------------(b)(6)(b) (6); President I Resolve to Save Lives(b)(6)Cc: SHOC <shoc@who.int>; Office of the Director-General <DGOffice@who .int>; SCHWARTLANDER,Bernhard F. (b)(6h; MAHJOUR, Jaouad (b)( ; FALL, lbrahima SoceCbH >; GREIN, Thomas (b)(6) MINHAS, Raman (b)(6); COX, PaulMichael (b)( >; AL-SHORBAJI, Farah (b)(6) _>; POOLE, Marcia""'::::===(b=)(6~); ~DR URY,P atrick Anthony CbH ; GRAAFF, Peter Jan ____ Cb)_C_6),>; Dr VAN KERKHOVE,M aria (b)(6); KABIR, SophiaNIH-001252------ (b)(6)'> ; FARESC, hristine Youssef (b)(6) Subject : The global health leaders call, Wednesday 4 March at 13:00 CETDear colleagues,Dr Tedros would like to invite you to the next informal discussion about the ongoing 2019 novelcoronavirus.The teleconference will be hosted on Wednesday, 4 March at 13:00 CET and the dial-in numberwith a passcode is attached.If you experience any technical difficult ies joining this conference call, please contact the WHOHQ EOC operator at: +41227912490It would be appreciated if you could kindly confirm your participat ion to Ms Sophia Kabir, email:------- CbH6Jt; mobile no. (b)(6)The agenda and background documents will be shared ahead of t he call.Best,M ikeNIH-001253From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Thu, 27 Feb 2020 04:44:07 +0000Conrad, Patricia (NIH/NIAID) [E)Subject : FW: [EXTERNALR) E:H ardball TonightFYI. (b)( .----- Original Message -----From: Matthews , Chris (NBCUniversal, MSNBC) <k ennedynixon @msnbc.com >Sent: Wednesday , Febrnary 26 , 2020 2-:3-9- P-M- -~~ To: Fauci , Anthony (NIH/NIAID) [E] (b)( >Subject: Re: [EXT ERNAL] RE: Hardba ll TonightWhen you can and are ready , T would love to have you on Hardball anytime in the 7pm hour tonight , tomorrow orFriday.Sent from my iPhone> On Feb 26, 2020, at 11:34 AM, Fauci, Anthony (NlH/NlAID) [EJ ______ CbH_6,)> wrote:>> Chris:> I am always happy to be on your show . I am hearing that they want us to hold on doing any interviews for thetime being since the POTUS might do a press conference tonight. And so the decision is still in flux.> Tony>> Anthony S. Fauci , MD> Director> National Institute of Allergy and Infectious Diseases Building 31,> Room 7A-03> 3 L Center Drive , MSC 2520> National Institutes of Health> Bethesda , MD 20892-2520> Phone (b) (6)> FAX: (301) 496-4409> E-mail: --------(b)(6) > The inf orma tion in this e-ma il and any of its attachments is confiden tial and may contain sensitive infonnation. Itshould not be used by anyone who is not the original intended recip ient. Tfyou have received this e-mail in errorplea~e inform the sender and delet e it from your mailbox or any other storage devices. The National lm;titule ofAllergy and Infectious Diseases (NIAID) shaJI not accept liability for any statements made that are the send er's ownand not exp ressly made on behalf of the NIAID by one of its representatives.>> ----- Original Message ---- -> From: Matthews , Chris (NBC Universa l, MSNBC) <kenn edynixon @msn bc.com >> Sent: Wednesday, February 26, 2020 9:-04- A-M-- -~= > To: Fauci, Anthony (NlH/NIAlD) [E) (b) ( >> Subject: Hardball Tonight>> Dear Tony>> Coul d you come on tonight to address the coronavirus? We'd like to> have you on anytime in the 7 hour. (b) (6)>> Best, ChrisNIH-001254NIH-001255>> Sent from my iPhoneFrom:Sent :To:Subject :Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 04:35:33 +0000Conrad, Patricia (NIH/NIAID) [E)FW: Can you chat?Please set this up. Thanks.From: Fox, Lauren <Lauren.Fox@turner .com>Sent: Wed nesday, February 26, 2020 5:41 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------=- (bc)(-=c >Subject : Can you chat?Hey Dr. Fauci,I wanted to reach out because I am working on a big piece about the effort behind the scenes to containthe coronavirus and I was hoping you could talk on background about that,Best,Lauren FoxLauren FoxCongre ssional ReporterCNN PoliticsLauren.F ox@turner.com(b)(6)NIH-001256From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 04:34:46 +0000Arturo CasadevallSubject: RE: My OpEd on the WSJ coming out Friday on convalescent serum forCoronavirusArturo:Thank you for your note and for sending the Op Ed. Nice Job! I hope that all is well w ithyou.Best,TonyFrom: Arturo Casadevall (b)(6)>Se nt: Wednesday, February 26, 2020 5:45 PMTo: Fauci, Anthony (NIH/NIAID) [E] ------=-c (b')"("=6')Subject: My OpEd on the WSJ coming out Friday on convalescent serum for CoronavirusDear Tony,I just had an OpEd accepted in the WSJ proposing the use of convalescent sera to stem the coronavirusepidemic. The text of the OpEd is below in blue font (scroll down). I am sure the WSJ will shorten it andedit it but at least you have an advance copy of it. I just wanted you to have it since the WSJ is readwidely in DC and I don't want anyone blindsiding you with questions about it.As you know I have been long proponent of passive antibody therapies in infectious diseases and thereis a huge body of historical data support ing this approach. Certainly, with modern blood bankingtechniques this option can be made quite safe and administration of a few cc's of serum could conferimmediate immun ity to those who will be exposed - like ER staff . I hope you agree with the messageand like it.Thank you for all you are doing for the country and humanity . If you need me for anything in this crisisrest assured that I am here.Warm regards,ArturoFrom: Taranto, James <james.tarant o@wsj.com>Sent : Wednesday, February 26, 2020 4:27 PMTo: Arturo Casadevall (b)(6)>Subject: Re: Asking for a quick decision on the submitted OpEd on stemming coronavirus epidemicOK, we'll take this and aim to get it out in Fr iday's paper, though it will likely need sometrimming for space.Dear Mr. Varadara jan,NIH-001257I wonder if the WSJ is interes ted in my Op Ed. I am trying to get a message out thatconva lescent serum (e .g. serum from people who recover) can be used to stem the coronavirusepidemic if admini stered to exposed people. This has been known for over a century, and iswell accepted, but not wide ly known, even among experts today. There was one report thatChina was beg inning to stockpile serum but there has been almost no discuss ion of this optionamong world public health authorities . Although I can get this published in a medical journalmy hope is to publish it instead in a venue of high readership since this is something that canbe done today to stem the epidemic. I am hoping that given the econom ic consequences of theoutbreak that the WSJ is interested . I included a brief bio below. Thanks for looking at this.ArturoProp osed op-ed.To Stem the Coronavirus Epidemic use Survivors Blood.(b) (4)NIH-001258Arturo Casadevall MD, PhDAuthor's brief bioArturo Casadevall, M.D., Ph.D., is a Bloomberg Distinguished Profes sor and Chair of theMolecular Microbiology and Immunology at Johns Hopkins School of Public Health. Hereceived his M.D . and Ph.D. degrees from New York University. He completed hisinternship/residency in internal medicine at Bellevue Hospital and specialized in InfectiousDiseases at the Albert Einstein College of Medkine . The author of over 800 papers , books andchapters, bis major research interests are in fungal pathogenesi s and the mechanisms ofantibody action. He is also interested in the problems with scientific enterprise and withcollaborators showed that misconduct accounts for the majority of retracted publications. Heis editor-in-chief of mBio, Deputy Editor of the Journal of Clinical Investigation and serves onseveral editoria l boards . He has served on several NIH committees including the NIAIDStrategic Plan , the Blue Ribbon Panel on Biodefense Research , the NAS panel that reviewedthe FBI investigation on anthrax attacks, the NAS Federal Regulations and Reportingcommittee and the National Science Advisory Board for Biosecurity . He was a CommissionerNIH-001259(b)(4)NIH-001260in the National Commission on Forensic Science and previously served as President of theMedical Mycology Society of the Americas. He is currently the Chair the Board of Governorsof the American Academy of Microbiology. He has received numerous honors includingelection to the American Society for Clinical Investigation , American Academy of Physicians ,American Academy of Microbiology , Fellow of the American Academy for the Advancementof Science, American Academy of Alts and Sciences and the National Academy of Medicine .Arturo Casadevall MD, PhDChair, Molecular Microbiology & ImmunologyAlfred & Jill Sommer Professor and ChairBloomberg Distinguished ProfessorJohns Hopkins School of Public Health615 N. Wolfe StreetRoom E5132Baltimore, Maryland 21205From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Fri, 6 Mar 2020 03:48:12 +0000To:(NIH/NIAID) [E]Marston, Hilary (NIH/NIAID) [E];Lerner, Andrea (NIH/NIAID) [E];Lane, CliffThanks .From: Marston, Hilary (NIH/NIAID) [E] (b)(6)>Sent: Thursday, March 5, 2020 10:15 PMTo: Fauci, Anthony (NIH/NIAID) [E]----- -(-b=-H"=6J>; Lerner, Andrea (NIH/NIAID) [E](b)(6); Lane, Cliff (NIH/NIAID) [E] (b)(6)Importance: HighFrom: "DLGDESK (HHS/ASPR/OPP)" <DLGDESK@hhs.gov>Date: Thursday, March 5, 2020 at 6 :19 PM --------~= To: "Stannard, Paula (HHS/I0S)" (b)(6) "Agnew, Ann (HHS/10S)"(b) (5)(b) (5}(b) (5lCbH >, "Trueman, Laura (HHS/IEA)" (b)(6)"Kadlec, ________ __.Robert (OS/ASPR/I0)" CbH61>), "Bird, Catherine (OS/OGC)"CbH >, "Hittle, Taylor (HHS/ASFR)" CbH6J>",A rbes , Sarah ---:-"""""".'"."."'::======~~~ (HHS/ASL)" CbH6)>",M urphy, Ryan (OS/ASPA)" CbH6)>,"Destro, Brenda (HHS/ASPE)" CbH >, "Nevel, Amy (HHS/ASPE)"-------- CbH6J>",T obias, Constance (HHS/DAB)" CbH6J>, 11 Giroir, Brett (HHS/OASH)" CbH >, "Schwartz, Erica (HHS/OASH)"CbH6, J"Severino, Roger (HHS/OCR)" CbH6J>"G, rigsby,Garrett (HHS/OS/OGA)" CbH6J>",K err, Lawrence (HHS/OS/OGA)"--------- CbH >, "Chang, Wi lliam (HHS/OGC)" CbH61>J, 11T ait sm an, Julie K (OIG/I0)" CbH6)>",G r iswold, Nancy (HHS/OMHA HQ)"--:-'."""'.'~-=(b=)(6)=>, "_=Ru_=ck e:r., .D.o:n.a.ld. (OS/ONC)" (b)(61J>, "Johnson, ....;.,=Lynn (ACF)" CbH6>1">M,e yers , David (AHRQ/ I00) "(b)(6) "McNellis, Robert (AHRQ/CEPI)" ==========:-;:~ ------------- (b)(6)>, "Patel, Anita (CDC/DDID/NCIRD/0D)" (b)(6), 11 Ethier, Kathleen (CDC/DDID/NCHHSTP/DASH)" CbH6)>",B rookes, Brady (CMS/DA)"(b)(6) "H inton, Denise(FDA/OC)" ---------- CbH6)>",C heever, Laura (HRSA)" (b)(6)NIH-000961"Espinosa, Diana (HRSA)" Cb)( >, "Macrae, Jim (HRSA)" Cb)( >,"Weahkee, Michael (IHS/HQ)" CbH6)>", McCollu m, Jeffrey T (IHS/HQ)"CbH6)>",F razier, Francis (IHS/HQ)"Francis (NIH/OD) [El" CbH >, Anthony Fauci CbH6)>H, ilaryMarston CbH1>6J, "Mccance-Katz, Elinore (SAMHSA/OAS)" -----~~ ":':""'.'"-:---.---".""'."(b")('6:)~ "S~hu-y,: B-r~-ya: n'" (O'.S"/A"S.P"R/'1.0")": ====--__C;b_H6~)>, "Yeskey, Kevin (OS/ASPR/10)" CbH6)R, ick Bright CbH6)>,"Disbrow, Gary (OS/ASPR/BARDA)" CbH6J>",P hillips, Sally (OS/ASPR/SPPR)"------- CbH >, "Greene, Jonathan (OS/ASPR/EMMO)" CbH6),11 De Bord, Kristin (OS/ASPR/SPPR)" CbH6)>",V ineyard, Michael(OS/ASPR/10)" CbH6)>",D odgen, Daniel (OS/ASPR/SPPR)"--------- (b)(6), "Imbriale, Samuel (OS/ASPR/SIIM)" (b)(6), "Donne IIy , Kelsey (OS/ASPR/SPPR)( CTR)" CbH6)>",H aris, Mariam(OS/ASPR/SPPR)( CTR)" CbH6)>",F ucci, Michael (OS/ASPR/SPPR)( CTR)"-------- (b)(6)>," Roman-Stolte, Claudia (05/ASPR/SPPR) (CTR)" (b)(6) , "Austin, Meredith (uscg.mil)" CbH6J>",P erdue,Christopher (OS/ASPR/SPPR)" CbH6)>",H errmann, Jack(O S/ ASPR/OEA)"_ __:__ _:_======:: (~b)(~6:),- ~R'o"b"_e'.'rt'"J"o-':.h-' n-so- n ---------- (b)(6)11W ong, Diana (OS/A SPR/SIIM)" CbH6J, >"Robertson, Lance (ACL)"CbH6)>",N icholls, Richard (ACL)" (b)(6)"Phillips, Christine (ACL") CbH6)>",B latner, Gretta (OS/A SPR/BARDA)"-------- CbH6)>",F eeney, Kathryn (OS/ASPR/10}( CTR)" CbH6J>,11 Shir I e y, Mayo (FDA/OC)" CbH >, "Sheehy, Janice (FDA/ORA)"(b)(6) "McDaniel, Eileen (HHS/OMHA)" CbH6)>,--:----:-----::======~~~Linda Lambert Cb)( >, "Gin, Julia (OS/ASPR/SPPR)" CbH6),"Adams, Steven A. (CDC/SNS/DSNS)" (b)(6), "Wolf, Laura (OS/ASPR/SIIM)"CbH6J>"L, ee, Scott (OS/A SPR/EMMO)" CbH6)>",C ooper, Kevin(OS/ASPR/ORM)" CbH6)>",M oudy, Robin (OS/ASPR/SPPR)"CbH6)>",L awrence, Theresa (OS/ASPR/SPPR") -:========~.C..b.=H.6. J".,B ,aker, Michael (OS/IEA)" ------- .C-b.H.-6-J>- -.-.-= ----------- Cc: "Holland, Tara (OS/ASPR/EMMO)" CbH >, "Delvecchio, Paolo(SAMHSA/OMTO}" CbH6)",L obos, Elisa (SAMHSA/OFR/0D)"-:-----:---:----:-::--::====:....:.__..:.>,_, "Bell, M__ar ch (.:H..,H__S./.O:,_C~~R )" CbH6)",F rohboese,Robinsue (HHS/OCR)" ~====~~-~----(b-):(6-·)," " Knutson, Donna (CDC/DDNID/NCEH/OD)' (b)(6) "Mackay, Thomas (OS/ASPR/EEAA)" ;____;,_ __ ..:.,__...:____;,_.=-~~-----=~......~. --~----"".'":"."':== C=Hb=6)'.M...a._n.g::.o:.. .'.:.P._.a:_u.I. .(..H.:._.H:~S:/.l.~O.. S)" CbH6)>",B lackford,Carol W. (CMS/CM)" CbH6J>"B, radsher, Kris (HHS/ASL)"CbH6)>",P ayne, Skip (CMS/OA)" CbH6J",G ettinger ,Andrew (OS/ONC)" CbH6)>",A bbey, Rachel (OS/OSCP)" -------~= -------- CbH6)>",C osgrove, Sandra (OS/ASPR/EEAA)" CbH6)>, 11 Ch a put, Daniel (OS/ONC)" CbH6)(b) (5)NIH-000962Dear Disaster Leadership Group (DLG) Members ,(b) (5)We are asking that you review this draft andprovide feedback to us by 8:00am on Friday, March 6. Please note that we are looking for subst antivefeedback only .If you have any quest ions or concerns, please reach out to me a ---------- Cb)( 6) and kindly copy the DLGDESK@hhs.gov.Thank you,Daniel Dodgen, Ph.D.Senior AdvisorOffice of the Assistant Secretary for Preparedness and Response (ASPR)Office of Strategy, Policy, Planning and Requirements {SPPR)HEALTHA ND HUMAN SERVICES(D HHS) I O'Neill House Office Building I 200 C Street SW I Washington,DC 20515o. (b)(---------(b)(6) I www .phe.govNIH-000963From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 3 Mar 2020 11:12:55 +0000(b)(6) (OS/IOS)Subject: RE: Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan2019-nCov I bioRxivOh, I see what they are getting at. They examined at the single cell level the expression of RNA for ACH2, whichis the receptor for the Coronavirus in the lung ,and found that when they looked at various demographic groups therewas greater expression of this recep tor in Asian males. They are thus hinting that this is the reason why there wassuch an explos ion of infections in China. This is possible, but the lowest level was in Northern Ltalians and take alook at what is happening in Nort hern Ttaly. I do not mean to put the paper down since there may be some truth init. However, this journal (bioRxiv) is not peer reviewed and the data are skimpy. Someone should do a morescholarly st udy.----- Origina l Message ------------=,.,..,.= From: (b) (6) (OS/1OS) (b) (Sent: Tuesday, March 3, 2020 5:54 AM-----~~To: Fauci, Anthony (NIH/NlAID) [E] (b)(6) >Subject: Re: Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-oCov I bioRxivThey asked if this proved certain ethnic groups more likely to get the disease and 1 said I had never anything likethat suggested to me by our leading scientists.> On Mar 2, 2020, at L0:44 PM, Fauci, Anthony (NIH/N[AJD) (E)>(b) ( wrote:I do not know what question they asked you about th is paper, but any question about this gene expression paper to anon-scientist would be unfair and inappropriate.-----Original Message------------=~=-- From: Cb) (6) (OS/IOS) Cb) (6)>Sent: Monday, March 2, 2020 9:55 PMTo: Fauci, Anthony (NlH/NIAID [filJ Cb) (6)> ; Redfield , Robert R. (CDC/OD) Cb) (6)Cc: Harrison , Brian (HHS/I OS) (b) (6),Subject: Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019 -nCov I bioRx ivWas asked about this on tv tonight.https: //www .biorxiv .org/content/ 10.110 1/2020.01 .26.9 19985vlNIH-001022From:Sent :Fauci, Anthony (NIH/NIAIO) [ElTue, 3 Mar 2020 03:26:29 +0000To:Cc:Subject:Collins, Francis (NIH/OD) [E);Giroir, Brett (HHS/OASH)Steele, Danielle (HHS/IOS);Tabak, Lawrence (NIH/OD) [E]RE: SARS CoV-2 in humanized miceDitto.From: Collins, Francis (NIH/OD) [E] (b)(6)Se nt: Monday, March 2, 2020 9:32 PM ------~= To: Giroir, Brett (HHS/OASH)Cc: Fauci, Anthony (NIH/NIAl ~D:)- '[:.:E: ']: ""~::::::::::~:·>; Steele, Danielle (HHS/10S)--------- (b)( ; Tabak, Lawrence (NIH/OD) [E] (b)( Subject: RE: SARS CoV-2 in humanized miceLarry has it right . Tony may want to add.FrancisFrom: Tabak, Lawrence (NIH/OD) [El (b)(6)Sent : Monday, March 2, 2020 8:14 PM -------=-=-=- To: Giroir, Brett (HHS/OASH)Cc: Collins, Francis (NIH/OD) ~[E:)':="===== (~b)~(~6)>; Fauci, Anthony (NIH/NIAID) [E]-------- CbH >; Steele, Danielle (HHS/10S) (b)(6) Subject: Re: SARS CoV-2 in humanized miceBrett,I hope this helps.LarryFrom : "Giroi r, Brett (HHS/OASH)" <- ------- (b) (6) , Date: Monday, March 2, 2020 at 7:25 PMTo: "Tabak, Lawrence (NIH/OD) [E]"_ _:__;___;_::...:,~~"""'.'""--:---:--".-::::==------=..,..=,Cc: Francis Collins (b)(6) 1>, Anthony Fauci (b)(6)>, "Stee le, ---=======::::!..~~ Danielle (HHS/ 10S)" CbH6)>, "Giroir, Brett (HHS/OASH)"(b)(6)Subject : RE: SARS CoV-2 in human ized miceNIH-001025Dear Larry,I appreciate your will ingness to cont inue to work on this and respond to the questions that I amreceiving .V/rBrettBrett P. Giroir, MDADM, US Public Health ServiceAssistant Secretary for Health (ASH)200 Independence Avenue, SWWashington, DC 20201Office Phone: (b) (6)From: Tabak, Lawrence (NIH/OD) [E] (b)(6)Sent : Thursday, February 20, 2020 5:29 PMTo: Giroir, Brett (HHS/OASH) ~ :.:======;:~ Cc: Collins, Francis (NIH/OD) [E] (b)(6)>; Fauci, Ant hony (NIH/N IAID) [E]-------- (b)(6); Steele, Danielle (HHS/10S) (b)(6)> Subject : Re: SARS CoV-2 in humanized miceBrett ,I have discussed with both Francis and Ton (b) (5l ·-----------------With regard to your questions:NIH-001026(b) (5)Hope this is helpful. Please let me know if you require additional info rmat ion .Best wishes,LarryFrom: "Giroir, Brett (HHS/OASH)" -------- (b)(6) 0 ate : Thursday, February 20, 2020 at 12:32 PM -------- ..----.-.-= To: "Tabak, Lawrence (NIH/OD) ;[E..]_". ._.:_. ..!======~(b)~(6) - Cc: "Stee le, Danielle (HHS/10S)" ---------- (b)(6) Subject: RE: SARS CoV-2 in human ized miceBrett P. Giro ir, MOADM, US Public Health ServiceAssistant Secretary for Health (ASH)200 Independence Avenue, SWWashington, DC 20201Office Phone: (b) (6)From: Tabak, Lawrence (NIH/OD) [El (b)(6)Sent : Thursday, February 20, 2020 12:19 PMTo: Giroir, Brett (HHS/OASH) (b)( >Cc: Steele, Danielle (HHS/10S) (b)(6) ,>Subject: Re: SARS CoV-2 in humanized miceNIH-001027(b) (5)(b)(5)ThanksLarryFrom: "Giro ir, Brett (HHS/OASH)" ----------- (b) (6) 1> Date: Thursday, Februa ry 20, 2020 at 12:17 PM ---------=--=-= To: "Tabak, Lawrence (NIH/OD) [El" (b)(6) ;.....:.-=======~~- Cc: "Steele, Danielle (HHS/10S)" ---------- (b)(6) Subject: RE: SARS CoV-2 in human ized miceLarrBrett P. Giroir, MOADM, US Public Health ServiceAssistant Secretary for Health (ASH)200 Independence Avenue, SWWashington, DC 20201Office Phone: (b) (6)From: Tabak, Lawrence (NIH/OD) [E] (b)(6)Sent: Wednesday, February 19, 202011 :04 PMTo: Giroir, Brett (HHS/OASH) (b)(6)Cc: Steele, Danielle (HHS/10S) (b)(6)Subject : FW: SARSC oV-2 in humanized miceBrett,Thanks for your consideration,LarryFrom: "Hasenkrug, Kim (NIH/N IAID) [El" ----------- (b)(6) Date: Wednesday, February 19, 2020 at 5:50 PMNIH-001028(b) (5)(b)(5)(b) (5)To: "Tabak,L awrence( NIH/OD) [E)" ,__ (b)( 6) ________Subject: SARS CoV-2 in human ized miceHi Dr. TabakBest regards ,KimKim J Hasenkrug, Ph.D.Senior InvestigatorChief, Retroviral Immunology SectionLaboratory of Persistent Viral DiseasesRocky Mountain LaboratoriesNational Institute of Allergy and Infectious DiseasesNational Institutes of Health903 S. 4th StreetHamilton, MT 59840(b)(6)Disclaimer:The information in this e-mail and any of its attachments is confidentialand may contain sensitive information. It should not be used by anyone whois not the original intended recipient. If you have received this e-mail inerror please inform the sender and delete it from your mailbox or any otherstorage devices. National Institute of Allergy and Infectious Diseasesshallnot accept liability for any statements made that are sender's own and notexpressly made on behalf of the NIAi D by one of its representativesNIH-001029(b) (5)(b) (5)From:Sent :Fauci, Anthony (NIH/NIAID) [E)Mon, 2 Mar 2020 00:48:25 +0000To:Cc:Cassetti, Cristina (NIH/NIAID) [E];Giroir, Brett (HHS/OASH)Conrad, Patricia (NIH/NIAID) [ElSubject: RE: COVID and ChloroquineThanks, CristinaFrom: Cassetti, Cristina (NIH/NIAID) [E)- --------(b)(6)> Se nt: Sunday, March 1, 2020 7:06 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [El -------- (b)(6) Giroir, Brett (HHS/OASH) (b )( 6)Cc: Conrad, Patricia {NIH/NIA ID) [El --------- (b) (6) > Subject: RE: COVID and Chloroqu ineHi,NIAD doesn't have ongoing trials with chloroquine and I heard that such tr ials are being conducted inChina.We are planning to evaluate chloroquine in animal models ASAP. If any the rapeutic with a good clinicalsafety profile ( like chloroquine) appears to be effective in vivo against COVID-19, we are planning toquickly add to them to the Remdesivir therapeutic trial as another arm.Let me know if you have other questions .Kind regards,CristinaCristina Cassetti, Ph.D.Deputy DirectorDivision of Microbiology and Infectious DiseasesNationa l Institute of Allergy and Infectious Diseases, NIH5601 Fishers Lane, Room 7GS1Rockville, MD 20852Tel: (b)(6)(b)(6)From: Fauci, Anthony {NIH/N IAID) [El -------- (b)(6) Se nt: Saturday, February 29, 2020 8:20 PMNIH-001057To: Giroir, Brett {HHS/OASH) (b) (6l> "":"::-"'.""":"::-::.::=====--=--c-:-= Cc: Cassetti, Cristina {NIH/NIAID) [E] ---------(b)(6)>; Conrad, Patricia (NIH/NIAID) [E] (b) (6)>Subject: RE: COVID and ChloroquineImportance: HighBrett:Thanks for the note. I will run this by the people in our Program and get back toyou.Best,TonyCristina:Are we or anyone else doing anything with clinical trials and chloroquine forCOVID-19? Please respond directly to ADM Giro ir .Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Giroir, Brett {HHS/OASH) -------- (b) (6)>Sent: Saturday, February 29, 2020 9-:-31- A-M- --=-,--== To: Fauci, Anthony {NIH/NIAID) [E)- ------- (b)(6) Subject: COVID and Chloroqu ineYou know the old data and the new data. New in vitro look promising.Do you have good visibility on the trials being conducted? Or is NIH runn ing any of these?Your time is precious, so 10 word response sufficient.NIH-00 1058Brett P. Giroir, MDADM, US Public Health ServiceAssistant Secretary for Health (ASH)200 Independence Avenue, SWWashington, DC 20201Office Phone: (b) (6)NIH-001059From:Sent:To :Subject:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 22:35:38 +0000Kadlec, Robert (OS/ASPR/10)RE: Your thoughtsMy thoughts - ----(-b) (5)Anthony S. Fauci, MDDirecto rNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone : Cb()6 )FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Kadlec, Robert (OS/ASPR/IO) ---------- (b)( > Sent: Saturday, February 29, 2020 10:03 PM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] -------- CbH6)> Subject: Your thoughtsImportance: HighTony I don't know if you saw this but wanted to ask your thought. Cb<)5 >Your thoughts always appreciatedbob<< File: CCDC Epi Report.pptx >> << File:The+Epidemiological+Characteristics+of+an+Outbreak+of+2019+ Novel +Coronavi rus+Diseases+(COVID-19)+-+China,+2020.pdf >>NIH-00 1073From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 03:55:20 +0000Collins, Francis (NIH/OD) [E]Cc: Tabak, Lawrence (NIH/OD) [E];Conrad, Patricia (NIH/NIAID) [E]Subject : RE: HHS COVID-19 Response· alignment of OPDIV/STAFDIV EffortsI would recommend Dr. Hilary Marston from my immediate office. Larry should go to thehear ing with usFrom: Collins, Francis (NIH/O D) [E] (b)(6)Sent: Saturday, February 29, 202010:48 PM ---------.., ~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Cc: Tabak , Lawrence (NIH/OD) [E] (bH6)>Subject: FW: HHS COVID-19 Response - alignment of OPDIV/STAFDIV EffortsHi Tony ,Quick question - who would you suggest is the appropriate NIH representa tive for this ASPR-ledtrans-HHS effort to coordinate COVID-19 response? You and I will be testifying in front of theHouse Approps Subcommittee on Wednesday morning . Would it be best for Larry to representNIH for the ASPR gathering (though he would normally attend the House hearing), or is theresomeone from NIAID that would be most appropriate?Thanks , FrancisFrom: Kadlec, Robert (OS/ ASPR/10) --------- (b)(6)Sent: Friday, February 28, 2020 10:23 AM -------~= To: Tru eman, Laura (HHS/IEA) (b)(6)>; Rowell, Scott (OS/ASA)(b)( >; Bird, Catherine (OS/OGC) (b)(6b; Moughalian,Jen (HHS/ASFR) (b)(6) , ; Arbes, Sarah (HHS/ ASL) (bH6)>;Murphy, Ryan (OS/ASPA) (b)(6)>; Destro, Brenda (HHS/ASPE)(bH >; Giroir, Brett (HHS/OASH) (bH6)>; Severino, Roger":":"':-:--:-:-'.:-=--::::-:-;====::::::.._;__ _ __,;_=(HHS/OCR) (bH >; Grigsby, Garrett (HHS/0S/OGA),,:___;_ _ _;_:====;: (b-);(:;6;;);>--"; -K"::.e---r-r,-:L--a-wrence ( HHS/0S/OGA) --------- (b.H.-=6);Charrow, Robert (HHS/OGC) (b)( ; Grimm, Christi A (OIG/10)...-.-.- --:====(=bH6=J>; =Gr-isw..ol:d., _Na~nc=y (H HS/OMHA _H_Q :) :_.!:::::======~~- 0 p Divs (b)(6)>; Johnson, Lynn (ACF) ---------- (b)(6)(b)(_R_o_b e rt so_n;,_ _L _a nce _(A;_C_L;_) ::::::~;;--=-----:::--:-:---:--:--(b--H:6::)->:;- =K.h anna, Gopal (AHRQ/100)(b)(6)>; Redfield, Robert R. (CDC/OD) (b)(6) Verma, Seema":'":-:--:-:-~-:-::::=====~_:_-~~(CMS/OA) (b)( Saxon, Bobby (CMS/CCIIO),,:____:_..:..:::==========::::...-----.-.c,.;----------------- (b)(6) Hinton , Denise (FDA/OC)NIH-001117":'-----:---:---'.==(b=)(6=)>=; E=-n=g=e~-l-s ,. T.:h.o.m_as (HRSA)- ------- CbH6;) Weahkee, Michael ~(IH.S../H.:Q.). .<- .;.....:=====~(b~)(6:);>-; -M-c-Coll um, Jeffrey T (IHS/HQ) (b )( 6) >; Frazier, Francis (IHS/HQ) (b)(6)>; Collins,~-".""""'.'"."'"'"'"-:"".:~~~=::::!...:,_ __ :.,,.,=.Francis (NIH/OD) [El CbH61 ); Fauci, Anthony (NIH/NIAID) [E]-------- CbH6)>;M ars ton, Hilary (NIH/NIAID) [E] Katz, Elinore (SAMHSA/OAS)CbH6)>; McCance---------------(b)(6); Krohmer, Jon (dot.gov) (b)(6)Cc: Ford-Barnes, Arwenthia (OS/ASPR/IO) CbC) 6J1W; aters, Cicely(OS/ASPR/OEA) CbH6);S huy, Bryan (OS/ASPR/IO) (b)(6) ________ _,Subject: HHS COVI0-19 Response - alignment of OPDIV /ST AF DIV EffortsDear ASPR Colleagues,We are at a critical juncture in our nation's response to COVID-19. As we pivot fromcontainment of the virus to mitigation of its impacts, it is imperative that HHS movesswiftly, transparent ly, and in a unified manner to protect lives and save Americans. TheSecretary has charged my office to lead efforts across the Department to prepare anddefend our health care system during the novel coronavirus outbreak through theHealth Care System Resilience Task Force.To date, this task force has engaged with public and private sector stakeholders tobroadly identify efforts that can be taken to help ensure preparedness in response to adomestic COVID-19 outbreak, and more importantly their gaps, challenges, andpotential areas of need from the federal government. Now, we must build on thatknowledge to expedite and execute a whole of HHS response to support protection ofthe health care system that spans public health, health care, and human services.Please join Dr. Kevin Yeskey, ASPR's Principal Deputy Assistant Secretary forPreparedness and Response, and Dr. Nancy Messonnier, CDC's Director of the NationalCenter for Immunization and Respirato ry Diseases, on Wednesday, March 4 from 9:00AM -10:15 AM, at the O'Neill House Office Building for a working session to aligncurrent activities and next steps to be executed as part of a coordinated HHS responseto COVID-19.Please provide the following information to ASPR.HCSRTF@hhs.gov no later thanMonday, March 2 at 12:00 PM, and be prepared to share and discuss at Wednesday'ssession.• Your Designee(s) name, t itle, and contact information• OPDIV/STAFFDIV name• OPDIV/STAFFDIV current and future top five priorities related toCOVID-19 (priority leads, descriptions, timelines)NIH-001118NIH-001119• OPDIV/STAFFDIV key activities and workgroups (current and underconsideration) related to COVID-19 response (include activity/workgroupleads, key purpose, timelines)• OPDIV/STAFFDIV key areas of concern or challenges identified todate• OPDIV/STAFFDIV core competencies or other assets it can bring toCOVID-19 response effortsWe look forward to working with you on this critical effort to defend the nation's healthcare system. Thank you in advance for your support and participation.Respectfully,Bob KadlecASPRFrom:Sent:To:Subject:Francis:Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 03:26:56 +0000Collins, Francis (NIH/OD) [E]RE: HHS COVI0 -19 Response - alignment of OPDIV/STAFDIV EffortsYou are correct about the Israeli vaccine. I cannot imagine that they would have a safe andeffective vaccine deployable in 90 days.TonyFrom: Collins, Francis (NIH/OD) [E]- -------- (b)( 6)> Sent : Friday, February 28, 2020 12:56 PMTo: Fauci, Anthony (NIH/NIA ID) [E].------- -,_(.b-)_(=.,->; ; Tabak, Lawrence (NIH/OD) [E](b)(6)Subject: FW: HHS COVID-19 Response - alignment of OPDIV/STAFDIV EffortsHi Tony and Larry,See below for a new Health Care Resilience Task Force being convened by ASPR.The initial meeting overlaps with our House approps hearing.Tony, who shall we send to this one?FCP.S. to Tony- I'm gett ing a lot of buzz about the Israeli claim to have fast track vaccine:https:// israelb .org/2020/02/israel-to-have-coronavirus-vaccine-within-3-weeks/ It looks to methat they are conflating having something ready to put into voluntee rs for a phase 1 trial, andhaving full scale production ready to go for the global needs. That still seems like it's a yearaway. Am I right?From: Kadlec, Robert (OS/ASPR/10) (b)(6)Sent: Friday, February 28, 2020 10:23 AMTo: Trueman, laura (HHS/IEA) _______ -,C;.H.b,=.6..)>; Rowell, Scott (OS/ASA)(b)( · Bird, Catherine (OS/OGC) (b)( >; Moughalian,Jen (HHS/ASFR) (b)(6) Arbes, Sarah (HHS/ASL) (b)(6)Murphy, Ryan (OS/ASPA) (b)(6)>; Destro, Brenda (HHS/ASPE)(b)(6); Giroir, Brett (HHS/OASH) <: (b)( >; Severino, Roger":""":":--:"':"":'."':~=====::...-__,; ~(HHS/OCR) CbH6)>; Grigsby, Garrett (HHS/OS/OGA)NIH-001124--------- CbH >; Kerr, Lawrence (HHS/OS/OGA) CbH6)>; Ch arrow, Robert (HHS/OGC) (b)(6)>; Grimm, Christi A (OIG/I0)--~--=====C=bH6=)>; G=ris=wo-ld-, .N:a_nc_y (H~H=S/O MHA HQ) (b)( >; Op Divs ---~-"."'-::::====(b:):( !.>.; .J.o:h.n. s on,. :L.y.n.n.. (.A..C.F:)~ < (b)(6)>;Robertson, Lance (ACL) (b)(6)>; Khanna, Gopal (AHRQ/10D)CbH6); Redfield, Robert R. (CDC/OD) CbH6)>; Verma, Seema":"".'"'""'."":""':"':'.""':"-:-"=======~--..~ (CMS/OA} CbH >; Saxon, Bobby (CMS/CCIIO)<_ _;___;_:::=========:::::...;_ .(.,b.,).(,~.6..) Hinton , Denise ( FDA/OC)CbH6)>; Engels, Thomas (HRSA) -co. CbH6?j>; Weahkee, Michael7(1-H:--S::-/7H:Q:-7:)======:::....:..-,; (b;H.,=6)>; McColl um, Jeffrey T (IHS/HQ)(b)(6); Frazier, Francis (IHS/HQ) --------- (b)(6) Collins, Francis (NIH/OD) [El (b)(6), ; Fauci, Anthony (NIH/NIAID) [El-------- (b)(6)>; Marston, Hilary (NIH/NIAID} [El (b)(6); Mccance- Katz, Elinore (SAMHSA/OAS) -------------- (b)(6)>; Krohmer, Jon (dot.gov) (b)( >Cc: Ford-Barnes, Arwenthia (OS/ASPR/10)- -:-----:---:----:--:-::=~...:_ (b)(6)>; W__a ters.,. .:C_i~ce~ly(OS/ASPR/OEA) CbH6)>;S huy, Bryan (OS/ASPR/10)- ------- CbH6)> Subject: HHS COVID-19 Response - alignment of OPDIV/STAFDIV EffortsDear ASPR Colleagues,We are at a critical juncture in our nation's response to COVID-19. As we pivot fromcontainment of the virus to mitigation of its impacts, it is imperative that HHS movesswiftly, transparent ly, and in a unified manner to protect lives and save Americans. TheSecretary has charged my office to lead effo rts across the Department to prepare anddefend our health care system during the novel coronavirus outbreak through theHealth Care System Resilience Task Force.To date, this task force has engaged with public and private sector stakeholders tobroadly identify efforts that can be taken to help ensure preparedness in response to adomestic COVID-19 outbreak, and more importantly their gaps, challenges, andpotential areas of need from the federal government. Now, we must build on thatknowledge to expedite and execute a whole of HHS response to support protection ofthe health care system that spans public health, health care, and human services.Please join Dr. Kevin Yeskey, ASPR's Principal Deputy Assistant Secretary forPreparedness and Response, and Dr. Nancy Messonnier, CDC's Director of the NationalCenter for Immunization and Respirato ry Diseases, on Wednesday, March 4 from 9:00AM -10:15 AM, at the O'Neill House Office Building for a working session to aligncurrent activities and next steps to be executed as part of a coordinated HHS responseto COVID-19.NIH-001125NIH-001126Please provide the following information to ASPR.HCSRTF@hhs.gov no later thanMonday, March 2 at 12:00 PM, and be prepared to share and discuss at Wednesday'ssession.• Your Designee(s) name, title, and contact information• OPDIV/STAFFDIV name• OPDIV/STAFFDIV current and future top five priorities related toCOVID-19 (priority leads, descriptions, timelines)• OPDIV/STAFFDIV key activities and workgroups (current and underconsideration) related to COVID-19 response (include activity/workgroupleads, key purpose, timelines)• OPDIV/STAFFDIV key areas of concern or challenges identified todate• OPDIV/STAFFDIV core competencies or other assets it can bring toCOVID-19 response effortsWe look forward to working with you on this critical effort to defend the nation's healthcare system. Thank you in advance for your support and participation.Respectfully,Bob KadlecASPRFrom:Sent:To:Cc:Subject:Att achments:Kyle:Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 15:45:23 +0000Zebley, Kyle (HHS/0S/OGA)Kerr, Lawrence (HHS/0S/OGA)RE: Current TF Agenda Draft/Request fo r AMA High-level TalkersTask Force VP Briefing 2-13-20 - with Fauci TP.docxHere is a talking point for the messaging secti on.Best,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Zebley , Kyle (HHS/05/0GA) -------- (b)(6) sent: Thursday, February 27, 2020 9:11 AMTo: Hall, Bill (HHS/ASPA) (b)(6)>; Murphy, Ryan (OS/ASPA) (b) (6);Trueman, Laura (HHS/I EA) (b)( >; Johnston, Darcie (HHS/I EA)=======::~;(;b)-(6-)]-; A:r:b-e-s," S arah (HHS/ASL) (b)( ; Morse , Sara (HHS/ ASL) (b)(6)>; Twomey, John K. (HHS/ASL) (b)(6)>; Pence, Laura':(' H:""H.-":S'-.::/- :A"-."S:""L..-"): ;:====::!-:....._~ (b.),.(.,.;; >Cc: Mango, Paul (HHS/10S) (b)(6) ; Bird, Catherine (OS/OGC)(b)(6) Grigsby, Garrett (HHS/OS/OGA) ,__"."""""''""""":":-""':-::::==(=b)~(~ >; Kerr , Lawrence(HHS/0S/OGA) (b)(6); Redfield , Robert R. (CDC/OD) (b)( >; McGowan ,Robert (Kyle) (CDC/0D/OCS) (b)(6)>; Fauci, Anthony (NIH/NIAID) [E] (b)(6) >;Conrad, Patri cia (NIH/NIAID) [E) (b)( 6); Kadlec, Robert (OS/ ASPR/10)-------- (b)( >; Shu y, Bryan (O S/ ASPR/10) (b)(6) Subject: Current TF Agenda Draft/Request for AMA High-leve l TalkersImportance: HighGood morning,NIH-001249Attached, please find a current draft of an agenda for a TF Briefing fo r VPOTUS this afternoon. Note thatt his is a draft and is not final. However, in order to prepare the Secretary, can ASPA, IEA, and ASL pleasehelp with 2-3 high-level talkers each the Secretary could highlight under the External Activity/Messagingsection of the agenda? Could you please send to me and Dr. Larry Kerr by 11 AM this morning?Apologies for the quick turnaround .Dr. Redfield, Dr. Fauci, and Dr. Kadlec, please note your presence on the agenda and please be preparedto speak to the topics assigned.Let me know if you have any questions. Thanks for your help.Kyle ZebleyChief of StaffOffice of Global Affairs (OGA)Office of the SecretaryU.S. Department of Health and Human ServicesDirect: (b)(6)/Mobile: (b)(6)Confidential and pre-d ecisiona l communi cationNIH-001250From:Sent:To:Subject:Attachments :Fauci, Anthony (NIH/NIAIO) [E)Sun, 1 Mar 2020 20:08:22 +0000Messonnier, Nancy (CDC/DDID/NCIRD/0D)RE: mitigation in communi t iesCOVID-19 Targeted Layered Mit igation Strategy_lnterim.022820.pdfI assume that you are OK with the document that Garrett just sent around. Seeattached.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Messonnier, Nancy (CDC/DDID/NCIRD/00) (b)( >Sent: Sunday, March 1, 2020 2:59 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E) (b)( >Subject: FW: mitigation in communitiesFrom: Messonnier, Nancy (CDC/DDID/NCIRD/0D)Sent: Sunday, March 1, 2020 2:59- -P-M~ ~ To: Redfield, Robert R. (CDC/OD) (b)(6)>Cc: Jernigan, Daniel B. (CDC/DDID/NCIRD/ID) <.l.,__ ___ C_b>_<.~ ... Schuchat, Anne MD (CDC/OD)(b)(6)>Subject : mitigat ion in communitiesHere are the basic high level principles of a miti ation strate y.NIH-00 1087(b) (5)(b) (Sl(b) (5lNIH-001088From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Fri, 28 Feb 2020 03:02:24 +0000Grigsby, Garrett (HHS/OS/OGA)Subject : RE:- ---------------- (b) (5)It is a tough decision, ------------ (b)(5) ·,From: Grigsby, Garrett (HHS/OS/OGA) (b)( > _______.._..Se nt: Thursday, February 27, 2020 5:27 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------=- c-c=>; Kadlec, Robert (OS/ASPR/I0)--------- (b)(6) ; Adams, Jerome (HHS/OASH) (b)(6) •> Cc: Harrison, Brian {HHS/I0S) (b)( Zebley, Kyle (HHS/0S/OGA)(b)( >Subject : FW: ----------------- (b) (5) 1 mp or tan c e: HighGentlemen,Any problem with this - see Marty's below. Need to know asap as I'd like toforward to NSC immediately. Many thanks!From: Cetron, Marty (CDC/DDID/NCEZID/DGMQ) ------ (b)(6)Sent : Thursday, February 27, 2020 5-:0-8- P-M- -- ...=.. ..., To: Grigsby, Garrett (HHS/05/0GA ) (b)(6)>Cc: Walker, Allison Taylor. (CDC/DDID/NCEZID/DGMQ) (b)(6) McGowan , Robert (Kyle)(CDC/0D/OCS (b)( Roohi, Shahrokh (CDC/0D1D/NCEZID/DGMQ) (b)(6)Elvander, Erika (05/0GA) (b)(6)>; Zebley, Kyle (HHS/05/0GA)(b)(6)>; Jernigan, Daniel 8. (CDC/DDID/NCIRD/ID) (b)(6)~~~= 00~Hi Garrett,CDC intendsThanks,Marty(b) (5)NIH-001231(b) (5)(b)(5)(b)(5)NIH-001232From:Sent :To:Subject:Sharon:Fa11ci,A nthony (NIH/N IAID) [E)Thu, 27 Feb 2020 04:31:21 +0000MsPRE; A note from Sharon PerlmanThanks for your note. It was great to hear from you. All is wel l with me and my family.hope the same for you This whole coronavirus situation is rather exhausting since I amwork ing 24/7 with no breaks at all. However , it needs to be done since this virus is a truet hreat to global heath.Best regards,TonyFrom: Ms P (b)(6)Sent: Wed nesday, February 26 , 2020 6:07 PM -----~~ To: Fauci, Anthony (NIH/NIAID) [E] ------- (b)(6)> Subject: A note from Sharon PerlmanHi Dr. Fauci,As I was watching my favorite CNN news show starring Chris Cuomo last night , tomy delight, there you were! And again, this morn ing with John Berman and AlisynCamerota on New Day.I do hope all that all is well with you and your family. We are all doing fine. My(b)(6)NIH-001266NIH-001267I would love to hear from you, when you have time.With best regards,SharonFrom:Sent :To:Cc:Subject:Fauci, Anthony (NIH/NIAID) [E)Thu, 27 Feb 2020 04:27:18 +0000Bennett WernerConrad, Patricia (NIH/NIAID) [ElRE: Clinical question, Sir ....Dear Drs. Werner and Ubl: --------------------------- =(b~, =,""'Thank you for your note. , \V~-----Original Message-----_______ _From: Bennett Werner (b) ( >Sent: Wednesday, February 26, 2020 6-:2-7- P-M- --=-::-=, To: Fauci, Anthony (NIH/NIAJD) [E] .__ _____ (b)_C.. . ·Su~ject: Clinical question, Sir. ...Dear Dr. Fauci(b)(6)(b)(6)By the way, we both feel you are an outstanding spokesperson and really appreciate both the work you do and yourclear explanations on Public TV (and elsewhere).Warm regards,Bennett E. Werner , M.D. F ACC FACPCleveland Clinic Cardiology (b) (Michelle D. Uhl, M.D.Cleveland Clinic - medical oncology (b) (6)NIH-001268From:Sent:To:Cc:Subject:Morgan:Fauci, Anthony (NIH/NIAID) [E)Thu, 27 Feb 2020 04:06:03 +0000Morgan FairchildConrad, Patricia (NIH/NIAID) [ElRE: Covid-19Thanks for the note and the offer to help. It would be great if you could tweet to your manyTwitter followers that although the current risk of coronavirus to the American public is low,the fact that there is community spread of virus in a number of countries besides China andincluding South Korea, Japan, Italy, Iran among others poses a risk that we may progress to aglobal pandemic of COVID-19. If that occurs we will surely have many more cases in the USA.And so for that reason, the American public should not be frightened, but should be preparedto mitigate an outbreak in this country by measures that include social distancing, teleworking,temporary closure of schools, etc. There is nothing to be done right now since there are so fewcases in this country and these cases are being prope rly isolated, and so go about your dailybusiness. However, be aware that behavioral adjustments may need to be made if a pandemicoccurs.Best regards,TonyFrom: Morgan Fairchild (b)(Sent: Wednesday, February 26, 2020 8:31 PM -----~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject: Covid -19Hi Dr. Fauci. I'm reaching out to see if I can help in any way to get good information out to the public, as Itried to do with AIDS. I have almost 10D,000 Twitter followers and have been tweeting articles to themthat I feel are helpfu l, but if you have any info I can help disseminate, please let me know.Also , a great job today and this week!!Hope you're well!Thanks!Best,MorganNIH-001269From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Thu, 27 Feb 2020 03:00:14 +0000Laura Landerman-Ga rberSubject : RE: Dr Sheldon Wolff Dr Fauci NIH --------------- (b)(6) Follow up 2/26/20Laura:Many thanks for your kind note . It was great to hear from you.Warm regards,TonyFrom: Laura Landerman-Garber (b)(6)> ---------- Sent : Wednesday, February 26, 2020 9:26 PM -----~ ~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject : Re: Dr Sheldon Wolff Dr Fauci NIH --------------- CbH6JF ollow up 2/26/20Greetings from New Hampshire. Today I was watch ing the news and there you were , once againpopping up in my life and making me not only smile by your kind and approachable style that Itruly remembe r from the Cb()6 ), but also taken care of by your expertise. Thank you foryour medica l leadership during these days as the Coronavirus spreads. Please know that yourlegacy of research and practice will live on for generations to come!I hope that these complex days are soon quieted for us here in the US and around the GlobePs (b)( --------------------------------- Amazing to th ink that so many of my questions were answered all those decades ago with youand Sheldon Wolff I remain forever gratefu l. Since I saw you last, CbH6) who youmet, moved to DC and works at American Psychologica l Association. Cb()6 ). Life marches 011. I hope you andyour family are wellBest,Laura Landerman-Garber, Ph .D.On Apr 7, 20 15, at 12: 18 PM, Fauci, Anthony (NIH/NIAID) [E]CbH6J wrote:Laura:Thank you so much for your beautiful note . I do remember you and am so happy thatyou reached out to communicate with me. I am very pleased to hear that you are doing sowell. You have "made my day" by your note . I wish you and your family all the best.NIH-001270Warm regards,TonyFrom: Laura Landerman-Garbe~r ~~------- (b)(6) Sent: Tuesday, April 07, 2015 10:31 AMTo: Fauci,A nthony (NIH/NIAID[)E ]Subject: Dr SheldonW olff Dr FauciN IH- ------------- (b) (6) Follow upSee below please. Thank you!!Sent from my iPhoneBegin forwarded message:From: Laura Landerman (b)(Date: April 7, 2015 at 10:06:28 AM EDTTo: "niaidnews @nia id.nih.gov" <niaidnews@nia id.nih.gov >Subject: Dr Anthony Fa uci/ NIH/ Dr SHeldon Wolff l (b)(6) 'followupReply-To: Laura Landerman (b) (6)Greetings from NH. I am trying to contact Dr Fauci after many~ears . I have followed his career like so man others do... (b)(6)I am not sure if this can find its way to Dr Fauci but I would soappreciate it if it could. To let him know that all those years ago,NIH-001271he left n outstanding impression on CbH6)___ I want to thank him from the bottom of my heart.Sincerely ,Laura M. Landerman-Garber , Ph.D.(b)(6)(b)(6)NIH-001272From: Fauci, Anthony (NIH/NIAID) [E)Sent : Thu, 27 Feb 2020 02:57:57 +0000To: LOUIS FORTUNATOSubject : RE: Dear Tony: Will you take the lead in the Coronavirus prob lem/ we alwayslove you/Saw you on CNN/Lou:I do not believe that there is a chance to republish Harrison Practice .Best regards,TonyFrom: LOUIS FORTUNATO (b)(6) ------------ Sent : Wednesday, February 26, 2020 9:38 PM ------- ~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject : Fwd: Dear Tony: Will you take the lead in the Coronavirus problem/ we always love you/Sawyou on CNN/Begin forwarded message:From: LOUIS FORTUNATO (b)(6)>Subject: Fwd: Any Chance of Harrison Practice being updated and replaced on themarket ? I loved it Tony/ Better than Harrison's TextbookDate : February 17, 2020 at 9:41:40 PM ESTTo: Cb) (6)Dear Tony Fauci MD:Any chance for Harrison Practice being republished again andupdated with the newest Pathophysiology and Treatments?It was better than Harrisons Textbook/More Precise and SuccinctPlease email me/I would greatly appreciate your responseeither wayYes or No//Dr Lou Fortunato(b) (6);Begin forwarded message:NIH-001273From: LOUIS FORTUNATO ----------- (b)(6)> Subject : HERE TONY IS ANOTHER CHAPTER OF MY FUTURE NUC MED BOOKDate : November 3, 2019 at 5:11:19 AM ESTTo: (b)(6)HERE TONY IS MY NOTES IN BONEIMAG ING FOR MY FUTURE BOOKLOU FORTUNATONIH-001274From: (b)(6)Sent: Wed, 26 Feb 2020 20:24:59 -0500To: Cassetti, Cristina (NIH/NIAID) [E]Subject: Fwd: [EXTERNALG] ene-RADAR platform for Real time Mobile (POC) Coronavirusdetection/ viral load monitoring/ Followup to our meeting at the ASPEN ideas festival -Please bandle.Sent from my iPhoneBegin forwarded message:From: "Dr. Anita Goel , M.D., Ph.D. " (bH6)>Date: Februa ry 26, 2020 at 7:58:54 PM ES-T- -------=-:-:-= To: "Fauci , Anthony (NIH/NlAID) [E]" (b)(6)Subject: FW: [EXTERNAL! Gene-RADAR platform for Real time Mobile(POC) Coronavirus detection/ viral load monitoring / Followup to our meetingat the ASPEN ideas festival -Dear Dr. Anthony Fauci,It was a great pleasure meeting you all a couple of years ago when we were both speakingat the Aspen Ideas Festival. Some of my contacts at the CDC recently briefed me about therapidly emerging threat of the coronavirus to the US and have been urging us to developan app for detecting coronavirus with high sensitivity and specificity on our Gene-RADARplatform . Our platform has the ability to quantify vi ral loads in ' real-time' which would be amuch more precise and accurate solution in deciding quarantine than the currentthermometers or even the current CDC coronavirus test which has a very poor Limit ofdetection (ie low sensitivity).We have a strong track record of responding to previous pandemic threats and rapidlybuilding Gene RADAR applications for Ebola and Zika and then getting them throughclinical validation as per the the FDA EUA approval process. Our Gene-RADAR Zika test wasFDA EUA certified right as the Zika crisis was coming to an end.I would love to work with you to see how we can help in your efforts to rapidly respond tothis deadly threat to the US and the world. Here are some of the capabilities of ourplatform that we believe could be an enabler for helping to stop this out break frombecoming a full-fledged global pandemic.NIH-001278• Gene-RADAR platfo rm for Real time Mobile (POC) Coronavirus detection/ viral loadmonitoringo Highly sensitive and specif ic - minimize false positives and false negativeso With very good LOD's we could potent ially start to catch peoplepresymptomatically and enable the early detection, early quarantinewould limit the spread and early intervention could lead to betteroutcomeso More precise viral load monitoring could help determine when to releasepeople from quarantine or ICU bedso Our platform's ability to quantify vial loads could change clinical trialendpoints for new drug candidates or (repurposed drug formulation s),thereby accelerating FDA approvals for novel therapeutic regimeno We already have an ISO 13485 certified manufactur ing facility (currently inBoston) that we are prepared to move as fast as possible to ramp up ourproductionWe would love to work with you to repurpose our FDA approved platformfor the above coronav irus applications assay and help your noble effortsto stop th is outb reak from becoming a full blown global pandemic thatcould costs thousands of lives and cause trillions of dollars of economicdamage to the global economy.We would love to speak with you to br ief on our capabilit ies and discuss how we canqualify for some of the emergency funding being made available to help tackle thispandemic threa t .Happy to jump on a phone call to discuss furthe r how we can helpHow Nanobiophysics can Stop Ebola and Other Global Pandemics• Forbes• Wired MagazineBest Wishes,Dr. Anita Goel, MD, PhDChairman &CEONanobiosym------------------------------------------------------------------www .nanobiosym .comemail: (b)(6)Mobile : (b)(6)http ://www. people. fas .ha rva rd .edu/~goel/email: goel@physics.harvard.edu----------------------------------------------------------------Selected Media links:Nanobiosym Gene-RADAR® X Prize Grand Prize Winner VideoNIH-001279NIH-001280Dr. Gael's Article in Scientific American WorldviewNanobiosym Chairman &CEO Named 2018 Uber ELITE Award WinnerFDA Grants Emergency Use Authorization for Gene-RADAR® Zika TestBBC Feature : The Genius Behind the "Tricorder that could revolutionize medicine"Nanobiosym Selected As One Of The Top Growth Stage Ventures By The 'Unreasonable 'GroupDr. Anita Goel, MD, PhD awarded 2019 SEEMA Entrepreneur of the Year Awa rdHow Nanobiophysics can Stop Ebola and Other Global Pandemics• Forbes• Wired MagazineNanobiosym Global Initiative Summit WebsiteWall Street JournalWashington PostBoston Globe GameChangersNational GeographicForbesNanobiosym Space NewsCBS NewsBoston Business JournalCNNDailyMailSpace.comPopular MechanicsForbesUS News and World ReportWiredDaily PressCBC RadioBoston Globe STATCONFIDENTIALITY: This email and attachments are intended for the above name only and are confidential. If you are notthe intended addressee. or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate, nor distribute it to anyone else or use It in a11y unauthorized manner. To do so is strictly prohibited and maybe unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in yourmail software and delete it from your computerCONFIDENTIALITY: This email and attachments are intended for the above name only and are confidentlal. If you are notthe intended addressee, or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate, nor distribute it to anyone else or use it in any unauthorized manner. To do so Is strictly prohibited and maybe unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in yourmail software and delete it from your computer.NIH-001281CONFIDENTIALITY: This email and attachments are intended for the above name only and are confidential. If you are notthe intended addressee, or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate , nor distribute it to anyone else or use it in any unauthorized manner . To do so is strictly prohibited and maybe unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in yourmail software and delete it from your computer.CONFIDENTIALITY: This email and attachments are intended for the above name only and are confidential. If you are notthe intended addressee, or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate, nor distribute it to anyone else or use it in any unauthorized manner. To do so Is strictly prohibited and maybe unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in yourmail software and delete it from your computer.CONFIDENTIALITY · This email and attachments are intended for the above name only and are confidential. If you are notthe intended addressee, or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate, nor distribute it to anyone else or use it in any unauthorized manner. To do so is strictly prohibited and maybe unlawful . If you receive this email by mistake, please advise the sender immedia tely by using the reply facility in yourmail software and delete it from your computerCONFIDENTIALITY : This email and attachments are intended for the above name only and are confidential. If you are notthe intended addressee , or the person responsible for delivering it to the intended addressee, you may neither copy,disseminate, nor distribute it to anyone else or use It in any unauthorized manner . To do so Is strictly prohibited and maybe unlawful. If you receive this email by mistake, please advise the sender immediately by using the reply facility in yourmail software and delete it from your computer.From:Sent:To:(b)(6)Wed, 26 Feb 2020 19:24:48 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Interview request from WTOP [Please reply all]Sent from my iPhoneBeg in forwarded messag e:From: "Ander son, Liz" <landerson@wtop .com>Date: February 26, 2020 at 6:57 :05 PM EST,------- -;;-c-;= To: "Fauci, Anthony (NIH/NlAID ) (E]" (b)(Cc: "Spitaln iak, Law·a" <lspitalniak @wtop.com >Subject: Interview request from WTOP [Please reply all]Good Even ing Dr. Fauci,My name is Liz Anderson, and I'm working the editor's desktonight at WTOP.Are you available for a brief live interview ( about 2 minu teslong) about what the latest COVID- 19 dev eloprne nts? Duringthis evening' s press conference, President Trump said you twospok e about it.The Washington Post is also reporting that the CDC has beeninformed about the first corona virus case of unknown originconfirmed in North ern California. We'd also like to talk aboutthat and what that could mean about the spread of this virus inthe state s.We have the following time slots open tonight:9:l0p9:40pNIH-00128210:lOp10:40p11 :I Opll:40pMany thanks for your time.Sincerely,Liz AndersonAE/Editor/Reporter, WTOP News202-895-5060 (newsroo m)landerson@wtop .comTwitter: @planetnounhttp://wtop .com/autho r/ landerson/http ://wtop .com/autho r/ liz-ande rson/1103.5 FM. WTOP.COMNIH-001283From:Sent:To:(b)(6)Wed, 26 Feb 2020 19:24:09 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: Interview request from WTOP [Please reply all)Sent from my iPhoneBegin forwarded message:From: "Anderson, Liz" <landerson@wtop.com>Date: February 26, 2020 at 7:01:22 PM E--S-T- --~~ To: "Fauci , Anthony (NIH/NIAID) [E]" CbH6>:Subject: RE: Interview request from WTOP !Please reply all]Wait- - I see you're at the press conference, too. If you have availability at one of the timeslisted , we'd love to have you.Many thanks,LizFrom: Anderson, LizSent: Wednesday, February 26, 2020 6:57 PMTo: (b)(6)>Cc: Spitalniak, Laura <lspitalniak@wtop.com>Subject: Interview request from WTOP [Please reply all]Good Evening Dr. Fauci,My name is Liz Anderson, and I'm working the editor's desktonight at WTOP.Are you available for a brief live interview ( about 2 minuteslong) about what the latest COVID-19 developments? Duringthis evening's press conference, President Trmnp said you twospoke about it.NIH-001284The Washington Post is also reporting that the CDC has beeninformed about the first coronavirus case of unknown originconfirmed in Northern California. We'd also like to talk aboutthat and what that could mean about the spread of this virus inthe states.We have the following time slots open tonight:9:l0p9:40p10:l0p10:40p11:l0p11 :40pMany thanks for your time.Sincerely,Liz AndersonAE/Editor/Reporter, WTOP News202-895- 5060 (newsroom)lande rson@w top .comTwitte r: @planetnounhttp ://wtop .com/au thor/ landerson/http://wtop .com/au t hor/ liz-anderson/1103.5 FMWTOP.COMNIH-001285From:Sent:To:(b)(6)Wed, 26 Feb 2020 19:22:28 -0500Conrad, Patricia (NIH/NIAID) [E)Subject:and NIHFwd: AM 970 the Answer Radio Request Re: Coronavirus Response from POTUSSent from my iPhoneBegin forwa rded message:From: Alex Gan ett <agarrett@nycradio.com >Date: Februa ry 26, 2020 at 7:13:41 PM E-S-T- ------=-:-:-= To: "Fauci , Anthony (NIH/NlAID) [E]" CbH6)Subject: AM 970 the Answer Radio Request Re: Coronavirus Response fromPOTUS and NIHHi Dr. Fauci,I hope you are well! Would love to welcome you to Kevin McCullough Radio on AM970 the Answer tom orrow to discuss the steps the White House and the NIH aretaking to combat coronavirus. Kevin is our drive-time host at 5 PM and he isnationally syndicated as well with 300+ affiliates fo r his broadcast!Look forward to hearing from you . Thanks Dr. Fauci!Alex GarrettProducer: Kevin McCullough RadioAM 570 the Mission WMCA: 3-4 PMAM 970 the Answer: 5-6 PMNIH-001286From:Sent :To:[E]Cc:(NIH/NIAID) [E]Subject:Eli ,Thanks,TonyFolkers, Greg (NIH/NIAID) [E] on behalf of Fauci, Anthony (NIH/NIAID) [E)Wed, 26 Feb 2020 21:50:05 +0000Laurencot, Elizabeth;Fauci, Anthony (NIH/NIAID) [E];Folkers, Greg (NIH/NIAID)Conrad, Patricia (NIH/NIAID) [E];Eisinger, Robert (NIH/NIAID) [E];Lane, CliffRE: NEJM content proof (Fauci)From: Laurencot, Elizabeth <elaurencot@nejm .org>Sent : Wednesday, February 26, 2020 4:45 PMTo: Fauci, Anthony (NIH/NIAID) [El------~ (b~)(~6)Cc: Conrad, Patricia (NIH/NIA ID) [El (b)(6) >; Eisinger, Robert (NIH/NIAID) [El(b) (5)~-======~~(bH ; Lane, Cliff (NIH/N IAID) [E) -------- (b)(6) Folkers, Greg (NIH/N IAID) [El (b)( >Subject: RE: NEJM content proof (Fauci)Dear Dr Fauci,Regarding the following information --Please clarify--- thank you!Best,Eli(b) (5)NIH-001287From: Folkers, Greg {NIH/ NIAID) [E) (b) ~ -------- > On Behalf Of Fauci, Ant hony (NIH/NIAID) [ElSent : Wednesday, February 26, 2020 3:48 PMTo: Laurencot, Elizabeth <elaurencot@nejm.org> ; Fauci, Anthony (NIH/N IAID) [El(b)(6)>Cc: Conrad, Patricia (NIH/NIAID) [El~-~--~=== (b:):(::6:::)!;:_.E.isin.g::e~:.r~, ~Robert (NIH/NI AID) [El(b)( ; Lane, Cliff (NIH/NIAI D) [El (b)(6)>; Folkers, Greg (NIH/N IAID)"[:E":-l:.-::=======. (b~~~(6) -------- Subject: RE: NEJM content proof (Fauci)Dear Eli,(b) (5)NIH-001288Thanks,TonyFrom: Laurencot, Elizabeth <elaurencot@nejm .org>Sent: Wednesday, February 26, 2020 9:04 AM ------~= To: Fauci, Anthony (NIH/NIAID) [E~] ======'~~ Cc: Folkers, Greg (NIH/NIAID) [E] CbH >; Conrad, Patricia (NIH/NIAID) [E](b)(6)>; Eisinger, Robert (NIH/NIAID) [El (b)(6)>; Lane, Cliff"(: N"":'.l'H".."'/7'.N"".I"A'."l''D:.""): '.-:[~E:]-===~-~ (b~H=6)Subject: RE: NEJM content proof (Fauci)Dear Dr Fauci,Many thanks for your quick reply and for the clear list of responses regarding the proof. I will reviewtoday and will let you know if there are any items needing fur ther discussion.The current plan is for publication early Friday afternoon. As I mentioned yesterday, there is a newarticle on Covid-19 that is also scheduled for publication that day, and the Journal editors would like youto mention it in your editorial. I expect to be able to send you a proof of that article sometime today.Best,EliFrom: Fauci, Anthony (NIH/N IAID) [E] (b)(6)Sent: Wednesday, February 26, 2020 7:37 AMTo: Laurencot, Elizabeth <elaurencot@nejm .org>Cc: Folkers, Greg (NIH/NIAID) [E] (b)(6)· Conrad, Patricia (NIH/NIAID) [E]"'.'--.---~~===:!._;__(.b..):(6::)>..;~ =E isinger, Robert (NIH/NIAID) [El (b)(6); Fauci, Anthony{NIH/NIAID) [E] (b)(6); Lane, Cliff (NIH/NIAID) [E] (b)(6)Subject : RE: NEJM content proof {Fauci)Dear Eli,Here are my answers to you r queries, and couple other minor changes:(b) (5)NIH-001289(b) (5)NIH-001290Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda, MD 20892-2520Phone: (b)(6)FAX: (301) 496-4409E-mail (b)(6)(b) (5)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives.NIH-001291From: Laurencot, Elizabeth <elaurencot@nejm.org >Sent : Tuesday, February 25, 2020 8:51 AM ------~~ = To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subj ect: NEJM content proof (Fauci)Import ance: HighDear Dr Fauci,Attached is the content proof of your editorial. Please read *A LL* of the fo llowi ng instructions andinform ati on carefully before you begin reviewing your proofs.First, please stop and take a moment now to confirm receipt, so that we can be assured that yourproofs did not end up in a spam folder .Your editoria l has been edited for grammar, consiste ncy, readability, adherence to Journal style, andclarity for nonspecialist readers. To expedite publication , we do not ask authors for specific approval ofroutine changes; please read the entire article to make sure your meaning has been retained. Note thatwe may be unable to make changes that conflict with Journal style or create grammat ical or otherproblems. Finally, please note that a delayed or incomplete response may delay publicatio n of youreditorial.Please read the entire proof carefully, including all queries. Please return your query rep lies and proofcorrections ** before 12pm (US Eastern) this Friday, February 28, 2020 **.Instruct ions are provided below . Note that you will be reading for content only; the article will berendered for print after the content has been finalized .The Journal's senior medical editors will be reading your article at th is stage. If they have any additionalcomments or queries for you, I will forward them to you in the next few days.TO ANSWER THE QUERIES: The proof contains in-line numbered query markers and a numbered list ofqueries at the end. The query markers and the queries are linked, so you can jump back and forth withinthe file. Please respond to all the queries (see below for instructions; please do ** NOT** use eannotationtools) and convey any additional changes as needed.TO RESPOND BY E-MAIL: If your corrections and your responses to the queries are straightforwa rd, weencourage you to respond by replying to this message. Please copy and paste the list of queries into ane-mail message or a Word document and type your responses there . You may also include a list ofchanges (e.g., page 1, line 20, change xxx to yyy). Again, please do ** NOT** use e-annotation tools inthe PDF file; the marks are small and easy to miss, which may lead to errors in your article.Please note that this material is confidential and embargoed until publication. If you have questionsabout our embargo policy, please contact NEJM Media Relations at 781-434-7847 or atMediasupport@nejm.org .Again, please do confirm receipt at this time . Thank you very much for your efforts with these contentproofs!NIH-001292NIH-001293Best,EliElizabeth Lauren~otSenior Manuscript EditorNew England Journal of Medicine617-487-6547elaurencot@nejm.orgTO READ THE PROOF: You will need Adobe Acrobat Reader software (version 4.0 or later) to view thisfile. Acrobat Reader is available free of charge at the Adobe Web site(http://www .adobe .com/products/acrobat/readerma in.htm l ).This email message is a private communication . The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privileged,and/or proprietary material. Any review, duplication, retransmission, distrib ution, or ot her use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited. If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you .This email message is a private communication . The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privileged,and/or proprietary material. Any review, duplication, retransmission, distribution, or other use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited . If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.This email message is a private communication. The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privileged,and/or proprietary material. Any review, duplication, retransmission, distribution, or other use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedNIH-001294recipient is unauthorized by the sender and is prohibited. If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.From:Sent:To:(b)(6)Wed, 26 Feb 2020 15:29:21 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Re: Seeking Or. Fauci for coronavi rus webina rLet us discussOn Feb 26, 2020, at 11 :59 AM, Conrad, Patricia (NIH/NIAID) [E]-----------(b) C6Jwrote:Patricia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer:The information in this e-mail and any of its attachments is confiden tial and may contain sensitive information. Itshou ld not be used by anyone who is nol the original intended recipient. If you have rece ived this e-ma il in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infectious Diseases (NIAID) shall not accept liability for any statement made that are sender's own and notexpressly made on behalf of the NIAID by one of its representatives.From: Chris Adams <cadams@nationalpress.org>Sent : Wednesday, February 26, 2020 11:01 AM --------~~ To: Conrad, Patricia (NIH/NIAID) [E] ________ (b_H_6)Subject: Seeking Dr. Fauci for coronavirus webinarPatricia:I hope you are doing well. Dr. Fauci has been a wonderfu l speaker for us in the past, andI'm reaching out to him today for a discussion on coronavirus.When the re are major news stories, we often will try to do a live webinar on the top ic witha leading expert or two.NIH-001295NIH-001296This is something we would do in our stud io at our office near Dupont Circle. We normallydo them for 45-60 minutes, and we take questions (visa Twitter) from our audience. Theaudience would be reporters who cover the topic, as well as others interested in the topic .It is a way to have an in-depth, thoughtful conversation about a pressing topic.Here are a couple we've done (the first is on Zika a few years ago):Zika panel discussion: https://nationalpress .org/topic/understanding -the -zikathreat/?st =O&t=&mm=VideoTed Koppel: https ://nat ionalpress.org/ t oolbox-topic/ lights-out -risks-t o-t he-power grid/?st= 7042&mm =VideoAutonomous vehicles panel discussion: https://nat ionalpress.org/top ic/wha ts-new-wit hautonomous-vehicles/?st=8474&t=Automat ion&mm =StoryWe'd like to do one of these on coronavirus . We'd love to have Dr. Fauci as our primeguest.We can schedule it around his demands, but would of course love to do it as soon aspossible.We know he is in demand at this moment. But he is such a singular expert on the topicwe'd love to have a discussion with him - one that would help get his message out tojournalists (and others) who need to be informed to best cover the topic.Is it possible to check with Dr. Fauci to see if this is possible?Thanks,Chris AdamsNational Press FoundationFrom:Sent :To:Cc:(b)(6)Wed, 26 Feb 2020 15:01:39 -0500Folkers, Greg (NIH/NIAID) [E)Eisinger, Robert (NIH/NIAID) [ElSubject: Re: ASF and CLIFF------- DRAFT response to Eli at NEJMPlease send this to Eli. ThanksOn Feb 26, 2020 , at 12:49 PM, Folkers, Greg (NIH/NIAID) [E](b) (6) wrote: ----------Dear Eli,NIH-001297(b)(5)From: Laurencot, Elizabeth <elaurencot@nejm.org>Se nt: Wednesday, February 26, 2020 11:54 AMTo: Fauci, Antho ny (NIH/NIAID) [E] (b)(6)>Cc: Folkers, Greg (NIH/NIAID) [E] (b)(6) >; Conrad, Patricia (NIH/NIAID)[E] (b)( >; Eisinger, Robert (NIH/NIA ID) [E] (b)(6)>;Lane, Cliff (NIH/NIAID) [E) (b)(6)Subject : RE: NEJM content proof (Fauci)Importan ce : HighDear Dr Fauci,Thank you very much for your consideration!Best,EliFrom : Laurencot, ElizabethSent: Wednesday, February 26, 2020 9:04 AM ----- -----= To: Fauci, Anthony (NIH/N IAID) [El (b)(6)>Cc: Folkers, Greg (NIH/NIAID) [El (b)(6)>; Conrad, Patricia (NIH/NIAID)[El CbH >; Eisinger, Robert (NIH/NIA ID) [El (b)(6);Lane, Cliff (NIH/NIAID) [El (b)(6)Subject: RE: NEJM content proof (Fauci)Dear Dr Fauci,NIH-001298(b)(5)Many thanks for your quick reply and for the clear list of responses regarding the proof . Iwill review today and will let you know if there are any items needing further discussion.The current plan is for publication early Friday afternoon. As I mentioned yesterday, thereis a new article on Covid-19 that is also scheduled for publication that day, and the Journaleditors would like you to mention it in your editorial. I expect to be able to send you aproof of that article sometime today.Best,EliFrom: Fauci, Anthony (NIH/NIAID) [El (b)(6)Sent: Wednesday, February 26, 2020 7:37 AMTo: laurencot, Elizabeth <elaurencot@ne jm.org>Cc: Folkers, Greg (NIH/NIAID) [El (b)(6); Conrad, Patricia (NIH/NIAIO)[El Cb)( >; Eisinger, Robert (NIH/NIAID) [El (b)(6);Fauci, Anthony (NIH/NIAID) [El (b)(6); lane, Cliff (NIH/NIAID) [E](b)(6)Subject : RE; NEJM content proof (Fauci)Dear Eli,Here are my answers to your queries, and couple other minor changes:NIH-001299(b) (5)(b) (5)NIH-001300Thanks,TonyAnthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301) 496-4409E-mail: (b)(6)The information in this e-mail and any of its attachments is confidential and maycontain sensitive information . It should not be used by anyone who is not the originalintended recipient. If you have received this e-mail in error please inform the senderand delete it from your mailbox or any other storage devices . The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statementsmade that are the sender 's own and not expressly made on behalf of the NIAID byone of its representatives .From: Laurencot, Elizabeth <elaurenco t@nejm.org>Sent: Tuesday, February 25, 2020 8:51 AM ------~~ To: Fauci, Ant hony (NIH/NIAID ) [El (b)(6)Subject: NEJM conte nt proof (Fauci)Importance : HighDear Dr Fauci,NIH-001301(b) (5)NIH-001302Attached is the content proof of your editorial. Please read *ALL* of the followinginstructions and information carefully before you begin reviewing your proofs.First, please stop and take a moment now to confirm receipt , so that we can be assuredthat your proofs did not end up in a spam folder.Your editoria l has been edited for grammar, consistency, readability, adherence to Journalstyle, and clarity for nonspecialist readers. To expedite publication, we do not ask authorsfor specific approval of routine changes; please read the entire article to make sure yourmeaning has been retained. Note that we may be unable to make changes that conflictwith Journal style or create grammatical or other problems. Finally, please note that adelayed or incomplete response may delay publication of your editorial.Please read the entire proof carefully, inclu ding all queries. Please return your queryreplies and proof corrections **before 12pm (US Eastern) th is Friday, February 28,2020**.Instructions are provided below . Note that you will be reading for content only; the articlewill be rendered for print after the content has been finalized .The Journal's senior medical editors will be reading your article at th is stage. If they haveany additional comments or queries for you, I will forward them to you in the next fewdays.TO ANSWER THE QUERIES: The proof contains in-line numbered query markers and anumbered list of queries at the end. The query markers and the queries are linked, so youcan jump back and forth within the file . Please respond to all the queries (see below forinstructions; please do **NOT** use e-annotation tools) and convey any additionalchanges as needed .TO RESPOND BY E-MAIL: If your corrections and your responses to the queries arestraightforward, we encourage you to respond by replying to this message. Please copyand paste the list of queries into an e-mail message or a Word document and type yourresponses there . You may also include a list of changes (e.g., page 1, line 20, change xxx toyyy). Again, please do * *NOT* * use e-annotation tools in the PDF file; the marks are smalland easy to miss, which may lead to errors in your article .Please note that this material is confidential and embargoed until publication. If you havequestions about our embargo policy, please contact NEJM Media Relations at 781-434-7847 or at Med iasupport@ne jm.org.Again, please do confirm receipt at this time. Thank you very much for your efforts withthese content proofs!Best,EliNIH-001303Elizabeth Lauren~otSenior Manuscript EditorNew England Journal of Medicine617-487-6547elaurencot@nejm.orgTO READ THE PROOF: You will need Adobe Acrobat Reader software (version 4.0 or later)to view this file. Acrobat Reader is available free of charge at the Adobe Web site(http ://www .adobe .com/products/acrobat/readermain .html ).This email message is a private communication. The information transmitted, includingattachments, is intended only for the person or entity to which it is addressed and maycontain confidential, privileged, and/or proprietary material. Any review, duplication,retransmission, distribution, or other use of, or taking of any action in reliance upon, thisinformation by persons or entities other than the intended recipient is unauthorized by thesender and is prohibited . If you have received this message in error, please contact thesender immediately by return email and delete the original message from all computersystems. Thank you.This email message is a private communication. The information transmitted, includingattachments, is intended only for the person or entity to which it is addressed and maycontain confidential, privileged, and/or proprietary material. Any review, duplication,retransmission, distribution, or other use of, or taking of any action in reliance upon, thisinformation by persons or entities other than the intended recipient is unauthorized by thesender and is prohibited. If you have received this message in error, please contact thesender immediately by return email and delete the original message from all computersystems. Thank you.<NEJMoa2002032 _Guan_ Content2 _ Author. pdf>From: Fauci, Anthony (NIH/NIAI0) [E)Sent: Wed, 26 Feb 2020 17:33:08 +0000To: Routh, Jennifer (NIH/NIAID) [E]Cc: Billet, Courtney (NIH/NIAID) [E];Stover, Kathy (NIH/NIAID) [E];Conrad, Patricia(NIH/NIAID) [E];Folkers, Greg (NIH/NIAID) [E];Marston , Hilary (NIH/NIAID) [E]Subject: RE: remarks for White House press conferenceAttachments : Fauci remarks Feb 26 - with minor edit .docxI have made a minor tweak .Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From : Routh, Jennifer (NIH/NIAID) [E] (b)(6)>Sent : Wed nesday, February 26, 2020 12 :26 PMTo: Fauci, Anthony (NIH/NIAID) [E] ·'======~~ Cc: Billet, Courtney (NIH/N IAID) [El (b)(6) >; Stover, Kathy (NIH/NIAID) [E)(b)(6J>; Conrad, Patricia (NIH/NIAID ) [E] (b)(6); Folkers, Greg(NIH/NIAID) [E] (b)(6); Marston, Hilary (NIH/NIAID) [El (b)( >Subject: remarks for White House press conferenceDr. Fauci,Attached for review are proposed remarks (in bullet format) for the White House press conference.Thanks,JenJennifer Routh [E]News and Science Writing BranchOffice of Communications and Government RelationsNational Institute of Allergy and Infectious Diseases (NIAID)NIH/HHS31 Center Drive Room 7A17CNIH-001309Bethesda, MD 20892Direct: Cb()Disclaimer: The information in this e-mail and any of its attachments is confidential and may contain sensitive information. It should not beused by anyone who is not the original intended recipient. If you have received this e-mail in error please inform the sender and delete itfrom your mailbox or any other storage devices. The National Institute of Allergy and Infectious Diseases shall not accept liability for anystatements made that are sender's own and not expressly made on behalf of the NIAID by one of its representatives.NIH-001310From :Sent :To:Subj ect :Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 16:49:43 +0000Conrad, Patricia (NIH/NIAID) [ElFW: BBC RadioWhat say you?Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Paul Coletti <paul.coletti@bbc.co .uk>(b)(6)Sent : Wednesday, February 26, 2020 11:47 AMTo: Fauci, Anthony (NIH/NIAID) [El --------- Subject: BBC RadioDear Dr. Fauci,Newshour on the BBC World Service is today cover ing the US preparedness on the CoronavirusWould you be available for int erview on this topic?We're on air at 3pm eastern and could speak to you live at around 3:10pm or alternat ively we couldrecord a few minutes between now and then . About 8 minutes duration and we've many ways toconnect to get good audio (no video as we are radio) .If there is interest from your side then I'm on+ ------ (b)(6)Yours sincerely,Paul ColettiTel: (b)(6)Tv. itter: @bbcworldservice, @pcolettiNewshour podcasts: www.bbc.eo.uk/ podcasts/series/newshourNIH-001311BBC World Service listen live: www.bbc.eo.uk/worldserviceradio/on-airNewshour is the award-winning news and current affairs programme 011 BBC World Sen·ice English. the radio and011/ine network which reaches 75 million listene,:f each week, including 11.5 million in the USA 011 National PublicRadio.Paul ColettiTel: Cb()6 )Twillcr: fa)bbcworldscrvice, @pcolettlNewshour podcasts: www.bbc.eo.uk/podcasts/sc1ies/newshourBBC World Service listen live: www.bbc.eo.uk/worldscrviceradio/on-airNewshour is the l/\Vard-11'i1111nie1w1sg allll cw·rent affairs programme 011B BC World Sen•ice English, the radio a11d011li11nee twork which reaches 75 million listene,~~e ach week, including 12.5 million in the USA 011 National PublicRadio.NIH-0013 12From:Sent :To:(NIH/NIAID) [E]Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 16:37:50 +0000Johnson, Martin S. (NIH/NIAID) [E];Auchincloss, Hugh (NIH/NIAID) [E];Harper, JillCc: Conrad, Patricia (NIH/NIAID) [E]Subject: RE: Appropriators going to have a call at 3:30 in Larry's office with HHS Op divson the COVID-19 Supplemental RequestMartin :You and Hugh should be on t he call.Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Johnson, Martins. (NIH/NIAID) [El (b)(6)Sent : Wednesday, February 26, 202011 :17 AMTo: Fauci, Anthony (NIH/NIAID) [E] Cb~>; Auchincloss, Hugh (NIH/N IAID) [E]----------- (b)(6J>; Harper, Jill (NIH/NIAID) [E] (b)(6)> Cc: Conrad, Patricia (NIH/NIA IO) [E] (b)(6)Subject : Appropriators going to have a call at 3:30 in Larry's office with HHS Op divs on the COVID-19Supplementa l RequestTony,Appropriators going to have a call at 3:30 in Larry's office with HHS Op Divs concerning the2020suplemental request.Larry wants someone from NIAID to also be on the call. Please advise who you want to attend .ThanksNIH-0013 13NIH-001314MartinFrom:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 16:36:36 +0000Conrad, Patricia (NIH/NIAID) [ElFW: SIBF inquiryPlease say no to this. Too busy.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Shannon Williams <shannon.w illiams@sibf.org>Sent: Wednesday, February 26, 2020 11:10 AMTo: Fauci, Anthony (NIH/NIAID) [El (b)(6J>Subject : SIBF inqui ryImportance: HighDear Dr. Fauci,I am writing to inquire about your willingness to address the Society ofInternat ional Business Fellows (SIBF) as part of our webinar series. SIBF is adistinguished organization of nearly 1600 global executives and senior leaders.Our C-level global membership would appreciate getting your perspectives on thecoronavirus outbreak. We are open to topics which could include .... What weknow and don't know ... As business and community leaders what SIBF memberscan do to prepare and educate t heir employees ... Safety of travel, etc.We were thinking the webinar could be approximately 30 minutes in length (15minutes of rema rks followed by 15 minutes of Q&A). SIBF's Commun icationsManager could work with someone on your team to set-up the webinar. SIBF is aNIH-001315NIH-001316non-profit, but we are able to provide a $2k honorarium to you or a charity ofyour choice .Thank you for your gracious consideration and att ention to our request . It is oursincere hope that you w ill be able to participate.Best regard s,Mr. Shannon George Williams I Director of ProgramsSociety of International Business Fellows (SIBF)715 Peachtree Street NE, Suite 200Atlanta, GA 30308P: (470) 378-1151 W: www.sibf.orgFrom:Sent :To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 16:27:37 +0000Conrad, Patricia (NIH/NIAID) [ElFW: MSNBC Guest Request 2/26FYI. Please handle as you see fit.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Hirsch, Nancy (NBCUniversal) <Nancy.Hirsch@nbcuni.com>Sent : Wednesday, February 26, 2020 10:59 AM --------::.:-=.. To: Conrad, Patricia (NIH/NIA ID) [E) (b)(6)>; Fauci, Anthony (NIH/NIAID) [El(b) ( >Subject: MSNBC Guest Request 2/26Hello Dr. FauciI hope this finds you well and I am sure receiving numerousrequestsWould you be avail to join anchor Ari Melber tonight 6 pm EST tospeak to Trumps presser and the latest on Coronavirus ?Thank you for letting me know if you can join soonest possible.NancyNancy HirschNIH-001317The Beat with Ari MelberMavericks with Ari MelberBooking Producer30 Rockefeller Plaza I New York, NY 10112(T) 212-664-4097( C) (b)(6).q,,MSNBCNIH-0013 18From: Fauci, Anthony (NIH/NIAIO) [E)Sent : Wed, 26 Feb 2020 15:22:01 +0000To: Eisinger, Robert (NIH/NIAID) [El;Greg FolkersSubject: FW: NEJM content proof {Fauci)See below. I will need your help on thi s.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)(b)(6) ----------The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces. The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its represent atives .From: Laurencot, Elizabeth <elaurencot@nejm.org>Sent : Wednesday, February 26, 202-0- 9-:0-4- A-M- -, ...,....,= To: Fauci, Anthony {NIH/NIAID) [El (b)(6)Cc: Folkers, Greg {NIH/N IAID) [E] (b)(6); Conrad, Patricia (NIH/NIAID) [E](b)(6); Eisinger, Robert (NIH/NIAID) [El (b)(6)>; l ane, Cliff"(. N"-' I-H-/:N--IA- l~D~) [~E~] ===.;..- ~ (b~H=6)Subject: RE: NEJM content proof (Fauci)Dear Dr Fauci,Many thanks for your quick reply and for the clear list of responses regarding the proof. I will reviewtoday and will let you know if there are any items needing fur ther discussion.The current plan is for publication early Friday afternoon . As I mentioned yesterday, there is a newarticle on Covid-19 that is also scheduled for publication that day, and the Journal editors would like youto mention it in your editorial. I expect to be able to send you a proof of that article sometime today.Best,EliFrom: Fauci, Anthony (NIH/N IAID) [E] ________ (b)(_6,)Se nt: Wednesday, February 26, 2020 7:37 AMTo: Laurencot, Elizabeth <elaurencot @nejm.org>NIH-0013 19Cc: Folkers, Greg (NIH/NIAID) [E] Cb)( >; Conrad, Patricia (NIH/NIAID) [E]---:----:-~~= (=b)=(6:!)>....;:_.E.isin.g::e~::r.;,_ =Robert (NIH/NIAID) [E] ~ (b)(6) .>; Fauci, Anthony(NIH/NIAID) [E] (b)(6); Lane, Cliff (NIH/NIAID) [E] (b)(6)>Subject: RE: NEJM content proof (Fauci)Dear Eli,Here are my answers to you r que ries, and couple ot her min or changes:(b) (5)NIH-001320(b) (5)NIH-001321Thanks,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b) (6)The information in this e-ma il and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sende r's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Laurencot, Elizabeth <elaurencot@nejm .org>Sent: Tuesday, February 25, 2020 8:51 AM ------~~ = To: Fauci, Anthony (NIH/ NIAID) [E) (b)(6)Subject: NEJM content proof (Fauci)Importance: HighDear Dr Fauci,Attached is the content proof of your editorial. Please read *ALL* of the following instructions andinformation carefully before you begin reviewing your proofs.First, please stop and take a moment now to confirm receipt, so t hat we can be assured that yourproofs did not end up in a spam folder.Your editorial has been edited for grammar, consistency, readability, adherence to Journal style, andclarity for nonspecialist readers. To expedite publication , we do not ask authors for specific approva l ofroutine changes; please read the enti re article to make sure your meaning has been retained. Note thatwe may be unable to make changes that conflict with Journal style or create grammat ical or otherproblems. Finally, please note that a delayed or incomplete response may delay publication of youreditorial.Please read the entire proof carefu lly, including all queries . Please return your query rep lies and proofcorrections **before 12pm (US Eastern) this Friday, February 28, 2020** .Instruct ions are prov ided below . Note that you will be reading for content only; the art icle will berendered for print after the content has been finalized .The Journal's senior medical editors will be reading your article at this stage. If they have any additionalcomments or queries for you, I will forward them to you in the next few days.NIH-001322NIH-001323TO ANSWER THE QUERIES: The proof contains in-line numbered query markers and a numbered list ofqueries at the end. The query markers and the queries are linked, so you can jump back and forth withinthe file. Please respond to all the queries (see below for instructions; please do ** NOT** use eannotationtools) and convey any additional changes as needed.TO RESPOND BY E-MAIL: If your corrections and your responses to the queries are straightforward, weencourage you to respond by replying to this message. Please copy and paste the list of queries into ane-mail message or a Word document and type your responses there. You may also include a list ofchanges (e.g., page 1, line 20, change xxx to yyy) . Again, please do ** NOT** use e-annotation tools inthe PDF file; the marks are small and easy to miss, which may lead to errors in your art icle.Please note that this material is confidential and embargoed until publication . If you have questionsabout our embargo policy, please contact NEJM Media Relations at 781 -434-7847 or atMediasupport@nejm.org .Again, please do confirm receipt at this time . Thank you very much for your efforts with these contentproofs!Best,EliElizabeth Lauren<;:otSenior Manuscript EditorNew England Journal of Medici ne617 -487 -6547elaurencot@nejm .orgTO READ THE PROOF: You will need Adobe Acrobat Reader software (version 4.0 or later) to view thisfi le. Acrobat Reader is available free of charge at the Adobe Web site(http://www .adobe.com/products/acrobat/readermain.html ).NIH-001324This email message is a private communication. The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privileged,and/or proprietary material. Any review, duplication, retransmission, distribution, or other use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited . If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.This email message is a private communication. The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privi leged,and/or proprietary material. Any review, duplication, retransmission, distribution, or other use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited . If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.From: Fauci, Anthony (NIH/NIAIO) [ElSent: Wed, 26 Feb 2020 15:18:06 +0000To: Cassetti, Cristina (NIH/NIAID) [E]Subject: FW: First in class, hemostatic drug - potential therapeutics for COVID-19Attachment s: NIAID EEEV - SP16_ Jan 28, 2020 - Read-Only - Read-Only.pdf, JACC manuscriptOct 2017 SP16 AM I (1).pdf, Serpin Pharma - Non-Confident ial Partnering Deck v29.pdfPlease take a look at this. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6lThe information in this e-ma il and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Cohava Gelber (b)( Sent : Tuesday, Februa-ry- 25-, 2-02-0 -8-:-4-5-- P-M-- ------, .....,....,= To: Fauci, Anthony {NIH/NIAID) [El ---------- (b)(6) Subject: First in class, hemostatic drug - potential therapeutics for COVID-19Import ance: HighDear Dr. Fauci,NIH-001327(b) (4)Please let us know how we can help.I have attache d a manuscript and company presentations for your review.Sincere ly,CohavaCohava Gelber , PhD, MBAExecu tive Chairperson & CEOSerpin Pharmawww .serpinpharma .com(b)(6)NIH-001328(b) (4)From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 202015 :17:35 +0000Mehta, Nehal N. (NIH/NHLBI) [E)Cc: Conrad, Patricia (NIH/NIAID) [E);Greg Folkers ---------(b)( ·) Subject : RE: Guidance for users of biologics in the age of Coronavirus.I am sorry Nehal, but I am really swamped right now and cannot make this apriority . I hope that you understand .Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b) (6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient. If youhave rece ived this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Mehta , Nehal N. (NIH/NHLBI) [E] (b)(6)>Sent: Tuesday, February 25, 2020 8:47 PM ------~= To: Fauci, Anthony (NIH/NIAID) [E) (b)( >Subject: Fwd: Guidance for users of biologics in the age of Coronavirus.DearTony -1 wonder if you would be willing to participate in a short piece regarding use of biologics withlooming Coronavirus for JAMA Dermato logy or JAMA Internal Medicine?Please see the email sent below to me by my colleague and collaborator Joel Gelfand fromPenn.I understand there are fierce demands on your time but we would be happy to draft for yourapproval.Many thanks for your consideration!All my best,NehalNIH-001329Nehal N. Mehta, MD MSCE FAHALasker Senior InvestigatorChief, Lab of Inflamm at ion and Cardiometaboli c DiseasesNational Heart, Lung and Blood InstituteBethesda MD 20892Email (b)(6) """':====~~-- Phone : (b)(6J1Begin forwa rded message :From: "Gelfand, Joel" ----------------- (b)(6) Date: February 25, 2020 at 8:12:48 PM ESTTo: "Mehta, Nehal N. (NIH/NHLBI) [E]" ----------(b)(6) Subject: Guidance for users of biologics in the age of Coronavirus.Dear Nehal,With the coronavirus border ing on a pandemic and the expectat ion that it will affect the US at somepoint, it seems to me we should be prepared to provide guidance to patients who are on immunemodulators for inflammatory disease. Specifically, many will wonder if patients should stop th eirbiologic if the vi rus becomes prevalent in their commun ity. There will also be questions about stoppingbiologics in the setting of acute infectio n with coronavirus.Any thoughts on this? My specific inte rests relates to patients with psoriasis or psoriatic arthr itis onbiologics but it's also relevant to patients with IBD, RA and other inflammatory diseases.JoelJoel M. Gelfand MD, MSCEProfessor of DermatologyProfessor of EpidemiologyVice Chair for Clinical Research (Dermatology)University of Pennsylvania, Perelman School of Medicinehttps ://www .med.upenn.edu/gelfand/NIH-001330From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 15:14:43 +0000Stover, Kathy (NIH/N IAID) [ElCc: Billet, Courtney (NIH/NIAID) [El;Folke rs, Greg (NIH/NIAID) [El;Conrad , Patricia(NIH/NIAID) [ElSubject : RE: FOR ASF REVIEW: Draft MA re: Fauci/Eisi nger/Redfield COVID-19 paperThis looks fine. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail (b)(6lThe information in this e-mail and any of its attachments is confidential and may contain sensitiveinfo rmation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Stover , Kathy (NIH/NIAID) [El (b)(6)Sent : Tuesday, February 25, 2020 5-:1-2- P-M- ---, .....,..,= To: Fauci, Anthony (NIH/NIAID) [El (b)(6)Cc: Billet , Courtney (NIH/N IAID) [El (b)(6); Folkers, Greg (NIH/NIAID) [E]_______ Cb _>C6); Conrad, Patric ia (NIH/NIAID) [E) (b)(6)Subject : FOR ASF REVIEW: Draft MA re: Fauci/Eisinger/Redfield COVID-19 paperHi Dr. Fauci,Please find attached for your review a draf t media availab ility about you r imminent NEJM paper onCOVID-19. We have named you as the spokespe rson in t he MA.Thanks much,KathyKathy StoverBranch ChiefNews and Science Writing BranchOffice of Communications and Governmen t RelationsNational Institute of Allergy and Infec tious DiseasesNational Institutes of Health31 Center Drive, Room 7A17FNIH-001331Bethesda, MD 20892(b)(6)Media line: (301) 402-1663NIH-001332From:Sent :To:(b)(6)Wed, 26 Feb 2020 09:23:22 -0500Thomas R. FriedenSubject: Re: FYIThanks, Tom.On Feb 25, 2020, at 3:41 PM, Thomas R. Frieden------------ Cb)( 6)>wrote:Tony,Nothing you don't already know ....TomFrom: Tom Frieden (b) (6) > ------------- Date: Tuesday, February 25, 2020 at 3:39 PMTo : Tom Frieden (b)(6)Subject : A COVID-19 Pandemic is Inevitable. Now what?Dear Colleague,It's now clear that COVID-19 will become a pandemic. We don't know if it will bemi ld, moderate or severe, or how many countr ies it will reach.As we shift from the initiation phase of the pandem ic to the acceleration stage, I'vehighlighted 8 things we must do now in a new CNN OpEd:htt p:// www .cnn.com / 2020/ 02/ 25/ health / coronavirus- pandemicfrieden/ index. htmlPlease share, and thank you for what you continue to do for pub lic health .All the best,TomIf you'd like to retweet, here's a link.NIH-001336From:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 12:47:09 +0000Collins, Francis (NIH/OD) [ElRE: Milken outreachThanks, Francis. It might be better for you to make an e-mail introduct ion and Iwill take it from there .Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the or iginal intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Collins, Francis (NIH/OD) [E] ------- (b)(6)>Sent: Wednesday, February 26, 2020 7:32 AM To: Fauci, Anthony (NIH/NIAID) [E] <.-l._ -__-__- --=C)b=~.~. . >Subject: RE: Milken outreachHe's at (b)(6) and ------(b)(6) Want to reach out directly or shall I make an e-mail introduction?FrancisFrom: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Sent: Wednesday, February 26, 2020 6:43 AMTo: Collins, Francis (NIH/OD) [El (b)(6)Subject: Re: Milken outreachFrancis:Thanks for the note. Milken can help in a number of ways including di rectly supporting the VRC. Also,as we start looking for Pharma to step up with us, his connections could be helpful.TonyOn Feb 25, 2020, at 12:58 PM, Collins, Francis (NIH/OD) [E] ------- Cb)~ > wrote:NIH-001337NIH-001338Hi Tony,I'm sure you know Michael Milken. I've worked with him over many years, and though heis a somewhat controversial figure he has certainly helped NIH in many ways. He reachedout to me last night to ask if there is anything he could do to help with the coronavirusvaccine effort. He had seen press reports that finding a pharma partner had beenchallenging - and wanted to volunteer his help in that regard, since he has deepconnections in the private sector. He also said that he'd be glad to help with anyphilanthropic needs, both through his own resources and his influence over members ofthe Giving Pledge.Are there useful actions that I can suggest to him?FCFrom:Sent:Fauci, Anthony (NIH/NIAIO) [E)Wed, 26 Feb 2020 10:59:30 +0000To: *'@ ~Subject : RE: Questions abou t the coronavirus-Chinese Media Inquiry :See answers below in redFrom: $.~~~ <xinenbo@thepaper.cn>Sent: Wednesday, February 26, 2020 1:08 AMTo: Fauci, Anthony (NIH/NIAID) [E) ----- -(.b.=H= >Subject: Questions about the coronavirus-Chinese Media Inquiry:Dear Dr Fauci,My Name is Paul Xin, I'm a journalist from Pengpai News(ThePaper) of Shanghai, which is one of themost important new medai in China. I 'm Sorry to bother you as you must be very busy. I noticed yourcomment about coronavirus on American media, I deeply hope you could answer few of myquestions.Your answers will be very helpful to me. The questions are below.Thank you very much!Sincerly ,Paul Xin1/You said on CNN that US have had pandemic preparedness plan that developed in preparation forpandemic influenza . Could you provide some detai ls of this plan? The plan outlines the differencesbetween containment and mitigation. It speaks of the thing that should be done if an outbreakoccurs in the USA. Thes inclue social distancing, use of telecommunication and telework, temporarilyclosing schools, avoiding crowed places such as indoor arenas and theaters.2/To prepare for potent ial communities spread of coronavirus in US, do you thin k that US need take themeasures similar with China? China was in the "reactive" mode of responding to an explosion of casesin Wuhan City and Hubei province with spread throughout China. China had to resort to verydramatic measures such as shutting down cities. The USA is now in a preparative mode and not areactive mode and so our response is much different than that of China.NIH-001339NIH-001340$}!.;Ji~;JUJr[i:i]/8"1~~Jcrp[, it:,if]~ ~~Wfrfijjfm..t.;fifmN~cpns39~From:Sent:To:Fauci, Anthony (NIH/NIAID) [E)Wed, 26 Feb 2020 10:46:23 +0000Conrad, Patricia (NIH/NIAID) [ElSubject: RE: Confirma tion from CNN's New DayGot it. Thanks .From: Conrad, Patricia (NIH/NIAID) [E) (b)(6)Sent: Wednesday, February 26, 2020 5:40 AMTo: Fauci, Anthony (NIH/NIAID) [E] -------=- (bcH-=- >Subject: Fwd: Confirmation from CNN's New DayFirm for 650 am hit today at med arts as per below.Sent from my iPhoneBegin forwarded message:From: "Figliola, Mike" <Mike.Figliola@turner .com>Date: February 26, 2020 at 3:33:40 AM EST -------~~ To: "Conrad, Patricia (NIH/NIAID) [E]" (b)(6)>, "Daniels, Ronnel(NI H/0D /0 RS) [CJ", ,....;._;...__.;..;....:.......(;b:;:):;(;:56)'>,-:"::R-:-y-:l--a n-d:,- :K-e:--n-:(--N:- I-H /0D/ORS) [El"--------- (b)(6)>, Jo-n-a-th-a-n -B-e=nn=ett= ~~.-------- (b)((;), "Jackson Farrar, Joy (NIH/OD/ORS) [E)' _______ (b_H_6)Subject: RE: Confirmation from CNN's New DayHi everyone,This is Mike with CNN's New Day. Hope you are well.This is to confirm Dr. Fauci will be a guest today, Wednesday 02.26.20 at around 6:50amEST to discuss:Coronavirus latest - are we facing an outbreak?You will be solo at 6:45am EST for the segments.John Berman, will both be conducting today's interview.Please arrive at the studio no later than 6:40am EST.Here is your studio confirmation:NIH-001341SHOW MANAGER : VENDOR STUDIO #2018562NIH Events Management (Medical Arts) Studio InfoNIH Control Room numbers are 301-827-8478 and 8479Encompass Booking and Circuit Number:Booking: 1-800-243-1995Circuit: 36TBGS 104492Our IFB: 301-496-1811 (we prefer to call into the station's IFB)Video : 1080i (59.94) - the audio is embedded .Please call the TOC with any technical questions at 301-827-8478Please confirm you have received this and are all set to go!Best,MMike FigliolaEditorial ProducerCNN's New Day212-275-8161mike.figliola@ turner .comCONFIDENTIALITY NOTICE: This e-mail transmission, and any documents , files orprevious e-mail messages attached to it, may contain confidential information that is legallyprivileged. If you are not the intended recipient, or a person responsible for delivering it tothe intended recipient, you are hereby notified that any disclosure , copy ing, distribution oruse of any of the information contained in or attached to this message is STRICTLYPROHIBITED . If you have received this transmission in error, please immediately notify usby reply e-mail at mike.fiq liola@turner .com or by telephone at (917) 670-9410, and destroythe original transmission and its attachments without reading them or saving them to disk.Thank you.NIH-001342From:Sent:To:Subject :Jon:Fauci, Anthony (NIH/NIAID) [E)Wed, 26 Feb 2020 01:32:22 +0000Jon LaPookRE: CBS Sunday MorningThe message would have to be that the situat ion continues to evolve and people need to follow the news and thereports from CDC. For example , a few weeks ago if you wanted to travel to Japan or South Korea , it was fine sincethere were few is any cases there. Now both cotmtries have a travel alert that says "Avoid all but essential travel".You should tell people that travel to places with few or no reported cases is fine. Only when you have communityspread (person to person to person) shou ld you be concerned about a specific travel destination. Also , you couldexplain to people that pandemics evolve when a new infectious disease is spreading by sustained community spreadin multiple countries in different regions of the globe. Once a [)andemic erupts. it is virtually impossible for anycountry to be free of cases. Peop le need to understand that. You can mitigate the effects , but you cannot avoidhaving infections since you cannot shut off the country from the rest of the world. Also, you need to speak of thereal and present danger of seasonal influenza every year. Do not let the fear of the unknown (i.e. a pandemic of anew infectious agent) distor t your evaluation of the 1isk of the pandemic to you relative to the risks that you faceevery day. The only thing that we can do is to prepare as best as possible and do not yield to wrreasonable fear.Best,Tony•··•-Original Message-----From : Jon LaPook ,,;::-;-..-.~ (~b)~(= >Sent: Tues day, February 25, 2020 6:34 -PM-- --- ~~ To: Fauci, Anthony (N1H/NlAID) [E] (b)( >Subject: CBS Sunday MorningHi Tony,1 have an unusual opportunity: the executive producer of CBS Sunday Morning has asked me to do a straight tocamera shpiel about COVID-L9 for this Sunday. 1 did something similar when people are panicking about Ebola.You and 1 have spoken enough about th is so that I feel comfortable with the basics. But I would love you to givesome thought to whether there are any misunderstandings that you would like cleared up or information you wouldlike disseminated.l would love to give some logical travel advice. I know there are so many unknowns, but r have had multiple peopleask me whether they should cancel their upcoming to trip to ... you name it (ltal y, Israel, San Francisco). T know itcomes down to risk/benefit , and - as you told me during the Ebola outbreak - people have all sor ts of vary ing leve lsof comfort with risk. But what do fac tually SAY to the 6 million people who will be watching people? : )Thanks,JonJonathan LaPook, M.D.Chief Medical Correspondent, CBS NewsProfessor of MedicineNYU Langone HealthTwitter @DrLaPookNIH-001344From:Sent:To:(b)(6)Tue, 25 Feb 2020 19:07:15 -0500McNeil Jr, Donald GSubject: Re: thought from a kibb itzer ...You make some very good points , Donald.On Feb 25, 2020, at 4:48 PM, McNeil Jr, Donald G <mcnei l@nytimes.com>w rote :I was just watching the HHS briefing online, and thinking about an article I read thismorning , and Bruce Aylward's description of what he saw in China, and a lot ofvideos I've watched on the South China Morning Post website (they're doing greatcoverage .) .In China, we in the media tend to report the horr ors and the lockdown and thegovernme nt's early lies ...But the truth is that a lot of average Chinese behaved incredibly heroically in theface of the virus: 25,000 doctors and nurses went into Wuhan to help, knowing theymight die. Average people gave up their stockpiles of masks so they could beshipped to Wuhan . Ne ighborhood committees brought food to thousands of little oldladies and checked on them every day, even as they asked them to stay behind theirdoors for fear of infection.Meanwhile , in America, people tend to act like selfish pigs interested only in savingthemselves. How can I hoard a mask? Where's my vaccine? This morning , Iread this appa lling article from Alabama . Here you have Americans com ing backfrom a horrifying experience overseas, and the President -- who is popula r inAlabama -- asks Alabama ns to take some of those fell ow Amer icans in. There iszero risk because they're going to be housed on a naval base.And yet, the answer is "No! Keep them out!" And their legislators encourage it.. ..I dunno -- that's the kind of behavior I expect from my fellow New Yorker s, notfrom Alabama.If the virus arrives -- and we both know it wilJ -- America is going to have to dobetter than that. Like the Chinese, Americans are going to have to look out for eachother the way we haven't since 9/ 11. Or maybe since World War II.But that's not the tone of the HHS briefings . They're an aggressive, defensiv e,almost smart-alecky "we got this" tone. The only time the tone was right when youNIH-001345NIH-001346were the third to take the mike and explain things to that kid shouting from the backwithout a mike about "What's the real message? What do we do?"Maybe there could be some thought given to mentally preparing Americans to worktogether in the face of the crisis? Quarantines are a very aggressive approach -- butthey require a lot of compassion or the people quarantined suffer.I might get around to writing an article about this, but my editors keep grabbing mefor minute by minute stuff and I'm way behind.DonaldFrom:Sent:To:(b)(6)Tue, 25 Feb 2020 18:59:02 -0500Cassetti, Cristina (NIH/NIAID) [E]Subject: Fwd: Surfactant Protein-D against coronavirusPlease handle.Begin forwarded message:From: Marc Salzberg Cb()6 JDate: February 25 , 2020 at 4:42:47 PM E--S-T- --~~ To: "Fauci, Anthony (NIH/NIAID) [E]" CbH6JSubject: Surfactant Protein-D against coronavirusDear Dr. Fauci,We are developing a recombinant human form of Surfactant Protein-D (AT-100), anendogenous collectin with strong irnrnune-modu latory properties. AT-100 showsanti-inflammatory and ant i-infectious properties. CbH4>There are data indicatin that SP-D clears coronavirus(b)(4)While we are discussing this with a number of academic institutions, I waswondering, though, whether you and the NIH are interested to collaborate oneva luating AT-100 against coronavirus. Please let me know , if you are willing toschedule a phone call with our Chief Medical Officer Dr. Paul Kingma and I todiscuss. There is obviously a sense of urgency behind this request.Best regards,Marc SalzbergAirway Therapeutics , Inc.Marc Salzberg, MDPresident &CEO1200 Johnson Ferry Rd., Suite 300Marietta, GA 30068Ph(b)(NIH-001347NIH-001348: :AIRWAY( • • THH"l..A I T ~From:Sent:To:(b)(6)Tue, 25 Feb 2020 18:33:00 -0500David - GmailSubject: Re: David Pyrce Reconnecting - Coronavirus Task ForceDavid:Thanks for your note and your keen interest in this important challenge of corona virus. TheWhite House Task Force is chosen by the President upon the advice of his senior staff. I amafraid that there will not be any additional members for now. Again, thank you for your interest.Best regards ,TonyOn Feb 25, 2020, at 5:29 PM, David ------------ (b)( wrote:Hello Dr. Fauci,I know you are extremely busy and will get right to the point. I would like to jo in thecoronavirus taskforce.I worked on the Ebola task force about six years ago, which had a similar sense of urgency,and recognize that assembling a SWAT team overnight is critically important in order tomonitor, contain and mitigate the spread of the coronavirus, not just for the United States,but on a worldwide basis.I've done a significant amount of work in infectious disease vaccine development at anumber of biotech firms (Vical, lnovio and lntrexon) in partnership with the NIH, VaccineResearch Center, DOD and the CDC.I also (b) (6) we discuss preparedness on a daily basis. Thoseconversations clearly indicate that the knowledge and expertise is severely lacking at boththe academic medical center level, as well as the community health level.I believe my assistance can be deployed in several areas where my experience in virology ,immunology, antivirals , Ebola, product development and strategic partnering could be ofimmediate value to research scientists, medical professionals and healthcare systems.1. Identification of emerging therapeutics.2. Fast track emerging therapeutics from pre-clinical to IND and fast-track clinical trials.3. Identify opportunities to accelerate the production of commercial quantities of therapeuticmaterial.4. Identify unique genomic fingerprints of responders and patients undergoing treatment toguide therapeutic selection and optimize interven tions.5. Interface with public and/or institutional stakeholders on a worldwide basis (24/7)regarding safety procedures, diagnostics, therapeutic interventions, etc.6. Other initiatives, representing areas where there is an immediate need to bring on boardand deploy an individual with deep expertise, who can provide leadership , drop in andrapidly advance those initiatives .NIH-001349With the urgently required , in order to provide a Navy SEAL like response , I would proposea consulting arrangement where I'm available 24/7, anywhere/a nytime , for as long asneeded . Please let me know your thoughts .Here is a brief snapshot of my C.V.1. SVP, Innovation and Chief Commercia l Officer - NantKwest (gene/cell therap ies,immunotherapeutics and molecular diagnost ics)2. SVP, Innovation and Chief Commercia l Officer - NantHealth {Al/bioinformatics-basedmulti-omics based molecular diagnostics and neoant igen-based therapeutics)3. Founder/CEO - Genomic Principles (neoantigen-based , individualized therapeut icvaccines)4. Founder/CEO Canton Biotechnologies {DNA-based therapeutics and vaccines)5. Chief Business Officer - lntrexon {gene/protein-based therapeutics and vaccines)6. Chief Business Officer - lnovio {gene-based therapeutics and vacc ines)7. VP, Business Development - Vical (gene-based therapeutics and vaccines) .I know you are busy and you can feel free to forward th is emai l to the appropriate individual.I can also be reached by cell phone (b)(6) to discuss furthe r.Best Wishes,David(b)(6)NIH-001350From :Sent :To:Fauci, Anthony (NIH/NIAIO) [ElTue, 25 Feb 2020 22:10:15 +0000NIAIDODAMSubj ect : FW: Hello from ----------(b)(6)Let us di scuss.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the origina l intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devi ces . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives.From: Groslyn Burton <burton@theasiagroup.com>Sent : Tuesday, February 25, 2020 10:59 AM ------ -==-- To: Fauci, Anthony (NIH/NIAID) [El (b)(6J>Subject: Hello from ---------- (b)(6)Dr. Fauci -(b)(6)I apologize for the directout of the blue message, however, my company The Asia Group has a pod cast called Tea Leaves and wewould be interested in having you as a guest to speak about the Coronavirus. I mentioned to my CEOthat you are the leading expert and that I had a connection with you. We would only take about 30-45mins of your time and would be happy to work around your schedule if this is something that you wouldbe willing to do. Below is a short description of the podcast and a link to our episodes. If able, I'd behappy to coordinate with your assistant.Looking forward to hearing back soon.Thanks,Groslyn "Foster" BurtonVice President, Culture and ValuesExecutive Assistant to the ChairmanDr. Kurt M. Campbell, Chairman and CEOThe Asia Group, LLCNIH-001351202-350-3285 - Office-----Cb()6 ) - Mobile 202-750-29 44 - Faxhe Asia Group announc ed the launch of Tea Leaves, a new podcas t that will focus on thecurrent affa irs, foreign policy, business, and arts of Asia. The podcasts' hosts, Dr. Kurt M.Campbell and Ambassador Richard Verma, will lead a series of revealing interviews withpolicymakers , business leaders, journalists, and artists exploring the most dynamic andconsequentia l region in the world.In a j oint statement, Campbell and Verma said, "We wanted to share our passion forAsia with listeners , both accomplished Asia hands and those with a budding interest inthe dynamic region. Our aim is to provide listeners with a greater understanding of theindividuals who focus on and live in the region, and how Asia affects our world. "The hosts bring significant experience and expe rtise to the podcast. Campbell is CEOand Chairman of The Asia Group, and served as Assistant Secretary of State for EastAsian & Pacific Affa irs from 2009 to 2013. Richard Verma is Vice Chairman andPartner at The Asia Group, and served as the United States Ambas sador to India from2015 to 2017.The first episode of Tea Leaves is now live on major podcast platforms , includingiTunes , Stitcher, and Overcast. Subsequent episodes will be animated by conversat ionswith the movers, doers, and thinkers who are driv ing today's Indo-Pacific. "We hopethat you will subscr ibe and give our first episode a listen," said Campbell and Verma.The link to the podcast is available here: https://itunes.apple.com/us/podcast/the-tea leaves-podcast /id 13 5 5207045NIH-001352From:Sent:To:(b)(6)Tue, 25 Feb 2020 16:08:53 -0500Conrad, Patricia (NIH/NIAID) [E)Subject: Fwd: The last Word with Lawrence O'DonnellLet us discussBegin forwarded message:From: "Shuster, Amy (NBCUniversal , MSNBC)" <amy.shuster @msnbc.com >Date: Februa ry 25, 2020 at 3:40:25 PM E-S-T- -----~~ To: "Conrad , Patricia (NIH/NIAID) [E]" (b)( , "Fauci,Anthony (NIH/NIAID ) [E]" (b)CSubject: The Last Word with Lawrence O'DonnellGood afternoon,I wonder if Dr. Fauci could join our program this evening at 10 pm to discuss the bestmeasures for the government and the American people to prepare for a coronaviruspandemic.Ali Velshi is hosting our show tonight on MSNBC.This would be a panel discussion this evening -w e're still working through details of thepanel.Interview would be from 10-10:20 pm EST.Please let me know if anything would be possible tonight.Many thanks,AmyAmy ShusterSenior ProducerThe last Word0 . 212-664-1657C. (b)(6)NIH-001353From:Sent:To:(b)(6)Tue, 25 Feb 2020 14:03:48 -0500Ziady, Hanna (NE)Subject: Re: Questions on coronavirus vaccine45 people. It will take 3 to 4 months to complete.On Feb 25, 2020, at 11 :12 AM, Ziady , Hanna (NE)<Hanna.Ziady @tum er.com>wro te:Thanks very much for the quick response.Do you know at this stage when the phase 1 trial will be completed and how many peoplewill participate in it?Many thanks,HannaHanna ZiadyWriter I CNN Business0: +44 207 693 1884M: + (b)(6)@hannaziadyFrom: "Fauci, Anthony (NIH/NIAID) [E]" ---------- (b)(6) Date: Tuesday, 25 February 2020 at 15:58To: "Ziady, Hanna (NE)" <Han na.Ziady@turner.com>Subject: RE: Questions on coronav irus vaccineThe phase 1 trial to determine safety for the mRNA vaccine platformthat NIH is doing with Moderna is scheduled to start within 2 months(some time in April) . However, this is just the first step in attempting tohave a vaccine available for use. Even proceeding at an emergencyspeed, a vaccine would not be available for use for at least 1 to 1.5years. It is characterized as a "vaccine".Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthNIH-001354Bethesda, MD 20892-2520Phone: Cb()6 )FAX: (301) 496-4409E-mail : Cb()6 )The information in this e-mail and any of its attachments is confidential and maycontain sensitive information . It should not be used by anyone who is not the originalintended recipient. If you have received this e-mail in error please inform the senderand delete it from your mailbox or any other storage devices. The National Institute ofAllergy and Infectious Diseases (NIAID) shall not accept liability for any statementsmade that are the sender's own and not expressly made on behalf of the NIAID byone of its representatives.From: Ziady, Hanna (NE) <Hanna.Ziady@turner .com>Sent: Tuesday, February 25, 2020 5:56 AMTo: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject: Questions on coronav irus vaccineDear Dr Fauci,Trust this mail finds you well .I have a few questions regarding the Moderna vaccine, which it wou ld be great to get yourinput on.Is it true that trials of the possible vaccine will start in April, but that, even if the first studyis positive, the vaccine might not become wide ly available until next year because of theneed for further studies and regulatory clearances?The company is characterizing this as a vaccine. Strictly speaking, what should it bereferred to as?If you have time for a quick telephone call this morning as soon as you're able that wouldbe great.Many thanks,HannaHanna ZiadyWri ter, CNN BusinessOffice : +44 207 693 1884Mobile : ------ (b)(6) @hannaziadyInformation in this email includ ing any attachments may be privileged or confidentia l andis intended exclusively for the addressee. The views expressed may not be official policy,but the personal views of the originator. If you have received this email in error, pleaseNIH-001355NIH-001356notify the sender by return e-mail and delete it from your system. You should notreproduce, distribute, store, retransmit, use or disclose its contents to anyone. Please notewe reserve the right to monitor all e-mail communication through our internal andexternal networks. Turner and the Turner marks are trade marks of Turner BroadcastingSystem Inc and are used under licence.Turner Broadcasting System Europe Limited (Company No. 1927955), TurnerEntertainment Networks International Limited (Company No. 2803512), TurnerBroadcasting System Holdings (Europe) Limited (Company Number 2802926) and CableNews International Limited (Company No. 5001368) are incorporated in England andWales and share the same registered office at Turner House, 16 Great Marlborough Street,London WlF 7HS.Information in this email includjng any attachment s may be privileged orconfidential and is intended exclusively for the addressee . The views expressed maynot be official policy , but the personal views of the originator. If you have receivedthis email in error, please notify the sender by return e-mail and delete it from yoursystem. You should not reproduce , distribute, store, retransmit , use or disclose itscontents to anyone. Please note we reserve the right to monitor all e-mailcommunication through our internal and external networks. Turner and the Turnermarks are trade marks of Turner Broadcasting System Inc and are used underlicence.Turner Broadcasting System Europe Limited (Company No. 1927955), TurnerEntertaimnent Networks International Limited (Company No. 2803512), TurnerBroadcas ting System Holdings (Europe) Limited (Company Number 2802926) andCable News International Limited (Company No. 5001368) are incorporated inEngland and Wales and share the same registered office at Turner House, 16 GreatMarlborough Street, London Wl F ?HS.From: (b)(6)Sent:To:Subject:Tue, 25 Feb 2020 13:56:38 -0500Conrad, Patricia (NIH/NIAID) [E)Re: cdc coronavirusThis does not change anything I said this AM. It is perfectly compatible with what I said. Noconflict at all.On Feb 25, 2020, at 1 :32 PM, Conrad, Patricia (NIH/NIAID) [E]----------- (b) (6)>wrote:Pis advisePatr icia L. ConradPublic Health Analyst andSpecial Assistant to the DirectorNational Institute of Allergy and Infectious DiseasesThe National Institutes of Health31 Center Drive, MSC 2520 - Room 7 A03Bethesda, Maryland 20892(b)(6)301-496-4409 faxDisclaimer :The informat ion in this e-mail and any of its attachments is confident ial and may contain sensitive information. Itshou ld not be used by anyone who is nol the original intended recipient. If you have received this e-mail in errorplease inform the sender and delete it from your mailbox or any other storage devices. National Institute of Allergyand Infectious Diseases (NIAID) shall not accept liability for any statement made that are sender's own and notexpressly made on behalf of the NIAID by one of its representatives .From: Jakaitis, Mike <mjakait is@wtop.com>(b)(6)Sent : Tuesday, February 25, 2020 1:26 PMTo: Conrad, Patricia (NIH/NIAID) [E) ---------- Subject: cdc coronavirusThe CDC today alerted Americans to begin to prepare for community spread of thecoronavirus ..... does t his changes Dr. Fauci's view on the virus? If so can he join us. If thisdoesn't change anything. We can use what he said this morning .... or if he wants to comeon and ta lk about the new CDC warning ... we would like to speak to him.NIH-001357From:Sent:To:Subject :Mr.Rae:(b)(6)Tue, 25 Feb 2020 13:52:31 -0500James RaeRe: touch screens transmitting CoronavirusThank you for your note.Best rega rds,A.S. Fauci> On Feb 25, 2020, at l: 36 PM, James Rae ------ (b)(6) wrote: >> Dear Dr. Fauci>> Thanks for your tv appearances to educate.>> Cell phone and other touch screens could be a major vector of transmission for Corona virus .>> Please suggest frequent cleaning of devices with alcoho l on your next tv appearance.>> Keep up the good work. I've watched you over the years. Your public education is much appreciated.>> Best regards,>> Jim Rae> Boston area> (b) (6) mobileNIH-001358From:Sent :To:Cc:(b)(6)Tue, 25 Feb 2020 13:09:02 -0500Emanuel, Ezekiel J(b)(6)Subject: Re:lt may well dimin ish somewha t as weather gets warmer. However, there is no guarantee that thiswill occur. More likely that it will become seasonal and go down in our summer and resurgenext winterOn Feb 25, 2020, at 12:48 PM, Emanue l, Ezekiel J -------- (b)(6) wro te:To get 1 million deaths of 1957 would requi re 200 million infections at adeath rate of 0.5%. That seems high number of infections .But what is the worldwide seasonal flu death numbers if the USA has 50,000deaths in a bad year and the 1957 number of deaths was 116,000? TheWHO says 650 ,000 death s worldwide from seasonal flu. So this could beworse but by about 40% not an order of magnit ude . Okay so I should bemore concerned .And do you think it will go down in late spring with warme r weather?Ezekiel J. Emanuel , M.D., Ph.D.Vice Provost for Global InitiativesDiane v.S. Levy and Robert M. Levy University Professo-r- --~~ Chair , Department of Medical Ethics and Health Policy ( (b)( ~ 1111 ) --------Co-Dire ctor, Health care Transformation InstituteUniversity of PennsylvaniaPhone : (b)(6)Fax: 2 15-898-6567From: Fauci, Anthony (NIH/NIAID) [E] ______ (b_H_ >Sent : Tuesday, February 25, 2020 12:32 PMTo: Emanuel, Ezekiel J (b)(6)>Subject : RE:Zek e:NIH-001359Ari is also calling me frequently . The virus has adapted itself very wellto humans with considerable community transmission (certainly inChina) now in other countries such as South Korea, Japan, Iran, Italy,etc. If it continues to spread via multiple generations of human tohuman transmission, then we will not be able to avoid considerableamounts of infect ions and spread in the USA. Seasonal influenza has amortality of 0.1%. The calculated mortality of COVID-19 to about 2.5%. It is probably lower since the denominator is likely larger than weappreciate due to asymptomatic infections . Even if the mortality goesdown to 0.5%, that is still equivalent to a pandemic influenza of 1957or 1968. In other words, it could be worse than you think.TonyAnthony S. Fauci, MODirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone: (b) (6)FAX : (301 496-4409E~mail: (b) (6)The information in this e-mai l and any of its attachments is confidential and maycontain sensitive information. It should not be used by anyone who is not the originalintended recipient. If you have received this e-mail in error please inform the senderand dele te it from your mailbox or any other storage devices . The National Institut e ofAllergy and Infectious Diseases (NIAi □) shall not accept liability for any statementsmade that are the sender 's own and not expressly made on behalf of the NIAID byone of its representatives .From: Emanuel, Ezekiel J (b) (6)Sent: Tuesday, February 25, 2020 10:47 AM -----~~ To: Fauci, Ant hony (NIH/NIAID} [E] (b)(6)>Subject:Tony,Ari is pestering me endlessly. What is your latest update and assessment oncoronavirus? I still am having a hard time seeing this as serious as everyoneelse. Am I blind? Yes very transmissible but low mortality like flu in manyways-the elderly , those with comorbidities, and total impact is likely to beless than flu. Also travel restrictions are delaying but not stopping virus.NIH-001360Am I missing something big or small?ThanksEzekiel J . Emanuel, M.D., Ph.D.Vice Provost for Global InitiativesDiane v.S. Levy and Robert M. Levy University Professo-r- --~= Chair, Department of Medical Ethics and Health Policy ( CbH~ 1111 ) --------Co-Director, Healthcare Transformation InstituteUniversity of PennsylvaniaPhone: Cb)(6)Fax: 215-898-6567NIH-001361From:Sent:To:(b)(6)Tue, 25 Feb 2020 13:04:40 -0500Cassetti, Cristina (NIH/NIAID) [E]Subject: Fwd: DDP4 Inhibitors and ACE2 Inhibitors :: Spike Protein Bind ing in MERS andSARSPlease bandle. ThanksBegin forwarded message:From: JoelMeyer (b) (6)Date: Februar y 25, 2020 at 12:32:24 PM E-S-T- ----=-c-= To: "Fauci , Anthony (NIH/NlAID ) [E]" (b)(Subject: DDP4 Inhibitors and ACE2 Inhibitors:: Spike Protein Binding inMERS and SARSDear Dr. Fauci,Is it possible that DDP4 and ACE2 inhibitors would be effective in preventingcoronavirus entry and thereby 'de-rail' the infectious cycle?Thank you for your work and guidance to NIAID!Sincerely,Joel R.L. Meyer(b)((b)(6)--------------------------------------------------------------------------------------https://www .ncbi.nlm.nih.gov/ pmc/articles/ PMC5891363/"Coronavirus entry is initiated by the binding of the spikeprotein (S) to cell receptors, specifically, dipeptidyl peptidase 4(DDP4) and angiotensin converting enzyme 2 (ACE2) for MERSCoVand SARS-CoV, respectively [1-5]"References1. Masters , PS., Perlman , S. Coronaviridae in Field's Virology. Knipe , OM.,Howley, PM., editors. Vol. 1. Lippincott, Williams &Wilkins; Philadelphia:2013. p. 825-858.2. Coleman CM, Frieman MB. Coronaviruses: important emerging humanpathogens. J Virol. 2014 ; 88:5209-5212 . [PubMed : 24600003]3. De Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS :recent insights into emergi ng coro naviruses. Nature Rev Microbiol. 2016;14:523-534. [PubMed : 27344959]NIH-001362NIH-0013634. Greenberg SB. Update on human rhinovirus and coronavirus infections.Sem Respir Crit Care Med. 2016 ; 37:555-571 .5. Vijay R, Perlman S. Middle East respiratory syndrome and severe acuterespiratory syndrome. Curr Opin Virol. 2016; 16:70-76 . [PubMed : 26855039)From: (b)(6)Sent:To:Subject:Tue, 25 Feb 2020 13:02:20 -0500Conrad, Patricia (NIH/NIAID) [E)Fwd: Doctor Radio followup specialPlease see if this is possible. ThanksBegin forwarded message:From: "Siege l, Marc" <Marc.Si ege l@nyulangone.org>Date: Februa ry 25, 2020 at 12:07: 19 PM- E-S-T- --~~ To: "Fauci, Anthony (NIH/NIAID) [E]" (b)(6J:Cc: "Conrad , Patricia (NIH/NIAID) [E]" (bH6J > , Beth Ameen<beth.ameen@siriusxm.com>Subject: Doctor Radio followup specialHi TonyAm wonde ring if you might have a few minute s to join us by phone again thisFriday between3 and 4 on coronavirusWould mean alot.MarcSent from my iPhoneNIH-001364From:Sent:Fauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 17:25:40 +0000To: Gary SimonCc: Graham, Barney (NIH/VRC) [E);Ledgerwood, Julie (NIH/NIAID) [E];'Chen, Grace(NIH/NIAID) [E)';Conrad, Patricia (NIH/N IAID) [E);Mascola, John (NIH/VRC) [E)Subject: RE: Coronavirus vaccineThanks, Garry. I will pass you r note on to the peop le who wil l be conduct ing thephase 1 vaccine tri al here at NIH.Best regards,TonyAnthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Gary Simon (b)(6)>sent: Tuesday, February 25, 2020 10:42 AM To: Fauci, Anthony (NIH/NIAID) [E)- _-_-_-_-_- ~~ C_Hb_6); Fauci, Anthony (NIH/N IAID) [E](b)(6)Subject: Coronavirus vaccineDear Tony,samples to NIH for immune assays.garyGary L. Simon, MD, PhD, MACPWalter G. Ross Profe ssor of Medici neNIH-001365Director, Division of Infectious DiseasesVice-Chairman, Department of Medicine(b)(6)F 202 741-2241Confidentiality Note: This e- mail is intended only for the person or entity to which itis addressed and may contain infor mation that is privileged, confidential orotherwise prote cted from disclosure. Disseminat ion, distri bution or copying of thise-mail or the informat ion herein by anyone other than the intended recipient, or anemployee or agent responsible for delivering the message to the intended recipient,is prohibit ed. If you have received this e-mail in error, please call (202) 741-3636and destroy the original message and all copies.NIH-001366From:Sent :To:Fauci, Anthony (NIH/NIAID) [E)Tue, 25 Feb 2020 17:15:43 +0000Cassetti, Cristina (NIH/NIAID) [E]Subject :variantsAttachments :FW: Collaboration proposal on --------------------------------=-- (b=)(4)Macrogen (Dr. Jeong-sun Seo) letter to Dr. Anthony Fauci.pdfPlease handle and res po nd to thi s person. Thanks.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b)(6)FAX : (301) 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinfo rmation. It should not be used by anyone who is not the original intended recipient. If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Ogan Gurel, MD (b)(6J>Sent : Tuesday, February 25, 2020 9:20 AM ------~~ To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)> _...;...;...;;.::::====~~-:'.'Cc: Jeongsun Seo MD PhD (b)(6); Changhoon Kim PhD(b)(6); Moon -Young Shin (b)(6) ---------- Subject : Collaboration proposal o --------------------- (b)(4 )Dear Dr. Fauci,Greetings and thank you for all your outstand ing scientific and policy leadership regarding the evolvingCovid-19 situation.I am writing to you from South Korea where, as you well know, we are experiencing a very difficultphase of the epidemic. Among the several groups I have been engaged with to address this crisis, I amwork ing with the genome sequencing company, Macrogen, which you may already be fami liar with(https ://dna.macrogen .com/eng /l . Dr. Jeongsun Seo, the Chairman of Macrogen, along with othercompany leaders and myself have been discussing (b)(4)(b) (4)NIH-001367(b) (4)Barring the institution of any extreme travel restrictions, I am planning to visit the Bethesda area nextweek (Macrogen U.S. HQ is located in Rockville). I know you are extraordinarily busy but if you (or keycolleagues) have time, I and other senior Macrogen colleagues would be happy to discuss the project, itsnecessary next steps, along with any other matters related to Korea as you wish. [Please note that I donot have any clinical symptoms or signs of Covid-19 nor any relevant contact history .]Thank you ve ry much for your attention to this matter and I hope that we may have a chance to advancethis important project together.Please take care and thanks again,Ogan(b)(6)m:hItt p ://www .linkedin.com/i n/ ogangurelNIH-001368From:Sent:To:Subject:Attachments :Let us discuss.Anthony S. Fauci , MDDirecto rFauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 17:08:19 +0000Eisinger, Robert (NIH/NIAID) [E];Greg FolkersF W: NEJM content proof {Fauci)N EJ Me2002387 _Fauci_ Content2_Author. pdfNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)(b)(6) ----------The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Laurencot, Elizabeth <elaurencot@nejm.org>Sent: Tuesday, February 25, 2020 8:51 AM ------~~ = To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)Subject: NEJM content proof (Fauci)Importance: HighDear Dr Fauci,Attached is the content proof of your editorial. Please read *ALL* of the following instructions andinformation carefully before you begin review ing your proofs.First, please stop and take a moment now to confirm receipt, so that we can be assured that yourproofs did not end up in a spam folder.Your editorial has been edited for grammar, consistency, readabi lity, adherence to Journal style, andclarity for nonspecialist readers. To expedite publication, we do not ask authors for specific approval ofroutine changes; please read the entire article to make sure your meaning has been retained . Note thatwe may be unable to make changes that conflict with Journal style or create grammat ical or otherproblems . Finally, please note that a delayed or incomplete response may delay publication of youreditorial.Please read the entire proof carefully, including all queries. Please return your query replies and proofcorrections **before 12pm (US Eastern) this Friday, February 28, 2020** .NIH-001369NIH-001370Instructions are provided below . Note that you wi ll be reading for content only; the article will berendered for print after the content has been finalized .The Journal' s senior medical editors will be reading your article at this stage. If they have any additionalcomments or queries for you, I wi ll forward them to you in the next few days.TO ANSWER THE QUERIES: The proof contains in-line numbered query markers and a numbered list ofqueries at the end. The query markers and the queries are linked, so you can jump back and forth withinthe file . Please respond to all the queries (see below for instructions ; please do ** NOT** use eannotationtoo ls) and convey any additional changes as needed.TO RESPOND BY E-MAIL: If your corrections and your responses to the queries are straightforward, weencourage you to respond by replying to this message. Please copy and paste the list of queries into ane-mail message or a Word document and type your responses there. You may also include a list ofchanges (e.g., page 1, line 20, change xxx to yyy). Again, please do ** NOT** use e-annotation tools inthe PDF file; the marks are small and easy to miss, which may lead to errors in your article .Please note that this material is confidential and embargoed until publication. If you have questionsabout our embargo policy, please contact NEJM Media Relations at 781-434-7847 or atMed iasupport@nejm.org .Again, please do confirm receipt at this time . Thank you very much for your efforts with these contentproofs!Best,EliElizabeth Lauren~otSenior Manuscript EditorNew England Journal of Medicine617-487 -6547elaurencot@nejm .orgTO READ THE PROOF: You will need Adobe Acrobat Reader software (version 4.0 or later) to view thisfile . Acrobat Reader is available free of charge at the Adobe Web site(http://www .adobe.com/products/acrobat/readerma in.htm l ).NIH-001371This email message is a private communication. The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privi leged,and/or proprietary material. Any review, duplication, retransmission, distribution, or ot her use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited . If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.From: Fauci, Anthony (NIH/NIAIO) [E)Sent: Tue, 25 Feb 2020 17:07:30 +0000To: Eisinger, Robert (NIH/NIAID) [E];Greg Folkers ----------- (b)(6)Subject: F W: NEJM content proof {Fauci)Attachments : N EJ Me2002387 _Fauci_ Content2_Author. pdfPlease tak e a look at this for me and proof to th e extent th at you ca n. Thank s.Anthony S. Fauci , MDDirecto rNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Laurencot, Elizabeth <elaurencot@nejm.org>Sent : Tuesday, February 25, 2020 8:51 AM ------~= To: Fauci, Anthony (NIH/NIAID) [E] (b)(6)>Subject: NEJM content proof (Fauci)Importance: HighDear Dr Fauci,Attached is the content proof of your editorial. Please read *ALL*o f the following instructions andinformation carefully before you begin review ing your proofs.First, please stop and take a moment now to confirm receipt, so that we can be assured that yourproofs did not end up in a spam folder.Your editorial has been edited for grammar, consistency, readab ility, adherence to Journal style, andclarity for nonspecialist readers. To expedite publication, we do not ask authors for specific approval ofroutine changes; please read the entire article to make sure your meaning has been retained . Note thatwe may be unable to make changes that conflict with Journal style or create grammat ical or otherproblems . Finally, please note that a delayed or incomplete response may delay publication of youreditorial.Please read the entire proof carefully, including all queries. Please return your query replies and proofcorrections * * before 12pm (US Eastern) this Friday, February 28, 2020** .NIH-001372NIH-001373Instructions are provided below . Note that you wi ll be reading for content only; the article will berendered for print after the content has been finalized .The Journal' s senior medical editors will be reading your article at this stage. If they have any additionalcomments or queries for you, I wi ll forward them to you in the next few days.TO ANSWER THE QUERIES: The proof contains in-line numbered query markers and a numbered list ofqueries at the end. The query markers and the queries are linked, so you can jump back and forth withinthe file . Please respond to all the queries (see below for instructions ; please do ** NOT** use eannotationtoo ls) and convey any additional changes as needed.TO RESPOND BY E-MAIL: If your corrections and your responses to the queries are straightforward, weencourage you to respond by replying to this message. Please copy and paste the list of queries into ane-mail message or a Word document and type your responses there. You may also include a list ofchanges (e.g., page 1, line 20, change xxx to yyy). Again, please do ** NOT** use e-annotation tools inthe PDF file; the marks are small and easy to miss, which may lead to errors in your article .Please note that this material is confidential and embargoed until publication. If you have questionsabout our embargo policy, please contact NEJM Media Relations at 781-434-7847 or atMed iasupport@nejm.org .Again, please do confirm receipt at this time . Thank you very much for your efforts with these contentproofs!Best,EliElizabeth Lauren~otSenior Manuscript EditorNew England Journal of Medicine617-487 -6547elaurencot@nejm .orgTO READ THE PROOF: You will need Adobe Acrobat Reader software (version 4.0 or later) to view thisfile . Acrobat Reader is available free of charge at the Adobe Web site(http://www .adobe.com/products/acrobat/readerma in.htm l ).NIH-001374This email message is a private communication. The information transmitted, including attachments, isintended only for the person or entity to which it is addressed and may contain confidential, privi leged,and/or proprietary material. Any review, duplication, retransmission, distribution, or ot her use of, ortaking of any action in reliance upon, this information by persons or entities other than the intendedrecipient is unauthorized by the sender and is prohibited . If you have received this message in error,please contact the sender immediately by return email and delete the original message from allcomputer systems. Thank you.From:Sent :To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 15:55:19 +0000Barasch, Kimberly (NIH/NIAID) [C]Subject :Attachments :FW: The global health leaders call, Wednesday 26 February at 13:00 CET(b)(4)Swisscom Call code.pdfPlease print out for tomorrow AM.Anthony S. Fauci , MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive, MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX : (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sen sitiveinformation . It should not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender's own and not expressly made onbehalf of the NIAID by one of its representatives .From: RYAN, Michael J. ------- (b)(6)Sent : Tuesday, February 25, 2020 4:10 AMTo: Redfield, Robert R. (CDC/OD)--------------------~~(b)(6) Chris.Elias ===================-~ (b)(6); Jeremy FarrarCb()6 ) Fauci, Anthony(b)(6)Conrad, Patricia (NIH/NIAID) [E](b)(6)------- >; Lynn Banks (b)(6); President I Resolve to Save Lives<president@resolvetosavelives.org> __________________ C_)b_(6)Tarik Mohammed ------------ Cc: SHOC <shoc@who.int>; Office of the Director-General <DGOffice@who .int>; SCHWARTLANDER,Bernhard F. CbH6l>M; AHJOUR, Jaouad (b)( ·>; FALL, lbra hima Soce(b)( >; GREIN, Thomas (b)(6); MI NHAS, Raman (b)(6):>; COX, PaulMichael (b)(6); AL-SHORBAJI,F arah CbH6.>J; POOLE, Marcia::=====(~b)(6~) ·> ; DRURY,P atrick Anthony (b)(6J,.>; GRAAFF,P eter Jan ------- (b)( ; Dr VAN KERKHOVE,M ar ia (b)(6J:>; KABIR, SophiaNIH-001375(b)(6)Subject: The global health leaders call, Wednesday 26 February at 13:00 CETDear colleagues,Dr Tedros would like to invite you to the next informal discussion about the ongoing 2019 novelcoronavirus .The teleconference will be hosted tomorrow Wednesday, 26 February at 13:00 CET and the dial- innumber with a passcode is attached.If you experience any technical difficulties joining this conference call, please contact the WHO HQ EOCoperator at: +41227912490It would be appreciated if you could kindly confirm your participation to Ms Sophia Kabir, email:------ (b)(6); mobi le no. (b)(6)Best,MikeNIH-001376From: (b)(6)Sent:To:Subject:Tue, 25 Feb 2020 07:30:31 -0500Conrad, Patricia (NIH/NIAID) [E)Fwd: Bloomberg Radio 2/25Let us discussBegin forwarded message:From: "Jameelah D Robinson (BLOOMBERG / NEWSROOM:)"<jrobinsonl58@b loomberg .net>Date: February 25, 2020 at 7:25:43 AM ESTTo: "NIAID NEWS (NIH/NIAID)" <NIAIDNEWS@nia id .nih.gov>Cc: "Fauci, Anthony (NIH/NIAID) [E]" (b)(6) 1.Subject: Bloomberg Radio 2/25Reply-To: "Jameelah D Robinson" <jrobinson158@bloomberg.net>Hi Dr. Fauci!I Hope this email finds you well. I'm emailing to see if you can join Tom Keene , BloombergSuveillance Anchor/Editor-at-Large on his radio show tomorrow morning as a PHONER at8:15am Et to discuss the Coronavirus. Please let me know if we can make this happen.Many thanks!-JameelahNIH-001377From:Sent:To:Subject:Fauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 03:27:11 +0000Conrad, Patricia (NIH/NIAID) [E)FW: NIAF and coronavirusLet us discuss.From: Elvis Oxley <eoxley@bdo.com>Sent: Monday, February 24, 2020 9:42 PMTo: Fauci, Anthony (NIH/NIAID) [E]-------= (b-)c(c-6=)Cc: Eric Jia-Sobota <esobota@bdo.com>Subject: NIAF and coronavirusDr. Fauci, I trust this email finds you well. It has been a few years since we've seen one anotheron the Hill or at a NIAF event but hopefully we will rectify that soon.I know you have a lot on your plat e, especially with the coronavirus, but I am curious if you havefive minutes for a call tomorrow so I can introduce you to my boss at BDO, Eric Jia-Soboda(https://www.linkedin .com/in/ eric-jia-sobota -02156036/ ). Eric is an expert in cost accountingfor Life Sciences companies and he wants to glean your perspect ive on the likely structure of theemergency coronavi rus budget request so that NIH and others can maximize those research andimplementation dollars at the most rapid pace. We would certainly appreciate your time.My best, ElvisElvis OxleyManaging DirectorIndustry Specialty Services-----(b)(6)( Mobile) 703-245-8665 (Direct)eoxley@bdo.comBOOGreater Washington D.C.8401 Greensboro Drive, Suite 800McLean, VA 22102www.bdo.comBDO USA, LLP, a Delaware limited liability partnership, is the U.S. member of BDO International Limited, a UKcompany limited by guarantee , and forms part of the international BDO network of independent member firms.BDO is the brand name for the BDO network and for each of the BDO Member Firms.IMPORTANT NOTICESThe contents of this email and any attachments to it may contain privileged and confidential information fromNIH-001383NIH-001384BOO USA, LLP. This information is only for the viewing or use of the intended recipient. If you are not theintended recipient, you are hereby notified that any disclosure, copying, distribution or use ot or the taking ofany action in reliance upon, the information contained in this e-mail, or any of the attachments to this e-mail, isstrictly prohibited and that this e-mail and all of the attachments to this e-mail, if any, must be immediatelyreturned to BOO USA, LLP or destroyed and, in either case, this e-mail and all attachments to this e-mail must beimmediately deleted from your computer without making any copies hereof. If you have received this e-mail inerror, please notify BOO USA, LLP by e-mail immediately.From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Tue, 25 Feb 2020 03:26:06 +0000Tabak, Lawrence (NIH/OD) [E)Subject: RE: Close of Day Note for 2/24/2020 re: coronavirus preparednessNo, I did not see this. You should tell Jim Gillman to copy me on everything that relates to thisissue since I am the one who will be dealing with the Congress, the President and the pressabout all of this.From: Tabak, Lawrence (NIH/OD) [El --------- (b)(6) Sent: Monday, February 24, 2020 9:4-1- P-M- ---,;-, = To: Fauci, Anthony (NIH/NIAID) (E] (b)(6)>Subject: FW: Close of Day Note for 2/24/2020 re: coronavirus preparednessTony,I assume you have already seen this, but just in case ....LarryFrom: "Gilman, James (NIH/CC/OD) [E]" CbH6)>Date: Monday , February 24, 2020 at 5:50 PM --------~~ To: "Tabak, Lawrence (NIH/OD) [El" CbH >, Francis Collins-------- CbH6)," Gottesman, Michael (NIH/OD) [El" CbH > Subject: Close of Day Note for 2/24/2020 re : coronavirus preparednessFrancis/ Larry/ Michael:NIH-001385(b)(5)(b) (5)JimNIH-001386From:Sent :To:Subject :Let us discuss.Fauci, Anthony (NIH/NIAID) [E)Mon, 24 Feb 2020 23:38:09 +0000Conrad, Patricia (NIH/NIAID) [E)FW: LA Magazine/ Interv iew requestFrom: jmcgahan (b) (6lSent : Monday, February 24, 2020 6-:0-3- P-M- - ::;..,..-,= To: Fauci, Anthony (NIH/NIAID) [E] -------- (b)(6)1> Subject : LA Magazine/ Interview requestDear Dr. Fauci,You and I haven't met. I'm a long-time writer for Los Angeles Magazine. We're doing a cover story forthe April issue on the threat of the new coronavirus poses to the 10 mill ion inhabitants of metropolitanLos Angeles. Would you be available for an interview on Wednesday?Thanks,JasonNIH-001387From:Sent:To:Fauci, Anthony (NIH/NIAIO) [E)Mon, 24 Feb 2020 22:42:57 +0000Conrad, Patricia (NIH/NIAID) [E)Subject: FW: Welcome packet & consent form I The Coronavirus Outbreak: TrackingCOVID-19 I ForumAttachments:room agenda .pdf3.2.20 Consent form .pdf, 3.2.20 Forum welcome document .pdf, 3.2.20 GreenLet us discuss.Anthony S. Fauci, MDDirectorNational Institute of Allergy and Infectious DiseasesBuilding 31, Room 7A-0331 Center Drive , MSC 2520National Institutes of HealthBethesda , MD 20892-2520Phone : (b) (6)FAX: (301 496-4409E-mail : (b)(6)The information in this e-mail and any of its attachments is confidential and may contain sensitiveinformation . It shou ld not be used by anyone who is not the original intended recipient . If youhave received this e-mail in error please inform the sender and delete it from your mailbox or anyother storage devices . The National Institute of Allergy and Infectious Diseases (NIAID) shall notaccept liability for any statements made that are the sender 's own and not expressly made onbehalf of the NIAID by one of its representatives .From: Dweck, Kristen <kdweck@hsph.harvard .edu>Sent : Monday, February 24, 2020 5:34 PMTo: (b)(6) Lipsitch, Marc (b)(6) ----:----========~~------ ""-""".""".---:-:=======~ Yip, Winnie Chi-Man >; Fauci, Anthony {NIH/NIAID) [E] _______ CbH_6)Cc: (b)(6)Osborn, Elizabeth (b)(6)>; Conrad, Patricia,(;N._. IH;/_N_I_AI_D.): ...[:E..~.) ===~:--:--:-:-- (_b)~(6)>; Barasch, Kimberly (NIH/N IAID) [CJ(b)(6) ; Folkers, Greg (NIH/NIAID) [E] (b)(6) •>; Lerner, Andrea.(. N- 1-H-/:N-- I_AI.D ..~ ) "[E."~)" =' ==~:.:..._-- (~b)~(6) --------- Subject: Welcome packet & consent form I The Coronavirus Outbreak : Tracking COVID-19 I ForumImp ortance: HighGood evening ,Please find attached , The Forum welcome document , green room agenda and consent form .The welcome packet includes information about our production along with what to wear while on camera. TheHarv ard T.H. Chan School of Public Health consent form is required for productio n ofwebcast series.Please sign and scan a copy of the consent fonn back by March 2, 202 0.We look forward to an excit ing event!NIH-001388NIH-001389Best,Kristen DweckKristen A. DweckDigital Media and Engagement Manager, The Leadership StudioHarvard T.H. Chan School of Public Health677 Huntington Avenue, Kresge 329 I Boston, MA 02115o: 617-432-1268 I f: 617-432-1780kdweck@hsph. harvard . edu~ HARVARD SCHOOLO F PUBLICH EALTH~ T.H.CHANJoin the conversation:The Forum I Twitter I YouTube I iPhone and iPadFrom :Sent :To:Subj ect :Fauci, Anthony (NIH/NIAIO) [E)